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Chronic obstructive pulmonary disease (COPD) in the horse is caused by exposure of
susceptible animals to dust and aeroallergens in poorly saved hay and straw. It is
characterized by recurrent episodes of airway obstruction in association with
neutrophilic pulmonary inflammation. As neutrophils have the capacity to secrete a
wide array of potentially histotoxic products such as reactive oxygen species,
proteases and cationic proteins, these cells have been proposed to be key mediators
of the lung injury observed in COPD. The functional status of neutrophils within
both the circulating granulocyte pool and the airways of horses with COPD remains
largely unexplored. Likewise, little is known of the kinetics of airspace neutrophil
recruitment and clearance during and after an acute episode of COPD or indeed the
subsequent fate of these cells.
I have demonstrated in vitro that isolated peripheral blood neutrophils may be primed
by exposure to inflammatory mediators such as lipopolysaccharide, platelet
activating factor and tumour necrosis factor-a. This results in enhanced respiratory
burst activity upon subsequent exposure to secretagogue stimuli. Indeed, priming
was found to be a necessary step in the induction of functional coupling of receptors
for the bacterial peptide fMLP in equine neutrophils.
I have also demonstrated that purified peripheral blood neutrophils undergo
apoptosis constitutively when aged in vitro and that the rate of apoptosis can be
modulated by exposure to a range of pro-inflammatory mediators. In other models
of neutrophilic inflammation, cells that have undergone apoptosis have been shown
to be recognized by phagocytes such as inflammatory macrophages, engulfed and
degraded without inciting an inflammatory response.
Acute COPD was induced in susceptible horses by exposure to a 5 h hay/straw
challenge. The kinetics and function of airspace neutrophils harvested by
bronchoalveolar lavage and peripheral blood neutrophils was monitored sequentially
for 14 days after challenge. Hay/straw challenge primed both peripheral blood and
airspace neutrophils for an enhanced secretagogue-induced respiratory burst.
Significant degranulation of neutrophils occurred within the airspaces as evidenced
iii
by a marked increase in neutrophil elastase in bronchoalveolar lavage fluid. As the
pulmonary inflammation resolved, airspace neutrophils underwent apoptosis and
were phagocytosed by alveolar macrophages in vivo. This work demonstrates
significant upregulation of neutrophil function in horses with COPD and provides
evidence of a pivotal role for neutrophil apoptosis in the resolution of the pulmonary
neutrophil burden in this disease.
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1.1 EQUINE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
Since man first domesticated the horse, moving it from its traditional range habitat,
an association has been recognized between the development of chronic pulmonary
disease and the feeding of dried forage in dusty stabling conditions. Indeed this is
not solely an affliction of the modern-day domesticated horse; a similar disorder
having been observed in zebras and Przewalskii wild horses when confined in zoos
(Beech, 1991). The syndrome of coughing, nasal discharge, exercise intolerance and
respiratory embarrassment has been known to both the equine fraternity and the
veterinary profession by a succession of pseudonyms; "hay sickness", "broken
wind", "alveolar emphysema", "heaves", "chronic bronchiolitis", "chronic small
airway disease", "chronic obstructive pulmonary disease" (COPD) and "recurrent
airway obstruction" (RAO). Since Sasse (1971) first introduced the term COPD to
describe horses with this syndrome, it has remained in common usage in Europe and
will be used throughout this thesis.
Given the similarity of the presenting clinical picture in many chronic equine lung
diseases and the necessity for comparison of data with other laboratories it is
important to clearly define, at the outset, the criteria for the diagnosis of COPD in the
horses studied in these investigations.
Horses were defined as suffering from COPD if they had a history (> 6 months) of
recurrent episodes of pulmonary disease, consistently induced by exposure to hay
and/or straw and characterized by clinical signs of airway obstruction, disruption of
pulmonary gas exchange (manifested by arterial hypoxaemia) and the presence of
increased numbers of bronchoalveolar neutrophils (> 5% neutrophils in
bronchoalveolar lavage fluid, BALF). Moreover, horses entered complete remission
from disease following their removal from a provocative environment containing hay
and/or straw to pasture or to a "controlled" environment (q.v.) in a well-ventilated
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stable, bedded on wood shavings and fed dust-free haylage. Horses which had a
history of developing obstructive pulmonary disease whilst at pasture during the
summer months, so-called summer pasture associated obstructive pulmonary disease
(Dixon and McGorum, 1990) were excluded from the study whether they satisfied
the preceding criteria or not.
1.1.1 EPIDEMIOLOGY OF EQUINE COPD
In the Northern Hemisphere, COPD is the most commonly recognized chronic
pulmonary disease of the horse (McPherson and Thomson, 1983) and in some
northern European countries is thought to be the primary cause of premature loss
through disease (Gerber, 1973). A recent retrospective study of 300 clinical cases of
pulmonary disease examined at The University of Edinburgh identified 54.8% of
horses as suffering from COPD (Dixon et al., 1995b). The recorded incidence of
COPD, although likely to be influenced by both local management practices and the
diagnostic criteria employed, has been reported to be as high as 54% and even 79%
amongst some horse populations in Switzerland (Bracher el al., 1991) and the
Netherlands (Sasse el al., 1985), respectively.
COPD is generally recognized in middle-aged to older horses and the incidence
increases with age (Naylor el al., 1992; Dixon et al., 1995b; Ainsworth, 1999). No
apparent sex or breed predilection has been observed (McPherson and Thomson,
1983; Beech, 1991).
1.1.2 CLINICAL MANIFESTATIONS OF DISEASE
The presenting clinical history and signs in COPD-affected horses can be highly
variable depending upon the severity and stage of disease and the level of exposure
of susceptible horses to airborne antigens and stable dust. Moreover, both the
diagnostic criteria and the sensitivity and specificity of diagnostic aids employed by
an individual clinician will affect the diagnosis rate. When in complete remission
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COPD-susceptible horses are clinically normal and indistinguishable from healthy
animals.
Coughing, mucopurulent nasal discharge, decreased exercise tolerance and
prolonged post-exercise dyspnoea may be detected in mildly affected animals
(McPherson et al., 1978; Beech, 1991; Naylor et al., 1992; Dixon et al., 1995b).
More severely affected cases exhibit tachypnoea and increasing degrees of dyspnoea
("heaves") at rest, often with a markedly increased expiratory effort necessitating
recruitment of the abdominal muscles (so-called double expiratory effort) which in
longstanding severely affected animals results in hypertrophy of the external
abdominal oblique muscles producing a characteristic "heave line". Such animals
may also show nostril flaring and anal pumping with breathing (Beech, 1991; Naylor
et al., 1992).
Abnormal respiratory sounds are detectable at rest on auscultation of the trachea at
the thoracic inlet (discontinuous fluid sounds) and the lung fields (inspiratory and
expiratory crackles and wheezes) in 50-70% of affected horses and such sounds are
more consistently detected (90%) during induced (by temporary nasal occlusion or
with a rebreathing bag) hyperpnoea (Naylor et al., 1992; Dixon et al., 1995b).
1.1.3 AETIOLOGY OF EQUINE COPD
COPD is an environmental lung disease. The development of pulmonary
hypersensitivity to inhaled material can almost be regarded as an occupational hazard
of the housed, domesticated equid. Indeed movement of affected animals to a "clean
air" environment either at pasture or stabled in a "controlled" environment (q.v.)
results in complete clinical remission (Thomson and McPherson, 1984; Derksen et
al., 1985a; Derksen et al., 1985b; McGorum et al., 1993d). Studies of stable
aerobiology have identified a plethora of materials that could be inhaled, such as
bacteria and their component endotoxins, fungal components (including spores,
hyphae and mycotoxins), noxious gases (e.g. ammonia and hydrogen sulphide),
forage mites, animal-derived material (e.g. hair and faeces) and plant fragments
(Clarke, 1987; Woods et al, 1993; McGorum et al., 1998). Spores of the
approximately 70 species of moulds and actinomycetes that are the main constituents
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of hay dust are of sufficiently small diameter (<5pm) to be respirable into the distal
small airways and alveoli (Clarke, 1987).
Specific antigen inhalation challenges (McPherson et al., 1979; Derksen et al., 1988;
McGorum et al., 1993d), intradermal antigen testing (Eyre, 1972; Halliwell et al.,
1979; McPherson et al., 1979; Evans et al., 1992), detection of serum precipitins
(Madelin et al., 1991), local pulmonary production of specific IgE and IgG
(Halliwell et al., 1993; Schmallenbach et al., 1998) and positive Prausnitz-Kiistner
passive cutaneous anaphylactic reactions and positive in vitro Schultz-Dale
anaphylactic reactions (Eyre, 1972) suggest that equine COPD is a pulmonary
hypersensitivity to inhaled mould antigens. Inhalation challenge with extracts of the
fungus Aspergillus fumigatus or the thermophilic actinomycete Faenia rectivirgula
induced pulmonary dysfunction and BALF neutrophilia in COPD-susceptible horses
but not control (non-COPD) animals (McPherson et al., 1979; Derksen et al., 1988;
McGorum et al., 1993d). Although the results of intradermal antigen testing and
measurement of serum precipitins to mould antigens did not reliably differentiate
COPD-susceptible and non-hypersensitive animals, COPD-affected horses did have a
greater percentage of positive skin reactions (Halliwell et al., 1979; Evans et al.,
1992; McGorum et al., 1993a).
Despite the aforementioned evidence specifically implicating hypersensitivity to
certain mould spores (Derksen et al., 1988; McGorum et al., 1993d), the exact range
of antigens involved remains unknown. Moreover, the pulmonary response to
inhalation of individual mould extracts (e.g. Aspergillus fumigatus, Faenia
rectivirgula) was substantially less than following "natural'' hay/straw challenge
(McGorum et al., 1993d), suggesting that other inhaled agents contribute to the
"natural" disease. Indeed, other important components of stable dust such as
endotoxin (McGorum et al., 1998) may act as non-specific irritants or toxins (Clapp
et al., 1994; Pirie et al., 1998) to enhance the response to mould antigens.
The stimuli for development of pulmonary hypersensitivity are unknown but
preceding viral infection (Gerber, 1973; McPherson and Lawson, 1974; Halliwell el
al., 1993) and an underlying genetic predisposition, as inferred from progeny testing
of two COPD-susceptible stallions (Marti et al., 1991), have been suggested.
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1.1.4 PATHOLOGY OF EQUINE COPD
Although a number of post-mortem studies have reported the gross, histopathological
and ultrastructural changes in mild, moderate and severe cases with active disease,
little comparative data from clearly defined asymptomatic, clinically diseased and
horses entering clinical remission is available.
Grossly, the lungs of asymptomatic and mildly affected animals appear normal. In
severely affected cases the lungs may fail to collapse upon opening the thorax due to
air trapping in the airways (Nicholls, 1978). This finding led early investigators to
erroneously conclude that these animals had emphysema (Gillespie and Tyler, 1969;
Gerber, 1973).
Pathological changes in the large, conducting airways are restricted to focal areas of
goblet and epithelial cell hyperplasia with loss and malformation of ciliated cells.
These bronchial changes correlated poorly with clinical disease and were considered
to be non-specific and of minor importance (Kaup et al., 1990b).
Pathology of the small airways and alveoli, although focal, is widely distributed
throughout the lungs and correlates well with the severity of clinical disease (Kaup et
al., 1990a; Nyman et al., 1991; Naylor el al., 1992). The consistent feature is that of
a neutrophilic bronchiolitis with an inflammatory exudate and excess mucus in
airway lumina and associated reactive changes in adjacent alveoli (Nicholls, 1978;
Winder and Von Fellenberg, 1988; Kaup et al., 1990a). Other bronchiolar features
include epithelial and goblet cell hyperplasia and metaplasia, Clara cell degranulation
and degeneration, peribronchiolar infiltration with monocytes, lymphocytes, mast
cells and plasma cells and fibrosis, airway smooth muscle hypertrophy and
perivascular plasma-lymphocytic cuffing (Nicholls, 1978; Winder and Von
Fellenberg, 1988; Kaup et al, 1990a; Nyman et al., 1991). Small airway
morphometry in acutely diseased animals confirmed increases in airway epithelial,
smooth muscle and total wall thickness (Broadstone et al., 1997). The above
changes lead to bronchiolar narrowing and mucus plugging of the small airways.
Alveolar changes including increased numbers of Kohn's pores, necrosis of type I
and transformation of type II epithelial cells, alveolar fibrosis and alveolar
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hyperinflation are focal and inconsistent, even in severely affected cases. Alveolar
emphysema is rare (Nicholls, 1978; Kaup et al., 1990a; Nyman et al., 1991).
Two recent in vivo studies provide preliminary insights into the functional pathology
of airway cells and extracellular matrix during episodes of equine COPD. Firstly,
Votion and Colleagues (1999) reported increased alveolar clearance consistent with
alveolar epithelial cell injury following exposure of COPD-susceptible horses to a
hay/straw challenge. Secondly, a 7-fold increase in the concentration of the
extracellular matrix polysaccharide, hyaluronate, in the tracheal lavage fluid of
COPD-affected horses in comparison to healthy controls was hypothesised to reflect
pathological remodelling of peribronchiolar connective tissue (Tulamo and Maisi,
1997).
The overall picture is one of limited irreversible structural lung pathology. This is
supported by the work of Naylor and colleagues (1992), who reported that the
severity of clinical signs was best correlated with the degree of bronchiolar
neutrophil infiltration and goblet cell metaplasia (potentially reversible features) in
percutaneous lung biopsies. The absence of significant permanent lung pathology is
also indicated by the recognition that, with appropriate management, many affected
horses may achieve full clinical remission (Thomson and McPherson, 1984; Dixon et
al., 1995d).
1.1.5 PATHOGENESIS OF EQUINE COPD
The increased concentrations of mould-specific immunoglobulins (Section 1.1.3) and
numbers of B lymphocytes (McGorum et al., 1993b; Watson et al., 1997; Rush et al.,
1998a) in BALF, increased levels of both free and lung parenchymal cell-associated
immunoreactive IgA and IgG(Fc) (Winder and Von Fellenberg, 1988) and localised
alveolar mast cell infiltration (Kaup et al., 1990a) in COPD-susceptible horses
support an immunological or allergic basis to the pulmonary hypersensitivity.
However, the absence of early signs of airway obstruction and the presence of a
delayed (3-5 h) inflammatory response following hay/straw challenge are suggestive
of a delayed, probably Type III, hypersensitivity response (McGorum et al., 1993c;
Robinson et al., 1996).
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The two cardinal and complimentary features of equine COPD are airway
inflammation and bronchoconstriction (Derksen, 1993; Robinson et al., 1996). Both
responses are likely to be initiated and interconnected by a complex array of
inflammatory mediators. The roles of inflammatory cells and mediators and their
associations with airway smooth muscle function in equine COPD will be reviewed.
1.1.5.1 Inflammatory cells
Increased neutrophil numbers in the tracheal secretions and/or BALF of affected
horses is the hallmark of the cellular inflammatory response in both clinical and
experimental studies of equine COPD (Nuytten et al., 1983; Derksen et al., 1985b;
Bracher et al., 1991;Vrins et al., 1991;Naylor et al., 1992;McGorum et al., 1993d;
Dixon et al., 1995c). The structure and function of neutrophils and their potential to
cause host tissue injury are discussed later. The kinetics and function of airspace
neutrophils in lung inflammation are reviewed in detail in Chapter 6.
The initiation of pulmonary inflammation in COPD-susceptible horses represents a
specific immune-mediated response to inhaled antigens rather than a non-specific
response to airborne irritants or toxins (McGorum et al., 1993d). Subsequent
neutrophil recruitment is probably orchestrated by chemoattractant cytokines,
eicosanoids and other lipid mediators (e.g. platelet activating factor, PAF) derived
from airway epithelial cells and resident lymphocytes, macrophages and mast cells
(Shelhamer et al., 1995; Lukacs et al., 1996).
The Th2 cytokine phenotype subset of CD4+ T-helper lymphocytes appears to
mediate and maintain airway inflammation in human atopic asthma (Lukacs et al.,
1996). CD4+ T-cells are also recruited to the lungs of COPD-susceptible horses
following exposure to hay and straw (McGorum et al., 1993b; Rush et al., 1998a)
and thus may mediate neutrophil maturation, recruitment and function in this disease.
The kinetics and cytokine profiles of pulmonary lymphocyte subsets in equine COPD
warrants urgent attention.
Although interest has focussed on airspace neutrophils as the key mediators of
pulmonary inflammation in COPD, resident alveolar macrophages may be critically
important throughout the genesis, amplification and mediation of lung injury and not
least in the resolution of this inflammation. Alveolar macrophages may recognize
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and phagocytose inhaled particles by both non-specific and specific immune
mechanisms via Fc, complement and IgE receptors (Rankin, 1989). Of note, mould
spores can directly stimulate pro-inflammatory chemokine (e.g. Interleukin (IL)-8,
macrophage inflammatory protein 1, MIP-1 and tumour necrosis factor-a, TNF-a)
synthesis and release (Rankin, 1989; Shahan et al., 1998) and superoxide anion
generation (Shahan et al., 1994) in rat alveolar macrophages. Stimulation of equine
alveolar macrophages with lipopolysaccharide (LPS) induces synthesis of the potent
neutrophil chemoattractants IL-8 and MIP-1 (Franchini et al., 1998). Equine
alveolar macrophages produce procoagulant activity in vitro (Grunig et al., 1988),
whose levels in tracheal secretions correlated well with the severity of chronic lung
disease (Grunig et al., 1988). Furthermore, secretion of reactive oxygen species
(ROS) and proteolytic enzymes by macrophages can induce both direct lung cell
injury and mucus hypersecretion (Rankin, 1989; Sibille and Reynolds, 1990; Pittet et
al., 1997). The role of alveolar macrophages in the resolution of lung inflammation
is discussed in detail in Chapter 6.
Mast cells may play a role in equine COPD through the release of cytokines
(Shelhamer et al., 1995) and histamine (Hare et al., 1999). Although both peripheral
blood basophils (Dirscherl et al., 1993) and pulmonary mast cells (Hare et al., 1999)
from COPD-susceptible horses release greater amount of histamine than cells from
normal animals when exposed to mould extracts in vitro, histamine levels are only
increased in BALF 5 h after hay/straw challenge (McGorum et al., 1993c). As
pulmonary neutrophil recruitment and airway obstruction are already well
established by this time (Fairbairn et al., 1993), the pathogenetic role of mast cell
products remains unclear.
The importance of bronchial epithelial cell-derived cytokines (e.g. IL-8 and
granulocyte-macrophage colony stimulating factor, GM-CSF) in the recruitment
(Shelhamer et al., 1995) and functional modulation (Cox et al., 1992) of airspace
neutrophils has received little attention in the horse and is likely to have been greatly
underestimated.
In contrast to allergic asthma in humans (Lukacs et al., 1996), eosinophils appear to
have no role in equine COPD (McGorum et al., 1993d; Robinson et al., 1996).
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1.1.5.2 Inflammatory mediators
Largely due to a lack of well-characterized immunological reagents, the mediators
involved in equine COPD have to date received little attention. Notable exceptions
are arachidonic acid-derived lipid mediators because commercially available human
radioimmunoassay kits for many are highly cross-reactive with the equivalent equine
molecules (Gray et al., 1989; Watson et al., 1992).
Increased concentrations of prostaglandin E2 and F2a in BALF (Watson et al., 1992)
and thromboxane B2 (Gray et al., 1989) and 15-hydroxyeicosatetranoic acid (15-
HETE) (Gray et al., 1992a) in plasma of COPD-susceptible horses following
hay/straw challenge indicates activation of the arachidonic acid cascade. However,
despite abrogating the thromboxane B2 response, the failure of a cyclooxygenase
inhibitor to reduce airway obstruction following challenge suggested that cyclo¬
oxygenase products were of minor importance in equine COPD (Gray et al., 1989).
Although BALF levels of the anti-inflammatory mediators prostaglandin E2 and 15-
HETE are increased after challenge, local airway mucosal production of
prostaglandin E2 is significantly reduced (Gray et al., 1992b), suggesting that a lack
of inhibitory prostanoid function may facilitate airway inflammation.
The cysteinyl leukotrienes (LTs), LTC4, LTD4 and LTE4 contract airway smooth
muscle, induce vasodilatation and mucus secretion and increase vascular
permeability potentially facilitating leucocyte migration. Leukotriene B4 potently
stimulates neutrophil chemotaxis (Busse, 1998). Some in vivo evidence suggests
involvement of these products of the 5-lipoxygenase pathway of arachidonic acid
metabolism in equine COPD. Doucet et al. (1991) found increased levels of LTE4 in
urine from horses with COPD, but concentrations of LTB4 and C4 in BALF were no
different to control animals (Watson et al., 1992). Inhalation of LTD4 and B4 in
normal horses caused bronchoconstriction and pulmonary neutrophil recruitment,
respectively, but the responses of asymptomatic COPD-susceptible horses were
highly variable (Marr et al., 1998b). However, pre-treatment with a 5-lipoxygenase
inhibitor did reduce airway obstruction in 2 of 6 COPD-susceptible horses after
hay/straw challenge (Marr et al., 1998a).
Although intravenously administered PAF causes transitory lung dysfunction and
pulmonary neutrophil retention in both COPD-susceptible and normal horses
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(Fairbairn et al., 1996), pre-treatment with a PAF-receptor antagonist had no effect
on either neutrophil recruitment or lung dysfunction when COPD-susceptible
animals were challenged (Marr et al., 1996b).
As discussed in Section 1.1.5.1, the role of histamine in the pulmonary response to
hay/straw challenge is unclear, but the poor response of clinical COPD cases to anti¬
histamine therapy would suggest that it is of minor significance (Beech, 1991).
The local pulmonary cytokine network is likely to play a central role in the
pathogenesis of airway inflammation in equine COPD (Shelhamer el al., 1995;
Lukacs et al., 1996) but the current paucity of such reagents for the horse have
hampered progress in this field.
Respiratory tract secretions from COPD-affected horses contain elevated levels of
proteolytic activity, especially collagenase (matrix metalloproteinase, MMP-8) and
gelatinase (MMP-2 and MMP-9) activity (Koivunen et al., 1996; Koivunen et al.,
1997a; Koivunen et al., 1997b). These are most likely of neutrophil and/or
macrophage origin and may have a causal relationship with mucus hypersecretion,
lung injury and the amplification of the airway inflammatory response (Kumagai et
al., 1999). Neutrophil granule enzymes, including MMP's are discussed in Section
1.2.2.
1.1.5.3 Bronchoconstriction
The pulmonary dysfunction detected in COPD-affected horses (see Section 1.1.6) is
rapidly relieved but not eliminated by administration of bronchodilators (Broadstone
et al., 1988; Robinson et al., 1993; Derksen et al., 1999), suggesting that
bronchospasm is a major component of the airway obstruction. The innervation of
the equine lung and the complex mechanisms involved in regulation of airway
smooth muscle tone in equine COPD have been extensively reviewed (Robinson et
al., 1996; Robinson, 1997b); hence only a brief discussion of the interactions
between airway inflammation and bronchspasm that are pertinent to this study will
be given.
The consistent bronchodilation afforded in affected animals by the anticholinergic
drugs atropine and ipratropium bromide (Broadstone et al., 1988; Robinson et al.,
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1993) indicate that bronchspasm is mediated in large part by activation of
muscarinic, M3 receptors by acetylcholine.
As well as acetylcholine release from parasympathetic nerves in response to inhaled
irritants and inflammatory mediators, airway smooth muscle contraction may also be
enhanced by local and central release of neuropeptides following stimulation of
excitatory nonadrenergic-noncholinergic sensory nerves. Of note, in laboratory
animals, prolonged bronchoconstriction per se, possibly through local neuropeptide
release, can also stimulate mucus secretion and neutrophil chemotaxis (Barnes,
1999).
Inhibitory sympathetic nerves release norepinephrine, activating P2 adrenoreceptors
to mediate bronchodilation. Although these receptors are present on airway smooth
muscle throughout the respiratory tract, in the lower airways, smooth muscle
relaxation only occurs in response to circulating norepinephrine. The inhibitory
effect of p2-adrenoreceptor stimulation is employed by P2 agonist bronchodilators.
The inhibitory nonadrenergic-noncholinergic system acts via nitric oxide release to
inhibit airway smooth muscle contraction; critically function of this inhibitory
system is consistently absent in COPD-affected horses (Yu el al., 1994). Whether
this reflects an underlying feature of COPD-susceptible animals or inactivation of the
neurotransmitter nitric oxide by local inflammatory mediators is unknown. In the
trachealis muscle at least, physiological concentrations of the neutrophil secretory
product hydrogen peroxide (H2O2), did not inactivate inhibitory nonadrenergic-
noncholinergic function in vitro (Olszewski el al., 1995).
A number of the inflammatory mediators released in equine COPD (Section 1.1.5.2)
can induce or enhance bronchspasm. In vitro, histamine, leukotriene D4 and
serotonin stimulation and blockade of cyclooxygenase (and by inference blockade of
potentially inhibitory prostaglandin synthesis) augment cholinergic contractile
responses of equine small airways (Olszewski et al., 1997; Olszewski et al., 1999).
An interesting finding from these in vitro studies was a high level of individual
variability in the contractile response to LTD4 of small airways isolated from COPD-
affected horses (Olszewski et al., 1999). In light of the variable response of COPD-
susceptible horses to inhaled LTD4 in vivo (Marr et al., 1998b), these data suggest
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significant heterogeneity in the relationship between inflammatory mediators and
bronchospasm.
The role of neutrophil secretory products in the bronchospastic response is not
entirely clear. In vitro, high concentrations of H2O2 (1 mM) can stimulate contraction
of isolated trachealis muscle (an upper airway muscle) and lower concentrations (100
pM) modulate neurotransmission and muscarinic receptor function and induce
cyclooxygenase activity (Olszewski el al., 1995). However, perhaps more critically,
the cholinergic tone of small airways (the focus of the inflammatory response in
COPD) harvested from both COPD-affected and control horses was unaffected by
co-incubation with zymosan-activated peripheral blood neutrophils, suggesting that
neutrophil secretory products are not involved in the pathogenesis of bronchospasm
(Olszewski et al., 1999).
A further important feature of the altered bronchomotor function in equine COPD is
the development of airway hyperresponsiveness. Enhanced sensitivity to non¬
specific bronchospastic agents such as histamine, methacholine and citric acid has
been reported in affected animals (Derksen et al., 1985a; Armstrong et al., 1986;
Fairbairn et al., 1993). Even after 7 h of exposure to hay and straw, airway
hyperresponsiveness persists in susceptible animals for up to 3 days (Fairbairn et al.,
1993). This may have significant implications for the management of clinical COPD
cases, wherein even transitory exposure to antigen can increase their susceptibility to
episodes of bronchospasm for prolonged periods.
Bearing in mind that the calibre of an airway varies as a factor of its radius to the
fourth power, the airway obstruction induced by bronehospasm will be exacerbated if
airway calibre is already diminished due to inflammation-driven airway wall
thickening
1.1.6 PATHOPHYSIOLOGY OF EQUINE COPD
The combined effects of airway inflammation, bronchospasm and increased mucus
secretion in affected horses lead to diffuse airway obstruction and the dyspnoea
detected clinically. Widespread obstruction of small airways is readily detectable in
severe cases by pulmonary mechanics testing where large increases in pulmonary
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resistance with a concomitant reduction in dynamic compliance are detected. The
horse responds to airway obstruction by increasing its respiratory effort, detectable as
an increase in the maximal change in intrapleural pressure. Diffuse airway
obstruction also results in abnormal distribution of ventilation causing an increase in
dead space and significant ventilation-perfusion mismatching (Nyman et al., 1991),
the net effect of which is impaired gas exchange and arterial hypoxaemia (reduced
PaC>2) (West, 1992). However, hypercapnia (increased PaCCb) is not a feature,
suggesting that hypoventilation does not occur in spite of the obvious increase in
respiratory effort that affected animals show. Hypoxaemia stimulates respiratory
drive, increasing respiratory rate and minute volume although tidal volume is
unchanged. To maintain tidal volume in the face of increased respiratory frequency,
affected horses change their breathing strategy to accommodate greatly increased
inspiratory and especially early expiratory flow rates (Robinson et al., 1999).
Many of the alterations in pulmonary function described above have been
documented in experimental hay/straw challenge studies in which affected animals
become severely dyspnoeic (Derksen et al., 1985b; McGorum et al., 1993d;
Vandenput et al., 1998; Robinson et al., 1999). Evaluation of pulmonary mechanics
is relatively insensitive to subtle changes in pulmonary function (mildly and
moderately affected horses) and difficult to perform routinely in clinical practice.
However, clinical assessment of the degree of dyspnoea correlates well with both the
degree of ventilation-perfusion mismatching (Nyman et al., 1991) and the associated
maximal change in intrapleural pressure (Dixon et al., 1995c).
The importance of inflammation and mucus plugging of small airways in the
development of lung dysfunction is clearly suggested by the failure of bronchodilator
therapy to return pulmonary resistance to baseline values in experimentally induced
COPD. Indeed, the degree of bronchiolar neutrophil infiltration and goblet cell
metaplasia in biopsy material (Naylor et al., 1992) and epithelial hyperplasia at
necropsy (Nyman et al., 1991) correlated with the severity of clinical signs and
ventilation-perfusion mismatching respectively, suggesting that these features have
significant effects on gas exchange.
Mucus hypersecretion may in fact be the rate-limiting step in the resolution of airway
obstruction. Epithelial metaplasia and loss of cilia (Section 1.1.4) will reduce
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mucociliary clearance rates and preliminary data suggest that excessive production of
airway mucins may persist long after the resolution of airspace neutrophilia and overt
lung dysfunction (Jeffcoat et al., 1998).
Assessment of alveolar epithelial cell permeability by scintigraphic evaluation of the
alveolar clearance of "mTechnetium-labelled diethylene triamine penta-acetate
(Votion et al., 1998) has clearly demonstrated markedly increased epithelial
permeability in the caudal lung fields of COPD-susceptible horses exposed to hay
and straw (Votion et al., 1999). This disruption of normal alveolar epithelial cell
physiology is likely to have significant consequences for gas exchange. Two
important conclusions can be drawn from this work. Firstly, the importance of
assessing functional airway pathology rather than relying on the less sensitive
structural assessment of biopsy or necropsy material. Secondly, this technique
detected sub-clinical lung injury in horses housed in a suboptimal "controlled "
environment (Votion et al., 1999). These findings are consistent with the elevated
concentrations of total protein and albumin in the pulmonary epithelial lining fluid
(PELF) of COPD-affected horses in contrast to healthy controls (Milne et al., 1994).
These findings may be highly pertinent to the evaluation of the role of neutrophils in
the pathogenesis of lung injury in equine COPD.
1.1.7 CLINICAL AND LABORATORY DIAGNOSIS OF EQUINE COPD
In many clinical cases of COPD a tentative diagnosis can be based upon a typical
history and clinical examination findings as outlined previously. However, clinical
findings alone are not specific for equine COPD and pulmonary disease may only be
readily detected in severely affected animals (McPherson et al., 1978; Dixon et al.,
1995b).
Whilst pulmonary function testing can confirm the presence of airway obstruction, it
remains a relatively insensitive, non-specific and time consuming technique for
routine evaluation (Viel, 1983; Dixon et al., 1995a). However, measurement of
pulmonary mechanics in combination with assessment of airway responsiveness to
inhaled methacholine may be useful in the detection of subclinically affected animals
housed in an inadequately managed environment (Vandenput et al., 1998).
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Measurement of arterial blood gas tensions and pH may be useful to identify or
confirm abnormal gas exchange in affected animals. However, the diagnostic
criterion of a PaC>2 below 85mmHg (temperature corrected) for COPD-affected
horses suggested by McPherson et al. (1978) is likely to exclude many less severely
affected animals; approximately 30% of the cases reported by Dixon et al. (1995c).
Assessment of the distribution of ventilation by the nitrogen washout test (Viel,
1983; Robinson et al., 1996) and alveolar epithelial cell permeability by scintigraphic
evaluation of alveolar clearance (Votion et al., 1998; Votion et al., 1999) are both
very sensitive measures of pulmonary function. Both techniques can detect sub¬
clinical or mildly diseased animals with no mechanical evidence of lung dysfunction.
Although they are not feasible for routine clinical evaluation, they are valuable
research tools.
Cytological evaluation of airway secretions collected by tracheal aspirate or BAL has
become a mainstay in the diagnosis of chronic respiratory disease (Mair, 1987a;
McGorum and Dixon, 1994; Moore and Cox, 1996).
Tracheal secretions are easily assessed and collected during bronchoscopy. Although
tracheal aspiration is less invasive than BAL, tracheal secretion cytology does not
correlate well with simultaneously collected BALF cytology (Derksen et al., 1989)
or histopathology in chronic lung disease (Larson and Busch, 1985). In a study of
300 cases of equine pulmonary disease (Dixon et al., 1995c), despite there being a
significant correlation between tracheal secretion and BALF neutrophil ratios in all
disease categories, including COPD, substantial overlap in tracheal secretion
neutrophil ratios was apparent between clinically normal and diseased horses.
Moreover examination of BALF cytology permits much clearer definition of
individual cells than in tracheal secretions which often contain large amounts of
mucus. The molecular and cellular composition of the PELF that is collected by
BAL appears to be homogeneous throughout different regions of the lung in both
normal and COPD-affected horses (McGorum et al., 1993e); hence a single BAL
should be representative of the state of health of the entire lung. The collection,
handling and interpretation of BALF is discussed in detail in Sections 2.7 and 2.8
and Chapter 6.
15
Several previous studies in both horses and humans have calculated PELF
concentrations of cells and molecular components by assessment of the dilution
factor in BALF based on endogenous references markers such as albumin or urea
(Reynolds, 1987; McGorum et al., 1993 f). However, both of these techniques have
the potential for significant error and many workers in the human field are moving
away from methods to assess the proportion of PELF in BALF, suggesting quotation
of the concentrations of BALF constituents simply on a per ml basis of recovered
BALF (Klech and Pohl, 1989; Rennard et al., 1998). The latter approach is used
throughout the current study.
1.2 THE NEUTROPHIL
Although inter-species differences exist with respect to specific aspects of neutrophil
structure and function (e.g. granule components, enzyme specificities, receptor
expression, ligand recognition and eicosanoid synthesis), the universal role and
capabilities of the polymorphonuclear granulocyte or neutrophil in the front line of
host defence is common to all mammalian species. Until the study of equine
neutrophil function has undergone the level of scrutiny enjoyed by its human
counterpart, any discussion of equine neutrophil biology must rely heavily on
comparative data. In this review, comparative data from human and experimental
animal studies will be discussed as a model for the equine neutrophil, except where
equine investigators have specifically addressed topics of discussion that are directly
pertinent to the current study.
Neutrophils are characterized by their multilobulated nucleus and, like other
granulocytes (eosinophils and basophils), by their distinctive cytosolic granules.
Neutrophils constitute approximately 50% of the circulating leucocyte pool from
whence they perform their primary task of seeking out, phagocytosing and
destroying pathogens invading host tissues with rapidity and precision. Individuals
in whom neutrophil function is deficient highlight the significance of efficient
neutrophil function for host survival. Deficiency in neutrophil number
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(neutropaenia), adhesion (leucocyte adhesion deficiency of cattle, dogs and humans),
respiratory burst activity (chronic granulomatous disease, myeloperoxidase
deficiency) or granule function (Chediak-Higashi syndrome) can lead to
development of recurrent life-threatening bacterial and fungal infections ( Gordon,
1994; Smith, 1994; Gerardi, 1996). However, the inappropriate or overexuberant
release of the neutrophil's cytotoxic arsenal can also injure host tissues and is now
implicated in the pathogenesis of many inflammatory diseases (Henson and
Johnston, 1987; Smith, 1994; Dallegri and Ottonello, 1997. See Section 1.6).
1.2.1 ORIGIN, DEVELOPMENT AND CIRCULATION
All blood cells originate from pluripotent stem cells in the bone marrow.
Neutrophils are derived from a common granulocyte-monocyte lineage, proliferating
in about 5 cell divisions from this myeloblast stage through promyelocyte,
myelocyte, metamyelocyte and band forms to become segmented neutrophils.
Development is closely regulated by the cytokines GM-CSF, granulocyte-colony
stimulating factor (G-CSF) and IL-3 (Tschudi et al., 1975; Bainton, 1988; Gordon,
1994). Stages beyond the myelocyte are no longer capable of further differentiation
and constitute the storage pool of the bone marrow from whence segmented
neutrophils are released into the circulation. Characteristic azurophil granules form
during the promyelocyte stage (Tschudi et al., 1975) and their number per cell is
reduced during subsequent mitoses (Bainton, 1988). In the healthy adult horse
approximately 500 billion new granulocytes enter the circulation daily and have a
half-life of 10.5 h (Carakostas et al., 1981; Bainton, 1988). During an inflammatory
response, transit time through the proliferating/mitotic phase and storage pool is
decreased (Terashima et al., 1996), the number of mitoses may be reduced (Sibille
and Reynolds, 1990) and the subsequent circulating half-life increases (Carakostas et
al., 1981).
The total body pool of mature neutrophils is classically considered to be divided
amongst the bone marrow storage pool, a circulating pool (accessible by
venepuncture) and a marginated pool of temporarily sequestered cells which are in
dynamic equilibrium with the circulating pool. Neutrophil margination is a
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physiological phenomenon related to the lower pressures and pulsatile flow of the
pulmonary circulation and the disparity in size between neutrophils and the
capillaries through which they are passing. Depending on the species studied, 40-
60% of pulmonary capillaries are narrower than the neutrophils passing through them
(Doerschuk et al., 1993). Consequently neutrophil transit is delayed as the cells
deform in order to squeeze through, before re-entering the circulating pool.
Neutrophils are also transiently retained in the capillaries of the bone marrow, liver
and especially the spleen (Lien et al., 1987; Hogg and Doerschuk, 1995; Peters,
1998).
The eventual fate of neutrophils reaching the end of their lifespan in healthy
individuals is unclear, but recent in vivo cell labelling studies suggest that many are
permanently retained within the spleen (possibly the lungs also) where they undergo
apoptosis (Bicknell et al., 1994).
1.2.2 STRUCTURE AND COMPONENTS
2Normal equine neutrophils have a transectional area of approximately 100 pm with
an estimated diameter of 6-7 pm (Bertram and Coignoul, 1982). Light microscopic,
ultrastructural and biochemical studies of neutrophils have demonstrated typical
nuclear morphology, a small central Golgi complex, mitochondria, endoplasmic
reticulum and characteristic populations of peroxidase-positive azurophilic granules,
peroxidase-negative specific granules, gelatinase or tertiary granules and secretory
vesicles (Bertram and Coignoul, 1982; Borregaard and Cowland, 1997). As well as
proteolytic and microbicidal proteins, these storage organelles also contain a large
number of preformed receptors and other membrane proteins, which, when
incorporated into the plasma membrane following organelle fusion and exocytosis,
can significantly alter neutrophil function (Borregaard and Cowland, 1997). A
summary of pertinent granule and secretory vesicle contents is presented in Table 1.
18
Granule Significant contents Function of contents
Azurophil (primary) Elastase }







a1-proteinase inhibitor Elastase inhibitor
Specific (secondary) CD11b/CD18b Endothelial adhesion
TNFReceptor Priming and activation
fMLP receptors Chemotaxis
G-protein sub-units Signal transduction
Cytochrome b558 Respiratory burst oxidase
Collagenase } Metallo-
Gelatinase } proteinases
Gelatinase (tertiary) CD11b/CD18 Adhesion
Cytochrome b558 Respiratory burst oxidase
fMLP receptors Chemotaxis
Gelatinase Metalloproteinase
Secretory vesicle CD11b/CD18 Adhesion
CD16 (FcyRIII) Immunoglobulin recognition
CD14 LPS recognition receptor
Complement receptors 1 & 3 Complement recognition
fMLP receptors Chemotaxis
Cytochrome b558 Respiratory burst oxidase
Table 1.1: Contents of human neutrophil granules and secretory vesicles
This list of granule contents is not exhaustive; included are those with either direct relevance
to the current study and/or those which have been studied in the horse (summarised in text).
After Borregaard and Cowland (1997)
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Ultrastructural examination has identified four types of equine neutrophil granules;
azurophil, specific and two other distinct types (Bertram and Coignoul, 1982). The
enzymatic contents of these cytosolic granules have received most attention, mainly
in the search for in vivo markers of equine neutrophil degranulation.
Bochsler el al. (1992) identified release of lysozyme, (3-glucuronidase, alkaline
phosphatase, acid phosphatase and proteolytic and collagenolytic activity from
equine neutrophils stimulated with phorbol ester in vitro. The granule fraction from
homogenates of purified equine neutrophils were shown to contain 5'nucleotidase,
alkaline phosphatase, acid phosphatase, a-mannosidase, (3-glucuronidase, P-
galactosidase and cytochrome c oxidase activity (Heyneman and Vercauteren, 1982).
MMP-9 monomer and dimer levels were significantly elevated in synovial fluid
collected from horses with septic arthritis and levels were correlated with the
synovial fluid white blood cell count (Clegg et al., 1997b). These same workers
subsequently showed that neutrophils were a major source of MMP-9 (gelatinase),
storing the enzyme intracellularly (Clegg et al., 1997a).
Equine neutrophil myeloperoxidase (MPO) and serine proteinases have been
extensively investigated. Two serine proteinases, equine neutrophil elastase (ENE)
2A and 2B, have been purified from neutrophils (Scudamore et al., 1993; Pemberton
et al., 1993; Dubin et al., 1994). Equine NE 2A has similar elastolytic activity to
human neutrophil elastase, whereas that of ENE 2B is several fold higher (Potempa
et al., 1986). Equine NE 2A and 2B show 68% and 86% sequence homology with
human neutrophil elastase, respectively (Dubin et al., 1994). Early work suggested
that equine neutrophils contained substantially less elastase than human neutrophils
but recent work in this laboratory using a immunological technique indicates that
equine neutrophils (0.8 pg/cell) actually contain similar amounts to their human
counterparts (Dagleish et al., 1999). Two intracellular ENE inhibitors, horse
leucocyte elastase inhibitor and equine a-l-antiproteinase inhibitor (a-lPI), have
also been described in the cytosol of equine neutrophils (Potempa et al., 1991;
Dagleish et al., 1999).
Myeloperoxidase purified from equine neutrophils was shown to have similar
electrophoretic and biochemical properties to human and bovine MPO (Mathy-
Hartert et al., 1998). The same workers subsequently developed a radioimmunoasay
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for equine MPO and reported elevated levels of MPO in the plasma of horses with
strangulating intestinal obstructions in comparison to animals with non-strangulating
intestinal obstructions and normal horses (DebyDupont et al., 1998; Grulke et al.,
1999).
1.3 ROLE OF NEUTROPHILS IN THE INFLAMMATORY RESPONSE
In order to perform their primary role of protecting the host from invading "foreign"
cells, neutrophils must accumulate at sites of tissue injury and pathogen entry. This
necessitates their extravasation from blood vessels by a co-ordinated series of events;
initial margination within a vessel with temporary tethering and rolling of neutrophils
along the endothelium prior to their arrest and firm adhesion, subsequent
transmigration across the endothelium and through extracellular matrix delivers
neutrophils to the inflammatory focus to phagocytose and kill micro-organisms.
1.3.1 NEUTROPHIL EXTRAVASATION
The mechanisms of neutrophil accumulation in the lung differ from those in the
systemic circulation. Neutrophils invariably leave the systemic circulation via post¬
capillary venules whereas transit to the airspaces is achieved almost exclusively via
the capillary system of the pulmonary circulation (Downey et al., 1993; Rossi and
Hellewell, 1994; Hogg and Doerschuk, 1995). The mechanisms of neutrophil
migration from systemic vasculature which have been derived from in vitro,
intravital microscopy and in vivo cell adhesion molecule monoclonal antibody
blocking studies will be reviewed followed by a discussion of the contrasting
features of transmigration in the lung.
1.3.1.1 Neutrophil margination and rolling
The release of components of invading micro-organisms (e.g. yV-formyl-methionyl-
leucyl-phenylalanine [fMLP] and LPS), secretion of locally generated inflammatory
mediators (such as TNF-a, IL-8, PAF, LTB4 and IL-1) or activation of complement
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stimulate the adhesive capacity of endothelial cells and prime (q.v.) neutrophils,
modulating their expression of adhesion molecules. Due to vasodilatation, flow in
the blood vessel slows such that neutrophils move from the axial stream of blood
cells to a more marginal course adjacent to vascular endothelium; also termed
margination. Transient, loose adhesion events between neutrophils and endothelial
cells cause the cells to "roll" along the vessel wall. These events are mediated by
low-affinity interactions between the constitutively expressed L-selectin (CD62L) on
neutrophil microvilli and sialyl Lewis X antigen (Sle\ CD15) on endothelial cells.
De novo expression of E-selectin and upregulation of P-selectin on the activated
endothelial cell also contribute to this process. The passage of neutrophils is thus
slowed but not stopped. Neutrophil adhesion molecule expression is tightly
regulated by both soluble and activated endothelial cell-associated cytokine levels
such that L-selectin is shed as intracellular granules fuse with the neutrophil plasma
membrane, increasing expression and avidity of the (32-integrin CD1 lb/CD 18 (Carlos
and Harlan, 1994; Rossi and Hellewell, 1994; Hogg and Doerschuk, 1995; Condliffe
et al., 1996).
1.3.1.2 Neutrophil arrest and firm adhesion
Binding of CD1 lb/CD 18 to its ligand, Inter Cellular Adhesion Molecule-1 (ICAM-
1), newly upregulated on activated endothelial cells, leads to arrest of the neutrophil
on the endothelial surface and firm adhesion. This stable binding is also supported
by homophilic binding of another member of the immunoglobulin superfamily,
platelet-endothelial cell adhesion molecule (PECAM)-l, expressed on both
leucocytes and endothelium, and by bridging of acute phase molecules such as
fibrinogen and complement fragments between CD1 lb/CD 18 and either ICAM-1 or
directly to the endothelial cell surface (Carlos and Harlan, 1994). The apparent
redundancy of mechanisms to facilitate firm adhesion of neutrophils emphasises its
importance in the extravasation process. Although the above paradigm has yet to be
confirmed in the horse, equine neutrophils express CDllb/CDl 8 and adhere to both
serum- and fibronectin-coated plastic in a CD18-dependent manner (Bochsler el al.,
1990; Marr el al, 1999). Moreover, adherence is enhanced by chemokines (IL-8),
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complement fragments (C5a) and lipid inflammatory mediators such as PAF and
LTB4 (Foster et al., 1997; Marr etal., 1999).
1.3.1.3 Neutrophil shape change, transendothelial migration and chemotaxis
The change from selectin- to integrin-dependent adhesion coincides with the
normally spherical neutrophil becoming activated and motile, appearing ruffled,
flattened and polarised. Microfilamentous (F-) actin that makes up much of the
intracellular cytoskeleton is intimately associated with both the plasma membrane
and many of its integral chemoattractant receptors and adhesion molecules, including
integrins. Receptor engagement stimulates actin polymerisation with addition of
actin monomers to the F-actin in a directed fashion toward the inciting stimulus,
thereby deforming the plasma membrane to produce a leading broad lammelipodium
and a thin trailing uropod. The polarized cell can then "crawl" along a chemotactic
gradient by constant cycling of actin monomers from the tail of the actin filaments
back to the point of membrane attachment and polymerization at the leading edge
(Snyderman and Goetzl, 1981; Bearer, 1993; Rosales and Juliano, 1995). A
chemotactic gradient is necessary for trans-endothelial migration to follow after
adhesion to the endothelium. The polarized cell, guided by PECAM-1 localised at
inter-endothelial cell junctions and aided by the high affinity binding between
CDllb/CD18 and ICAM-1, migrates either between or directly through endothelial
cells to pause transiently before breaching the endothelial basement membrane
(DeLisser and Albelda, 1998; Feng et al., 1998).
Dissolution of basement membrane is achieved, at least in part, by the tightly
focussed activity of neutrophil MMPs activated in situ by elastase either expressed
on the neutrophil's surface or released locally (Owen et al., 1995; Delclaux et al.,
1996; Kumagai et al., 1999).
Finally neutrophils migrate through the extravascular interstitial matrix along a
chemotactic gradient toward the inflammatory stimulus. This is achieved by a chain
of repetitive engagement and disengagement between extracellular matrix
glycoproteins such as fibrinogen and fibronectin and both (31- (CD 1 la/CD 18) and
p2-integrins that integrate with the cytoskeleton. Granule exocytosis is preferentially
focussed on the leading edge of the lamellipodium, providing the ability for directed
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movement along a chemotactic gradient (Clapp et al., 1994; Rosales and Juliano,
1995; Werr et al., 1998). Indeed, repetitive engagement and cross-linking of p2-
integrins may act as a further priming stimulus prior to initiation of phagocytosis and
the respiratory burst (Liles et al., 1995).
1.3.1.4 Neutrophil extravasation in the lung
The leucocyte-endothelial cell adhesion cascade described above is now generally
accepted to underpin neutrophil extravasation from post-capillary venules in the
systemic vascular beds. However, the use of blocking antibodies, antisense
oligonucleotides and mutant mice with targeted deletion of specific adhesion
molecules has demonstrated that in some circumstances neutrophil emigration from
the pulmonary circulation into the interstitium or alveolar space occurs without
involvement of selectins, p2-integrins or ICAM-1 (Wegner, 1994; Hogg and
Doerschuk, 1995; DeLisser and Albelda, 1998). The requirement for p2-integrins in
particular, appears to be governed by the inflammatory stimulus employed. For
example, pulmonary neutrophil accumulation in response to Escherichia coli and
LPS is p2-integrin-dependent whereas the responses to Streptococcus pneumoniae
and C5a are not (Doerschuk et al., 1990). As discussed in Section 1.2.1, the disparity
in diameter between neutrophils and pulmonary capillaries underlies the
physiological sequestration of the marginated pool of neutrophils in the lung.
Sequestration is also governed by biomechanical properties of the neutrophil,
particularly cell size and stiffness or deformability (Downey et al., 1990; Selby et al.,
1991). During an inflammatory response, stimulation of neutrophils by local or
circulating inflammatory mediators causes an increase in their cell volume and a
reduction in deformability, thereby slowing neutrophil transit time through
pulmonary capillaries still further. These features alone may facilitate arrest of
stimulated neutrophils in direct contact with activated endothelial cells for sufficient
time to initiate the process of transendothelial migration outlined in Section 1.3.1.3
(Worthen et al., 1989; Downey et al., 1993; Hogg and Doerschuk, 1995; DeLisser
and Albelda, 1998).
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1.3.2 NEUTROPHIL PHAGOCYTOSIS AND THE RESPIRATORY BURST
Having migrated into tissues, the neutrophil utilises a series of mechanisms for the
recognition, engulfment and intracellular destruction of foreign material. The
engulfment process (phagocytosis) and/or exposure to locally generated secretagogue
stimuli lead to assembly of the respiratory burst oxidase at either the cell and/or
phagolysosomal (surrounding ingested material) plasma membrane. Neutrophil
activation or "triggering" of the respiratory burst oxidase initiates a massive increase
in cellular oxygen consumption (hence "respiratory burst") and the elaboration of
microbicidal reactive oxygen species (ROS). In this thesis, the use of the term
"activation", as it pertains to neutrophils, will be restricted to activation of the
respiratory burst.
1.3.2.1 Phagocytosis
Phagocytes, including neutrophils, recognize and phagocytose large particles (>0.5
pm) by one of three basic mechanisms. Complement receptor 3 (CR3,
CD1 lb/CD 18) on phagocytes can recognize some pathogenic agents (e.g. bacteria
such as E. coli, streptococci and staphylococci and bacterial fragments such as LPS)
by direct interaction with LPS and bacterial surface glycoproteins. However,
recognition and phagocytosis is achieved more usually and indeed much more
efficiently, if particles have been previously opsonised by complement or specific
immunoglobulin. Particles opsonised with immunoglobulin are bound by Fey
receptors (FcyR's I, II and III) whereas those opsonised with complement (C3bi)
bind to CR3. It is important to note that prior neutrophil stimulation/priming will
have already increased the expression of these as well as many other surface
receptors through exocytosis of specific granules and secretory vesicles. Although
the mechanisms of particle uptake vary slightly (membrane ruffling and pseudopod
extrusion initiate FcyR-mediated uptake, whereas complement-coated prey sink into
the cell surface after receptor engagement), the re-organisation of cytoskeletal F-
actin facilitates enclosure of the ingested particle within a phagolysosome (Hellewell
and Williams, 1994; Caron and Hall, 1998).
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1.3.2.2 Activation of the respiratory burst
Although it is clear that activation of the nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase (respiratory burst oxidase) following phagocytosis
underpins the microbicidal capacity of the neutrophil; the precise methods by which
micro-organisms are killed is not clear (Babior et al., 1973; Weiss, 1989; Rosen et
al., 1995; Wientjes and Segal, 1995).
The NADPH oxidase catalyses the generation of superoxide anions (O2", the
precursor for the neutrophil's arsenal of ROS) by the one-electron reduction of
oxygen in which NADPH acts as the electron donor.
NADPH
202 + NADPH ► 202" + NADP + H+
Oxidase
The activated enzyme is composed of five subunits: p40PHOX, (PHOX = PHagocyte
OXidase), p47P110x, p67PHOX, p22PHOX and gp91PHOX. When cells are quiescent, the
enzyme is maintained in the inactive state by physical separation of its components;
p40PHOX, p47PHOX, and p67"H0X forming a complex in the cytosol whilst p22PHOX and
gp91PH0X occur as a heterodimeric flavohaemoprotein (Cytochrome bsss) in the
membranes of specific granules and secretory vesicles. Neutrophil stimulation leads
to phosphorylation of p47PHOX followed by migration of its entire complex to the
cell's plasma membrane or plasma membrane that has been incorporated into a
phagolysosome. Cytochrome bs58 is delivered to the plasma membrane by fusion
and exocytosis of specific granules and secretory vesicles where, co-ordinated by
two low molecular weight guanine nucleotide-binding proteins (Rac2 and Rapl A),
the complete oxidase is assembled and superoxide anions are discharged into the
extracellular milieu or the phagolysosome (Weiss, 1989; Wientjes and Segal, 1995;
Babior, 1999).
The free radical superoxide anion may dismutate, either spontaneously or be
catalysed by intracellular superoxide dismutase:
202" + 2H+ ► H202 + 02
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Superoxide anions and hydrogen peroxide may themselves mediate microbial killing
but it seems likely that further oxidation generates more toxic ROS (Weiss, 1989;
McColl and Showed, 1994; Rosen et al., 1995). In the neutrophil, MPO can oxidize
halide ions (typically chloride) in the presence of hydrogen peroxide to form highly
toxic hypohalous acids (Weiss, 1989; Anderson et al., 1997; Ochoa et al., 1997):
MPO
H202 + CI" + H ► HOCI + H20
Although great contention has surrounded the neutrophil's ability to generate the
highly reactive hydroxyl radical (HO*), this does appear to occur by interaction of
superoxide anions with redox sensitive metal ions (probably iron molecules supplied
by lactoferrin) via the Haber-Weiss reaction (Weiss, 1989; Rosen et al., 1995):
02" + Fe3+ ► Fe2+ + 02
Fe2+ + H202 ► HO* + HO" + Fe3+
Once this cascade of ROS generation begins, many of the products generated, as well
as being directly microbicidal, can also react with other intracellular molecules to
produce further toxic products. For example, superoxide anions can react with nitric
oxide to produce peroxynitrite and the H202-MPO-chloride system can convert the
hydroxy-amino acids threonine and serine to the extremely reactive aldehydes,
glycoaldehyde, 2-hydroxypropanal and acrolein (Rosen et al., 1995; Anderson et al.,
1997).
Despite the elaboration of an impressive range of oxidative cell toxins, auto-
oxidative stress-induced cell injury is prevented by both the compartmentalisation of
these reactions within phagolysosomes and by the presence of intracellular anti¬
oxidants such as ascorbate and glutathione. However, in certain circumstances, the
cell's complement of ROS may be turned to teleological advantage by initiating the
programme of apoptosis following ingestion of potentially pathogenic particles
(Coxon et al., 1996; Watson et al., 1996b).
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1.3.2.3 Degranulation
It is clear from the preceding review of neutrophil extravasation and respiratory burst
activity that degranulation or exocytosis of intracellular granule contents is critical
for the appropriate interaction of the neutrophil with its surroundings. Granule
contents facilitate recognition, interaction and reaction with extracellular stimuli.
Moreover, degranulation responses are graded to reflect the nature and magnitude of
the inciting stimulus. Granules are recruited to the plasma membrane in a
hierarchical fashion. This is governed principally by a combination of the sensitivity
of granules to intracellular signalling transients such as increases in intracellular
calcium and the density of plasma membrane attachment or fusion proteins in the
granule membrane (Borregaard and Cowland, 1997). Thus secretory vesicles,
delivering adhesion molecules and chemoattractant receptors to the plasma
membrane are mobilised most readily, followed by gelatinase granules. Despite an
apparent cascade of granule exocytosis to match the cell's functional requirements
during its path from vascular sequestration to activation in tissues, the regulation of
granule recruitment is capable of exquisite fine tuning. The exocytosis of neutrophil
elastase from azurophil granules provides a good example. Priming agents can
increase the surface expression of elastase molecules without release into the
extracellular milieu (Owen et al., 1997). Whereas secretion of elastase can vary
from exocytosis of the contents of a single azurophil granule to release of much of
the cell's protease load (Tiou and Campbell, 1996; Owen and Campbell, 1999).
1.3.3 REGULATION AND AMPLIFICATION OF THE INFLAMMATORY
RESPONSE
Although neutrophils are key effector cells, they are also capable of a significant
regulatory role both locally at the site of inflammation and at distant sites through the
release of soluble mediators. The terminally differentiated neutrophil retains
considerable capacity for de novo cytokine synthesis and release (Cassatella, 1995)
and neutrophil respiratory burst products may themselves act as local cell signalling
molecules or generate further chemotactic agents by cleavage of local substrates
(Henson and Johnston, 1987).
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In vitro, stimulation of neutrophils by a variety of agents can induce synthesis and
release of further pro-inflammatory stimuli such as TNF-a, IL-1P, IL-8, IL-6, PAF
and LTB4, thereby amplifying the inflammatory response and potentially recruiting a
further wave of neutrophils to the inflamed site (Bazzoni et al., 1991; Baggiolini et
al., 1994; Furie and Randolph, 1995). Models of LPS-induced acute lung
inflammation in rodents demonstrate the significance of neutrophil-derived cytokines
in the amplification of inflammation in vivo. The early phase (<6h) of the
inflammatory response is associated with cytokine expression in alveolar
macrophages. However, at later time points (6-12 h) neutrophils become the
dominant source of TNF-a, IL-ip, IL-6 and MIP-2 (Xing et al., 1993; Xing et al.,
1994; Wohlford-Lenane et al., 1999). Moreover, cytokine synthesis appeared to be a
feature specific to airspace neutrophils and was not recognized in neutrophils
sequestered in the pulmonary vasculature. Neutrophils also constitutively expressed
transforming growth factor-P (TGF-P), a cytokine intimately involved in tissue
repair.
Neutrophil-derived ROS may also contribute to further granulocyte recruitment.
Reaction of superoxide anions with nitric oxide forms peroxynitrite, a potent
neutrophil priming agent (Rohn et al., 1999). Also neutrophil-derived oxidants
stimulate generation, enhanced surface expression and release of PAF from
endothelial cells as well as increasing expression of P-selectin with the potential to
enhance neutrophil recruitment and extravasation (Mclntyre et al., 1995).
1.4 NEUTROPHIL PRIMING
Regulation of neutrophil function to prevent premature or inappropriate activation of
the respiratory burst whilst facilitating neutrophil accumulation at sites of
inflammation is paramount to minimise inadvertent host tissue injury. A key
regulatory feature of neutrophil function is the concept of neutrophil "priming" as an
intermediate step in the progression from a circulating quiescent cell to triggering of
the respiratory burst in a fully activated cell recruited to an inflammatory focus
(Lehrer et al., 1988; Smith, 1994). Priming, although initially defined as an in vitro
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phenomenon (Guthrie et al., 1984), is now recognized as a prerequisite for efficient
neutrophil recruitment and paradoxically, in the pathogenesis of neutrophil-mediated
host tissue injury (Smedly et al., 1986; Worthen el al., 1987; Williams et al., 1993).
"Priming'' is defined as a mechanism whereby the response of the neutrophil to a
subsequent ("activating") stimulus is synergistically enhanced following exposure to
a prior (priming) stimulus (Downey et al., 1995; Condliffe et al., 1998b).
Both physiological pro-inflammatory mediators such as bacterial products, cytokines
and lipid mediators and physico-chemical changes in the surrounding environment
may prime neutrophils. The latter are important considerations in the purification of
neutrophils for in vitro studies, wherein excessive cell trauma during venepuncture
and subsequent manipulation or exposure to markedly hypotonic conditions
(Edashige et al., 1993; Kitchen et al., 1996b) can prime cells.
In vitro, physiological priming stimuli may initiate priming only ("dedicated
primers", e.g. PAF, TNF-a) or may prime cells at low concentrations but directly
activate the respiratory burst at higher concentrations (e.g. C5a). Both the response
to an individual priming agent and the time required to initiate the primed state can
vary greatly. This may, at least in part, reflect engagement of different receptors and
intracellular signalling pathways. The majority of physiological priming agents
signal through one of three main plasma membrane receptor types. 1. The classical
chemoattractant, seven transmembrane spanning domain, heterotrimeric G-protein-
linked, receptors (e.g. PAF, fMLP, C5a, IL-8). 2. Integral single transmembrane
domain cytokine/growth factor receptors linked to the cell interior by tyrosine
phosphorylation pathways (e.g. TNF-a, GM-CSF). 3. Adhesion molecules that
require spatial clustering, cross-linking or ligation to initiate signalling (e.g. P2-
integrins and selectins) (Bokoch, 1995; Downey et al., 1995; Liles et al., 1995).
A review of the biological properties of the putative equine neutrophil priming
agents investigated in the current study is presented in Chapter 3.
The intracellular signalling pathways and second messengers contributing to the
mechanisms of neutrophil priming and activation remain under intense debate and
are outwith the scope of the current work, but have been recently reviewed (Pabst,
1994; Bokoch, 1995; Downey et al., 1995; Condliffe et al., 1998a; Condliffe et al.,
1998b).
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1.4.1 CONSEQUENCES AND INDICES OF NEUTROPHIL PRIMING
The initial in vitro description of neutrophil priming by Guthrie and colleagues
(1984) demonstrated significantly enhanced (10-20 fold) neutrophil oxidant
generation (superoxide anions and H2O2) in response to immune complexes, phorbol
12-myristate 13-acetate (PMA) and fMLP following pre-incubation with LPS. It is
thought that circulating quiescent human neutrophils are entirely unresponsive to
fMLP (Pabst, 1994) and neutrophils isolated under optimal conditions are minimally
responsive to this formyl peptide (Haslett et al., 1985). Consequently, the effect of
priming agents on agonist-induced (particularly fMLP) superoxide anion generation
has become the gold standard for the investigation of neutrophil priming both in vitro
and ex vivo (Haslett et al., 1985; Kitchen et al., 1996b; Condliffe et al., 1998b).
Review of the mechanisms of neutrophil extravasation (Section 1.3.1) clearly
suggests that the functional changes required to initiate neutrophil margination and
adhesion are likely to be intimately associated with priming.
Exposure of neutrophils to inflammatory mediators, including priming agents, in
vitro stimulates cell shape change (Haslett et al., 1985; Kitchen et al., 1996a) and
decreases their deformability (Worthen et al., 1989). Not only is the extent of
neutrophil shape change predictive for their subsequent chemotactic capacity (Haston
and Shields, 1985) and fMLP-stimulated superoxide anion generation (Haslett et al.,
1985; Kitchen et al., 1996b) but the associated cell stiffening (lower deformability) is
also a critical determinant of neutrophil retention in pulmonary capillaries in vivo
(Worthen et al., 1989; Selby et al., 1991;Ussov et al., 1996).
The ability of priming agents to regulate human neutrophil adhesion molecule
expression and to enhance agonist-induced adhesion in vitro is well recognized
(Haslett et al., 1985; Young et al., 1990; Condliffe et al., 1996) and modulation of
equine neutrophil adhesion molecule expression and function by such agents has
been described (Bochsler et al., 1990; Foster et al., 1997; Marr et al., 1999). Not
only does priming regulate neutrophil adhesion per se (Condliffe et al., 1996) but the
bi-directional interaction between neutrophil and endothelial cell integrins, selectins
and their ligands can also act as neutrophil priming stimuli (Liles et al., 1995;
Ruchaud-Sparagano et al., 1998). Therefore priming of intravascular neutrophils
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may facilitate neutrophil margination and arrest in the microvasculature with
subsequent adhesion molecule-dependent neutrophil transmigration providing a
further priming stimulus to enhance respiratory burst activity on arrival at the
inflammatory focus.
Agonist-induced lipid mediator release (e.g. LTB4, arachidonic acid) can also be
augmented (Doerfler et al., 1994), with the potential to enhance subsequent
neutrophil recruitment/chemotaxis (LTB4) and activation (arachidonic acid).
Priming agents appear to have dual effects on the regulation of neutrophil-mediated
proteolytic activity. Firstly, and perhaps of prime pathogenetic importance, is the
ability of priming agents to greatly enhance agonist-stimulated membrane-bound
elastase expression (Owen et al., 1997). Retention of membrane-bound serine
proteinases appears to be a critical mechanism for the maintenance of focussed
proteolytic activity in the presence of protease inhibitors and may be singularly
important in both transendothelial cell migration and host tissue injury (Owen et al.,
1995; Owen and Campbell, 1999). Degranulation with extracellular secretion of
granule enzymes is an integral part of neutrophil activation and ROS generation
(Section 1.3.2.3). However, initial investigation of LPS priming of agonist-
stimulated azurophil granule exocytosis in both human and equine neutrophils
suggested that although secretion was enhanced by priming, these responses were
substantially less "primable" than superoxide anion generation (Haslett et al., 1985;
Fittschen et al., 1988; Bochsler et al., 1992). This discrepancy remained unexplained
until recently when pre-incubation with LPS in the presence of 1% serum (in contrast
to the previous studies) was reported to enhance fMLP-stimulated elastase release
from human neutrophils nearly 20-fold (Ottonello et al., 1997). We have recently
produced similar data with equine neutrophils (T.J. Brazil and M.P. Dagleish,
unpublished observations). These findings illustrated two points. Firstly, the
importance of serum components in the recognition mechanism of LPS by
neutrophils (reviewed in Chapter 3) and secondly the significance of priming for
neutrophils to achieve their full microbicidal potential.
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1.4.2 NEUTROPHIL PRIMING IN VIVO
Neutrophil priming has been reported in a plethora of clinical inflammatory disease
states and experimental animal models.
Most heartening for the laboratory investigator is confirmation that detection of
primed peripheral blood neutrophils in vivo is correlated with the pathophysiological
consequences predicted by in vitro priming models. A clear example of this is the
strong correlation between the proportion of shape changed neutrophils in peripheral
blood (assessed ex vivo) and the size of the sequestered pulmonary granulocyte pool
in extrapulmonary inflammatory diseases (Ussov et al., 1996).
In vitro modelling receives further credence from in vivo studies demonstrating
priming of peripheral blood neutrophils following experimental infusion of well
documented in vitro neutrophil priming agents. Intravenous administration of LPS
(Cerasoli el al., 1990) and TNF-a (Wewers et al., 1990; Kapp et al., 1991) in human
subjects and LPS in horses (Krumrych et al., 1996) enhances peripheral blood
neutrophil respiratory burst activity. Of note, enhanced neutrophil oxidative activity
was also induced by inhalation of LPS by human subjects (Michel et al., 1995).
Primed neutrophils have been reported in the blood of human patients with vasculitis
and inflammatory bowel disease (Ussov et al., 1996), bacterial infections (Bass et al.,
1986; Follin et al., 1989), acute respiratory distress syndrome (ARDS) (Zimmerman
et al., 1983; Chollet-Martin et al., 1992) and allergic asthma (Meltzer et al., 1989).
Indeed, in human ARDS, the degree of peripheral blood neutrophil priming (fold
enhancement of H2O2 release compared to control patients) correlated with the
severity of lung injury (Chollet-Martin et al., 1992). Severe trauma rapidly (3-6 h)
primes neutrophils in human patients and this may be a major risk factor for their
subsequent development of multiple organ failure and ARDS (Botha et al., 1995).
Elevated circulating levels of potential neutrophil priming agents (e.g. TNF-a, IL-8,
LPS) correlated with both the degree of neutrophil priming and the severity of lung
injury in human ARDS (Chollet-Martin et al., 1992; Pittet et al., 1997), are an
important prognostic indicator for the development of ARDS in high risk human
patients (Donnelly et al., 1993) and were correlated strongly with mortality in horses
with acute inflammatory or ischaemic intestinal diseases (Steverink et al., 1995).
2> 2>
Functional assessment of both circulating and extravasated neutrophils is a critically
important aspect of dissecting the pathogenesis of neutrophil mediated diseases
(Pittet et al., 1997). However, it is important to note that although priming
significantly enhances pulmonary sequestration of neutrophils, this does not
necessarily lead to neutrophil extravasation or indeed lung injury (Martin el al.,
1989; Garat et al., 1995;Ussov et al, 1996).
1.5 APOPTOSIS AND CLEARANCE OF EFFETE NEUTROPHILS
Although much study has focussed on the mechanisms underlying the kinetics
(Boggs, 1967), recruitment and accumulation (Arai et al., 1990; Carlos and Harlan,
1994; Rossi and Hellewell, 1994) of neutrophils during an inflammatory response,
the eventual fate and disposal of the amassed load of neutrophils at the inflamed site
has only been addressed relatively recently (Haslett, 1992). Physical clearance
mechanisms may be important in certain body systems, such as expulsion of cells
and debris from the respiratory tract by the mucociliary apparatus and cough reflex
and emigration of neutrophils via the circulation in the renal vasculature (Hughes et
al., 1997). For many years it was assumed that the majority of recruited neutrophils
met their fate in inflamed tissues by undergoing necrosis and disintegration, with
their fragments being scavenged by macrophages (Hurley, 1983). However, such a
fate would inevitably lead to local host tissue damage following liberation of the
cells' injurious contents.
The observations of Newman and co-workers (1982) however, indicated that as
neutrophils "aged" in culture they came to be recognized, ingested intact and rapidly
degraded by macrophages, quite unlike freshly isolated cells. This led to the
discovery that the critical permissive step in this clearance mechanism was in fact the
capacity of the neutrophil to undergo constitutive apoptosis or programmed cell
death (Savill et al., 1989b). Identification of the stereotypical features of nuclear
chromatin condensation and pyknosis (Wyllie et al., 1980b) and strictly ordered
internucleosomal DNA cleavage (Wyllie, 1980a; Hale et al., 1996) confirmed the
apoptotic phenotype (reviewed further in Chapter 4). This has led to a major
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research effort to understand the regulation of the age-dependent and constitutive
programme of neutrophil apoptosis and subsequent macrophage recognition, with a
view to developing new therapeutic strategies that could facilitate this beneficial
process and thereby counter neutrophil-mediated tissue injury (Haslett, 1997; Savill,
1997a).
The modulation of the constitutive rate of neutrophil apoptosis by physiological
inflammatory stimuli is reviewed and discussed in Chapter 4 in the light of data
generated in the current study of equine neutrophils.
1.5.1 APOPTOSIS
Apoptosis was initially defined and differentiated from cell death leading to necrosis
by its distinct morphological phenotype. Cellular swelling, disintegration of the
nucleus and cytoplasmic organelles and loss of plasma membrane integrity,
frequently associated with a surrounding inflammatory response, are common
features of cell necrosis. In contrast, cells undergoing apoptosis shrink and
membrane integrity is maintained as their nuclear chromatin condenses into one or
more dense "pyknotic" globes prior to their non-phlogistic elimination by adjacent
phagocytes (Kerr et al., 1972; Wyllie et al., 1980b; Kerr et al., 1995; Majno and
Joris, 1995). This formulaic, genetically programmed, form of cellular suicide drives
many forms of "physiological" cell deletion. This ranges from tissue remodelling
during embryological development, through cellular renewal of evanescent tissues
(e.g. intestinal epithelia) to the elimination of cells marked by malignant
transformation, immune selection or viral infection (Kerr et al., 1972; Wyllie et al.,
1980b; Ben-Sasson et al., 1995; Hale et al., 1996). The ordered fragmentation of
chromatin into 180-200 bp multiples by endonucleases that belies its morphological
condensation and produces the characteristic ladder pattern on electrophoresis of
DNA is recognized as the defining biochemical feature of apoptosis (Wyllie, 1980a;
Bortner et al., 1995; Squier et al., 1995).
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1.5.2 INTRACELLULAR MECHANISMS AND REGULATION OF APOPTOSIS
Apoptosis may be stimulated by cell injury (e.g. ionising radiation, viral infection,
and elaboration of granzyme B by cytotoxic T lymphocytes) and physiological
stimuli of either cell surface receptors and/or transcriptional mechanisms (Ashkenazi
and Dixit, 1998) or it may be constitutive, as observed in granulocytes. However,
two features of the mechanics of apoptosis are clear. Firstly, irrespective of the
inciting stimulus, the final common pathway of cell death is consistent. Secondly, in
contrast to necrotic cell death, cells undergoing apoptosis actively participate in a
genetically predetermined suicide. In non-haematopoetic cells, ablation of protein or
RNA synthesis delays or blocks apoptosis, confirming that it is an active process
requiring translation of certain gene products (Wyllie et al., 1984). In granulocytes
however, the reverse is true; apoptosis is rapidly promoted by inhibition of protein
synthesis (Whyte et al., 1997), suggesting that granulocytes' inexorable progression
to apoptosis is temporarily checked by synthesis of survival proteins.
Much of the current knowledge regarding the molecular regulation of apoptosis and
the phagocytosis of dead cells has come from studies of the nematode
Caenorhabditis elegans in which 131 of its 1090 adult somatic cells undergo
apoptosis during development (Hale et al., 1996). Targeted gene mutation has
defined the genes specifically responsible for initiation of apoptosis, suppression of
cell death, phagocytosis of dead cells and finally their digestion. Although the
molecular basis of apoptosis in mammalian cells is more complex, with many more
gene products involved in control of each of the phases described above, structural
and functional mammalian homologues of some terminal effector molecules have
now been defined. It is now clear that the structural changes observed in apoptosis
are universally driven by a family of proteases with cysteine at their active site
cleaving peptides at an aspartate residue, collectively termed "caspases" (Barinaga,
1998; Thornberry and Lazebnik, 1998). Furthermore, in most healthy living cells
caspase activity and hence apoptosis is actively suppressed by a family of molecules
whose key players are bcl-2 and bcl-XL (Adams and Cory, 1998).
Intracellular signalling in apoptosis and the gene products regulating caspase family
activity remain areas of intense study and are subject to regular review (Bellamy et
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al., 1995; Eastman, 1995b; Hale et al., 1996; Barinaga, 1998; Adams and Cory,
1998; Thornberry and Lazebnik, 1998; Ashkenazi and Dixit, 1998) but are beyond
the scope of this review.
1.5.3 FUNCTIONAL CONSEQUENCES OF NEUTROPHIL APOPTOSIS
It appears that the pathway from commitment to apoptosis, to macrophage
recognition has evolved a plethora of mechanisms to limit the pro-inflammatory
capacity of effete neutrophils in inflamed tissue. These mechanisms help to maintain
the fine balance between successful anti-microbial defence and collateral host tissue
injury. A key feature is the maintenance of neutrophil plasma membrane integrity
long after the initiation of the apoptotic programme, hence preventing leakage of
noxious contents from the dying cell (Savill et al., 1989b). Specific apoptosis-related
changes in cell surface phenotype serve to limit neutrophil effector functions such as
adhesion (Dransfield et al, 1995) and secretory activity (Whyte et al., 1993b)
through down-regulation of both receptor expression and function. This effectively
insulates the apoptotic neutrophil from pro-inflammatory stimuli in the surrounding
milieu. Further discussion of the functional consequences of neutrophil apoptosis is
presented in Chapter 4 in the context of functional data from apoptotic equine
neutrophils.
1.5.4 MACROPHAGE RECOGNITION OF APOPTOTIC NEUTROPHILS
Expression of novel molecules on the celFs exterior, such as the membrane
aminophospholipid, phosphatidylserine (Homburg et al., 1995), appears to "flag up"
the dying cell as being ready for macrophage tethering and subsequent elimination
(Savill, 1998). Indeed, some alterations in cell surface phenotype are so profound
and specific that they now underpin highly sensitive assays for the definition of
apoptosis in individual neutrophils (Dransfield et al., 1994; Martin et al., 1995).
Unlike phagocytosis of many other particles, the recognition mechanisms initiating
ingestion of apoptotic neutrophils by macrophages do not stimulate secretion of pro¬
inflammatory mediators, such as arachidonic acid derivatives or cytokines (Meagher
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et al., 1992; Fadok et al., 1998). In fact, uptake of apoptotic cells, at least in vitro,
appears to actively suppress the generation of pro-inflammatory cytokines via an
autocrine/paracrine feedback loop (Fadok et al., 1998). Furthermore, the very
inflammatory mediators (for example GM-CSF and TNF-a) that enhance neutrophil
function and regulate neutrophil longevity may act simultaneously to recruit more
macrophages into a clearance role as well as increasing their "appetite" for apoptotic
neutrophils (Ren and Savill, 1995).
The capacity of resident or inflammatory phagocytes to dispose of apoptotic
neutrophils is considerable, with individual macrophages being capable of ingesting
multiple effete cells via a number of discrete recognition mechanisms (Hart et al.,
1996). A further fail-safe disposal mechanism is offered by a number of other cell
types, not usually phagocytic in nature, which may be recruited into a clearance role;
the so-called "semi-professional" phagocytes, such as renal mesangial cells (Savill et
al., 1992). The recognition that several highly efficient recognition mechanisms are
available to a single macrophage phenotype (Savill, 1997b) further suggests that
macrophage clearance of apoptotic neutrophils represents a key damage-limiting
feature in the successful resolution of an inflammatory focus.
The initial characterization of human neutrophil apoptosis in vitro by Savill and
colleagues (1989) identified morphologic phenotypes in ageing neutrophils identical
to those that had been recognized in vivo in inflamed lungs, joints and glomeruli.
Due to the rapidity with which effete cells are recognized, engulfed and degraded by
macrophages (probably < 60 min) (Duvall et al., 1985; Bursch et al., 1990; Majno
and Joris, 1995), estimates of apoptosis rates in vivo derived from static observations
(i.e. histological or cytological preparations) are likely to considerably underestimate
its importance (Savill, 1997a).
Observations from rodent models of inflammation such as LPS- (Cox et al., 1995)
and oleic acid-induced lung injury (Hussain el al., 1998), and from human
inflammatory diseases such as the acute respiratory distress syndromes of neonates
(Grigg et al., 1991) and adults (Matute-Bello el al., 1997) have provided compelling
evidence for apoptosis as a pivotal regulator of neutrophil-mediated inflammation.
Moreover, pharmacological manipulation of apoptosis and macrophage clearance
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already shows considerable promise in the therapy of eosinophil-mediated
inflammation (Tsuyuki et al., 1995; Woolley et al., 1996).
1.6 ROLE OF NEUTROPHILS IN HOST TISSUE INJURY
The benefits to host defence afforded by the neutrophil's armoury of microbicidal
secretory products are, paradoxically, frequently overshadowed by the detrimental
effects of these indiscriminate cytotoxins on host tissues. This is particularly so in a
plethora of non-septic inflammatory diseases of humans such as vasculitis, ARDS,
rheumatoid arthritis, glomerulonephritis, psoriasis, inflammatory bowel disease,
asthma and myocardial infarction in which neutrophil products have been implicated
(Henson and Johnston, 1987; Malech and Gallin, 1987; Haslett, 1992; Smith, 1994).
Furthermore, the pathogenetic significance of neutrophil-derived cytotoxins is now
well recognized in equine medicine, particularly in intestinal reperfusion and
mucosal injury (Laws and Freeman, 1995; Moore et al., 1995; Inoue et al., 1998) and
septic arthritis (MacDonald and Benton, 1996; Clegg et al., 1997a).
It is important to emphasise that such effects may be subtle and the significance of
functional cell injury may be eclipsed in the search for structural pathological
correlates of neutrophil activation (Henson and Johnston, 1987). For example,
hypochlorous acid-induced increases in equine colonic mucosal permeability may
have significant consequences for intestinal function in the absence of major
structural pathology (MacDonald and Benton, 1996). Similarly, pulmonary gas
exchange is likely to be particularly sensitive to compromise of alveolar epithelial
cell function (Votion et al., 1998).
Sections 1.2 and 1.3 reviewed the range of potentially injurious neutrophil products.
Although many neutrophil-derived oxidants have been directly or indirectly
implicated in mammalian cytotoxicity both in vitro and in vivo, hypochlorous acid
(HOC1) is probably the most important (for a review see Weiss, 1989). Such
oxidants can induce oxidation/decarboxylation and peroxidation of membrane amino
acids and phospholipids respectively, generating chemotactic peptides and toxic
aldehydes (Fantone and Ward, 1982; Rosen et al., 1995; Anderson et al., 1997).
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Granule enzymes have broad substrate specificity with the capability to degrade
almost all components of the extracellular matrix (Dallegri and Ottonello, 1997).
Strongly cationic proteins such as defensins, serine proteinases, lysozyme and
bactericidal/permeability increasing factor can severely disturb cell surface charge
and enzyme function leading to membrane permeabilisation (Henson and Johnston,
1987).
However, there are two recurrent themes central to the pathogenesis of cellular
injury. Firstly, that neither ROS nor proteolytic enzymes alone completely explain
the destructive potential of neutrophil secretory products in vivo (Welbourn et al.,
1991). There is significant co-operation and synergy between different agents to
optimise cytotoxic activity. Perhaps the best studied example of this synergy is the
inactivation of human a-1 proteinase inhibitor (a-1 PI; the most abundant high
affinity serine proteinase inhibitor) by oxidation of an active site methionine residue
by H2O2, HOC1 and MMP's. This reduces the association rate between a-1 PI and
elastase 2000-fold, thereby facilitating elastolytic activity (Weiss, 1989; Dallegri and
Ottonello, 1997).
The fact that many toxic neutrophil secretory products are rapidly neutralised by the
presence of often saturating levels of their respective antioxidants and antiproteases
introduces the second critical feature necessary for cytotoxic activity; the need to
avoid or exclude inhibitors. This is primarily achieved through creation of a peri¬
cellular micro-environment at the point of apposition with the target cell that may
stoichiometrically exclude antiproteases and/or, through tightly focussed respiratory
burst activity, result in such high concentrations of proteases and ROS that
antiprotease/antioxidant defences are overwhelmed. Clearly, neutrophil priming,
sequestration of neutrophils in the microvasculature and adhesion molecule
engagement will only serve to exacerbate the situation (Owen et al., 1995; Liou and
Campbell. 1996; Dallegri and Ottonello, 1997; Owen and Campbell, 1999).
This synergistic co-operation between oxidants and proteases in the pathogenesis of
host tissue injury is summarised in Figure 1.1.
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Figure 1.1 Schematic representation of the interaction of neutrophil secretory
products and their inhibitors in the pathogenesis of host tissue injury
Stimulation of respiratory burst activity leads to secretion of reactive oxygen species (e.g.
H202), proteolytic granule enzymes (e.g. neutrophil elastase) and cationic proteins.
Inappropriate or overexuberant neutrophil activation in the face of inadequate or physically
excluded inhibitors (anti-oxidants and proteinase inhibitors e.g. glutathione and a-1 PI) can
result in host tissue injury. See text for further details.
Neutrophils with a characteristic multilobulated nucleus are depicted in blue.
02": superoxide anions, SOD: superoxide dismutase, MPO: myeloperoxidase, HOCI:
hypochlorous acid, a-1 PI: a-1-Proteinase Inhibitor.
After Dallegri and Ottonello (1997)
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Failure to terminate the inflammatory response, with continued recruitment of
neutrophils or inadequate clearance of effete neutrophils will similarly increase the
likelihood of unsolicited neutrophil-mediated tissue injury. To this end, low pH and
high concentrations of cations and hypochlorous acid (all features of inflamed
tissue) can inhibit macrophage uptake of apoptotic neutrophils in vitro (Haslett,
1997).
1.7 WHAT ROLE FOR THE NEUTROPHIL IN EQUINE COPD ?
Identification of a neutrophilic bronchiolitis as the archetypal pathological feature of
equine COPD (Nicholls, 1978; Winder and Von Fellenberg, 1988; Kaup et al.,
1990a) and the generally consistent finding of elevated numbers or proportions of
neutrophils in the tracheal secretions or BALF of clinically affected animals (Nuytten
el al., 1983;Bracher et al., 1991; Vrins et al., 1991; Dixon el al., 1995c) provides
strong circumstantial evidence for a causative role for neutrophils in disease
pathogenesis. In a prospective clinical and lung biopsy histopathology study, Naylor
et al. (1992) reported that bronchiolar neutrophil infiltration showed the strongest
correlation with clinical assessment of disease severity.
Although tracheal secretion and BALF neutrophil ratios tend to be higher in more
severely affected animals (Bracher et al., 1991; Vrins el al., 1991) and neutrophils
are consistently recruited to the airways after at least 5 h of experimental challenge
(Derksen el al., 1985b; McGorum et al. 1993d), some studies indicate that
neutrophils recruitment is not a prerequisite for airway dysfunction. In some
susceptible animals, airway dysfunction is detectable prior to significant pulmonary
neutrophil accumulation (Fairbairn et al., 1993). Also intratracheal delivery of F.
rectivirgula antigen to both COPD-susceptible and control ponies, despite increasing
BALF neutrophil numbers in both groups, only induced airway.obstruction in
susceptible animals (Derksen et al., 1988). A recent study of hay/straw challenged
COPD-susceptible and healthy ponies clearly discriminated the groups on the basis
of airway morphometry but not on neutrophil infiltration (Broadstone et al., 1997).
Although these data raise issues of sample size and the precise definition of control
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and COPD-susceptible animals, it is clear that there is considerable heterogeneity in
both the inflammatory and functional airway responses of susceptible horses to
antigen exposure.
As previously noted the functional status as opposed to the mere accumulation of
neutrophils is likely to be the critical determinant of their pathogenetic role.
Preliminary studies suggest that basal (Marr et al., 1997a) and agonist-stimulated
(Olszewski et al., 1999) superoxide anion generation is enhanced in peripheral blood
neutrophils from COPD-susceptible horses following hay/straw challenge. Variable
increases in BALF neutrophil buoyant density in COPD-affected horses has been
interpreted as evidence of heterogeneous cell activation in the airways (Tremblay et
al., 1993). Olszewski and Laber (1993) reported increased ROS generation from
tracheo-bronchial lavage cells compared to peripheral blood neutrophils from
affected horses.
Increased levels of protease, MMP-9 type gelatinase, MMP-8 type collagenase and
p-glucuronidase activity have been detected in the tracheal secretions of horses
affected with COPD, suggestive of neutrophil degranulation in the airways. The
levels of enzyme activity correlated with either the proportion of neutrophils in
tracheal secretions or the severity of clinical signs (Von Fellenberg, 1987; Maisi et
al., 1994; Koivunen et al., 1997a; Koivunen et al., 1997b). Initial interest in the role
of ENE stemmed from the erroneous conclusion that severely affected horses
developed significant emphysema (reviewed in Section 1.1.4). On the assumption
that unregulated neutrophil elastase activity would be central to the pathogenesis of
the equine COPD, analogous to human COPD and pulmonary emphysema (Janoff,
1985), detailed investigation of ENE and its most abundant inhibitor (a-lPI)
followed. However, more detailed pathological studies of equine COPD (Section
1.1.4) and the discovery that equine plasma contained not only greater amounts of a-
1PI than human plasma but also at least 4 related glycoproteins (serine proteinase
inhibitors, Spi 1-4) with multiple isoforms, rendered this hypothesis less tenable.
Moreover, although equine Spi 1 was structurally similar to human a-lPI, containing
an oxidation-sensitive methionine residue at its active site, this residue was
substituted in the Spi 3 gene product (and probably also Spi 2 and 4) providing
oxidation resistance (Patterson and Bell, 1989; Patterson et al., 1991). A further
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difference between the human and equine molecules is the absence of
chemoattractant activity of the equine ENE/a-lPl complex for equine neutrophils in
marked contrast to its human equivalent (Scudamore et al., 1993).
A direct causal relationship between BALF neutrophil secretory products and airway
obstruction/hyperresponsiveness has been studied in vitro. Although H2O2
modulates the contractility of isolated equine trachealis muscle (Olszewski et al.,
1995), co-incubation with activated neutrophils had no effect on cholinergic small
airway contractile responses (Olszewski et al., 1999).
Attempts to demonstrate a direct causative relationship between the presence of
granulocytes or their secretory products in BALF and airway hyperresponsiveness in
vivo have been unrewarding, even in human asthma, despite intensive study (Haley
and Drazen, 1998). Undoubtedly the effects of airway inflammation such as mucus
hypersecretion and plugging of small airways and airway wall thickening with
concomitant narrowing of airway calibre will exacerbate airway obstruction and the
consequences of hyperresponsiveness. However, the precise role of neutrophils in
equine COPD is likely to remain elusive without use of experimental techniques such
as neutrophil depletion or inhibition of specific neutrophil secretory products in vivo.
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1.8 AIMS OF THE STUDY
A prerequisite to address the role of neutrophils in equine COPD is an understanding
of the kinetics, functional status and eventual fate of neutrophils recruited to the lung.
In light of current understanding of neutrophil biology and the pathogenesis of
equine COPD the following aims were developed:
1. Definition of a purification method for equine neutrophils that minimised cell
priming.
2. Characterization of priming and activation in equine peripheral blood neutrophils
in vitro with a view to developing assays that could be used as an index of
functional neutrophil priming in vivo.
3. Characterization of apoptosis in equine peripheral blood neutrophils in vitro that
would permit recognition of neutrophil apoptosis in vivo.
4. Development of methods to facilitate assessment of the functional status of
neutrophils recruited to the airways and harvested by BAL.
5. Assessment of the kinetics and function of peripheral blood and airspace
neutrophils following experimental hay/straw challenge of COPD-susceptible
horses.
6. Investigation of a potential role for neutrophil apoptosis and macrophage




2.1 THE ISOLATION OF NEUTROPHILS FROM PERIPHERAL BLOOD
When performing in vitro studies on isolated neutrophils, a number of criteria must
be optimised when selecting a purification method. Cell purity is paramount but the
method must be rapid, maintain maximal cell viability and facilitate recovery of as
many cells as possible from the initial sample to avoid the potential selection of a
functionally biased cell subpopulation. Furthermore, it is well recognized that sub-
optimal preparative techniques e.g. those causing cellular osmotic stress (Edashige et
al., 1993; Kitchen et al., 1996b) or the use of reagents containing even trace amounts
of LPS (Haslett et al., 1985) may lead to cell priming and/or activation and thus
significantly alter the results of subsequent functional studies.
Blood was drawn by venepuncture from healthy adult horses (either immediately
post-mortem or from normal animals which records indicated had no history of
respiratory disease) healthy human volunteers and anticoagulated with 1 ml of 3.8%
sodium citrate per 10 ml of blood in 50 ml sterile polyethylene tubes. Aliquots of
equine blood were submitted to the Clinical Pathology Laboratory, Royal (Dick)
School of Veterinary Studies, Easter Bush Veterinary Centre for total and differential
leucocyte counts. Total leucocyte counts were obtained using an automated
haematology analyser (Baker/Biochem 9100, Biostat, Cheshire, UK) and a manual
differential leucocyte was performed on slides stained automatically (Miles
Haematech 2000, Bayer, Newbury, UK) with a modified Wright's trichrome stain.
2.1.1 PURIFICATION OF HUMAN PERIPHERAL BLOOD NEUTROPHILS
Human neutrophils were isolated on discontinuous hypotonic plasma/Percoll
gradients exactly as detailed by Haslett et al. (1985) using sterile, LPS-free (<0.1
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ng/ml LPS by the Chromagenix Limulus amoebocyte lysate assay) reagents and
laboratory plastic-ware. This method has been documented to yield neutrophils that
have minimal alterations in both their priming status (with respect to fMLP-
stimulated superoxide anion generation) (Haslett et al., 1985) and their resting cell
morphology (less than 8% shape change as assessed by flow cytometry, [Cole et ah,
1995]). All procedures were carried out at room temperature, unless otherwise
stated. The tubes of blood were centrifuged (300 x g, 20 min). The resulting
supernatant of platelet-rich plasma was carefully aspirated and either centrifuged
(2,500 x g, 20 min) to produce platelet-poor plasma (PPP), or used to prepare
autologous serum by recalcification with 20 pM CaCf at 37°C. Five ml of 6%
dextran T-500 was added to the original cell pellet and 0.9% NaCl was then added to
make a final volume of 50 ml. Following thorough but gentle mixing the contents
were allowed to stand for 30-45 min to allow erythrocyte sedimentation.
The overlying leucocyte-rich plasma layer was carefully aspirated and centrifuged
(300 x g, 6 min), and the mixed leucocyte cell pellet was resuspended in 2 ml PPP
and transferred to a 15 ml polystyrene tube. The leucocytes from two 50 ml tubes
could be used for a single gradient. A stock solution of 90% v/v Percoll was
prepared in 0.9% NaCl (100% v/v Percoll: 0.9% NaCl, 9:1, v/v) and then further
diluted with fresh autologous PPP to produce density gradients of 42% and 51%
Percoll/PPP, which were maintained at 4°C until use. The resuspended cell pellet
was underlayered sequentially with 2 ml of each of the 42% and 51 % Percoll
gradients, then centrifuged (275 x g, 10 min). Neutrophils were harvested from a
broad band at the 42%/51% interface. Mononuclear cells remained in a narrower
band at the upper PPP/42% interface.
Isolated neutrophils were then washed sequentially in PPP (500 x g, 6 min), PBS
without Ca2+ and Mg2+ (PBS w/o; Sigma, Poole, Dorset), pH 7.4 (300 x g, 6 min) and
PBS with Ca2+and Mg2+, pH 7.4, (PBS; Sigma, Poole, Dorset) (300 x g, 6 min).
Cytocentrifuge preparations of isolated neutrophil populations were prepared by
centrifuging (300 x g, 3 min) 100 pi of cells suspended in PBS w/o on to glass slides
(Shandon Cytospin 3, Southern Instruments Ltd., Runcorn, UK). These were air-
dried and fixed in methanol for 2 min. Cell purity was based on differential cell
counts of 500 cells stained with a modified Wright-Giemsa stain (Diff-Quik)
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examined under oil immersion (x 1000 magnification). Cell counts were determined
using an Improved Neubauer haemocytometer (Fisher Scientific, Leicester, UK) and
viability assessed by trypan blue exclusion.
2.1.2 PURIFICATION OF EQUINE PERIPHERAL BLOOD NEUTROPHILS
Three different methods for isolating neutrophils were compared, namely, two
single-step techniques with discontinuous isotonic Percoll gradients (Pycock et al.,
1987; Jain et al., 1990) and a modification of the method described above (Section
2.1.1) for isolating human neutrophils using discontinuous hypotonic plasma/Percoll
gradients (Haslett el al., 1985). In all methods, Percoll was maintained at 4°C until
use, but all other procedures were performed at room temperature.
2.1.2.1 Method 1; Jain et al. (1990)
Three ml of citrated whole blood was underlayered with 2.5 ml 59% isotonic Percoll
(100% Percoll: 10 x Hank's balanced salt solution [HBSS]; sterile de-ionised water,
5.9:1:3.1, v/v/v) and 2.5 ml 75% isotonic Percoll (100% Percoll: 10 x HBSS; sterile
de-ionized water, 7.5:1:1.5, v/v/v) in a 15 ml polyethylene tube and centrifuged (400
x g, 20 min). Leucocytes were aspirated from the two interfaces; mononuclear cells
from the upper (plasma/59% Percoll) and neutrophils from the lower (59%/75%
Percoll) interface using a glass Pasteur pipette.
2.1.2.2 Method 2: Pycock et al. (1987)
Stock isotonic Percoll was prepared (100% Percoll: 10 x HBSS, 9:1, v/v). This stock
(90% Percoll in HBSS) was subsequently diluted with 1 x HBSS to the appropriate
concentration. Three ml of citrated whole blood was underlayered with 5 ml 70%
Percoll and 5 ml 85% Percoll in a 15 ml polyethylene tube and centrifuged (400 x g,
20 min). Leucocytes were aspirated from the two interfaces; mononuclear cells from
the upper (plasma/75% Percoll) and neutrophils from the lower (70%/85% Percoll)
interface using a glass Pasteur pipette.
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2.1.2.3 Method 3: Haslett et al. (1985)
This method was identical to that described for human blood above (Section 2.1.1),
except that due to the high erythrocyte sedimentation rate of equine whole blood, the
initial centrifugation and dextran sedimentation steps could be omitted. Whole
citrated blood was allowed to sediment under gravity for 30 min at room temperature
and the upper leucocyte-rich plasma layer was carefully aspirated and centrifuged
(367 x g, 6 min). Percoll/PPP (41 %/52% Percoll) gradients were prepared, layered
beneath the resuspended mixed leucocyte pellet, centrifuged and cells harvested as
described.
Isolated equine neutrophils were then washed sequentially in PPP (500 x g, 6 min),
PBS w/o, pH 7.4 (300 x g, 6 min) and PBS, pH 7.4 (300 x g, 6 min). A more
extensive wash protocol (four washes in PBS w/o/0.1% BSA, pH 7.4 and one wash
in PBS/0.1% BSA, pH 7.4) was necessary in experiments investigating the
mechanism of LPS priming in equine neutrophils, to reveal the serum dependence of
the LPS effect (see Section 3.3.2.2).
Cytocentrifuge preparations of the isolated neutrophil populations were prepared,
differential cell counts performed and cell number and viability determined as
described in Section 2.1.1. Neutrophil recovery values were calculated using the
differential cell counts generated by the Clinical Pathology Laboratory (Section 2.1).
Table 2.1 shows the cell purity, viability and recovery rates for equine neutrophils
isolated using the three different Percoll gradient methods outlined above.
Although the yield of neutrophils following the plasma/Percoll gradient step of the
Haslett method was significantly lower than following the gradient step in the other
two methods (49%, versus 64.5% for method 1 and 75% for method 2) cell losses
during the subsequent wash protocol were significantly less (14% versus 38%
method 1 and 40% for method 2). The cause of this discrepancy was not determined
but may have reflected an enhanced adhesive capacity of the cells due to partial
priming during the latter two isolation methods.
Hence, the method of Haslett and co-workers (1985) generated cells of consistent
and high purity (98.2 ± 0.3%) and superior cell viability and recovery compared to
the methods of Jain et al., (1990) and Pycock et al., (1987).
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Jain et al., 1990 96.3 ±2.4 98.0 ±0.5 26.5 ±2.6
Pycock et al., 1987 98.7 ± 0.6 97.7 ± 0.9 35.0 ±4.7
Haslett et al., 1985 98.2 ± 0.3 99.3 ± 0.1 43.8 ±2.6
Table 2.1: Comparison of equine neutrophil populations isolated by three previously
published techniques for equine and human neutrophils.
Data represent mean ± SEM of n = 4 -15 separate experiments.
This method was chosen as the technique of choice for the subsequent experiments,
especially given the requirement for a uniform isolation method in experiments
comparing the function of equine and human neutrophils. Using this method,
isolated neutrophils were typically ready for use within 105 min of blood sampling.
Variable numbers of eosinophils frequently contaminated the final preparations of
human neutrophils (4.5 ± 1.6%, n = 5). However, a smaller number of eosinophils
contaminated the equine preparations performed in parallel (1.2 ± 0.5%, n = 5). The
equine eosinophils generally settled either below the 42/51% Percoll interface or
with the erythrocyte pellet. This suggests a significant difference in density between
these two equine cell types. Indeed, equine neutrophil and eosinophil populations of
high purity (>99%) can be resolved on simple discontinuous gradients (Foster et al.,
1992) whereas subsequent immunoselection techniques are necessary to achieve
similar results with human eosinophils (Stern et al., 1992).
The light microscopic appearance of freshly isolated equine and human neutrophils is




Figure 2.1a,b: Light microscopic appearance of freshly isolated human and equine
peripheral blood neutrophils
Human and equine peripheral blood neutrophils were isolated as described in Sections 2.1.1
and 2.1.2.3, respectively.
a: Photomicrograph of freshly isolated human neutrophils (magnification x 1480)
b: Photomicrograph of freshly isolated equine neutrophils (magnification x 1480)
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Under the conditions of this preparative technique, the individual lobulated segments
of human neutrophils were generally more rounded and both the individual lobes and
their fine interconnecting chromatin strands were more clearly defined than those in
equine neutrophils.
The method of Haslett et al. (1985) has been reported to induce minimal priming and
shape change of human neutrophils (Condliffe et al., 1996). In 12 sequential
neutrophil isolations from different horses, basal shape change assessed by light
microscopy (see Section 2.3.1.1) was confirmed to be extremely low at 2.9 ± 1.3%.
The ability of this isolation method to produce equine neutrophils that were
minimally primed or activated was confirmed in subsequent experiments (see
Section 3.2.1) which demonstrated little if any basal or fMLP-stimulated respiratory
burst activity in freshly isolated cells.
2.2 ASSESSMENT OF NEUTROPHIL RESPIRATORY BURST ACTIVITY
The increase in NADPH oxidase activity and ROS generation that underlies the
respiratory burst of activated neutrophils was assessed by a chemiluminescence (CL)
microtitre plate-based method (ML3000 Microtitre Plate Luminometer, Dynex
Technologies Ltd., Billingshurst, UK). This method permitted collection of kinetic
data from multiple samples in parallel (Blair et al., 1988) and, by addition of
different luminigenic probes to mixed cell populations in BALF samples, allowed
differentiation of the neutrophil CL signal from that of other cell types.
2.2.1 CHEMILUMINESCENCE MEASUREMENT OF RESPIRATORY BURST
ACTIVITY
The conditions selected for the CL assay were based on those recommended by
Benbarek et al. (1996) and the luminometer manufacturer (Phagocyte
Chemiluminescence, Luminescence Application Note, Dynex Technologies Ltd.,
Billingshurst, W. Sussex); hence the luminigenic probes lucigenin and luminol were
used at final concentrations of 0.25 mM and ImM respectively and all assays were
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conducted at physiological pH (7.4) at 37°C. It is important to note however, that the
normal physiological temperature for the horse is 37.8°C and not 36.8°C as in
humans. Although CL of human and equine neutrophils has been shown to be
temperature dependent (Washburn et al., 1982; Allen, 1986; Benbarek et al., 1996),
no difference in the CL response of canine granulocytes has been demonstrated over
the range 37 - 39°C (Burgener el al., 1998). Hence, 37°C was chosen for both
equine and human cells as a compromise to allow direct comparative studies between
horse and human neutrophil function.
2.2.1.1 Preparation of luminigenic probes
Lucigenin: 6.3 mg of lucigenin (bis-N-methylacridinium nitrate) was dissolved in 50
ml PBS/0.1% BSA, pH 7.4 to give a final concentration of 0.25 mM. Fresh
lucigenin was prepared daily and stored in the dark at 37°C until use.
Luminol: Stock luminol (10 mM) was prepared by dissolving 88.6 mg luminol (3-
aminophthalhydrazide) in 5 ml 0.1 M NaOH, then adding PBS/0.1% BSA, pH 7.4 to
make up to 50 ml. Luminol was stored in 1 ml aliquots at -20°C until use. Once
thawed, stock luminol was diluted to 1 mM with PBS/0.1% BSA, pH 7.4 and
equilibrated in the dark at 37°C.
2.2.1.2 Chemiluminescence assay
Lucigenin (0.25 mM) or luminol (1 mM) was added (100 pi) to each microtitre plate
well and allowed to equilibrate at 37°C for 15 min prior to the addition of 80 pi of
freshly isolated cells. Following a further 5 min incubation period, basal CL was
recorded over 12 min to ensure that the cells were not basally activated (stable basal
peak CL <0.005 Relative Light Units - RLU). Cells were discarded if basally
activated. After pre-incubation, 20 pi of buffer or stimulus was added to triplicate
wells and CL recorded at regular intervals over an appropriate time course. The CL
response to fMLP (0.01 nM - 1 pM), zymosan-activated plasma (ZAP, 10% v/v),
PMA (0.01 ng - 1 pg/ml), LTB4 (0.01 nM - 1 pM), hrIL-8 (10-100 ng/ml), LPS
(0.1 ng - 10 pg/ml), PAF (0.1 nM - 1 pM), hrTNFa (0.01 - 100 ng/ml) and erTNFa
(0.1 - 1000 pg/ml) was assessed.
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2.2.1.3 Data collection and analysis
Data were recorded and analysed on-line (Cellular Chemiluminescence, Dynex
Technologies Ltd., Billingshurst, W. Sussex) to produce mean peak and integral
(area under the curve) CL values in arbitrary RLU and nodal time [the time required
for a set number of neutrophils to reach peak CL velocity (Allen, 1986)] data. CL
values measured from triplicate blank wells (luminigenic probe and buffer only)
were subtracted from values measured for all test samples.
CL data may be analysed using any of the above parameters (integral or peak CL,
nodal time) or initial rate of increase in CL velocity (slope analysis) when neither
neutrophils nor substrate (luminigenic probe) are rate limiting and reaction kinetics
approximate zero-order (Allen, 1986). The kinetic geometry of the CL response
varies with the concentration of a stimulus and to a lesser extent with the number of
neutrophils (Allen, 1986; Lieberman et al., 1996), (see Figure 2.2a). Hence, using a
constant number of cells, CL was monitored over sufficient time to observe both the
onset and complete decay of the response, to avoid missing a delayed CL peak or
indeed a biphasic response as has been reported by certain groups for luminol-
dependent CL (Lum-DCL) responses of human neutrophils to fMLP (Dahlgren et al,
1985) and low concentrations of PMA (Allen, 1986). Integral CL values provide a
measure of cumulative CL activity and account for both the rate of increase and the
peak CL velocity and is considered the most useful parameter for inter-assay
comparisons (Blair et al., 1988). Although the kinetic geometry of neutrophil CL
responses to different stimuli varies considerably (compare PMA, Figure 2.2a and
fMLP, Figure 3.9), integral and peak CL values for an individual stimulus are usually
well correlated (Van Dyke and Van Dyke, 1986). Integral and peak CL values for
equine neutrophils in response to the agonists used routinely in these studies were
highly correlated (fMLP + serum +/- LPS, r = 0.97, Figure 2.2b; PMA, r = 0.82;
ZAP, r = 0.83, p<0.0001). Consequently, the integral CL value was chosen for data
representation as it allowed better characterization of the response of equine
neutrophils to a particular stimulus. Henceforth, all CL data are presented as integral
values unless otherwise stated.
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Figure 2.2a,b: Assessment of equine neutrophil respiratory burst activity by
Lucigenin-dependent chemiluminescence (Luci-DCL)
a: Concentration-dependence of PMA-stimulated Luci-DCL kinetics. Neutrophils (1 x 106)
were stimulated with 1 pg/ml, 100 ng/ml, 10 ng/ml and 1 ng/ml PMA and Luci-DCL was
recorded every 2.25 min (80 cycles) over 180 min. Nodal times were 34.0, 38.6, 45.3 and
76.8 min respectively. Values represent the mean of triplicate samples from a representative
experiment of five that gave similar results.
b: Correlation of integral and peak Luci-DCL values. Neutrophils (1 x 106) were
incubated with PBS or LPS (0.01,0.1, 1, 10 & 100 ng/ml) in the presence of serum for 60
min prior to stimulation with fMLP (1 pM). Luci-DCL (RLU) was recorded every 10 s (30






2.2.2 EFFECT OF CELL NUMBER ON LUCIGENIN-DEPENDENT
CHEMILUMINESCENCE (Luci-DCL)
Although the initial velocity of CL generation immediately post-stimulation is
independent of neutrophil number, the peak and hence integral values of luminigenic
probe-dependent neutrophil CL are proportional to the number of cells used (Allen,
1986). This was confirmed using PMA-stimulated (10 ng/ml) Luci-DCL responses
measured over 180 min with increasing numbers of equine neutrophils, where the
intensity of Luci-DCL was shown to be dependent on cell number (Figure 2.3). A
weak CL response was detectable with as few as 50,000 neutrophils per well (0.25 x
106 cells/ml) and this response increased up to 1 x 106 cells (5 x 106 cells/ml) but
both integral and peak values diminished at high cell concentrations e.g. 5 x 106 cells
(25 x 106 cells/ml); see Figure 2.3. A similar effect was recognized by Benbarek et
al. (1996) where the use of very high cell numbers was also associated with a
diminution of CL values, even when a greater assay volume was used. Subsequently
all assays were performed using lxl 06 neutrophils/well (equivalent to 5 x 106
cells/ml).
2.2.3 NEUTROPHIL PRIMING ASSAYS
In experiments designed to investigate priming of equine neutrophils, cells
resuspended in PBS were incubated in a final volume of 1 ml in 2 ml round-
bottomed Eppendorf tubes in a shaking waterbath at 37°C for 5 min prior to the
addition of known human priming agents at predetermined optimal times: LPS
(0.1 ng - 1 pg/ml, 30, 60 or 90 min) in the presence and absence of 1% heat-
inactivated autologous serum, PAF (0.1 - 10 pM, 10 min) and hrTNFa (0.01 - 100
ng/ml, 30 min), erTNFa (0.1 - 1000 pg/ml, 30 min) or hrIL-8 (10 - 100 ng/ml, 30
min). In initial priming experiments, the concentration of hrTNFa used was based
on units of cytotoxic activity (U/ml). Subsequently human and equine rTNFa were
compared on a weight of protein basis. During incubation periods greater than 15
min, the Eppendorf tubes were removed briefly every 15 min and gently tapped to
ensure that the cells remained fully suspended throughout the priming period.
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Figure 2.3: Effect of cell number on PMA-stimulated Luci-DCL in equine neutrophils.
Integral Luci-DCL values from increasing numbers of neutrophils in response to 10 ng/ml
PMA measured over 180 min. Values represent mean ± SEM of 3 separate experiments
each performed in triplicate.
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The neutrophil concentration was adjusted in these experiments to maintain the same
number of cells (1 x 106) in the final CL assay. At the end of the incubation period,
cells were transferred to the luminometer microtitre plate and the assay performed as
detailed above.
2.2.4 OPTIMISATION OF CHEMILUMINESCENCE TIME COURSES FOR
INDIVIDUAL AGONISTS
Following the initial experiments described above to determine the optimal priming
conditions and the effect of cell number and agonist concentration on Luci-DCL
responses, the time course of the CL signal stimulated by individual secretagogue
agonists was determined. Subsequently, CL was recorded for 5 min with fMLP, 30
min for PAF, LPS and human and equine rTNF-a and for 90 min with all other
agonists.
To ensure that the post-peak decline in the CL response to a stimulus was not due to
cell death, neutrophil viability was determined after a 180 min time course by their
ability to exclude trypan blue. The results presented in Table 2.2 confirm that cell
viability was maintained over 180 min and was unaffected by stimulation with either
ZAP or PMA.
2.3 ASSESSMENT OF NEUTROPHIL SHAPE CHANGE
Stimulation of neutrophils by priming or secretagogue/chemotactic agents initiates or
enhances changes in cell shape; this includes ruffling of the plasma membrane,
pseudopodia extrusion and polarization, and is associated with re-structuring of the
cytoskeleton, particularly F-actin (Fernandez-Segura et al., 1995). This response is
thought to represent frustrated phagocytosis and is considered to be a very sensitive
indicator of priming (Haslett et al., 1985).
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Buffer 97.6 ± 0.6 6
ZAP (10% v/v) 94.9 ± 1.8 7
PMA (0.1 ng/ml) 97.7 + 1.3 2
PMA (1 ng/ml) 96.4 ± 1.29 3
PMA (10 ng/ml) 97.1 ± 1.0 5
PMA (100 ng/ml) 92.6 ±2.7 4
PMA (Ipg/ml) 96.2 ± 1.2 2
Table 2.2: Viability of equine neutrophils after 180 min CL time course.
Neutrophils were stimulated with buffer, ZAP (10% v/v) or PMA (0.1 - 1000 ng/ml) and Luci-
DCL recorded over 180 min. Cells were harvested from the microtitre plate and viability
assessed by trypan blue exclusion. The viability of freshly isolated cells was 99.3 ± 0.1%
(Table 2.1).
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2.3.1 SHAPE CHANGE ASSAY
Neutrophils (2 x 106 / 900 pi PBS in 2 ml round-bottomed Eppendorf tubes) were
incubated at 37°C for 5 min in a shaking waterbath. Duplicate samples were then
incubated for 10 min with 100 pi buffer or agonist. Incubations were terminated by
the addition of an equal volume of 2.5% glutaraldehyde. In priming experiments,
cells were incubated with priming agents as detailed in Section 2.2.3, prior to the
addition of 100 pi buffer or agonist.
Shape change was quantified by light microscopy and/or flow cytometry and cell
ultrastructure and surface morphology were assessed with transmission (TEM) and
scanning (SEM) electron microscopy, respectively.
2.3.1.1 Light microscopy
At least 200 neutrophils were examined by phase contrast microscopy at x 400 on a
haemocytometer and shape change quantified as the percentage of cells extruding
more than one small pseudopodium (see Figure 2.4) as previously described by
(Kitchen el al., 1996a).
2.3.1.2 Flow cytometry
Shape change was quantified by flow cytometry (EPICS Profile II, Coulter
Electronics, Luton, Bedfordshire, UK) using a minor modification of the method
described by (Cole el al., 1995). Ten thousand events were analysed by
measurement of forward angle light scatter. A gate was set to include the unimodal
distribution of unstimulated (buffer only) cells and shape change was quantified as
the percentage of cells lying outside the gate following stimulation (see Figure 2.4).
2.3.1.3 Comparison of methods
In previous studies, shape change measured in human neutrophils by flow cytometry
correlated closely with values obtained by direct light microscopic assessment, with
the exception that the flow cytometric method slightly over-estimated the extent of
basal shape change and slightly under-estimated the proportion of cells in highly
activated cell populations (Cole et al., 1995).
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Figure 2.4: Assessment of equine neutrophil shape change.
Polarized light microscopic appearance (panels A & B, magnification x 500) and flow
cytometer frequency histograms (panels C & D) of glutaraldehyde-fixed equine neutrophils
following incubation (10 min, 37°C) with buffer (panels A & C) or 10% v/v ZAP (panels B &
D). Horizontal bar (panel C) indicates position of the gate delineating non-shape changed
cells. Using this analysis 97.4% of the cell population in panel D was considered to be
shape changed following activation by ZAP (10% v/v). Representative experiment of 10.
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Light microscopy data for equine neutrophils were strongly correlated with those
obtained by flow cytometry (r = 0.94, p<0.0001, Figure 2.5). All subsequent equine
neutrophil shape change experiments were analysed by flow cytometry.
2.3.2 ULTRASTRUCTURAL MORPHOLOGY
The ultrastructural morphology of populations of quiescent (incubated in PBS, 90
min, 37°C), primed (100 ng/ml LPS, 0.1% heat-inactivated autologous serum, 90
min) or activated neutrophils (ZAP 5% v/v, 10 min) was examined by transmission
(TEM) and scanning electron microscopy (SEM).
Cells were pelleted (230 x g, 6 min), resuspended and fixed in 1 ml sodium
cacodylate buffer (0.1M, pH 7.4)/2.5% glutaraldehyde then re-pelleted (250 x g, 6
min). Mr S. Mitchell of the Electron Microscopy Unit, Department of Preclinical
Veterinary Science, Royal (Dick) School of Veterinary Studies kindly performed
subsequent processing.
The ultrastructural morphology of apoptotic equine neutrophils was assessed after 20
h in culture (see Section 2.6.1). Cells were harvested (see Section 2.6.2) and
prepared for TEM.
2.3.2.1 Transmission electron microscopy
After post-fixation with 1% osmium tetroxide in 0.1 M sodium cacodylate buffer for
45 min, samples were washed three times in distilled water prior to dehydration in
acetone and infiltration in a mixture of araldite CY212 (Agar Scientific Ltd.,
Stansted, UK) and dodecenyl succinic anhydride (DDSA - Agar Scientific Ltd.). At
the final stage of infiltration and embedding, an accelerator containing 67%
dibutylphthalate (Agar Scientific Ltd.) and 33% dimethylaminomethylene-30 (Agar
Scientific Ltd.) was added to the araldite and DDSA mixture to harden the samples.
One pm thick specimens were then cut on an ultramicrotome (Reichert
Ultramicrotome OMU4, Leica UK Ltd., Milton Keynes, UK) utilising a glass knife.
Sections were then stained with toluidine blue and examined under light microscopy
to select appropriate areas to obtain sections for TEM examination. Sixty nm thick
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Figure 2.5: Comparison of light microscopy and flow cytometry for measurement of
shape change in equine neutrophils
Cells were incubated with buffer or ZAP (10 and 1% v/v), PMA (100, 10 and 1 ng/ml), fMLP
(1 |iM and 100 nM), PAF (100 nM) and LTB4 (100 and 10 nM) for 10 min. Cells were fixed
with 2.5% glutaraldehyde and shape change quantified by light microscopy and flow
cytometry as described above, (r = 0.94, p<0.0001). Pooled data from 54 assays (values
represent mean of duplicate samples) from 4 separate experiments.
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citrate (LKB Ultrastainer,Leica UK Ltd.) and examined and imaged in a TEM
(Philips EM400, Philips Electron Optics, Eindhoven, The Netherlands).
2.3.2.2 Scanning Electron microscopy
After impregnation with three changes of a combination of purified paraffin and
plastic polymers (Paraplast Plus, Sherwood Medical, Athy, Eire), the specimens were
embedded in this material. Ten pm thick sections were cut from each block and
mounted on aluminium stubs (Pin Stub, Emitech Ltd., Ashford, Kent) using
conductive carbon cement (Leit-c, Neubauer Chemikalien, Munster, Germany) and
coated with gold-palladium (Gold/Palladium target, Emitech Ltd) in a sputter coater
(SC500 Sputter Coater, Emscope Laboratories Ltd., Ashford, Kent). Samples were
examined and imaged in a SEM (Philips EM505, Philips Electron Optics) operated at
30.2 kV.
2.4 ASSESSMENT OF NEUTROPHIL CHEMOTAXIS
Neutrophils resuspended in PBS (3 x 106 cells/ml) were incubated with 1% serum for
90 min in the presence or absence of LPS (final concentration 1 pg/ml) and then
chemotaxis assayed in a Neuroprobe™ 96-well chemotaxis chamber (Porvair
Filtronics Ltd, UK) incorporating a 5 pm pore size polycarbonate filter (10 pm thick)
(Falk et al., 1982; Elarvath and Leonard, 1982). PBS (Sigma, control), fMLP (0.01 -
1000 nM) or ZAP (10% v/v) was placed into the lower wells (35 pi) and 225 pi of
neutrophil suspension added to the upper wells. The chamber was incubated in a
humidified 5% C02 atmosphere at 37°C for 90 min. The filter was then removed,
the upper surface scraped with a cell scraper, washed with 0.9% saline, air dried,
fixed in methanol and stained with Diff-Quik (Falk et al., 1982; Harvath and
Leonard, 1982). Cell migration into, and retention within the filter was quantified by
measuring the optical density of each well footprint at 500 nm in a MR 5000 plate
reader (Dynex Technologies Ltd, Billingshurst, West Sussex, UK).
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2.5 MEASUREMENT OF |3H] fMLP BINDING TO NEUTROPHILS
The [ HJfMLP binding assay was based on the method described by O'Flaherty et al.
(1991). Equine and human neutrophils (12.5 x 106/ml) were pre-incubated for 90
min in PBS plus 1% serum in the presence or absence of 1 pg/ml LPS then diluted
with an equal volume of ice-cold PBS containing 10 mM N-(2-hydroxymethyl)
piperazine N'-2-ethanesulphonic acid (HEPES) buffer (pH 7.4), centrifuged (235 x g,
6 min) and resuspended at 5.26 x 106 cells/ml. 950 pi of cells (5 million) were
carefully layered onto 400 pi of silicone oil in 1.5 ml Eppendorf tubes. [3H]fMLP
binding was performed by incubating cells, in triplicate, in the above buffer at 4°C
for 60 min with 0.0632, 0.2, 0.632 or 2 nM [3H]fMLP alone or 2 nM [3H]fMLP with
sufficient fMLP to make up final ligand concentrations of 2 - 6320 nM in half log
dilution steps. Incubations were terminated by centrifugation (11,300 x g, 2 min,
4°C) through the silicone oil cushion. Aliquots (200 pi) of the supernatant were
transferred to scintillation vials. Following aspiration of the residual supernatant and
silicone oil, the tips of the Eppendorf tubes containing the cell pellet were cut off and
transferred to scintillation vials. The pellets were incubated with 500 pi methanol for
20 min. Four ml of scintillation fluid was added to each sample prior to scintillation
counting. Data underwent Scatchard analysis using LIGAND software (Munson and
Rodbard, 1980) where the number of fMLP molecules bound per neutrophil was
calculated using Avogadro's constant and the number of picomoles of fMLP bound
per 5 x 106 cells.
2.6 ASSESSMENT OF EQUINE NEUTROPHIL APOPTOSIS IN VITRO
2.6.1 NEUTROPHIL CULTURE
Freshly isolated equine and human neutrophils were resuspended (5 x 106/ml) in
"Monofeed" (MF) (Iscove's modified Dulbecco's medium supplemented with 10%
autologous serum - prepared by recalcification of platelet-rich plasma - and 100 U/ml
penicillin and streptomycin). Neutrophils (625,000 cells/135 pi) were aged in culture
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in polypropylene flat-bottomed flexiwells at 37°C in an humidified 5% CO2
atmosphere for up to 36 h with either MF (control) or test reagent (15 pi). The effect
of culture with LPS (0.1 ng - 10 pg/ml), hrGM-CSF (500 U/ml), PAF (1 pM), fMLP
(1 pM), PMA (0.1 ng - 1 pg/ml), hrTNFa (0.01 - 100 ng/ml), erTNFa (0.1 pg - 1
ng/ml), zymosan activated serum - a biological source of C5a (ZAS - 10% v/v) or
dexamethasone (DEX; 0.1 nM -1 pM) were investigated. Also the effect of
phagocytosis of opsonised ovine erythrocytes (OsRBC) was investigated by culture
of these particles with neutrophils at a ratio of 3:1.
2.6.2 MORPHOLOGICAL ASSESSMENT OF NEUTROPHIL APOPTOSIS
Neutrophil apoptosis was assessed morphologically in accordance with the method
of Savill et al. (1989) for human neutrophils. At appropriate time points (typically
after 8 and 20 h in culture) cells were gently resuspended and 100 pi (approximately
5 x 105 neutrophils) harvested from each well using a cell saver pipette tip,
cytocentrifuged (300 x g, 3 min) and the resulting slide preparations air dried, fixed
with methanol and stained with Diff Quik. Use of cell saver pipette tips during
harvesting results in less cell trauma and associated disruption of light microscopic
morphology compared to standard tips (Dr. J. Murray, personal communication) and
allowed recovery of the vast majority of cells. Cell viability was assessed in parallel
by trypan blue exclusion. Cell morphology was examined by x 1000 oil immersion
light microscopy and apoptotic neutrophils defined as cells containing one or more
darkly staining pyknotic nuclear remnants (see Figure 4.1). For each condition
examined, 500 cells were counted on triplicate slides with the observer blinded to the
assay conditions.
2.6.2.1 Assessment of cell adhesion
To ensure that adhesion of non-apoptotic cells to the culture vessel did not lead to an
artefactually increased proportion of apoptotic cells being harvested from the
flexiwells, cell adhesion was assessed by methylene blue staining. Following
resuspension and complete aspiration of well contents, residual cells were fixed with
neutral buffered formalin (100 pi, 4% in PBS, 1 h, room temperature). Plates were
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centrifuged (235 x g, 5 min), the formalin discarded and then stained (30 min) with
pre-filtered 1% methylene blue. Excess dye was washed away with distilled water,
the cells lysed with 100 mM HC1 and the optical density of wells was measured at
630 nm in a MR 5000 plate reader (Dynex Technologies Ltd.). This showed that
only a very small proportion of cells were not recovered and failed to demonstrate
any significant difference in rates of adhesion between different culture conditions
(data not shown).
2.6.3 EFFECT OF CELL DENSITY ON THE RATE OF CONSTITUTIVE
EQUINE NEUTROPHIL APOPTOSIS
As the rate of constitutive human neutrophil apoptosis in vitro has been shown to be
modulated by cell density (Hannah et al., 1998), this effect was investigated for
equine neutrophils in the culture system described above. Cells were cultured for 20
h at 2.5, 5, 7.5 and 10 x 106/ml and the rates of constitutive apoptosis compared. As
in human cells, the rate of apoptosis in equine neutrophils cultured for 20 h was
inversely proportional to the cell density (see Figure 2.6), although this trend was not
statistically significant. All subsequent experiments were performed with cells
resuspended at 5 x 106/ml.
2.6.4 ASSESSMENT OF EQUINE NEUTROPHIL APOPTOSIS BY CHROMATIN
FRAGMENTATION
The chromatin of cells undergoing apoptosis fragments in a characteristic
internucleosomal pattern that is recognized as a distinctive "ladder" on
electrophoresis of DNA. Cells (4 x 106) were aged in culture and harvested as
detailed in Sections 2.6.1 and 2.6.2 and centrifuged (2,000 x g, 2 min). Cells were
then lysed in 0.5 ml, 6 M guanidine hydrochloride containing 20 mM Tris
(hydroxymethyl) aminomethane-Cl (Tris), pH 8.0 and 0.1% N-lauryl sarcosine. An
equal volume of Tris-Cl pH 8.0-buffered phenol/CHCE (1:1) was added and the
mixture inverted 6 times. The organic phenol/CHCl3 phase was then spun out
(11,300 x g, 10 min) at room temperature. The upper DNA-containing phase was
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Figure 2.6. The effect of cell density on constitutive apoptosis in equine neutrophils
Cells were cultured for 20 h at the densities shown. Cells were resuspended and percent
apoptosis assessed morphologically on Diff Quik-stained cytocentrifuge preparations.
Values represent mean ± SEM of 5 separate experiments, each performed in triplicate.
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removed, placed in a new microcentrifuge tube and precipitated from solution by the
addition of an equal volume of propan-2-ol and 1/10 volume 3 M sodium acetate
solution. The DNA was pelleted (11,300 x g, 5 min) and resuspended in 100 pi TE
buffer (10 mM Tris-Cl, 1 mM EDTA-Na, pH 8.0) containing 50 pg/ml RNase A.
After incubation at 37°C for 15 min the DNA was loaded onto a 1.6% agarose gel
and electrophoresed (100 volts, 2 h) through 0.5 x TBE Buffer (0.5 x TBE - 89 mM
Tris, 89 mM boric acid, 5 mM EDTA) and then imaged by staining with 0.5 pg/ml
ethidium bromide and photographed with a polaroid camera over an UV
transilluminator. A 1 Kbp DNA ladder marker (Life Technologies, Paisley, UK) was
also included.
2.6.5 ASSESSMENT OF EQUINE NEUTROPHIL APOPTOSIS BY ANNEX1N V
BINDING
As cells become apoptotic, plasma membrane phospholipid asymmetry is lost such
that phosphatidylserine becomes exposed on the outer leaflet of the membrane. This
can be detected by the binding of Annexin V (Homburg et al., 1995), a protein that
binds to phospholipids especially phosphatidylserine, in a calcium-dependent
manner. Neutrophils were harvested and incubated on ice for 10 min with FITC-
labelled Annexin V diluted 1:4 in Annexin V Buffer. Preliminary experiments
showed that the proportion of aged cells binding Annexin V was very similar,
irrespective of whether samples were analysed immediately after cell harvest and
staining or following subsequent fixation (3% paraformaldehyde/PBS, 10 min),
washing (1000 x g, 2 min), resuspension in buffer (PBS/0.2% BSA/0.1% sodium
azide) and overnight storage at 4°C (data not shown). Samples were analysed in a
FACScan flow cytometer (Becton Dickinson, Oxford, UK). 10,000 events were
analysed and a gate set to determine the percentage of Annexin V-FITC positive
cells.
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2.6.6 TERMINAL DEOXYNUCLEOTIDE TRANSFERASE MEDIATED UTP
NICK END-LABELLING (TUNEL) OF APOPTOTIC EQUINE NEUTROPHILS
To allow simultaneous identification of nuclear condensation and DNA
fragmentation in apoptotic neutrophils, the terminal 3'-OH groups of fragmented
DNA were labelled in situ by TUNEL using a FragEL™ DNA Fragmentation
Detection Kit (Calbiochem - Novabiochem, Nottingham, UK). Cytocentrifuge
preparations of aged neutrophils were prepared on TESPA- (3-
aminopropyltriethoxysilane) coated slides, fixed (4% formalin/PBS, 10 min), air
dried (2 h) and stored at -70°C until use. Positive control specimens were prepared
by incubation with 5 pg/ml DNase 1 at 37°C for 30 min. Labelled DNA was
detected with DAB (3,3'-diaminobenzidine tetrahydrochloride) and slides
counterstained with methyl green.
2.7 CLINICAL EVALUATION AND CHARACTERIZATION OF CHRONIC
OBSTRUCTIVE PULMONARY DISEASE-SUSCEPTIBLE HORSES
2.7.1 SUBJECTS
Six horses (two Thoroughbreds, one Thoroughbred-cross, two Cob crosses and one
mixed breed), (4 geldings, 2 mares), median age 17.5 years (range 12 - 30), median
body weight 518 kg (range 454 - 580) with a history of recurrent respiratory disease
following exposure to mouldy hay and straw were used for the hay/straw challenge
experiments.
2.7.2 HAY / STRAW CHALLENGE
During the study, horses were housed individually, in well ventilated stables (4.9 m x
4.0 m x 3.6 m high, open-fronted, Yorkshire boarding ventilation at the rear), bedded
on wood shavings and fed haylage (ensiled grass) ad lib; henceforth termed
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"controlled environment". All animals were treated with anthelmintics every 6
weeks and vaccinated against tetanus every 2 years.
Hay/straw challenge was performed in an enclosed, poorly ventilated (ridge
ventilation only) stable (3.4 m x 3.6 m x 3.6 m high). Deep litter straw bedding was
maintained in the stable for at least 2 weeks prior to any challenge. Poorly saved
hay, that often had both a musty odour and evidence of mould contamination, was
fed in a hay rack and on the floor. The hay was shaken out prior to the horse's entry
and once during the challenge period. The same batch of poorly saved hay was used
in all challenges.
A clinical scoring system was designed in an attempt to quantify clinical signs of
respiratory disease prior to and following hay/straw challenge. Six parameters were
evaluated on clinical examination combining categorical and continuous data, from
which a total score out of 10 was computed, see Table 2.3.
Carotid arterial blood, collected with a 21 g, 40 mm needle into heparinised syringes
(Arterial Blood Sampler, Chiron Diagnostics, Halstead, UK), was stored on ice until
analysed (maximum delay - 20 min) for PaCL, PaCCL and blood pH in a Corning 238
Blood Gas Analyser (Ciba Corning Diagnostics Ltd., Halstead, UK).
Venous blood was collected as described previously (Section 2.1) for total and
differential leucocyte counts and neutrophil isolation.
2.7,3 COLLECTION OF BRONCHOALVEOLAR LAVAGE FLUID (BALF)
BALF was collected transendoscopically via a 2 or 3 m video-endoscope (Olympus
CF 200HL or Olympus XQ30, Olympus Keymed, Southend-on-Sea, UK). Horses
were sedated with a combination of romifidine (30 pg/kg, i/v; Sedivet, Boehringer
Ingleheim Ltd., Bracknell, UK) and butorphanol (20 pg/kg, i/v; Torbugesic, Willows
Francis Veterinary, Crawley, UK) and further restrained with a nose twitch during
BALF collection. Bronchoalveolar lavage (BAL) was performed by wedging the tip
of the endoscope in the lobar bronchus of the accessory lobe of the right lung
(Sweeney et al., 1992b; Halliwell el al., 1993), followed by rapid infusion of 300 ml
(5 x 60ml) of pre-warmed (37°C) 0.9% NaCl through the biopsy channel of the

















Auscultation - trachea0 Normal 0
Abnormal (Fluid sounds) 1
Auscultation - lung fields'1
Normal breath sounds 0







TOTAL Maximum score 10
Table 2.3 Clinical Scoring system adopted for systematic clinical examination
Notes: a: score 1 for either spontaneous cough or cough during induced hyperpnoea.
b: determined at rest prior to restraining horse.
c: auscultation over distal cervical trachea; categorised as normal breath sounds or
evidence of accumulation of respiratory secretions.
d: determined at rest and during and after 2 min of hyperpnoea induced with a 20 L
rebreathing bag.
e: wheezes and crackles
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hand using a 60 ml syringe. Typically, this procedure was completed in 60 s. The
BALF was stored in sterile 50 ml polypropylene tubes at room temperature until
processed in the laboratory (maximum delay - 20 min).
In order to study the temporal cellular and biochemical changes in BALF following
hay/straw challenge, a sequential BAL protocol in different lobes was developed.
This was designed to minimise the effects of prior BAL, which has been shown to
affect both BALF cell number and function in a number of species, including the
horse (Cohen and Batra, 1980; Ohmann and Babiuk, 1986; Haley et al., 1989;
Sweeney et al., 1994).
A baseline BAL was performed in the right accessory lobe at least 10 days prior to
hay/straw challenge. The times and sites of BALF collection before and after
challenge are shown in Table 2.4. Having entered the correct bronchus, the
endoscope was advanced until wedged and the BAL performed as described above.
A sham challenge protocol was performed (bronchoscopy and BAL only), to ensure
that sequential BAL alone did not cause significant alterations in BALF cell numbers
and proportion (6 horses) or BALF cell function as assessed by Luci- and Lum-DCL
(3 horses).
2.7.4 SCORING OF TRACHEAL SECRETIONS
The volume of tracheal secretions was assessed and scored during endoscopic
inspection at the level of the thoracic inlet prior to BAL. Secretions were scored
semi-quantitatively on a scale of 0 -5 (see Table 2.5), using a modification of the






BASELINE > -10 d right accessory (RB3)
l + 5 h right accessory (RB3)
2 + 24 h left caudal (LB2, IV)
3 + 4 days right caudal (RB2, 4L)b
4 + 7 days left caudal (LB2, 4L)D t
5 + 14 days right accessory (RB3)
Table 2.4 Times and anatomic sites of BAL for sequential BAL protocol following hay /
straw challenge
Names of bronchi are as described by Sweeney et at. (1992b).
Notes: a: letters and figures in brackets refer to nomenclature described by Sweeney et at.
(1992b).
b: in one animal following challenge, these samples were collected from RB2 and
LB2 respectively, using a 3m endoscope,







A few flecks3 1
Multiple blobs 2
A complete stream <1/3 diameter of
trachea
3
A complete stream >1/3 but <1/2
diameter of trachea
4
A complete stream > 1/2 diameter of
trachea
5
Table 2.5: Semi-quantitative endoscopic scoring scale for tracheal secretions.
Note: a: scores of 0 and 1 were considered normal
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2.7.5 CHALLENGE PROTOCOLS
All horses were confirmed to be free of pulmonary disease as assessed by clinical
examination, arterial blood gas analyses and BALF cytology, after at least 8 weeks
either at pasture or housed in a controlled environment. After a minimum of 10 days
in a controlled environment, horses were confirmed to be susceptible to COPD by
exposing them to either a 5 h or an overnight (8 h) hay/straw challenge, followed by
clinical examination and BAL. Horses were defined as suffering from COPD if they
developed clinical signs of airway obstruction (clinical score > 3; see Table 2.3)
associated with accumulation of neutrophils in the airspaces (BALF neutrophilia
>5%) (McGorum et al., 1993b). Horses were then either returned to pasture or
housed in a controlled environment for at least 8 weeks prior to further study.
Following a minimum period of 10 days after the baseline evaluation horses
underwent hay/straw challenge for 5 h as described in Section 2.8.2, followed by
sequential evaluations as detailed in Table 2.4. At each time point, a clinical
examination was performed, arterial and venous blood samples were collected
(Section 2.8.2) and bronchoscopy was performed with scoring of tracheal secretions
(Section 2.8.4) and collection of BALF (Section 2.8.3).
2.8 ANALYSIS OF CELLULAR AND MOLECULAR COMPONENTS OF
BRONCHOALVEOLAR LAVAGE FLUID (BALF)
2.8.1 PROCESSING OF BALF
After collection, all aliquots of BALF were pooled, the volume measured and the
percentage recovery of the instilled fluid determined. Aliquots of raw BALF were
taken for determination of total cell count, using an haemocytometer, cell viability by
trypan blue exclusion and for determination of differential cell counts on
Leishman's-stained cytocentrifuge preparations. After challenge, BALF often
contained significant macroscopic amounts of mucus that markedly hindered initial
attempts to isolate neutrophils from the BALF by density gradient centrifugation. In
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this laboratory, BALF had traditionally been filtered through a single layer of cotton
gauze to remove surfactant and mucus. However, residual mucus often remained
after gauze filtration, so other methods of mucus removal were investigated.
Biochemical dispersal of mucus by dithriothreitol (DTT) has been used to facilitate
cytological interpretation of induced sputum samples from humans (Keatings and
Barnes, 1997). The effect of DTT on equine BALF was assessed by incubation of
DTT (0.01 - 1% w/v) with 2 ml aliquots of raw BALF from 3 animals for up to 60
min. Mucolysis was assessed visually to determine the optimal concentration that
eliminated visible mucus flecks. Mucolysis was only observed at concentrations of
DTT > 0.1%. Given that DTT is a strong reducing agent, the effect of the same
concentrations on ZAP-stimulated Luci-DCL of peripheral blood neutrophils was
examined. The Luci-DCL response to ZAP (10% v/v) was significantly attenuated at
concentrations > 0.01% (data not shown). These findings were consistent with the
effects of DTT reported previously (Wu el al., 1997), so this method of mucus
removal was not pursued.
A nylon gauze mesh (Nytex gauze, Nytex, UK, 60 pm pore size) was compared to
cotton gauze for its ability to efficiently remove mucus from raw BALF without
affecting cellular recovery or content. Absolute and differential cell counts of raw
BALF from 11 randomly selected clinical cases were compared after filtration
through one layer of either cotton gauze or sterile nylon mesh. There was no
significant difference between absolute and differential cell counts compared to raw
BALF with either filtration method but no visible mucus was present after filtration
through nylon gauze (data not shown). Subsequently all BALF was filtered through
sterile nylon gauze prior to further processing.
After filtration, BALF cells were pelleted (340 x g, 6 min) and the supernatant
decanted and centrifuged further (1800 x g, 10 min) to remove any residual cellular
or particulate debris and stored in aliquots at -70°C and -20°C until analysis.
BALF cells were washed twice (PBS w/o/0.1% BSA/10 mM HEPES, pH 7.4 and
PBS /0.1% BSA/10 mM HEPES, pH 7.4; 235 x g, 6 min) prior to resuspension at
12.5 x 106/ml in PBS for chemiluminescence and at 0.5 x 106/ml in PBS /0.1 % BSA,
pH 7.4 for preparation of cytospins for immunocytochemical staining.
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2.8.2 BRONCHOALVEOLAR LAVAGE FLUID CYTOLOGY
Differential cell counts were determined by counting 500 cells on duplicate
Leishman's-stained cytospins prepared by centrifuging 100 pi raw BALF (300 x g, 3
min). Absolute BALF cell counts were determined for each cell type by multiplying
the cell ratio (%) by the total cell count/100. Duplicate Diff Quik-stained cytospins
were prepared for enumeration of apoptotic neutrophils (See Section 6.2.5) as
morphologic identification of these cells was clearer than on Leishman's-stained
slides. Cells were identified using established morphological criteria for equine
BALF (McGorum and Dixon, 1994; Moore and Cox, 1996; Freeman and Roszel,
1997). Neutrophils, lymphocytes, macrophages, eosinophils, mast cells, basophiloid
cells (McGorum and Dixon, 1994) and epithelial cells were counted separately.
2.8.3 ISOLATION OF NEUTROPHILS FROM BALF
2.8.3.1 Density gradient centrifugation
Although other workers (Grunig et al., 1990; Tremblay et al., 1993) have failed to
purify neutrophils from equine BALF with sufficient purity and recovery for
meaningful in vitro studies, this has been achieved by density gradient centrifugation
in other species (Cerasoli et al., 1988; Koh el al., 1993; Brown et al., 1995; Delclaux
eta/., 1997).
Utilising the same protocol described for the isolation of peripheral blood neutrophils
(Section 2.1), a broad range of cell densities was apparent in the post-challenge
BALF samples, as determined from differential counts of cells harvested from both
density interfaces and the cell pellet. Although neutrophils were enriched at the
42%/51% interface (4.4% neutrophils to 23.2% and 16.6% to 63.5% in 2
representative experiments), significant numbers of both lymphocytes and
macrophages were also present. It appeared that, not only was there a broad range of
cell densities in post-challenge BALF, but that these densities varied between horses
and with the duration of challenge and timing of the BAL. Different plasma/Percoll
density gradients were employed in an attempt to accommodate this (combinations of
plasma/Percoll dilutions ranging from 30-48% (2% steps) in the upper layer and 50-
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60% in the lower layer) but these only ever resulted in a modest enrichment of the
neutrophil dominant band.
Two multi-step Percoll gradients reported to successfully resolve human and sheep
BALF neutrophils (Cerasoli et al., 1988) and human blood eosinophils (Stern et al.,
1992) respectively, and a commercial leucocyte-resolving medium (Histopaque
1077) were also employed with similarly unsatisfactory results.
Continuous isotonic Percoll gradients were generated to provide a more versatile
method of resolving cells of very similar density. These were generated by
centrifugation (58,000 x g, 30 min, 4°C) of 70% isotonic Percoll/PBS in a 34° fixed
angle rotor centrifuge (Sorval RC-5B, Sorval UK Ltd., Stevenage, UK) against a
reference tube containing marker beads (Pharmacia, Uppsala, Sweden) of known
density (1033, 1049, 1062, 1075, 1087, 1098, 1122 and 1141 SG), (Figure 2.7). The
performance of the gradients was also assessed using mixed peripheral blood
leucocytes. Gradients were centrifuged (400 x g, 10 min, room temperature) and the
purity of cells harvested from the visible isopycnic bands assessed. The mixed blood
leucocytes were resolved into three bands (Figure 2.7) composed of 99.6 ± 0.05% (n
= 3) mononuclear cells; 99.6 ± 0.4% neutrophils and erythrocytes/eosinophils
respectively. BALF cells did not resolve uniformly, typically lying in two broad
bands with many cells interspersed between these two bands (Figure 2.7).
Differential counts of the cells harvested from the bands showed them to be very
mixed populations (see legend to Figure 2.7). This confirmed that after challenge
there was considerable overlap in the densities of the different cell types collected
from the airspaces by BAL and it was not possible to resolve them into sufficiently
pure populations based on their biophysical properties alone.
2.8.3.2 Immunological methods
When methods for cell purification based on biophysical properties have proved
impractical, positive or negative selection of phenotypically homogenous cell
populations with immunomagnetic beads has been used (Stern et al., 1992).
Although a commercial supplier (StemSep, Metachem Diagnostics Ltd.,
Northampton, UK) offered to attempt to establish and supply a panel of
immunomagnetic reagents for negative selection of neutrophils from equine BALF,
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Figure 2.7: Separation of mixed peripheral blood and BALF leucocytes on continuous
Percoll gradients
Left gradient: BALF cells; upper band - neutrophils 57.5%, lymphocytes 32.0%,
macrophages 10.1%; lower band - neutrophils 50.9%, lymphocytes 20.3%, macrophages
28.7%, eosinophils 0.1%.
Middle gradient: Density marker beads
Right gradient: Mixed blood leucocytes; upper band - neutrophils 0.5%, lymphocytes
65.3%, monocytes 34.2%; middle band - neutrophils 100%; lower band - erythrocytes and
eosinophils.
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lack of funds precluded pursuing this method further.
2.8.3.3 Flow cytometric methods
Recently, a method for the flow cytometric determination of oxidative burst in BALF
leucocytes collected from normal horses has been described (Raidal et al., 1998a).
However, previous work in this laboratory had indicated that it was not possible to
successfully resolve individual populations of BALF leucocytes after hay/straw
challenge based upon their forward and side light scatter profiles alone (McGorum el
al., 1993b). This would prevent accurate gate analysis of a pure neutrophil
population
2.8.3.4 Measurement of neutrophil specific chemiluminescence
One of the goals of isolating neutrophils from equine BALF was to assess changes in
their oxidative activity following recruitment to the lung. The mechanisms
underlying the CL response of phagocytes in the presence of different luminigenic
probes suggested that it might be possible to differentiate the CL signal generated by
neutrophils from that generated by other BALF phagocytes. Lum-DCL from
phagocytes is almost entirely dependent upon the haemoprotein myeloperoxidase
(Aniansson el al., 1984; Allen, 1986; Benbarek et al., 1996) found in the azurophilic
granules of neutrophils and the lysosomes of monocytes (Klebanoff, 1991), whereas
Luci-DCL is independent of myeloperoxidase and associated with superoxide anion
generation (Aniansson et al., 1984; Allen, 1986; Benbarek et al., 1996). Moreover,
as monocytes mature or migrate into tissues and transform into macrophages in vivo,
their myeloperoxidase is lost (Nichols et al., 1971; Borregaard et al., 1993),
suggesting that they would produce little if any Lum-DCL. It has been confirmed for
human BALF cells, from CL studies of alveolar macrophages mixed with peripheral
blood neutrophils in vitro (Ward et al., 1990) and from BALF harvested from
patients with various inflammatory lung diseases (Williams and Cole, 1981; Ward et
al., 1990; Dalhoff et al., 1994) that Lum-DCL almost exclusively reflects neutrophil
respiratory burst activity. We tested this hypothesis for equine BALF cells.
BALF from four horses, processed as described in Section 2.9.1, was supplemented
with allogenic peripheral blood neutrophils to produce samples containing 0-90%
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blood neutrophils (10% steps) whilst maintaining the cell concentration. Basal
(buffer only) and ZAP-stimulated Luci- and Lum-DCL were measured. Data from
the four animals were pooled and linear regression coefficients were calculated by
least squares analysis for the relationships between Luci- and Lum-DCL and
neutrophil and alveolar macrophage counts. ZAP-stimulated Lum-DCL increased
linearly with increasing PMN percentage and this correlation was highly significant
(Figure 2.8a). No other significant positive linear relationships were recognized.
This indicated that ZAP-stimulated Lum-DCL was almost exclusively generated by
PMN and might be used as an index of BALF PMN oxidative activity ex vivo.
To confirm that this conclusion remained valid with a mixed population of BALF
cells in vivo, the relationships between PMN counts and PBS-, fMLP-, ZAP- and
PMA-stimulated Luci- and Lum-DCL of BALF cells collected during the hay/straw
challenge experiments were analysed retrospectively (Spearman Rank correlation
coefficients). Data from all time points were pooled for this analysis. PBS-, fMLP-,
ZAP- and PMA-stimulated Lum-DCL were all strongly correlated (r = 0.70, 0.67,
0.76 and 0.78, respectively, p<0.0001 for all measurements) with the BALF
neutrophil percentage. The correlation between ZAP-stimulated Lum-DCL and
BALF neutrophil percentage is shown in Figure 2.8b. The weaker correlation
between the Lum-DCL of post-challenge BALF cells and the proportion of
neutrophils compared to the experiments using peripheral blood neutrophils shown in
Figure 2.8a may have been due to differences in the priming status and hence
respiratory burst activity of neutrophils recruited to the lung after challenge
(discussed in detail in Chapter 6). PMA- and fMLP-stimulated Luci-DCL were less
strongly correlated (r = 0.489 and 0.48, respectively; p<0.01) with the BALF
neutrophil percentage. These findings suggested that it was appropriate to quantify
the effect of hay/straw challenge on BALF phagocyte oxidative activity by CL and
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Figure 2.8a,b: Lum-DCL of equine BALF cells is neutrophil-dependent
a: BALF cells (processed as described in Section 2.9.1) were supplemented with allogenic
peripheral blood neutrophils to produce samples containing 0-90% neutrophils. ZAP-
stimulated Lum-DCL (measured over 90 min) increased linearly with the percentage of
neutrophils (linear regression co-efficient calculated by least squares analysis, r2 = 0.81,
p<0.0001). Pooled data from four experiments.
b: ZAP-stimulated Lum-DCL of BALF cells harvested in challenge experiments (processed
as described in Section 2.9.1). Lum-DCL and percentage PMN in BALF were closely
correlated (Spearman Rank correlation co-efficient r = 0.76, p<0.0001). Pooled data from 6
time points (n = 6).
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2.8.4 MEASUREMENT OF RESPIRATORY BURST ACTIVITY IN BALF
CELLS BY CHEMILUMINESCENCE
Lucigenin- and Lum-DCL of BALF cells and isolated peripheral blood neutrophils
were measured in parallel in response to PBS, fMLP (1 pM), ZAP (10% v/v) and
PMA (100 ng/ml) at each pre- and post-challenge time point. In these experiments,
following isolation, blood neutrophils were washed in an identical manner to that
described for BALF cells (Section 2.9.1).
PBS- and fMLP-stimulated CL was recorded over a 5 min time course and PBS-,
ZAP- and PMA-stimulated CL was recorded over a 90 min time course.
Concentrations of fMLP, ZAP and PMA were selected from the concentration
response curves generated during earlier in vitro studies (Sections 3.2.1; ZAP and
PMA and 3.2.3.2; fMLP).
To ensure that any changes in BALF neutrophil function were not caused by the
trauma of endoscopic BALF collection per se, in vitro sham lavage experiments were
performed using peripheral blood neutrophils harvested from horses (n = 3) in
remission. Two aliquots of neutrophils (100 x 106) were resuspended at 1 x 106/ml
in 0.9% NaCl at 37°C. One aliquot was aspirated through the endoscope by hand
using a 60 ml syringe (BAL sample) and the other was maintained on the bench at
room temperature (Control sample). Half the cells in each aliquot were prepared (see
Section 2.9.1) immediately (t = 0) and PBS- and fMLP-stimulated Luci- and Lum-
DCL were measured as described above. The remaining neutrophils were allowed to
stand for 90 min (the maximum recorded delay between BAL and measurement of
BALF cell CL) prior to preparation and measurement of CL (t = 90). There was no
significant difference in either the Luci- or Lum-DCL response of the neutrophils
that had undergone the sham BAL procedure compared to control cells at either time
point (Luci-DCL data [RLU]: t = 0; Control, PBS 0.08±0.02, BAL, PBS 0.0210.02,
Control, fMLP 0.2410.09, BAL, fMLP 0.49+0.04. t = 90; Control, PBS 0.0410.01,
BAL, PBS 0.110.02, Control, fMLP 0.2810.07, BAL, fMLP 0.4010.09, n = 3,
p>0.05).
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2.8.5 MEASUREMENT OF EQUINE NEUTROPHIL ELASTASE TYPE 2A (ENE
2A) IN BALF SUPERNATANT BY ELISA
Purification of ENE 2A, production and characterisation of an ovine polyclonal
antibody to ENE 2A and the development of the specific sandwich ELISA for ENE
2A was performed by Dr M. P. Dagleish, Department of Veterinary Clinical Studies,
Royal (Dick) School of Veterinary Studies (Dagleish, 1999a).
Micro-ELISA plate wells (Dynex Technologies Ltd., Billingshurst, UK) were coated
with 50 pi of sheep anti-ENE 2A (1.5 pg/ml) in 0.1 M carbonate/bicarbonate buffer.
Following overnight incubation at 4°C, plates were washed 6 times with 0.9% NaCl
containing 0.05% Tween 20 (0.9% NaCl-T20). Samples (in duplicate) and standards
(in triplicate) were diluted in 5% dried skimmed milk in PBS (MPBS) containing
0.05% Tween 20; 50 pi of each standard or sample were added per well. Purified
ENE 2A was used to generate a standard curve over the range 0.5 to 4.0 ng/ml. After
addition of samples and standards, plates were incubated at room temperature (21°C)
for 1 h followed by washing 6 times in 0.9% NaCl-T20. Fifty microlitres of affinity
purified sheep anti-ENE 2A conjugated to horseradish peroxidase (HRPO) (1 pg/ml
in 5% MPBS containing 0.05% Tween 20) was added per well and the plates were
incubated for a further hour at room temperature followed by a final 6 washes in
0.9% NaCl-T20. To initiate colour development 50 pi of 3,3',5,5'-
tetramethylbenzidine (TMB - Dynex Technologies Ltd., Billingshurst, UK) was
added per well as a soluble substrate for the HRPO enzyme and the reaction
terminated by addition of 25 pi of 0.18 M H2SO4. The colour intensity was
measured at 490 nm on a MR7000 ELISA plate reader (Dynex Technologies Ltd.,
Billingshurst, UK). ENE 2A is recognized by ELISA whether in the free or
complexed state (Dagleish, 1999a).
To ensure that ENE release from neutrophils was not induced by the trauma of
endoscopic BALF collection per se, in vitro sham lavage experiments (n = 3) were
performed as described in Section 2.9.4 above. Cell-free supernatants were prepared
as described in Section 2.8.1 both immediately after aspiration and 90 min later, prior
to measurement of ENE 2A by ELISA. Only small amounts (< 10 ng/ml) of ENE
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2A were detectable in the supernatants from both sham BAL and control cells at both
time points and these were not significantly different (data not shown).
2.8.6 MEASUREMENT OF EQUINE NEUTROPHIL ELASTASE ACTIVITY IN
BALF SUPERNATANT
Elastase activity in BALF supernatant was assayed using the specific neutrophil
elastase substrate N-methoxysuccinyl-ALA-ALA-PRO-VAL p-nitroanilide
(Nakajima et al., 1979).
The substrate was dissolved in dimethyl sulphoxide (10 mg/ml) and stored at 4°C
until use. Standards (ENE 2A) were diluted in buffer (50 mM Tris, 0.5 M NaCl,
0.1% triton XI00, pH 8.0) and 50 pi of each standard or sample were added, in
triplicate, to a 96-well plate. Supernatant samples from all horses at all time points
were measured on a single plate. Purified ENE 2A was used as a standard over the
range 0.16-20 ng/50pl. Following the addition of 50 pi substrate (0.1 ng/ml in
buffer) the change in absorbance produced by cleavage of the chromogenic substrate
was measured at 405 nm in a MR7000 ELISA plate reader (Dynex Technologies
Ltd., Billingshurst, UK). Absorbance was measured 1 min after addition of the
substrate and then at regular intervals until the optical density values of the 20 ng
ENE 2A/50 pi standard wells reached a plateau (typically 90 min). A standard curve
was generated from the change in absorbance (absorbance at plateau - absorbance at
1 min) of the ENE 2A standards from which the concentration of elastase in the
BALF samples could be computed. The long-term stability ofN-methoxysuccinyl-
ALA-ALA-PRO-VAL p-nitroanilide facilitates a very sensitive assay because,
providing the concentration of the chromogenic substrate is non-limiting, the change
in absorbance resulting from cleavage by even very low concentrations of elastase
remains linear for at least 12 h (Delclaux et al., 1997). In parallel experiments,
absorbance was repeatedly measured over 18 h, in an attempt to detect very low
concentrations of ENE. The change in absorbance with the 0.16 ng ENE 2A/50 pi
standard remained linear over this period (data not shown).
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2.8.7 IMMUNOCYTOCHEMICAL LOCALISATION OF ENE 2A IN BALF
CELLS
For immunocytochemical evaluation, cytospins of peripheral blood leucocytes and
BALF cells were prepared on TESPA-coated slides and fixed in freshly prepared 4%
paraformaldehyde in PBS (45 min, 45°C). Thereafter the slides were transferred to
70% ethanol and stored at 4°C. Cytospin preparations were then further dehydrated
in 95% ethanol and endogenous tissue peroxidase activity was blocked by incubation
with 3% H2O2 in methanol for 20 min followed by washing in running tap water for
5 min. Slides were placed in an humidified chamber and non-specific binding of the
rabbit anti-sheep antibody eliminated by incubating cells in 5% normal rabbit serum
in PBS (5% NRS/PBS) for 30 min, followed by incubation with the sheep anti-ENE
2A antibody (2.5 pg/ml in 5% NRS/PBS) for 90 min. Slides were washed three
times (5 min each) in PBS, prior to the addition of a rabbit anti-sheep antibody
conjugated to horseradish peroxidase (Dako Ltd., High Wycombe, UK) diluted 1/400
in 5% NRS/PBS for 60 min. Three washes in PBS (5 min each) preceded staining
with a 3-amino-9-ethylcarbazole (AEC) peroxidase substrate kit (Vector
Laboratories, Peterborough, UK) used as per the manufacturer's instructions.
Following the appearance of grossly visible red colouration (10-12 min) the slides
were washed in running tap water for 2 min followed by counterstaining in Mayer's
Haematoxylin and blueing with Scott's Tap Water Replacement. Slides were
initially mounted in Crystal/Mount (Biomeda Corp., Foster City, USA) followed by
DPX mounting medium. Preparation of cytospins of mixed peripheral blood
leucocyte populations indicated that the antibody identified exclusively neutrophils.
Negative control preparations were treated identically except that the sheep anti-ENE
antibody was substituted with an identical concentration of normal sheep IgG (2.5
pg/ml in 5% NRS/PBS).
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2.8.8 IMMUNOCYTOCHEMICAL LOCALISATION OL APOPTOTIC
CHROMATIN IN BALL CELLS BY THE TUNEL METHOD
To confirm that the densely staining inclusions recognized in alveolar macrophages
on Diff Quik-stained cytospins of BALF represented apoptotic nuclear chromatin,
additional cytospins were prepared from BALF cells collected 24 h after challenge.
These were fixed and stained for terminal deoxynucleotide transferase mediated UTP
nick end-labelling (TUNEL) as described in Section 2.6.6.
2.8.9 ASSESSMENT OF ULTRASTRUCTURAL MORPHOLOGY OF BALF
CELLS
To aid the identification of apoptotic neutrophils present both free within BALF and
within phagocytic alveolar macrophages, BALF cells were examined
ultrastructurally by TEM. BALF was collected from horses 24 h after challenge and
40 x 106 cells were washed, fixed, prepared, examined and imaged as described in
Section 2.3.2.1.
2.8.10 MEASUREMENT OF IL-8 AND TNF-a IN EQUINE BALF
Equine IL-8 was measured in the BALF supernatant by Dr M. Francini, Institute for
Veterinary Physiology, University of Zurich, Switzerland, who has previously cloned
and expressed erIL-8 and prepared a polyclonal rabbit anti-erIL-8 antiserum
(unpublished data). Triplicate samples of BALF supernatant and erIL-8 standards
(100 pg - 100 ng/ml) were blotted onto a nitrocellulose membrane and incubated (30
min, room temperature) in assay buffer (PBS/1% Tween/1% BSA). The membrane
was washed in PBS, incubated in assay buffer containing the polyclonal rabbit anti-
erIL-8 antiserum (90 min, room temperature) and washed a further three times in
assay buffer prior to incubation with an alkaline phosphatase-conjugated mouse anti-
rabbit monoclonal antibody (45 min, room temperature). After further washing in
PBS, the nitrocellulose was immersed in substrate solution until a dark spot was
readily recognizable at the site of the 100 ng/ml erIL-8. The membrane was washed
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in distilled water, air dried and the test and standard reactions digitised and analysed
by densitometry (Gel-Doc 2000, Bio-Rad, Hercules, USA) to generate a standard
curve and permit determination of the concentration of IL-8 in the test samples.
Additional attempts were made to measure equine TNF-a and IL-8 using human and
ovine cytokine ELISA systems by Mr J. Deighton, Department of Medicine,
Cambridge University School of Clinical Medicine. Three methods were utilised: (i)
a human assay system using monoclonal anti-human TNF-a and IL-8 capture
antibodies, with detection by a polyclonal anti-species conjugated antibody; (ii) a
second human ELISA system, using plates coated with a polyclonal anti-human IL-8
and detection with a biotinylated polyclonal anti-human IL-8 antibody and extra-
avidin conjugated alkaline phosphatase, and (iii) an ovine cytokine ELISA system
using a monoclonal anti-sheep IL-8 coating antibody with detection using a
secondary polyclonal conjugated anti-sheep IL-8 antibody. In all systems standard
curves were generated using the appropriate species recombinant cytokine.
2.9 STATISTICAL ANALYSES OF DATA
Data from the in vitro studies of neutrophil function were expressed as mean ± SEM
values of (n) number of independent experiments. Data were analysed using
ANOVA followed by the Student-Newman-Keuls post-test or by the student's paired
t-test. The effect of LPS priming on [3H]fMLP binding to equine neutrophils was
analysed using a paired one-tailed student's t-test. EC50 values were obtained by
analysis using Kaleidagraph (Macintosh) or GraphPad Prism (GraphPad Software
Inc.) software.
Data collected from the in vivo challenge studies and ex vivo neutrophil function
experiments were not normally distributed and were expressed as median and (range)
values for n animals. Consequently, paired and unpaired analyses of these data were
performed using the Wilcoxon Sign Rank and Mann Whitney tests, respectively.
Correlations were examined using the Spearman Rank Sign test and where one
variable was controlled, linear regression coefficients were calculated by least
squares analysis for the relationship to a measured variable. Multiple groups (e.g.
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Sham BAL data from different lung segments) were compared using the Kruskal-
Wallis test. Within group analyses of data collected from the in and ex vivo
hay/straw challenge studies were performed by comparison of data from post-
challenge time points with that collected at baseline. Analyses were performed using
either Minitab (Minitab Inc., Pennsylvania, USA) or GraphPad Prism (GraphPad
Software Inc.). Results were considered to be significant at the 5% level.
2.10 MATERIALS
2.10.1 REAGENTS AND LABORATORY EQUIPMENT
Bakers' yeast (Saccharomyces cerevisae), BSA, DNase 1, Dextran T500,
dithriothreitol, IMLP, glutaraldehyde, HEPES buffer, Histopaque 1077, LPS from
Escherichia coli serotype 0111 :B4, lucigenin, luminol, Mayer's Haematoxylin,
methylene blue, normal sheep IgG, normal rabbit serum, N-methoxysuccinyl-ALA-
ALA-PRO-VAL p-nitroanilide, penicillin/streptomycin, PMA, PBS, PBS w/o, rabbit
anti-sheep HRPO conjugated antibody, RNase A, TESPA, Trizma base, triton X-100,
Tween 20, trypan blue and zymosan were purchased from Sigma (Poole, Dorset,
UK). Iscove's modified Dulbecco's medium, Dulbecco's Modified Eagle Minimal
Essential Medium and HBSS were purchased from Gibco Life Technologies
(Paisley, UK). 0.9% NaCl was purchased from Ivex Pharmaceuticals (Larne, N.
Ireland). All tissue culture reagents were certified as endotoxin-free by the
manufacturers. Percoll was obtained from Pharmacia (Uppsala, Sweden).
Laboratory plasticware was purchased from Becton Dickinson Labware (Oxford,
UK) or Alpha Laboratories (Eastleigh, UK) unless otherwise stated. Round-
bottomed 2 ml Eppendorf tubes were purchased from Eppendorf (Hamburg,
Germany). Cotton gauze (Propax) was purchased from Smith & Nephew (Brierfield,
UK). 3.8% sodium citrate was purchased from Phoenix Pharmaceuticals Ltd
(Gloucester, UK). Silicone oil F-50 was obtained from Croylek Ltd, (Surrey, UK).
PAF and LTB4 were purchased from Novabiochem (Nottingham, UK). Rough
mutant Salmonella typhimurium Ra 60 was a gift from Dr I. Poxton, Department of
Microbiology, Medical School, University of Edinburgh. ErTNFa was a gift from
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Dr M. Barton, Department of Large Animal Medicine, University of Georgia, USA
and the HL801 hybridoma cell line producing erTNFa neutralising antibody was a
gift from Dr R. MacKay, Department of Large Animal Medicine, University of
Florida, USA. Annexin V - FITC and Annexin V Buffer were purchased from
Biowhittaker (Wokingham, UK). HrTNFa and hrGM-CSF and hrIL-8 were
purchased from Genzyme (Cambridge, MA). The hrTNFa neutralising antibody
(MAB 210) and mouse isotype control (IgGi) antibody (MAB 002) were purchased
from R&D Systems (Abingdon, UK). Canine anti-sheep red blood cell antibody
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was purchased from VMRD, Inc, (Pullman, USA). [ H]fMLP (specific activity 1.48-
3.219 TBq [40-87 Ci/mmol]) was purchased from NEN Life Science Products
(Stevenage, UK). Scintillation fluid (Flo-Scint IV) was purchased from Packard
Biosciences B.V. (Groningen, Netherlands). Diff Quik was purchased from B M
Brown Ltd (Reading, UK). Leishman's stain and DPX mounting medium were
purchased BDH (Loughborough, UK). All other chemicals were of molecular or
reagent grade and were obtained from Sigma (Poole, UK) or BDH (Loughborough,
UK).
2.10.2 PREPARATION AND STORAGE OF REAGENTS
Stock LPS (1 mg/ml in PBS) was stored at -20°C and once thawed was
disaggregated in a sonicating waterbath for 10 min. Stock PAF (10 mM in ethanol),
PMA (dissolved in DMSO, diluted to 1 mg/ml in PBS), fMLP (dissolved in DMSO,
diluted to 1 mM in PBS) and LTB4(1.49 x 10"4 M in ethanol) were stored at -20°C.
Stock hrTNFa (10 pg/ml in PBS), erTNFa (12.5 ng/ml in PBS) and hrIL-8 (10
pg/ml in PBS) were stored at -80°C. All antibodies were stored at -20°C. All other
reagents were stored as per the manufacturers' instructions.
Autologous heat-inactivated serum was prepared by the addition of 220 pi of 10 mM
CaCl2 to 10 ml of platelet-rich plasma, incubating for 90 min at 37°C in an
humidified 5% CO2 atmosphere, then heating at 56°C for 30 min.
Zymosan-activated plasma (ZAP) and serum (ZAS) were used as a source of the
complement fragment C5a and were produced by adding 5 mg/ml zymosan to PPP or
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serum followed by sonication and incubation at 37°C for 60 min. The suspension
was centrifuged (1400 x g, 15 min) and the supernatant removed and stored in 100 pi
aliquots at -20°C. ZAP and ZAS were used in all experiments at a final
concentration of 10% (v/v). The same batches of ZAP and ZAS were used for all in
vitro studies and fresh batches were prepared for use in the ex vivo hay/straw
challenge studies.
Heat killed baker's yeast (5 g /100 ml PBS, boiled, 30 min) were washed twice in
PBS, disaggregated by aspiration (twice) through a 29 G needle, washed again and
opsonised by incubation with 10% pooled horse serum/PBS (50 x 106 particles/ml) at
37°C for 30 min (Johannisson et al., 1995). The yeast were again washed twice and
disaggregated, then resuspended at appropriate concentrations in PBS and stored in
aliquots at -20°C. Control particles were prepared in an identical manner except they
were incubated with PBS alone.
Opsonised ovine erythrocytes (OsRBC) were prepared freshly as required. Ten ml of
ovine blood, anticoagulated with 3.8% sodium citrate, was centrifuged (800 x g, 10
min). Two ml of the RBC pellet was washed three times in PBS, diluted in PBS to a
haematocrit of 1% and incubated (37°C, 30 min) with a sub-aggregating
concentration (1/40 from stock) of canine anti-sheep red blood cell antibody. Cells
were washed twice then resuspended at appropriate concentrations in PBS (CL
studies) or Iscove's modified Dulbecco's medium (apoptosis studies). Control cells
(sRBC) were prepared in an identical manner except they were incubated with PBS
alone.
HL801 hybridoma cells (200,000 - 300,000/ml) were cultured in Dulbecco's
Modified Eagle Minimal Essential Medium (high glucose with L-glutamine, without
sodium pyruvate) supplemented with 10% horse serum and 100 U/ml
penicillin/streptomycin at 37°C in an humidified 5% CCB atmosphere. For in vitro
antibody production, cells were cultured in Dulbecco's Modified Eagle Minimal
Essential Medium supplemented with ultra low IgG-containing foetal calf serum and
100 U/ml penicillin/streptomycin. Culture supernatant was harvested, centrifuged to
remove cellular debris and stored at -20 °C.
Supernatant IgGl concentration was measured using a commercial radial
immunodiffusion kit (Nanorid, The Binding Site Ltd., Birmingham, UK).
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Phosphate-Buffered Saline (PBS) for use in immunocytochemistry (Sections 2.6.6
and Section 2.8.7) was prepared by addition of 8 g NaCl, 0.2 g KC1, 1.15 g Na2HPC>4
and 0.2 g KH2PO4 to 1 litre de-ionised, distilled water. pH was adjusted to 7.2-7.3.
The carbonate/bicarbonate buffer (0.1 M), ENE 2A ELISA coating buffer (Section
2.8.5) was prepared by addition of 1.59 g Na2CC>3 and 2.93 g NaHCCb was dissolved
in 1 litre de-ionised, distilled water. pH was adjusted to 9.6 if necessary. The buffer
was stored in 50 ml aliquots at -20°C.
Scott's Tap water replacement was prepared by addition of 7 g NaHC03 and 40 g
MgSC>4 to 2 litres of tap water.




CHARACTERIZATION OF PRIMING AND ACTIVATION IN EQUINE
PERIPHERAL BLOOD NEUTROPHILS IN VITRO
3.1 INTRODUCTION
The key role that neutrophils play in the vanguard of the acute cellular response to
infection and injury necessitates tight co-ordination of the complex events that
regulate both their recruitment to sites of inflammation and their ability to destroy
invading micro-organisms (Haslett et al., 1989b; Rossi and Hellewell, 1994; Bokoch,
1995; Downey et al., 1995). Since these cells are recognized primarily as the
linchpin of the innate immune response to invading micro-organisms, much attention
has been focussed on the neutrophil's armoury of reactive oxygen and nitrogen
species, proteolytic enzymes and antibacterial peptides (reviewed in Section 1.3).
However, the "fallout" from this beneficial inflammatory response can, through the
inappropriate or excessive secretion of histotoxic or pro-inflammatory substances by
the neutrophil, contribute to host tissue damage. This sequence of events is
increasingly being recognized and elucidated in the horse (reviewed in Section 1.6).
As detailed in Section 1.4, the responsiveness of granulocytes to secretagogue stimuli
is governed by whether these cells have been previously exposed to priming agents
such as bacterial products (e.g. LPS and N-formylated peptides), cytokines (e.g.
TNF-a, IL-8 and GM-CSF) and lipid-derived mediators (e.g. PAF and LTB4)
(Bochsler et al., 1992; Condliffe et al., 1998b). In many species, such agents
sensitise the neutrophil to enhance certain functional responses, such as superoxide
anion generation, adhesion, cell surface serine proteinase expression, release of
proteolytic enzymes and the generation of lipid mediators, when subsequently
exposed to secretagogue agonists (reviewed in Section 1.4.1). Priming also regulates
the relative expression of surface adhesion molecules, most notably CD62-L (L-
selectin) and the major p2-integrin, CD18/CD1 lb (Condliffe et al., 1996). Thus, the
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augmentation of these effector functions following exposure to priming agents would
seem to be a critical step to realise integrated and optimal neutrophil microbicidal
activity. In addition, neutrophil priming is thought to be crucial to the initial
recruitment of these cells to an inflamed site (Worthen et al., 1987) and appears to be
a prerequisite for neutrophil-mediated host tissue damage both in vitro (Smedly et
al., 1986) and in vivo (Worthen et al., 1987; Williams et al., 1993). It is important to
note however, that priming appears to be a potentially reversible event [at least in
vitro', (Kitchen et al., 1996b)] and that the retention of primed cells in, for example,
the pulmonary capillary bed does not necessarily equate with tissue damage (Ussov
et al., 1996).
To re-iterate, the key principal of the priming concept demands that exposure to a
priming agent that potentiates a secretory response to a subsequent activating
stimulus should not by itself elicit that response (Downey et al., 1995; Condliffe et
al., 1998b). Indeed, pulling the trigger of the loaded "neutrophil" gun prior to
selection of an appropriate target has the potential for disastrous consequences, not
least if this occurs in intravascular neutrophils or cells still in the process of transiting
the endothelium. In vitro studies suggest that unprimed, circulating neutrophils are
entirely unresponsive to secretagogue stimuli such as fMLP (Elbim et al., 1993;
Pabst, 1994). This highlights the importance of using a neutrophil isolation method
that does not prime cells when studying these events in vitro (Haslett et al., 1985;
Pabst, 1994).
Neutrophil priming was initially defined (Guthrie et al., 1984) in studies examining
the enhancement of secretagogue-induced oxidant generation by the NADPH
oxidase; hence the focus on the respiratory burst in the characterization of this
phenomenon in the horse. The chemiluminescence model used in these studies was
specifically developed for its high sensitivity for detecting the kinetics of oxidant
(especially superoxide anion) release from cells (Allen, 1986) and its flexibility in
the study of the respiratory burst from a mixed population of cells (Ward et al.,
1990). Lucigenin only measures externally secreted oxidants (Dahlgren et al., 1985)
and the CL response is 99% inhibited by superoxide dismutase (Allen, 1986;
Benbarek et al., 1996) suggesting that such data is qualitatively similar to that
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derived in the more traditional superoxide dismutase-inhibitable cytochrome C
reduction assay (Guthrie et al., 1984; Kitchen et al., 1996b).
In preliminary experiments, a panel of potential neutrophil agonists was screened for
their ability to stimulate the respiratory burst (Luci-DCL) in freshly isolated
neutrophils.
The arachidonic acid metabolite, LTB4 has been detected in inflammatory exudates
in the horse (Higgins and Lees, 1984) and is a potent chemoattractant for equine
neutrophils in vitro (Lees et al., 1986; Watson et al., 1987; Foster et al., 1992).
Leukotriene B4 has also been shown to augment adherence (Marr et al., 1999), the
phagocytic and bactericidal capacity of equine neutrophils (Watson, 1988) and can
stimulate recruitment of radiolabeled neutrophils to the lungs of normal horses
(Marr et al., 1998b). However, LTB4 is known to be a weak secretagogue for human
neutrophils (Rollins et al., 1983; Snyderman and Uhing, 1992; Edwards, 1994b).
The synthetic tripeptide, fMLP, which mimics the effects of a number of bacterial
cell wall-derived peptides, has been widely used as a model agonist for studying the
response of mammalian neutrophils to bacterial infection, sepsis and tissue injury
(Becker, 1987). This peptide has been detected in culture supernatants from a
number of bacteria including Escherichia coli and in samples of dust associated with
neutrophilic environmental lung disease in man (Siegel et al., 1994). The large and
consistent nature of the secretory and chemotactic response induced by fMLP in
human neutrophils has also made it the agent of choice in studies exploring the
mechanisms underlying receptor-mediated priming and activation (Becker, 1987).
However, despite possessing a small number of seemingly identical high affinity
fMLP receptors (Snyderman and Pike, 1980), equine neutrophils appear to display a
very different pattern of responses compared to human neutrophils, to the extent that
most recent reports have regarded the equine fMLP receptor as being of little
functional significance (Camp and Leid, 1982; Sedgwick et al., 1987; Scudamore et
al., 1993). This conclusion is supported by the lack of any inflammatory response
when fMLP is injected intradermally in the horse, even at concentrations as high as
10 mM per 100 pi injection volume (McEwen and Lumsden, 1991). Despite this, a
number of early in vitro studies have reported fMLP effects in equine neutrophils,
including induction of chemotaxis [albeit only at very high concentrations (Zinkl and
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Brown, 1982), and concentration-dependent lysosomal enzyme release (Snyderman
and Pike, 1980). The latter observation suggested that superoxide anions might be
produced under appropriate conditions since release of lysosomal enzymes and
superoxide anions usually occur concurrently (Haslett et al., 1985). Although two
studies have stated that fMLP could induce superoxide anion generation in equine
neutrophils (Snyderman and Goetzl, 1981; Bertram, 1985), no experimental data
were presented to support these assertions. Hence, while specific species differences
have been demonstrated in studies of inflammation in the horse (Slauson et al., 1985;
Bertram, 1985; Scudamore et al., 1993; Lindberg et al., 1998), the precise function
and role of the fMLP receptor in equine neutrophils remains uncertain.
Interleukin-8 is a CXC chemokine, produced by many cell types including
monocytes/macrophages, neutrophils and epithelial cells and is a potent and selective
agonist of human neutrophils, stimulating shape change, adhesion, bioactive lipid
synthesis, degranulation and the respiratory burst (Baggiolini et al., 1994). There is,
however, some controversy surrounding the ability of IL-8 to directly stimulate
respiratory burst activity (Baggiolini et al., 1992). For example, Elbim and
colleagues (1994) demonstrated that IL-8 acts as a potent priming agent in human
neutrophils, while others have suggested that this agent is, at best, a weak priming
agent and that its more important functions are the regulation of neutrophil adhesion
and migration (Roberts et al., 1993). Interleukin-8 has been implicated in the
pathogenesis of equine COPD (Franchini et al., 1998) and hrIL-8 has been reported
to augment adhesion of equine neutrophils to serum- and fibronectin-coated plastic in
a CD18-dependent manner (Marr et al., 1999). Francini and colleagues (1998)
demonstrated an increase in the neutrophil chemotactic activity of BALF collected
from COPD-susceptible horses when housed in dusty conditions. They related this
to increased synthesis of IL-8 mRNA by alveolar macrophages stimulated in vitro.
Although not a physiological stimulus, the complex plant derived lipid, PMA has
been widely used in neutrophil activation and signal transduction studies (Lehrer and
Cohen, 1981; Lundqvist et al., 1996), including a number of studies in equine
neutrophils (Auer et al., 1990; Bochsler et al., 1990; Bochsler et al., 1992; Benbarek
et al., 1996; Moore et al., 1997; Marr et al., 1997a; Marr et al., 1999). PMA binds
directly to protein kinase C (bypassing plasma membrane receptors), leading to its
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sustained activation and redistribution with subsequent stimulation of neutrophil
superoxide anion generation (Auer et al., 1990; Bochsler et al., 1992; Moore et al.,
1997; Marr et al., 1997a), chemiluminescence (Benbarek et al., 1996), adhesion
(Marr et al., 1999), aggregation and degranulation (Moore et al., 1997) and (3?
integrin expression (Bochsler et al., 1990).
Incubation of plasma or serum with the yeast cell wall component zymosan activates
complement via the alternative pathway, generating the glycoprotein anaphylotoxins
C3a and C5a (Edwards, 1994a). Only C5a is chemotactic for neutrophils and can
also induce adhesion, degranulation and the respiratory burst (Edwards, 1994b).
Although hrC5a can stimulate superoxide anion generation and augment adherence
of equine neutrophils (Bochsler et al., 1992; Foster et al., 1997; Marr et al., 1999),
equine rC5a is not commercially available and therefore zymosan activated plasma
(ZAP), as a biological source of C5a, has been used in the study of equine neutrophil
activation (Sedgwick et al., 1987; Slauson et al., 1987).
A plethora of mammalian cell types are stimulated following exposure to
lipopolysaccharide (LPS), a complex glycolipid component of gram-negative
bacterial cell walls (Ulevitch and Tobias, 1995). Gram-negative bacterial sepsis and
endotoxaemia following bacterial lysis are major factors implicated in the morbidity
and mortality associated with acute lung injury and multi-organ failure in man and
this endotoxin-associated lung injury is largely neutrophil dependent (Brigham and
Meyrick, 1986; Welbourn and Young, 1992). Similarly, endotoxaemia and its
subsequent complications appear to play a critical role in disease pathogenesis and
mortality associated with gram-negative sepsis and gastro-intestinal mucosal injury
in the horse (Hunt et al., 1986; Morris, 1991; Moore et al., 1995). Of particular
interest to this study is the implication that LPS plays a central role in the response to
inhaled organic toxic dust (Castranova et al., 1996; Deetz et al., 1997; Schenker et
al., 1998; Wohlford-Lenane et al., 1999) and in the exacerbation of allergic asthma
in humans (Michel et al., 1996). Moreover, conventionally managed stables (horses
bedded on straw and fed dry hay) contain total airborne LPS concentrations greater
than those shown to cause bronchial hyperresponsiveness and pulmonary
inflammation in normal human subjects (McGorum et al., 1998). Indeed,
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preliminary investigations in this laboratory suggest at least a complementary role for
LPS in the pathogenesis of equine COPD (Pirie et al., 1998).
Endotoxin has long been recognized as a potent priming agent of human neutrophils
(Guthrie et al., 1984; Haslett et al., 1985; Pabst, 1994) and the mechanisms of cell
interaction with LPS have undergone intense scrutiny (Wright, 1991; Ulevitch and
Tobias, 1994; Ulevitch and Tobias, 1995). In view of the relative lack of information
regarding the effects of endotoxin on equine neutrophils, the response of these cells
to LPS and other human granulocyte priming agents was investigated. Bochsler and
co-workers (1992) demonstrated that LPS binds avidly to equine neutrophils but is a
weak stimulus of superoxide anion generation. Also, LPS alone failed to directly
trigger a CL response in equine neutrophils (Benbarek et al., 1997; Benbarek et al.,
1998). However, the data in these latter two studies were quite variable with
neutrophils from several horses showing a clear concentration-dependent CL
response to LPS. Smooth forms of LPS, as used in the studies reported herein, do
not stimulate a CL response in human neutrophils, whereas rough forms, in which
the variable length hydrophobic O-polysaccharide moiety is lost (Poxton, 1995), can
directly activate the neutrophil respiratory burst (Kapp et al., 1987).
The cytokine TNF-a is produced by a wide variety of cells involved in the acute
inflammatory response, including macrophages, endothelial cells and neutrophils
(Edwards, 1994b). TNF-a has been shown to play a key role in the response of the
horse to endotoxaemia (MacKay, 1991; Cargile el al., 1995). In vitro, TNF-a has
been primarily recognized as a potent priming agent of human neutrophil function
(McColl et al., 1990; O'Flaherty et al., 1991; Condliffe et al., 1998b) and a stimulus
for phagocytosis (Shalaby et al., 1985; Klebanoff et al., 1986) and adhesion to
biological surfaces (Schleiffenbaum and Fehr, 1990) but alone it is a weak stimulus
of superoxide anion generation (Kitchen et al., 1996a). However, at high
concentrations TNF-a may cause some direct respiratory burst activity of neutrophils
in suspension (Klebanoff et al., 1986; Kapp and Zeck-Kapp, 1990; Zeman et al.,
1996) and it is clearly able to stimulate superoxide generation in neutrophils that
have been primed by other soluble agents or through adhesion (Schleiffenbaum and
Fehr, 1990).
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The acetylated phosphoglyceride lipid, PAF, is generated by the action of
phospholipase A2 on ether-linked phospholipids. Numerous cell types involved in
the inflammatory response including neutrophils, platelets, monocytes/macrophages,
mast cells and vascular endothelial cells (Chung, 1992) can release PAF. PAF has
multiple effects on human neutrophils in vitro, stimulating cell polarisation and
aggregation (Rossi et al., 1993), chemotaxis (Shaw et al., 1981), adhesion (Ingraham
et al., 1982), upregulation of surface adhesion molecules (Condliffe et al., 1996) and
it is a weak stimulus of the respiratory burst (Gay et al., 1986). However, PAF also
operates as a potent neutrophil priming agent for enhanced superoxide anion
generation, aggregation and degranulation in response to fMLP (Vercellotti et al.,
1988; Gay, 1993; Kitchen et al., 1996b). PAF has profound effects on
cardiopulmonary function when administered to humans systemically (Chung, 1992).
It is a potent mediator of equine neutrophil chemotaxis (Foster et al., 1992) and
adhesion (Foster et al., 1997; Marr et al., 1999) but a poor stimulus of superoxide
anion generation (Marr et al., 1997a). Intradermal injection of PAF produces dose-
dependent increases in vascular permeability in the horse (Mills et al., 1995) and
intravenous administration stimulates rapid but reversible increases in heart rate,
respiratory rate and pleural pressure with recruitment of neutrophils, eosinophils and
platelets to the lungs (Fairbairn et al., 1996).
Although this chapter focuses upon the neutrophil respiratory burst, other functional
responses implicit in the neutrophil priming/activation paradigm have been studied
as necessary. For example, exposure of neutrophils to uniform (i.e. non-gradient)
concentrations of inflammatory mediators or chemoattractants in vitro stimulates
many functional and biochemical changes, including cell polarization or shape
change. This latter effect has a number of significant functional correlates; for
example, microscopic scoring of neutrophil shape change correlates well with the
chemotactic capacity of these cells measured using the Boyden chamber technique
(Haston and Shields, 1985). More importantly, shape change correlates closely with
the priming status of neutrophils measured by subsequent agonist-stimulated
superoxide anion generation (Haslett et al., 1985; Kitchen et al., 1996b). Also
priming-induced cytoskeletal alterations reduce neutrophil deformability, which, in
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vivo increases their sequestration within the pulmonary capillary bed (Haslett et al.,
1987; Worthen el al., 1989; Selby et al., 1991). This study centres upon
characterization of the CL response of the equine neutrophils to three secretagogue
agonists PMA, ZAP and fMLP and the modulation of these responses following
exposure to the well-substantiated human neutrophil priming agents LPS, TNF-a and
PAF. This model of equine neutrophil priming was specifically developed with a
view to its application to the ex vivo study of neutrophils harvested from horses
susceptible to COPD. It was anticipated that this would provide an index of the
functional status of equine neutrophils both in the circulating granulocyte pool and
those recruited to the airspaces following exposure of these susceptible animals to a
hay/straw challenge.
3.2 RESULTS
3.2.1 EQUINE NEUTROPHIL ACTIVATION: THE RESPIRATORY BURST
In preliminary experiments, a panel of potential neutrophil agonists was screened for
their ability to stimulate Luci-DCL in freshly isolated cells. These included PMA,
ZAP, human and equine rTNF-a, LPS, PAF, fMLP, LTB4, and hrIL-8 as soluble
stimuli and opsonised heat-killed yeast as a particulate stimulus.
Leukotriene B4 (0.1 pM) stimulated a very small but significant response (control,
0.2 ± 0.03 RLU; LTB4, 0.3 ± 0.04 RLU; n =11, p <0.0001) suggesting that, as in
human neutrophils, this agent is a relatively poor secretagogue.
Incubation of freshly isolated neutrophils with fMLP (1 pM) did not stimulate Luci-
DCL compared to buffer treated control cells (control, 0.2 ± 0.04 RLU; fMLP, 0.3 ±
0.1 RLU; n = 17, p >0.05) consistent with the work of Benbarek et al. (1996).
In this assay, hrIL-8 (1 pg/ml) did not stimulate a respiratory burst (control, 0.2 ±
0.03 RLU; hrIL-8, 0.2 ± 0.04 RLU; n = 11, p >0.05).
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3.2.1.1 Activation of the respiratory burst by PMA
PMA stimulated concentration- and time-dependent Luci-DCL (Figure 3.1a,b) with
an EC50 of 13.9 ± 2.5 ng/ml (n = 4), a maximal response to 100 ng/ml PMA with a
nodal time of 34.6 ± 5.8 min. This is consistent with previously published data in
equine cells [95% confidence interval of 0.4 - 9.9 ng/ml (Moore et cil, 1997) and an
EC50 of 5 ng/ml (Marr, 1996)] and is very similar to the EC50 value of 6.5 ng/ml
reported for human neutrophils (Lieberman el al., 1996).
3.2.1.2 Activation of the respiratory burst by ZAP
ZAP stimulated a concentration-dependent respiratory burst (Figure 3.2a) over a time
course similar to PMA but with a shorter nodal time (Figure 3.2b). While the
duration of the CL response to ZAP did show some variation between donors (e.g.
compare Figures 3.2b and 3.8), nodal times were very consistent. In all subsequent
experiments, including the ex vivo challenge studies, CL was measured over 90 min
using 10% v/v ZAP.
3.2.1.3 Activation of the respiratory burst by phagocytosis
Phagocytosis-stimulated Luci-DCL was measured following the addition of
opsonised heat-killed yeast, or yeast incubated with PBS alone, at a ratio of 3 yeast
particles per neutrophil. Phagocytosis was confirmed to have taken place by light
microscopic examination of Diff-Quik stained cytospin preparations of cells
harvested at the end of the assay (data not shown). Interaction with non-opsonised
particles stimulated a significant respiratory burst but this was greatly enhanced
(p<0.01, n=5) following opsonisation (Figure 3.3). The kinetics of the Luci-DCL
response to opsonised yeast were also significantly faster (nodal time 23.3 ± 2.2 min,
n = 5) than in response to non-opsonised yeast (nodal time 72.2 ± 10.3 min, p<0.01).
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Figures 3.1a,b: Activation of equine neutrophil respiratory burst by PMA
a: Concentration-response curve for PMA-stimulated Luci-DCL in equine neutrophils.
Values represent the mean ± SEM of 4 separate experiments, each performed in triplicate,
b: Time course of PMA-stimulated (100 ng/ml) Luci-DCL in equine neutrophils. The data
points represent mean of triplicate determinations from a single experiment representative of
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Figure 3.2a,b: Activation of equine neutrophil respiratory burst by ZAP
a: Concentration-response curve for ZAP-stimulated Luci-DCL. Values represent mean ±
SEM of 3 separate experiments, each performed in triplicate.
b: Time course of ZAP-stimulated (10% v/v) Luci-DCL. Data points represent the mean of
triplicate determinations from a single experiment representative often. Nodal time: 20.7
min (mean: 23.5 ± 1.05 min).
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PBS Y OY PMA
Figure 3.3: Phagocytosis-stimulated respiratory burst in equine neutrophils
Neutrophils were stimulated by addition of non-opsonised (Y) or opsonised yeast (OY) at a
ratio of 3 yeast particles/cell or PMA (100 ng/ml) as a positive control. Luci-DCL was
recorded over 90 min. Values represent mean ± SEM of integral data from 5 separate
experiments (n = 3 for PMA), each performed in triplicate. (** ; p<0.01, Y vs OY)
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3.2.1.4 Comparison of Lucigenin- and Luminol-dependent chemiluminescence
As discussed in Section 3.1 above, luminigenic probe-dependent CL measured in the
presence of lucigenin is generated predominantly by externally secreted superoxide
anions (Benbarek el al., 1996). Measurement of Luci-DCL permitted qualitative
comparison of CL data with previously published studies of both human and equine
neutrophils that utilised the superoxide dismutase-inhibitable cytochrome C
reduction assay to quantify superoxide anion release. However, Lum-DCL
[generated exclusively by the myeloperoxidase-hydrogen peroxide system (Dahlgren
et al., 1985)] was utilised in ex vivo studies to assess the neutrophil-specific
respiratory burst activity within a mixed population of BALF cells (see Section
2.8.3.4). Thus, the kinetics of PMA- and ZAP-stimulated Lum-DCL in peripheral
blood neutrophils were characterized and compared to Luci-DCL responses. This
revealed quantitative differences in the CL responses to both ZAP and particularly
PMA (Figure 3.4). Analysis of the kinetics of PMA-stimulated Lum-DCL revealed
that this was due to a much lower peak CL velocity with a concomitant reduction in
total (integral) CL, although nodal times were similar. The kinetics of ZAP-
stimulated Luci- and Lum-DCL differed markedly. The luminol signal was bimodal
with a very early peak (nodal time 2 min) that waned rapidly (4 min) followed by a
gradual increase to a second smaller peak at 60-70 min, indicating two phases of









Figure 3.4a,b: Comparison of PMA- and ZAP-stimulated Luci-DCL and Lum-DCL in
equine neutrophils.
Cells were stimulated with PMA (100 ng/ml) or ZAP (10%) and CL recorded over 90 min.
a: Time course of PMA (black lines)- and ZAP (red lines)-stimulated Luci (plain lines)- and
Lum (hatched lines)-DCL. Data points represent the mean of triplicate determinations from a
single experiment representative of 6.
b: Comparison of total (integral) CL in the presence of Lucigenin (closed bars) or Luminol
(hatched bars). Values represent mean ± SEM of integral data from 6 separate experiments,
each performed in triplicate.
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3.2.1.5 Direct effect of LPS, TNF-a, PAF and hrIL-8 on the respiratory burst in
equine neutrophils
In these studies, activation of the respiratory burst measured by Luci-DCL was used
to define equine neutrophil priming. The ability of LPS, TNF-a, PAF and hrIL-8 to
directly stimulate a respiratory burst was determined prior to investigating the
priming capacity of these agents (see Section 3.3).
Figure 3.5a shows that LPS was only able to stimulate respiratory burst activity at
very high concentrations of (>10pg/ml). This minor activation may in part reflect
the presence of residual plasma factors, which can interact with LPS to trigger
neutrophil CL (Benbarek et al., 1998) or may be due to contamination of the smooth
LPS preparations used with rough forms of LPS, which are able to directly trigger
human neutrophil CL (Kapp et al., 1987).
The ability of human and equine rTNF-a to directly stimulate CL in equine
neutrophils was compared. Human rTNF-a stimulated CL at concentrations greater
than 10 ng/ml (Figure 3.5a) but this response was highly variable between donors.
Equine rTNF-a produced a similarly variable response but displayed activity at
substantially lower concentrations (100 pg/ml, Figure 3.5a). The effect of erTNF-a
was only tested up to 1 ng/ml because the highest concentration of stock erTNF-a
available was 12.5 ng/ml. In spite of regular shaking of the microtitre plate during
the luminometer cycle, it is possible that some cell adhesion occurred, which is well
recognized to enhance the ability of TNF-a to directly stimulate superoxide anion
generation in neutrophils (Schleiffenbaum and Fehr, 1990).
PAF stimulated a very weak but significant CL response only at the highest
concentration tested (1 pM), (Figure 3.5b, control 0.1 ± 0.02 RLU; PAF 0.7 ± 0.2
RLU, n = 3, p<0.05). This compares to data presented by Marr et al., (1997) who
observed a small increase in superoxide anion generation in equine neutrophils
treated with 10 pM PAF alone. They also reported a significant response to 1 pM
PAF following pre-incubation with cytochalasin B, but only in one group of donors
tested. PAF (1 pM) alone does not stimulate significant superoxide anion
generation in human neutrophils under most assay conditions (Vercellotti el al.,
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Figure 3.5a,b: Direct effect of LPS, equine and human rTNF-a and PAF on respiratory
burst activity in equine neutrophils
Following addition of agonists at the concentrations shown, Luci-DCL was recorded over 60
min. Values represent mean ± SEM of 3 separate experiments each performed in triplicate,
a: Concentration-response curves for equine (diamonds) and hrTNF-a (squares) and LPS-
stimulated Luci-DCL (triangles).
b: Concentration-response curve for PAF-stimulated Luci-DCL (* ; p<0.05)
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Human rIL-8 did not stimulate respiratory burst activity in equine neutrophils at any
of the concentrations tested (0.1-1000 ng/ml).
3.2.2 NEUTROPHIL ACTIVATION: CELL POLARIZATION
Neutrophils in the circulation and those isolated under conditions of stable tonicity
and free of endotoxin are smooth and spherical (Howard et al., 1990; Fernandez-
Segura et al., 1995). Stimulation leads to changes in surface morphology, with the
appearance of ridges, ruffles, the extrusion of one or more pseudopodia and
ultimately polarization with a front to tail polarity. Changes in cell volume, area and
granularity also occur following stimulation (Fernandez-Segura et al., 1995; Keller et
al., 1995). These changes result from alterations in the distribution and degree of
polymerisation of F-actin (Howard et al., 1990; Bearer, 1993; Fernandez-Segura et
al., 1995). The nature of these changes is also governed by the agonist employed, its
concentration and the duration of exposure (Keller el al., 1995).
In these studies, freshly isolated equine neutrophils were smooth and spherical when
examined under phase contrast microscopy (see Figure 2.4, panel A). Under SEM
and TEM they were spherical with short microvilli (SEM and TEM, Figures 3.6a,b)
and occasional surface microridges (SEM, Figure 3.6a). As reported previously
(Pycock et al., 1988), stimulation with ZAP resulted in dramatic shape change and
polarization that was readily apparent under phase contrast microscopy (Figure 2.4,
panel B). Also large surface ridges, ruffles, folds and long, granule-free lamellipodia
associated with polarization, with an obvious front to tail polarity, were observed
under SEM and TEM (Figures 3.6c,d).
Although the flow cytometry assay cannot differentiate the form of shape change
induced by an individual agent (Keller et al., 1995), the proportion of cells
responding correlates closely with microscopic scoring (see Section 2.3.1.3).
The secretagogue agonists, PMA and ZAP caused a dramatic, concentration-
dependent, shape change response in freshly isolated equine neutrophils (% shape
change: control, 9.9 ± 2.1%; 10 ng/ml PMA, 83.3 ± 7.1%; 5% ZAP, 91.5 ± 2.6%, 10
min, p<0.0001, n=7, Figure 3.7a), with 10 ng/ml PMA and 5% ZAP inducing
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Figure 3.6a: Scanning electron photo¬
micrograph of freshly isolated neutrophils
(Magnification x 11560)
Figure 3.6b:Transmission electron photo¬
micrograph of freshly isolated neutrophil
(Magnification x 13500)
Figure 3.6c: Scanning electron photo¬
micrograph of ZAP-stimulated (5%, 10 min)
neutrophils (Magnification x 18500)
Figure 3.6dTransmission electron photo¬
micrograph of ZAP-stimulated (5%, 10min)
neutrophil (Magnification x 10270)
Figure 3.6a,b,c,d: Scanning and transmission electron microscopic morphology of
quiescent and activated equine neutrophils prepared as described in Section 2.3.2
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maximal responses (data not shown). In line with its potent chemotactic effect on
equine neutrophils, LTB4 (10 nM) stimulated significant shape change (% shape
change: control, 9.9 ± 2.1%; 10 nM LTB4, 56.9 ± 8.3%, p<0.002, n=7, Figure 3.7a).
Human rIL-8 had no effect (% shape change: control, 9.9 ± 2.1%; lpg/ml hrIL-8,
14.6 ± 4.3%, p>0.05, n=7, Figure 3.7a), although the same batch of recombinant
cytokine had been shown to be biologically active toward human neutrophils by
other workers in the laboratory (Dr L. Bruce, personal communication). This was
somewhat disappointing in light of the significant effect of hrIL-8 on equine
neutrophil adhesion reported by Marr and colleagues (1999).
Freshly isolated equine neutrophils did not polarize when exposed to 1 pM fMLP (%
shape change: control, 9.9 ± 2.1%; fMLP, 11.3 ± 3.0%; p >0.05, n = 7, Figure 3.7a).
The inability of fMLP to induce cell polarization in equine neutrophils is in marked
contrast to its effects in human neutrophils which undergo rapid and concentration-
dependent shape change in response to this agent (Kitchen et al., 1996a) (Figure
3.14).
Incubation of cells with either hrTNF-a or PAF induced significant shape change
(Figure 3.7b), however, incubation of cells with 1 pg/ml LPS for up to 90 min did
not induce a significant response (Figure 3.7b).
Direct stimulation of significant cell polarization by TNF-a and PAF, in the absence
of an effect on spontaneous superoxide anion release, is consistent with the priming
paradigm recognized in human neutrophils (Haslett et al., 1985; Kitchen et al.,
1996b). The failure of 1 pg/ml LPS to stimulate shape change over a 90 min
incubation is again in contrast to its effect in human neutrophils, which undergo
striking shape change when incubated with as little as 10 ng/ml for 60 min (Haslett et
al., 1985).
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PBS PAF TNF-a LPS
Figure 3.7a,b: Induction of equine neutrophil shape change by secretagogue agonists
and priming agents
Neutrophils were incubated for 10 min (LPS, 90 min), fixed with glutaraldehyde and analysed
by flow cytometry. Values represent mean ± SEM of 7 separate experiments, each
performed in duplicate.
a: Effect of PBS, 5% ZAP, 10 ng/ml PMA, 1 pg/ml hrlL-8, 1 pM fMLP or 10 nM LTB4.
(* : p<0.01;**: p<0.0001).
b: Effect of PBS, 1 pM PAF, 200 u/ml hrTNF-a or Ipg/ml LPS.
(* : p<0.05;**: p<0.001).
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3.2.3: PRIMING IN EQUINE NEUTROPHILS
3.2.3.1 Enhancement of ZAP-stimulated respirator}' burst by priming agents
Preliminary experiments were designed to characterize ZAP-stimulated Luci-DCL
following exposure of equine neutrophils to recognized priming agents to facilitate
subsequent assessment of fMLP-stimulated responses. The effect of ZAP was
significantly enhanced by pre-treatment with 100 ng/ml LPS + 1 % heat-inactivated
autologous serum for 90 min (147 ± 10%, n = 8, p<0.01, Figure 3.8). Priming
increased the initial rate, peak velocity and total (integral) amount of CL generation
(see Figure 3.8).
Pre-incubation with both human and erTNF-a (30 min) likewise primed the ZAP-
stimulated respiratory burst (hrTNF-a, 200 U/ml: 247 ± 54.5%, n = 4, p<0.05,
erTNF-a, 1 ng/ml: 227 ± 10%, n = 3, p<0.05). However, pre-incubation of equine
neutrophils with 1 pM PAF (a concentration shown to induce a significant shape
change response, see Section 3.2.2.1) for 10 min had no effect on ZAP-stimulated
Luci-DCL. These data confirmed that equine neutrophils were capable of being
primed for an enhanced respiratory burst.
3.2.3.2: Induction of fMLP-stimulated respiratory burst by priming agents
Incubation of neutrophils with 1 pM fMLP alone did not stimulate superoxide anion
release compared to buffer treated control cells (see Section 3.2.1 and Figures 3.8 &
9). Initially, following LPS + serum priming, a significant and rapid fMLP-induced
respiratory burst was apparent (LPS + buffer, 0.4 ± 0.1 peak RLU; LPS + fMLP, 2.4
± 0.1 RLU, n = 8, p<0.05), although this was less marked than that obtained with
ZAP (Figure 3.8). This is the first documentation that functional coupling of fMLP
receptors in equine neutrophils can stimulate respiratory burst activity. Due to the
fast kinetics of this response, a more detailed time-course was examined (Figure 3.9).
The kinetics of fMLP-induced Luci-DCL in LPS-primed equine neutrophils
demonstrated an extremely brisk superoxide anion response with significant CL
detectable as early as 30 sec after fMLP addition, with peak CL occurring between
60-120 sec. Thereafter, respiratory burst activity abated rapidly with virtually
complete loss of the response by 4 min. This pattern of superoxide anion generation
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Figure 3.8: Effect of LPS priming on ZAP- and fMLP-stimulated respiratory burst in
equine neutrophils
Neutrophils were incubated with PBS or 100 ng/ml LPS + 1% heat-inactivated autologous
serum for 90 min prior to stimulation with PBS, 10% v/v ZAP or 100 nM fMLP. Luci-DCL was
monitored over 60 min. The Luci-DCL signal generated by PBS or LPS pre-treated cells
stimulated with PBS, and PBS pre-treated cells stimulated with fMLP was not significantly
different to baseline; these values have been omitted for clarity. Values represent mean of
triplicate measurements from a single experiment, representative of eight.
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is very similar to that reported for human neutrophils (Dahlgren et al., 1985). The
optimum conditions for LPS priming were then investigated. The effect of LPS on
fMLP-stimulated Luci-DCL was observed to be both time- and concentration-
dependent (Figures 3.10a-c). Addition of 1% heat-inactivated autologous serum
significantly potentiated both the temporal initiation of the response and the
sensitivity of the cells to LPS (Figures 3.1 Oa-c). Cells co-incubated for 30 min with
heat-inactivated autologous serum and LPS at concentrations > 100 ng/ml became
responsive to fMLP (Figure 3.10a). In the presence of serum, the maximal response
was observed by 60 min with a mean EC50 of 19.1 ± 4.7 ng/ml for LPS (Figure
3.10b). In the absence of serum, a 90 min LPS-incubation was required to achieve
an equivalent maximal response, albeit with the cells remaining less sensitive to LPS
(+ serum; EC50 of 11.7 ± 2.6 ng/ml, - serum; EC50 of 71.5 ± 2.7 ng/ml. Figure 3.10c).
Of note, the true serum dependence of the LPS priming effect in equine neutrophils
shown above, was only revealed when an extensive initial wash protocol was
employed (see Section 2.1.2), suggesting that a significant amount of LPS-binding
protein (LBP) or its equine equivalent remains tightly associated with neutrophils,
when they are inadequately washed.
In human neutrophils, LPS priming for enhanced superoxide anion generation is well
recognized to be largely serum-dependent, due to a requirement for LBP in the
cellular recognition of LPS (Aida and Pabst, 1990; Shapira el al., 1995); these data
would suggest the involvement of a similar LBP/CD14 mechanism for LPS priming
in equine neutrophils. Indeed, we demonstrated that human serum could substitute
for equine serum (species' autologous sera prepared freshly) in augmenting the LPS
priming of equine neutrophils and vice versa (Figure 3.1 la,b). In both cross over
experiments, using a 30 min pre-incubation period, human serum was significantly
more effective in its enhancement of LPS priming of both human (p<0.05, repeated
measures ANOVA) and equine cells (p<0.01) than equine serum. This effect was
also apparent for human cells after 60 min (p<0.05). This could indicate that there
are qualitative and/or quantitative differences in the lipopolysaccharide binding
proteins present in normal human serum compared to equine serum and may, in part,
explain the lower sensitivity of equine cells to LPS under these assay conditions.
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Figure 3.9: Time course of fMLP-stimulated Luci-DCL
Time-course of fMLP-stimulated Luci-DCL following a 90 min pre-treatment with PBS or 1
pg/ml LPS both performed in the presence and absence of 1% heat-inactivated autologous
serum. Values represent mean ± SEM of 3 separate experiments each performed in

































Figure 3.10a,b,c: LPS priming in equine neutrophils: Concentration-response curves
Cells were stimulated with fMLP (1 pM) after incubation with buffer or LPS (0.1 -1000 ng/ml)
in the presence (circles) or absence (triangles) of 1% serum for (a) 30, (b) 60 or (c) 90 min.













Figure 3.11a: Human serum enhances LPS priming of equine neutrophils
Equine neutrophils were stimulated with fMLP (1pM) after incubation with buffer or LPS (0.1
-1000 ng/ml) in the absence (triangles) or presence of 1% equine (closed circles) or human
(open circles) serum for 30 min. Values represent mean ± SEM of three separate
experiments, each performed in duplicate.
[LPS] (ng/ml)
Figure 3.11a,b: Equine serum enhances LPS priming of human neutrophils
Human neutrophils were stimulated with fMLP (1pM) after incubation with buffer or LPS
(0.1-1000 ng/ml) in the absence (triangles) or presence of 1% equine (closed circles) or
human serum (open circles) for 30 min. Values represent mean ± SEM of % of response in
the absence of LPS in three separate experiments, each performed in duplicate.
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been studied in the horse and consequently, appropriate reagents for its quantitative
analysis are, as yet, not available. In other species the complex of LPS and
lipopolysaccharide binding protein is recognized by the glycosyl-
phosphatidylinositol-anchored membrane protein CD 14 (Wright et al., 1990).
Human neutrophils in whole blood express 1,900 - 4,400 CD 14 receptors, with no
change in expression following neutrophil isolation (Antal-Szalmos et al., 1997). To
investigate this mechanism further, equine neutrophils were screened for their ability
to bind a panel of currently available anti-human CD 14 monoclonal antibodies.
6
Neutrophils and mixed mononuclear cells (1x10 cells/ml) harvested from Percoll
gradients were washed then resuspended in 50 pi of one of a panel of anti-human
CD 14 or isotype control antibodies (dilutions in brackets) and incubated (30 min) on
ice in a 96-well plate. Three fluorescent conjugates were screened, TUK 4 (1/10,
DAKO, High Wycombe, UK), MY 4 (1/20, Coulter Electronics Ltd., Luton, UK) and
a control goat anti-mouse polyclonal F(Ab')2 (1/20, DAKO). The unconjugated
antibodies, MR3 (1/50), NC 2 (1/20), UCHM1 (1/10, SAPU, Carluke, UK), SAPU
CD 14 (1/20, SAPU), 61D3 (1/20) and a control MOPC IgGl (1/20, EACC) were,
further incubated on ice (30 min) with a secondary fluorescent antibody conjugate.
MR3, NC2 and 61D3 were gifts from Dr Ian Dransfield, Rayne Laboratory,
University of Edinburgh. Human monocytes were incubated with TUK 4, MY 4,
UCHM1 and SAPU CD 14 to generate positive control data. Antibody binding was
analysed by flow cytometry (EPICS Profile II). No CD 14 cross-reactivity was
observed with equine neutrophils, although positive staining of human monocytes by
TUK 4, MY 4, UCHM 1 and SAPU CD 14 was detected (data not shown). Hence the
presence or absence of CD 14 on these cells and a more detailed dissection of this
mechanism, remains to be explored in the horse.
The 1MLP effect on Luci-DCL in LPS primed neutrophils was also shown to be
concentration-dependent with an EC50 of 10.2 ± 3.9 nM (Figure 3.12). This appears
to be very similar to that demonstrated graphically by Snyderman and Pike (1981)
for fMLP-stimulated lysozyme release from cytochalasin B-treated equine
neutrophils. This value is less than that reported for human blood neutrophils (91 ±
14 nM) and substantially lower than for guinea pig blood neutrophils (32 pM)
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(Zimmerli et al., 1986). Interestingly, however, this EC50 for equine neutrophils is of
the same order of magnitude as for human (14 ± 19 nM) and guinea pig (5.8 nM)
neutrophils functionally primed in vivo, by exudation (Zimmerli et al., 1986).
To examine whether LPS was unique in its ability to induce functional coupling of
the fMLP receptor in equine cells, the effects of PAF and hrTNF-a were also
investigated (Figure 3.13). Subsequently, the concentration dependence of the
priming effects of PAF and human and erTNF-a were studied. In contrast to its
effect in human cells (Kitchen et al., 1996a; Kitchen et al., 1996b) and, despite
demonstrating a significant concentration-dependent shape change effect, PAF
appeared to have a very weak effect in augmenting fMLP-stimulated superoxide
anion generation in equine neutrophils (Figure 3.13, Table 3.1).
Human rTNF-a induced a major up-regulation of iMLP-induced Luci-DCL (Figure
3.13, Table 3.1). However, at the concentration used in the initial experiments
shown in Figure 3.13, hrTNF-a (200 U/ml) treatment alone stimulated a significant
Luci-DCL response, indicating that this cytokine was also acting as a modest direct
secretagogue. Further experiments, including comparison with erTNF-a,
demonstrated concentration-dependent and comparable priming of the fMLP
response with both recombinant cytokines (Table 3.1).
The potential for hrIL-8 to prime equine neutrophils was also examined by
incubating cells with 1 pg/ml hrIL-8 (30 min, 37°C) prior to stimulation with fMLP
(lpM). In agreement with previous data showing no shape change or secretagogue





Figure 3.12: Concentration-response curve for fMLP-stimulated Luci-DCL in LPS
primed equine neutrophils
Equine neutrophils were pre-incubated with PBS (open triangles) or 1 pg/ml LPS + 1%
serum (closed circles) for 90 min prior to addition of lucigenin and stimulation with 0.01 -
1000 nM fMLP. Luci-DCL was recorded at 8 s intervals for 5 min. Values are expressed as
% of maximum response to 1000 nM fMLP and represent mean ± SEM of triplicate
determinations from a single experiment representative of three (mean maximal Luci-DCL
9.9 ± 0.6 RLU).
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Figure 3.13: Comparative priming effect of LPS, PAF and hrTNF-a on fMLP-stimulated
Luci-DCL in equine neutrophils
Neutrophils were pre-incubated with LPS (1 pg/ml, 90 min) + 1% heat-inactivated autologous
serum, PAF (100 nM, 10 min), hrTNF-a (200 U/ml, 30 min) or PBS (90 min) prior to
stimulation with PBS (open bars, left of pair) or 100 nM fMLP (closed bars, right of pair). CL
was recorded at 8s intervals for 5 min. Peak values presented as mean ± SEM of three











LPS + 1% serum
(1 pg/ml, 60 min)
19.1 ± 3.5 19.1 ±4.7 ng/ml 5
PAF
(1 pM, 10 min)
3.1 ± 1.1 10.4 + 2.6 nM 4
hrTNF-a
(10 ng/ml, 30 min)
64.4 ± 7.9 1.2 ± 0.5 ng/ml 3
hrTNF-a
(1 ng/ml, 30 min)
40.5 ± 12.0 1.2 ± 0.5 ng/ml 3
erTNF-a
(1 ng/ml, 30 min)
29.9 + 8.7 0.21 ± 0.03 ng/ml 3
Table 3.1: Capacity of different priming agents to induce functional coupling of fMLP
receptors in equine neutrophils
Cells were incubated with priming agents (concentrations and incubation periods as
indicated in column 1) prior to stimulation with fMLP (1 pM). Luci-DCL was recorded over 5
min. The incubation conditions in column 1 resulted in the maximal Luci-DCL responses in
column 2 with an EC50 as quoted in column 3. Pre-incubation with PBS only prior to
stimulation with fMLP (1 pM) gave a mean (range) Luci-DCL response of 1.37 (0.2 -2.9)
RLU. Values represent mean ± SEM of n separate experiments each performed in
duplicate.
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3.2.3.3 Induction of fMLP-stiniuIated shape change by LPS
In contrast to the effects of ZAP (5% v/v, 10 min), which caused a dramatic shape
change response, freshly isolated equine neutrophils did not polarize when exposed
to 1 pM fMLP for the same period of time (see Section 3.2.2.1 and Figures 3.7a &
3.14). Likewise, incubation of cells with buffer alone for 90 min did not influence
this lack of response to fMLP (% shape change: control, 12.9 ± 1.5%; fMLP, 16.8 ±
2.1; n = 4, p >0.05, Figure 3.14). However, following treatment of cells with 1
pg/ml LPS for 90 min, fMLP induced a modest but significant increase in equine
neutrophil shape change (% shape change: LPS 14.5 ± 3.8%; LPS + 1 pM fMLP,
29.4 ± 5.0%; n = 4, p <0.05, Figure 3.14) with an EC50 for 1MLP of 1.9 ± 0.9 nM
(data not shown). In marked contrast, human neutrophils undergo a rapid and
concentration-dependent shape change response to fMLP alone (Kitchen et al.,
1996a) (Figure 3.14).
The effect of LPS priming on fMLP-stimulated equine neutrophil shape change was
somewhat variable between donors; a small population of shape-changed cells being
observed following incubation with LPS and serum in two donors, consistent with
the human neutrophil/LPS priming paradigm. Moreover, in these two experiments
the cells subsequently showed a much more dramatic, concentration-dependent
polarization response to fMLP (% shape change: LPS/serum, 24.2 and 29.1%;
LPS/serum + 1 pM fMLP, 46.0 and 86.8%, respectively). However, the variance
between donors precluded a significant statistical analysis. Ideally further
experiments should be performed to elucidate this effect in detail. However, such
variation may be associated with individual donor phenotype in terms of LPS
sensitivity, as has been reproducibly demonstrated in normal human subjects
following LPS inhalation (Kline et al., 1999). Furthermore, the reproducible
variation in clinical response was mirrored in the cytokine secretory response of
isolated alveolar macrophages and blood monocytes. Further studies will be required
to establish similar phenotypic variation in neutrophil responses and whether this has
an underlying genetic basis.
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EQUINE NEUTROPHILS HUMAN NEUTROPHILS
Figure 3.14: Effect of LPS priming on fMLP-induced shape change in equine and
human neutrophils
Equine or human neutrophils were pre-incubated for 90 min with PBS or 1 pg/ml LPS prior to
stimulation with buffer or 100 nM fMLP for 10 min. Representative flow cytometry
histograms of glutaraldehyde-fixed equine (left panels) and human (right panels) neutrophils
are shown (pre-incubation / stimulation conditions are indicated within the panels). Data
represent mean forward light scatter (x axis) plotted against cell number (y axis). Similar
data were obtained from 3 additional experiments, each performed in duplicate.
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3.2.3.4 LPS fails to induce fMLP-mediated chemotaxis in equine neutrophils
Analysis of chemotaxis data failed to demonstrate any chemotactic response of
unprimed equine neutrophils to 0.01-1000 nM fMLP (Figure 3.15). In contrast to the
above superoxide anion generation and cell polarization data, pre-treatment of equine
neutrophils with 1 pg/ml LPS (+ serum) for 90 min did not facilitate fMLP-directed
chemotaxis (Figure 3.15). Positive control chemotaxis data were obtained both in
equine cells using ZAP (Figure 3.14) and in human cells using fMLP (data not
shown).
3
3.2.3.5 [ H]fMLP radioligand binding studies
To determine that the effect of fMLP was likely to be receptor-mediated, radioligand
binding studies were undertaken to quantify fMLP receptor number and affinity in
equine neutrophils and to examine the effects of LPS priming on receptor expression.
Scatchard analysis of [ HJfMLP binding to equine neutrophils demonstrated a single
1
set of high affinity fMLP receptors (Kd 9.3x10 M), with a mean of 660 ± 159 (n =
3) receptors per cell (Figure 3.16a). This compares to data obtained in parallel
experiments in human neutrophils, where Scatchard analysis demonstrated a two
-8
receptor site model with a mean of 36,000 low affinity receptors (Kd 3.2 x 10 M)
-i°
and 2,100 high affinity receptors (Kd 9.2 x 10 M) per cell (Figure 3.16b), consistent
with previous reports (O'Flaherty et al., 1991). Following LPS (+ serum) priming of
equine cells (1 pg/ml, 90 min), a similar single receptor site model fit was again
obtained (Kd 1.4 x 10 '°M), but with a significant 2.5 fold increase (p<0.05, n = 3) in
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Figure 3.15: Failure of LPS to induce fMLP-stimulated chemotaxis
Equine neutrophils were incubated for 90 min with PBS + 1% serum in the presence (closed
circles) or absence (open circles) of 1 pg/ml LPS. Chemotaxis towards fMLP (0.01 - 1000
nM) or ZAP (10% v/v, no LPS pre-incubation) was assayed using a Neuroprobe 96-well
chemotaxis chamber incorporating a 5 pm pore filter which was stained with Diff-Quick prior
to measurement of optical density. Values represent mean ± SEM of 5 separate
experiments, each performed in triplicate. (* : p < 0.01).
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Figure 3.16a: Scatchard analysis of [3H]fMLP binding to equine neutrophils
Equine neutrophils were pre-incubated for 90 min in PBS and 1% heat-inactivated
autologous serum in the presence (closed circles) or absence (open circles) of 1 pg/ml LPS
prior to assessment of [3H]fMLP binding as detailed in Section 2.5. Scatchard transformed
data are shown where each point represents the mean of three experiments each performed
in triplicate.
Figure 3.16b: Scatchard analysis of [3H]fMLP binding to human neutrophils
Human neutrophils were pre-incubated for 90 min in PBS and 1% heat-inactivated
autologous serum prior to assessment of [3H]fMLP binding as detailed in the Section 2.5.
Scatchard transformed data are shown where each point represents the mean of three
experiments each performed in triplicate.
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3.2.3.6 Failure of priming to enhance PMA-stimulated chemiluminescence
PMA is a potent stimulus of the respiratory burst in equine neutrophils (Section
3.2.1.1), and although it is not a physiological secretagogue, this response has been
reported to be enhanced by certain priming agents and has been has been widely used
in the investigation of human neutrophil priming. Enhancement of PMA-stimulated
superoxide anion generation has been recognized following priming with LPS in
both human (Bochsler et al., 1990) and equine cells (Bochsler et al., 1992) and with
PAF (Gay et al., 1986; Vercellotti et al., 1988) and TNF-a (Berkow et al., 1987) in
human cells. However, more recent studies found no difference in the response of
human neutrophils to PMA when primed with hrTNF-a (Bajaj et al., 1992). When
equine neutrophils were primed with these agents using the conditions described in
Table 3.1, no enhancement of PMA-stimulated Luci-DCL was observed in
comparison to cells incubated with buffer alone (n = 3). In fact, after pre-incubation
with LPS, PAF and hrTNF-a, there was a trend toward an inhibition of Luci-DCL in
comparison to the PMA-induced response observed in PBS-incubated cells.
However, this did not reach statistical significance with any of the priming agents
(data not shown). Although none of the studies referred to above used CL to
quantify the respiratory burst, enhancement of PMA-stimulated Lum-DCL has been
reported after pre-incubation of human neutrophils with sub-activating
concentrations of fMLP and C5a (Bender et al., 1983). Moreover, lucigenin should
be more sensitive than luminol to an enhanced release of superoxide anions
following priming. This possible biochemical anomaly in the PMA-stimulated
response in equine neutrophils primed in vitro warrants further study, particularly in
light of the enhanced CL response to PMA in blood neutrophils harvested from
COPD-susceptible horses 24 h after hay/straw challenge (see Section 5.2.8.3).
3.3 DISCUSSION
Prediction of the functional consequences of neutrophil behaviour in vivo by
extrapolation from models of priming and activation in isolated populations of cells,
pre-supposes that their function equates with that of cells within the circulation. The
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importance of employing a neutrophil isolation technique that produces a highly
purified population of minimally primed cells has been established as a crucial factor
in studying the true responsiveness of human neutrophils (Haslett et al., 1985;
Watson el al., 1992; Pabst, 1994), but this factor has not been previously addressed
in equine leukocytes.
In view of the absent, extremely weak or inconsistent in vitro (Camp and Leid, 1982;
Zinkl and Brown, 1982; Sedgwick et al., 1987; Benbarek et al., 1996) and in vivo
(McEwen and Lumsden, 1991) responses elicited by fMLP in the horse, the lack of
effect of fMLP on superoxide anion release in this species was attributed to a lack of
any functional fMLP receptor coupling. Indeed, in agreement with this previously
held view, we were unable to detect any chemotactic or polarization response to
fMLP in unprimed equine neutrophils despite the very clear mobility effects of this
agent in human neutrophils, which are observed even in "quiescent", unprimed cells
(Qu el al., 1995; Condliffe et al., 1996; Kitchen et al., 1996a).
The data presented here regarding the ability of priming agents to induce functional
coupling of fMLP receptors in equine neutrophils, the minimal basal shape change
and fMLP-stimulated Luci-DCL that we observed in freshly isolated cells supports
the choice of the two-step plasma-Percoll isolation method employed. Indeed,
previous reports of fMLP-stimulated secretion in freshly isolated equine neutrophils
(Snyderman and Pike, 1980; Snyderman and Goetzl, 1981; Bertram, 1985) raises the
possibility that the neutrophil isolation techniques used in these studies caused some
degree of priming. Moreover, the fMLP-stimulated lysozyme release demonstrated
by Snyderman and Pike (1980) followed treatment with cytochalasin B, a non-
physiological priming agent. Recently, we have shown that equine neutrophils do
not release elastase in response to fMLP alone but show a major degranulation
response following LPS priming (Dr. M.P. Dagleish and T.J. Brazil, unpublished
observations); these data again support the notion that priming is a prerequisite for
functional coupling of fMLP receptors in equine neutrophils. Lurthermore, the non-
reproducible CL response of equine neutrophils to fMLP observed by Benbarek and
co-workers (1996) may have been related to a variable state of priming in different
batches of isolated cells.
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However, even the most physiologically stringent isolation technique is unlikely to
leave cells entirely unperturbed, with adhesion molecule expression, in particular
known to be especially sensitive to the rigours of neutrophil isolation (Kuijpers et al.,
1991; Watson et al., 1992). Until specific reagents for the recognition of equine
neutrophil surface markers are developed, progress toward an optimal isolation
method for these cells will be hampered. Perhaps the most robust and physiological
benchmark for assessment of an isolation technique is the behaviour of isolated cells
following re-infusion into the donor animal. Indeed, the modification of this plasma-
Percoll method for rabbit neutrophils produces cells that, following 11'in-tropolonate
labelling and re-infusion, circulate and respond to pharmacological induction of
neutrophilia and neutropaenia in a manner identical to that of unmanipulated cells
(Haslett et al., 1987). Assessment of unstimulated CL generation following cell
isolation and discarding cells where there was evidence of basal activation was a
further important quality control measure employed in the current characterization of
equine neutrophil priming.
It is important to recognize that Luci- and Lum-DCL responses reflect different
aspects of respiratory burst activity in neutrophils and hence are not directly
comparable. Lucigenin, a relatively large molecule (510 Daltons) remains
extracellular and hence detects only externally secreted reactive oxygen species
(predominantly superoxide anions) whereas luminol (177 Daltons) is also able to
penetrate cells and interacts almost exclusively with hydrogen peroxide and its
breakdown products catalysed by myeloperoxidase (Dahlgren et al., 1985).
However, comparisons between data from the different time points in ex vivo
experiments remain valid, providing that assay conditions with each luminigenic
probe are constant.
The CL response we observed following PMA stimulation is consistent with data
reported previously in both equine and human neutrophils (Aniansson et al., 1984;
Allen, 1986; Benbarek et al., 1996). Burgener and colleagues (1998) studied
homologous ZAS-stimulated Lum-DCL in canine neutrophils and observed a small
peak of activity at 30 s, but they only recorded CL for 2 min, precluding comparison
of kinetics to those observed here. The bimodal ZAP-stimulated Lum-DCL seen in
equine cells may have similar origins to that observed in human neutrophils in
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response to fMLP; the initial peak being associated with extracellular release of
MPO and H2O2 followed by a delayed secondary peak of CL generated
intracellularly (Briheim et al., 1984). However, measurement of fMLP-stimulated
Lum-DCL in equine neutrophils during the ex vivo experiments did not reveal a
bimodal response. The biochemical and physico-chemical mechanisms governing
these differences between species and agonists are complex ( Benbarek et al., 1996;
Harbecke et al., 1996) and warrant further investigation.
The highly sensitive CL assay employed in this study demonstrated that fMLP-
stimulated Luci-DCL could be observed but only following LPS pre-treatment i.e.
consistent with this being a primed response (Guthrie et al., 1984; Haslett et al.,
1985). fMLP-stimulated Luci-DCL was also observed following pre-incubation with
PAF and TNF-a, both well recognized neutrophil priming agents in man (Kitchen et
al., 1996a; Kitchen et al., 1996b), however, PAF primed this response only very
weakly in equine neutrophils. Furthermore, this priming effect was not restricted to
fMLP, since LPS and TNF-a also enhanced ZAP-stimulated Luci-DCL.
The enhanced responses following priming probably reflect both an increase in the
response of individual cells and the recruitment of more cells to a responsive
subpopulation (Bass et al., 1986; Elbim et al., 1993).
The induction of fMLP-induced shape change following priming was also of interest,
not least because a very brisk polarization response is observed in human neutrophils
and that is independent of priming status (Kitchen et al., 1996b). In human
neutrophils however, LPS exposure has been shown to enhance the rate and maximal
extent, and reduce the lagtime, of F-actin polymerization induced by fMLP (Howard
et al., 1990). In equine neutrophils, the pre-incubation conditions necessary for LPS-
induced priming of enhanced fMLP-stimulated Luci-DCL responses did not produce
statistically significant cell shape change with LPS alone. Hence in this species,
unlike in man (Haslett et al., 1985), measurement of cell shape change alone, rather
than more complex cytoskeletal changes, may not be the most appropriate or indeed
accurate method of detecting cell priming or of modeling the control of cytoskeletal
elements in vitro. This necessity for LPS priming to facilitate equine neutrophil
shape change by functional fMLP receptor-ligand coupling could provide an
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important and novel model to dissect signal transduction pathways linking priming
responses to cell polarization.
Priming with PAF and TNF-a, however, did induce significant cell shape change in
the absence of a respiratory burst, consistent with the human neutrophil priming
scenario (Haslett et al., 1985; Kitchen et al., 1996b). The concepts of priming and
subsequent activation of equine neutrophil effector functions derived from these data
are offered as a summary paradigm in Figure 3.17.
Detailed characterization of the priming effect of LPS in equine cells demonstrated
that enhancement of the fMLP-stimulated Luci-DCL response, although requiring
slightly higher LPS concentrations (>10 ng/ml) than human cells (Haslett el al.,
1985; Young et al., 1990; Shapira et al., 1995), evolved over a very similar time-
course. In other species, the enhanced sensitivity of cells to LPS in the presence of
serum (Aida and Pabst, 1990; Yang et al., 1994; Shapira et al., 1995) reflects the
formation of a complex between LPS and a serum LBP, recognized by the glycosyl-
phosphatidylinositol-anchored membrane protein, mCD14 (Wright et al., 1990; Yang
et al., 1995). CD 14 co-operates with the pattern recognition receptor, Toll-like
receptor-2, to stimulate signal transduction and cell activation (Yang et al., 1998).
The ability of human and equine serum to substitute for one another in these
experiments suggests that a functional homologue of LBP is indeed present in equine
serum and provides strong evidence for a similar paradigm underlying at least one
mechanism of LPS interaction with equine neutrophils. However, the presence of a
mCD14 cannot be inferred directly from these data, as complexes of LPS and soluble
(s)CD14 can stimulate human neutrophils with similar potency to LPS/LBP
(Hailman et al., 1996). However, it seems unlikely for an equine sCD14 to be
present in plasma in the absence of a functional mCD14 homologue in neutrophils.
LPS has also been demonstrated to activate human neutrophils in the absence of
serum proteins (Ulevitch and Tobias, 1995), via L-selectin (Malhotra et al., 1996),
the integrin CD1 lc/CD18 (Ingalls and Golenbock, 1995) and both soluble (Hailman
et al., 1996) and membrane-bound CD 14 (Shapira et al., 1995). One or more of
these pathways might be involved in the priming of equine neutrophils observed in
the absence of serum. Although work is underway to define an equine CD 14 (Dr
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Figure 3.17: Proposed paradigm of equine
neutrophil priming and activation
SEM of ZAP-stimulated cells (x 18500)
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dissection of this potential LBP/CD14 mechanism and the elucidation of other LPS
receptors in neutrophils, remain to be explored in this species.
The chemotaxis data presented (Figure 3.15) are in agreement with most previous
reports in equine neutrophils (Snyderman and Pike, 1980; Camp and Leid, 1982;
Naef et al., 1982), which showed no chemotactic effect of fMLP. However, Zinkl
and Brown (1982) and Sedgwick et al. (1987) observed a chemotactic effect of
fMLP but only at extremely high, non-physiological, concentrations i.e. 100 pM.
Taken together, these data suggest that fMLP is at best a very poor chemotactic agent
for equine neutrophils and that LPS exposure is unable to modulate this lack of
response. Of note, LPS exposure actually reduces the chemotactic responsiveness of
human neutrophils to fMLP (Haslett et al., 1985), but other priming agents (e.g. GM-
CSF) can enhance fMLP-directed chemotaxis (Weisbart et al., 1986); however the
response of equine neutrophils to ZAP in our system was unaffected by LPS (data
not shown).
3
Scatchard analysis of [ HJfMLP binding to equine neutrophils was able to confirm
the presence of specific fMLP binding sites in equine neutrophils and also identified
a 2.5-fold increase in fMLP receptor number following LPS priming, without
altering the single receptor site model fit or changing receptor affinity. A similar
single site model for equine neutrophils was described by Snyderman and Pike
(1980) in which they identified 630 ± 184 receptors per cell, equivalent to the
number we found in unprimed cells. A single fMLP receptor site has also been
identified in rabbit neutrophils where receptor expression was increased eight-fold
following intravenous endotoxin administration but this was not accompanied by any
comparable effect on neutrophil function, suggesting that the two effects were not
directly related (Goldman et al., 1986). This point is reinforced by studies in human
neutrophils which have demonstrated that the increase in fMLP receptor expression
observed in response to priming (Zimmerli et al., 1990; O'Flaherty et al., 1991) or
bacterial infection (Follin et al., 1989), either lags behind (O'Flaherty et al., 1991) or
does not correlate with (Follin et al., 1989; Zimmerli et al., 1990), the enhanced
functional response. Increased receptor numbers result from translocation of
preformed fMLP receptors from intracellular compartments to the plasma membrane
as a consequence of fusion of specific granules and particularly secretory vesicles
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with the cell surface during priming (Sengelov et al., 1994). The probability that the
small change in fMLP receptor number identified in equine cells post LPS treatment
is a consequence, rather than the cause, of priming is supported by the observation
that receptor numbers for other human neutrophil agonists (e.g. C5a), whose
responses are equally enhanced, are not affected by LPS (Zimmerli et al., 1990). It is
unlikely therefore, that a change in receptor number alone represents a major control
point determining the magnitude of the fMLP receptor-mediated response. Hence,
the dramatic augmentation of the fMLP response observed, most likely occurs at a
level downstream from ligand-receptor binding in the signal transduction cascade
(Condliffe et al., 1998b). Indeed many of the intracellular biochemical alterations
linked to priming have been shown to be dissociated from primed effector functions
and much work is in progress to differentiate the biochemical consequences of
priming from its origins (Downey el al., 1995; Condliffe et al., 1998b). Further
studies are required to dissect both the precise mechanism of LPS interaction with
equine neutrophils and the subsequent intracellular signalling steps that stimulate
functional coupling of fMLP receptors. However, this very dramatic and selective
priming response observed in the equine neutrophil may offer an ideal model for the
investigation of functional coupling of leukocyte G-protein-linked chemoattractant
receptors.
Neutrophil priming has significant pathophysiological consequences in vivo and
characterization of priming and activation in equine neutrophils in vitro was the
initial step toward being able to evaluate the functional status of neutrophils
harvested from the peripheral blood and airways of COPD-susceptible horses
following hay/straw challenge. Indeed, the observation that priming appeared to be a
prerequisite for functional coupling of fMLP receptors in equine neutrophils
suggested that the ex vivo response of peripheral blood and airspace neutrophils to
fMLP could be employed as an "index of functional priming".
In vivo priming of neutrophil oxidative activity has been observed experimentally
following intravenous infusion of inflammatory mediators such as LPS (Cerasoli et
al., 1990) and TNF-a (Wewers et al., 1990; Kapp et al., 1991) and clinically in
association with bacterial infection (Bass et al., 1986; Follin et al., 1989), severe
trauma (Botha et al., 1995), ARDS (Zimmerman et al., 1983; Chollet-Martin et al.,
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1992) and allergic asthma (Meltzer et al., 1989) in man. Also intravenous
administration of LPS to horses enhanced peripheral blood neutrophil oxidative
activity measured by reduction of nitrotetrazolium blue (Krumrych et al., 1997).
However, many of these examples are likely to involve a complex interactive
network of pro-inflammatory stimuli in plasma.
The primed state of human neutrophils exudating into suction-induced skin chambers
(Zimmerli et al., 1986; Follin et al., 1991) and the observation that ligation of
neutrophil p2-integrins in vitro also primes these cells, demonstrates the interactions
between adhesion and priming (reviewed in Section 1.4.1).
The pivotal role of priming in determining neutrophil behaviour is re-inforced by the
recent recognition that the pro-inflammatory fate of primed cells is not immutable.
Isolated neutrophils can undergo a dynamic cycle of priming - depriming and
repriming (Kitchen et al., 1996b) and although priming is stabilised by plasma
(Brown et al., 1997), this flexibility infers a subtle mechanism for the limitation of
collateral host tissue damage at an inflamed site. Moreover, the profound, yet
diverse, regulatory effects that priming agents can have upon the constitutive rate of
neutrophil apoptosis, may strongly influence the manner in which an inflammatory
responses resolves (Lee et al., 1993; Murray et al., 1997; Savill, 1997a).
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CHAPTER 4
CHARACTERIZATION OF APOPTOSIS IN EQUINE PERIPHERAL
BLOOD NEUTROPHILS IN VITRO
4.1 INTRODUCTION
The capacity of the neutrophil to accumulate at an inflamed site and to secrete pro¬
inflammatory and histotoxic agents ensures that this cell plays a key role in the
initiation, amplification and/or resolution of acute inflammation. Indeed, neutrophils
have been implicated as mediators of tissue destruction in a wide range of
inflammatory diseases in both man and the horse (reviewed in Section 1.6).
The seminal work of Newman et al. (1982) demonstrating phagocytosis of "aged"
neutrophils by macrophages initiated investigation of the behaviour of neutrophils as
they aged in culture as a model for their fate following accumulation at an
inflammatory site. A series of detailed studies by Haslett and colleagues
demonstrated that neutrophils underwent constitutive apoptosis (reviewed in Section
1.5) when aged in culture and this was the signal for initiation of a novel macrophage
recognition mechanism (Savill et al., 1989a; Savill et al., 1989b; Haslett et al.,
1989b; Savill et al., 1990). Furthermore, demonstration that this paradigm was
active in vivo (Savill et al., 1989b) hinted at an explanation for the clearance of a
large neutrophil burden without permanent structural tissue damage in the resolution
of neutrophil-dependent diseases such as pneumococcal pneumonia in humans
(Haslett, 1992). Downregulation of the functional integrity of neutrophils
undergoing apoptosis (Lee et al., 1993; Whyte et al., 1993b) gave credence to this
hypothesis and suggested that pharmacological manipulation of apoptosis may offer
therapeutic potential in inflammatory diseases in which neutrophils and their
histotoxic products had been implicated (Haslett, 1992). It was clear that if
neutrophil apoptosis was to be harnessed to beneficial therapeutic effect, several
questions required immediate attention. Firstly, how interaction with inflammatory
mediators, other host tissue structures and pathogens might regulate neutrophil
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longevity. Secondly, the intracellular signalling pathways and effector molecules
regulating the apoptotic programme. Finally, what changes in neutrophil and
macrophage phenotype might facilitate the recognition and clearance of effete
neutrophils (Savill et al., 1993; Haslett, 1997; Savill, 1997a).
The development, maturation and functional status of mammalian neutrophils are
finely regulated by a broad array of growth factors, cytokines and bacterial products,
to tailor cell number, functional capacity and longevity to the changing demands of
host defence in everyday life (Condliffe et al., 1998b). Following the observation
that inflammatory mediators such as LPS, GM-CSF and C5a inhibited the rate of
constitutive human neutrophil apoptosis and pari passu prolonged functional
longevity (Lee et al., 1993), a great number of inflammatory mediators and potential
therapeutic compounds have been screened for their ability to modulate both
apoptosis and the recognition of effete cells.
An initial paradigm suggesting that mediators with the capacity to prime or activate
neutrophils would promote survival (with the concomitant risk of enhancing the
potential for tissue destruction) is now recognized as an oversimplification of
nature's inherent capacity to ensure the survival of the whole organism. The
teleological sagacity of this innate regulation began to emerge with the identification
of an early pro-apoptotic effect of the inflammatory cytokine TNF-a (Takeda et al.,
1993; Murray et al., 1997). More recent studies have identified a similar modulatory
role for several fundamental priming/activation-dependent functions (such as p2-
integrin engagement and transendothelial migration) in stimulating apoptosis as a
direct result of neutrophil recruitment (Coxon et al., 1996; Walzog et al., 1997;
Watson et al., 1997b). Although there are discrepancies in the literature e.g. (Baran
et al., 1996), in general, phagocytosis of opsonised bacteria and other particles
(Coxon et al., 1996; Watson et al., 1996a; Watson et al., 1996b) appears to rapidly
induce apoptosis leading to early removal of both the activated neutrophil and its
pathogenic prey. The nature of the immune complexes involved in particle
opsonisation and the mechanism of their subsequent recognition may further regulate
this process by the neutrophil (Gamberale et al., 1998).
Apoptosis within an inflammatory focus may be modulated by many physico-
chemical signals. Heat shock (Watson et al., 1996a) and alkaline conditions
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(Leblebicioglu and Walters, 1999) drive apoptosis in vitro, whereas hypoxic
conditions significantly prolong cell survival (Hannah et al., 1995); all micro-
environmental factors that may be profoundly perturbed in an inflamed nidus.
My recognition of cell morphology consistent with the neutrophil apoptosis /
macrophage phagocytosis paradigm in clinical cytology preparations of neutrophilic
equine BAL, synovial, uterine and peritoneal fluids led to the current investigation
and characterization of equine neutrophil apoptosis (T. Brazil, unpublished
observations, 1995 - 1996).
4.2 RESULTS
4.2.1 CHARACTERIZATION OF APOPTOSIS IN EQUINE NEUTROPHILS
4.2.1.1 Equine neutrophils aged in culture demonstrate morphological features
of apoptosis
In preliminary experiments, light microscopic examination of Diff Quik-stained
cytocentrifuge preparations of isolated equine neutrophils aged in culture for 8 h,
revealed a small proportion of cells exhibiting morphological changes consistent
with apoptosis (Savill el al, 1989b; Kerr et al., 1995). The most prominent features
were nuclear pyknosis with condensation of nuclear chromatin into one or more,
densely staining, rounded remnants and cytoplasmic vacuolation (Figure 4.1c).
These cells were readily distinguished from non-apoptotic neutrophils (Figures 4.1a
& c). Ultrastructural examination of these cells revealed the stereotypical
morphology of apoptosis (Kerr et al., 1972; Savill et al., 1989b; Kerr et al., 1995).
Nuclear chromatin was condensed into clearly demarcated, typically ovoid,
fragments with margination of denser, more granular aggregates that frequently
formed a crescent, tightly apposed to the inner surface of the nuclear envelope
(Figure 4.2b). Cytoplasmic vacuolation was prominent and intracellular organelles,
including cytoplasmic granules, although appearing crowded, were retained (Figure
4.2b). Moreover, despite loss of the small pseudopodia found in freshly isolated
cells, the cell membrane remained intact (Figures 4.2a & b). Nucleolar prominence,
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another common ultrastructural feature of apoptosis in other cell types (Savill el al.,
1989b; Kerr el al., 1995), was infrequently observed, but this may just reflect the
absence of nucleoli from the planes of the sections studied (Kerr et al., 1995).
Further quantitative TEM would be required to determine the true frequency of this
ultrastructural feature. The intense plasma membrane ruffling, blebbing or budding
[sometimes referred to as zeiosis (Majno and Joris, 1995)] that is associated with
cytoskeletal modification during apoptotic cell death is well recognized in many cell
types (Cohen el al., 1992; Kerr el al., 1995; Majno and Joris, 1995). This feature has
not been routinely reported in apoptotic neutrophils but dramatic membrane blebbing
has been observed in neutrophils driven to undergo apoptosis by the protein synthesis
inhibitor, cycloheximide (Sullivan et al., 1996). However, whilst counting apoptotic
cells in a haemocytometer, very occasional equine neutrophils were seen to have
such a bizarre, budding appearance. Such morphological changes are likely to be
short-lived (Kerr et al., 1995) and thus undetectable or overlooked without sequential
scanning electron or phase contrast microscopic studies.
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Figure 4.1e: 20 h in culture
Light microscopic morphology
(Diff-Quik, x 1100)
Figure 4.1b: Freshly isolated cells
Annexin V binding (10,000 events)
Figure 4.1d: 8 h in culture
Annexin V binding (10,000 events)
Figure 4.1f: 20 h in culture
Annexin V binding (10,000 events)
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Figure 4.2a: Transmission electron photomicrograph of a freshly isolated equine
neutrophil.
Cells prepared as described in Section 2.3.2. (Magnification x 13000)
Figure 4.2b: Transmission electron photomicrograph of an equine neutrophil aged in
culture for 20 h.
Cells prepared as described in Section 2.3.2. (Magnification x 12000)
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4.2.1.2 Equine neutrophils undergo time-dependent constitutive apoptosis in
vitro
Equine neutrophils aged in culture underwent time-dependent constitutive apoptosis
with 6.7 ± 1.6% (mean ± SEM, n = 4), 27.7 ± 5.4%, 39.9 ± 3.2%, 53.6 ± 5.1%, 60.1
± 6.3%, and 68.2 ± 3.3% of cells having typical light microscopic morphology at 6,
12, 18, 24, 30 and 36 h respectively (Figure 4.3). Membrane integrity and hence cell
viability, was maintained throughout this time course with 99.8 ±0.1% (mean ±
SEM, n= 4), 99.6 ± 0.2%, 99.0 ± 0.4%, 98.8 ± 0.6%, 97.6 ± 0.4% and 97.7 ± 3.3% of
cells continuing to exclude trypan blue at 6, 12, 18, 24, 30 and 36 h respectively
(Figure 4.3). Moreover, cell loss was minimal (Figure 4.3), despite the presence of a
small but increasing numbers of cell ghosts (anucleate cells) beyond 24 h. In all
subsequent experiments, the effects of time and various interventions on the rate of
apoptosis were quantified by light microscopy of cell populations harvested after 8
and 20 h in culture. The light microscopic morphology of cells harvested after 0, 8
and 20 h of culture is shown in Figures 4.1a, c and e.
4.2.1.3 Apoptosis in equine neutrophils is associated with the ability of cells to
bind Annexin V
Freshly isolated equine neutrophils demonstrated minimal Annexin V binding
(Figure 4.1b). As cells aged in culture, an increasing number acquired the ability to
bind Annexin V; this effect paralleled the appearance of typical apoptotic
morphology (Figure 4.1 a-f). This suggested that equine neutrophils undergoing
apoptosis experience the typical loss of plasma membrane asymmetry, with exposure
of phosphatidylserine on the external leaflet, as recognized in other species' cells,
including neutrophils (Fadok et al., 1992; Homburg et al., 1995).
Other workers have suggested that structural re-organisation of plasma membrane
phospholipids is an early event in the apoptotic cascade and may precede both the
appearance of typical morphological changes and fragmentation of DNA (Mower et
al., 1994). The proportion of equine neutrophils binding Annexin V was strongly
correlated with the proportion of apoptotic cells based on morphological criteria (r =
0.92, p<0.0001, pooled data after 0, 8 and 20 h in culture from 11 separate
experiments each performed in triplicate (morphology) and duplicate (Annexin V
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Figure 4.3: Time course of constitutive apoptosis in equine neutrophils
Equine neutrophils (5 x 106 cells/ml) were incubated as described in Section 2.6.land
harvested at the time points indicated. Cells were resuspended and apoptosis (%) (squares)
assessed morphologically on Diff Quik-stained cytocentrifuge preparations. Cell loss
(triangles) and viability (circles) were determined from haemocytometer counts and the
proportion of cells excluding trypan blue, respectively. Values represent mean ± SEM of four
separate experiments each performed in triplicate (apoptosis) or duplicate (viability and cell
loss).
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binding), (raw data not shown). A regression line plotted from these data passed
almost exactly through the origin, offering a statistical inference that these two
features of constitutive equine neutrophil apoptosis are temporally associated (data
not shown).
4.2.1.4 Exhibition of apoptotic morphology is associated with time-dependent
internucleosomal DNA fragmentation
Data from numerous in vitro and in vivo cell culture systems suggest that DNA
integrity and cell morphology should be examined in parallel to confirm that cell
death has occurred via apoptosis (Bortner et al., 1995). Although both single strand
breaks and cleavage into large fragments are recognized in association with apoptosis
in some cell types (Bortner et al., 1995; Hale et al., 1996), in general
internucleosomal DNA cleavage produces the characteristic "DNA ladder"; the
biochemical hallmark of the apoptotic process (Wyllie, 1980a; Bortner et al., 1995;
Squier et al., 1995). Electrophoresis of DNA extracted from freshly isolated equine
neutrophils demonstrated homogeneous, high molecular weight DNA with minimal
electrophoretic mobility (Figure 4.4). After 8 h in culture, a classical "ladder"
pattern of oligonucleosomal DNA fragments was observed and this was greatly
enhanced after 20 h (Figure 4.4). DNA fragmentation assays are, at best, semi¬
quantitative, but work in murine thymocytes indicates that the quantity of lower
molecular weight DNA present is related to the number of dying cells, indicating that
apoptotic cells degrade all of their DNA (Wyllie and Morris, 1982).
Thus, qualitatively, these DNA fragmentation data are temporally comparable to the
progression of neutrophil apoptosis quantified morphologically.
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Figure 4.4: DNA fragmentation in ageing equine neutrophils
Electrophoresis in 1.6% agarose of DNA extracted as described in Section 2.6.4, from
freshly isolated equine neutrophils (0 h) and cells incubated for 8 and 20 h in MF at 37°C
either in the absence (Control) or presence of LPS (1 pg/ml). Ethidium bromide-stained DNA
viewed by ultraviolet fluorescence. Note ladder pattern of low molecular weight DNA at 8
and 20 h time points that was enhanced in the presence of LPS; loss of high molecular
weight DNA is especially prominent at 20 h in the presence of LPS. Experiment
representative of three that gave similar results. (MW: DNA molecular weight markers; 1
kilobase ladder).
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4.2.1.5 Simultaneous in situ identification of chromatin condensation and DNA
fragmentation
The morphology and DNA integrity of individual cells can be assessed
simultaneously under light microscopy by in situ staining of DNA by the TUNEL
(Terminal deoxynucleotide transferase mediated d-UTP
[desoxyuridinetriphoshphatej-biotin nick end-labelling) method (Ben-Sasson et al.,
1995). The TUNEL method can label breaks in DNA in individual nuclei in situ by
the specific binding of the DNA polymerase, terminal deoxynucleotide transferase
(TdT), to the exposed 3'-OH ends of cleaved DNA. The TdT catalyses the addition
of biotinylated deoxynucleotides at this site. These are subsequently detected using a
streptavidin-horseradish peroxidase conjugate. TUNEL staining of cytocentrifuge
preparations of cells aged in culture for 8 h clearly localised fragmented DNA to
cells with morphologically pycnotic nuclei and demonstrated the variation in the
number and size of condensed chromatin fragments (Figure 4.5a & b). Negative
control specimens (substitution of distilled water for TdT) showed no labelling and
positive control specimens (pre-incubation of freshly isolated cell preparations with 1
pg/ml DNase 1 for 20 min after proteinase K exposure of DNA) demonstrated wide
spread low grade labelling of cells that had normal nuclear morphology (data not
shown).
Although TUNEL-positive cells were readily identified amongst non-apoptotic cells
after 8 h in culture, poor resolution of individual TUNEL positive cells and a high
level of non-specific labelling was observed in cells incubated for longer periods
(e.g. 20 h) making accurate enumeration impossible. The TUNEL method is
notorious for problems with sensitivity and particularly specificity, due to difficulties
in obtaining homogenous exposure of DNA within condensed chromatin and the
frequency of both physiological (both cell necrosis and proliferation can cause false
positive TUNEL results) and preparation-related artefactual DNA breaks (Lucassen
et al, 1995; Labat-Moleur et al., 1998). Hence, even with careful assessment of cell
morphology, this technique was considered to be only of value for the qualitative
identification of apoptotic chromatin in neutrophils cultured for short time periods.
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Figure 4.5a: Photomicrograph of TUNEL-stained apoptotic equine neutrophils aged in
culture for 8 h.
Cells aged in culture for 8 h were stained by TUNEL as described in Section 2.6.6. TUNEL
positive nuclei were detected with DAB (brown staining) and sections counterstained with
methyl green. (Magnification x 1200).
Figure 4.5b: Photomicrograph of TUNEL-stained apoptotic neutrophil aged in culture
for 8 h demonstrating multiple condensed nuclear chromatin fragments.
Cells aged in culture for 8 h were stained by TUNEL as described in Section 2.6.6. TUNEL
positive DNA detected with DAB (brown staining) and section counterstained with methyl
green. (Magnification x 1380).
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Although methods to improve the sensitivity and specificity of TUNEL in paraffin-
embedded tissue sections have been suggested (Lucassen et al., 1995; Labat-Moleur
el al., 1998), the reliability of the previous techniques precluded the need to pursue
this method in cultured neutrophils.
In conclusion, light microscopic and ultrastructural morphology, exposure of
Annexin V binding sites and evidence of internucleosomal DNA fragmentation
confirmed that equine neutrophils undergo constitutive apoptosis in vitro.
4.2.1.6 Apoptosis is associated with down-regulation of receptor-mediated
respiratory burst activity
Freshly isolated neutrophils mount a major respiratory burst in response to ZAP and
PMA (Section 3.2.1). To investigate whether this capacity was maintained as cells
aged and underwent apoptosis and whether the different mechanisms of cellular
activation (receptor-mediated versus direct activation of protein kinase C) were
important, Luci-DCL in response to these secretagogue agonists was measured
before and after 20 h in culture. After 20 h, ZAP-stimulated Luci-DCL was
significantly diminished to 19.6 ± 12.2% (n = 3) of the baseline response, in spite of
only 50.3 ± 11.6% of cells having morphological features of apoptosis (Figure 4.6).
This was not due to any reduction in cell viability as > 99% of cells continued to
exclude trypan blue. This suggested that the diminished CL response of ageing cells
preceded visible chromatin condensation. Further evidence that apoptotic cells
remained viable was provided by the preservation of the PMA-stimulated response
(107.4 ± 32.3% of baseline) indicating that the cells' capacity to assemble their
NADPH oxidase and generate a respiratory burst remained intact. These data give
provisional evidence for equine neutrophils becoming insulated from physiological
receptor-mediated secretagogue stimuli at an early stage after commitment to
apoptotic death, effectively disabling their pro-inflammatory potential. This
hypothesis could be pursued by studying the response to these and other receptor-
mediated stimuli over a more detailed time course and investigating receptor
expression where appropriate. Ideally, populations of apoptotic and non-apoptotic
cells should be purified, to test whether the CL response of non-apoptotic cells after





































Figure 4.6: Chemiluminescence response of equine neutrophils undergoing apoptosis
ZAP (10% v/v)- and PMA (100 ng/ml)-stimulated Luci-DCL was measured in freshly isolated
neutrophils and in cells harvested after 20 h in culture (ZAP: open bars, PMA: hatched bars).
Apoptosis (closed squares) was assessed morphologically on Diff-Quik-stained
cytocentrifuge preparations. Chemiluminescence (CL) data represents % of ZAP- and PMA-
stimulated Luci-DCL in freshly isolated cells. Values represent mean ± SEM of three
separate experiments each performed in triplicate. (* ; p<0.05)
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might be achieved by counter-flow centrifugation with an elutriation rotor (Savill et
al., 1989b) or by negative selection of cells that did not bind Annexin V in a
fluorescence-activated cell sorter (Homburg el al., 1995).
4.2.2 REGULATION OF APOPTOSIS IN EQUINE NEUTROPHILS
Lee and colleagues (1993) demonstrated the ability of inflammatory mediators such
as LPS, GM-CSF and C5a to inhibit neutrophil apoptosis in vitro, suggesting that the
lifespan of neutrophils at an inflammatory site is likely to be markedly influenced by
the complex array of mediators in the surrounding milieu.
In preliminary experiments, a number of priming and activating agents whose effects
on equine neutrophils had already been characterized (see Chapter 3) were screened
for their ability to regulate the rate of constitutive apoptosis in these cells. Apoptosis
was routinely assessed in neutrophils after 8 and 20 h in culture to identify any
temporal differences in the effect of a particular mediator. For some of these agents,
human cells were examined in parallel in order to highlight any potential inter¬
species variation in the regulation of neutrophil apoptosis in vitro. Unfortunately,
difficulties in co-ordinating the contemporaneous availability of human and equine
cells in two different laboratories precluded undertaking such studies on a regular
basis. Parallel studies were only performed if the cells were available for culture
within 30 min of each other.
The bacterial product fMLP and the bioactive lipid PAF, had no effect on the
constitutive rates of equine or human neutrophil apoptosis (Figure 4.7a & b). The
eicosanoid, leukotriene B4 (100 nM) although reported to inhibit human neutrophil
apoptosis (Hebert et al., 1996) had no effect on equine neutrophil apoptosis (data not
shown). The human recombinant cytokine GM-CSF, a classical inhibitor of human
neutrophil apoptosis (Lee et al., 1993; Hebert et al., 1996), again had no effect on the
rate of equine neutrophil apoptosis but did significantly inhibit apoptosis in human
cells after both 8 and 20 h in culture (% apoptosis: 8 h; Control 10.0 ± 1.2%, GM-
CSF 2.9 ± 0.5%, p<0.05. 20 h; Control 50.1 ± 8.2%, GM-CSF 34.7 ± 7.4%, p<0.05,
n = 3), see Figure 4.7a & b.
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Figure 4.7a,b: Regulation of neutrophil apoptosis by inflammatory mediators;
comparison of equine and human cells
Equine (open bars) and human (closed bars) neutrophils (5 x 106/ml) were incubated in MF
at 37°C either alone (control) or in the presence of LPS (1 pg/ml), GM-CSF (100 U/ml), fMLP
(1 pM) or PAF (1 pM) for (a) 8 or (b) 20 h. Cells were resuspended and percent apoptosis
assessed morphologically on Diff Quik-stained cytocentrifuge preparations. Values
represent mean ± SEM of three separate experiments, each performed in triplicate.
(* ; p<0.05 compared with time-matched species control).
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apoptotic effect of LPS in equine cells at 20 h which contrasted strikingly with the
marked inhibitory effect of LPS on human neutrophil apoptosis at both time points
(Figure 4.7a & b). However, DNA fragmentation studies clearly showed enhanced
chromatin cleavage in equine neutrophils in the presence of LPS at both 8 and 20 h
(Figure 4.4). The detailed investigation of this effect is described below (Section
4.2.2.2).
4.2.2.1 ZAS inhibits equine neutrophil apoptosis
Equine neutrophils were incubated with 10% ZAS, as a biological source of C5a, to
investigate the effect on the rate of apoptosis of a physiological ligand that directly
triggers the respiratory burst. Studies in human neutrophils have reported both pro-
(Hebert et al., 1996) and anti-apoptotic (Lee et al., 1993) effects of the complement
fragment, C5a. ZAS was used because in initial experiments ZAP led to marked cell
clumping at 20 h that made assessment of cytospins very difficult. Three
experiments, utilizing different donors, compared the abilities of ZAP and ZAS
(prepared from the same blood sample) to stimulate a respiratory burst. These
produced almost identical results (data not shown). ZAS (10% v/v) profoundly
inhibited equine neutrophil apoptosis at both 8 and 20 h (Figure 4.8) suggesting that
activation of neutrophils at an inflammatory site has the potential to significantly
prolong their lifespan.
To test this hypothesis further, equine cells were incubated with PMA (0.1 - 1000
ng/ml), another soluble agonist with the ability to directly trigger the respiratory
burst. At concentrations less than 10 ng/ml no effect on the rate of constitutive
apoptosis was observed. However, at concentrations greater than 10 ng/ml, there
was significant loss of both cell numbers and viability (trypan blue exclusion) after
only 8 h in culture (10 ng/ml PMA: 70% recovery and 93% viability, mean of n = 2).
Moreover, after both 8 and 20 h, this concentration of PMA resulted in an increased
number of cells with abnormal morphology (% normal morphology: 8 h; control
90.2, PMA 45.8. 20 h; control 59.1, PMA 31.1, mean of n = 2 experiments). The
abnormal cells were typically swollen and highly vacuolated; some had enlarged
nuclear lobes connected by fine strands of chromatin, others had loosely and
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Figure 4.8: ZAS, a biological source of C5a, inhibits equine neutrophil apoptosis in
vitro
Equine neutrophils (5 x 106/ml) were incubated in MF at 37°C either alone (open bars) or in
the presence of ZAS - 10% v/v (closed bars) for 8 and 20 h. Cells were resuspended and
percent apoptosis assessed morphologically on Diff-Quik-stained cytocentrifuge
preparations. Values represent mean ± SEM of six separate experiments, each performed
in triplicate. (* ; p<0.05,** ; p<0.001 compared with time-matched control).
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Raidal et al. (1998a) reported significant cell lysis following a 30 min incubation of
equine neutrophils with 100 ng/ml PMA. These bizarre morphological features
observed in response to PMA have also been described in human neutrophils with
both PMA and following ingestion of opsonized zymosan and most likely represent a
form of toxic or oxidative stress-induced death that is different to both classical
apoptosis and necrosis (Takei et al., 1996).
4.2.2.2 LPS promotes apoptosis in equine neutrophils
Having identified an unexpected pro-apoptotic effect of LPS in equine neutrophils,
further studies were performed to confirm and dissect this effect in more detail. In a
series of ten experiments, LPS (1 pg/ml) consistently enhanced apoptosis at both 8
and 20 h (Figure 4.9a). This pro-apoptotic effect was both time and concentration-
dependent (8h; EC5o 96.7 ± 2.5 ng/ml, 20h; EC5o 32.3 ± 2.4 ng/ml, n = 3, see Figure
4.9b). Moreover, this was confirmed by DNA fragmentation studies at both 8 and 20
h (Figure 4.4).
The marked contrast to the data acquired in parallel from human cells (Figure 4.7a &
b) suggested that this effect was a novel variation in equine neutrophils. Further
experiments were performed to discount a number of potentially artefactual causes
for this finding.
To ensure that that this effect was not specific to a particular batch or type of LPS,
equine and human cells were incubated in parallel with two different batches of
Escherischia coli Olll .B4 (the LPS type used routinely in these studies) and a rough
mutant Salmonella typhimurium LPS Ra 60. At 20 h, all three forms of LPS
consistently promoted apoptosis in equine neutrophils and inhibited apoptosis in
human neutrophils (data not shown).
LPS is well recognized to upregulate the expression of leucocyte integrins (Bochsler
et al., 1990) and to stimulate neutrophil adhesion to a variety of surfaces (Young et
al., 1990; Worthen et al., 1992) and this effect is enhanced in the presence of plasma
(Hailman et al., 1996). We hypothesised that any enhancement of LPS-stimulated
adhesion of non-apoptotic equine neutrophils to the flexiwells in comparison to
human cells, could lead to a lower recovery of non-apoptotic cells, thereby
artificially increasing the proportion of apoptotic equine cells harvested. This could
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Figure 4.9a,b: LPS enhances apoptosis in equine neutrophils in vitro
Equine neutrophils (5 x 106/ml) were incubated in MF at 37°C for 8 and 20 h. Cells were
resuspended and percent apoptosis assessed morphologically on Diff Quik-stained
cytocentrifuge preparations.
a: Cells incubated in the absence (open bars) or presence of 1 pg/ml LPS (closed bars).
Values represent mean ± SEM often separate experiments, each performed in triplicate,
b: Cells incubated, either alone or in the presence of LPS (0.1 - 10000 ng/ml) for 8 h
(squares) and 20 h (circles). Values represent mean ± SEM of three separate experiments,
each performed in triplicate.
( * ; p<0.05, ** ; p<0.001 compared with time-matched control).
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lead to the erroneous conclusion that LPS was pro-apoptotic in equine neutrophils.
Therefore, an experiment was performed comparing equine and human neutrophil
adhesion and apoptosis, in parallel. Cells were harvested using the standard
resuspension technique (Section 2.6.2) and the proportion of cells that remained
adherent to the wells was quantified by methylene blue staining, subsequent cell lysis
and measurement of optical density (Section 2.6.2.1). Although adhesion was
slightly enhanced in the presence of LPS, this effect was greater in human than
equine cells and the same pro- and anti-apoptotic responses were observed (20 h data
is shown in Figure 4.10), effectively ruling out an adhesion-related effect.
4.2.2.3 Effect of TNF-a on apoptosis in equine neutrophils
While TNF-a has been demonstrated to induce apoptosis in human neutrophils, most
studies suggest that this is a transient (2 - 12 h) effect (Takeda et al., 1993; Murray et
al., 1997), with TNF-a causing a paradoxical inhibition in the rate of apoptosis at
later time points (Colotta et al., 1992; Murray et al., 1997). Flowever, Watson and
co-workers (1996a) reported a pro-apoptotic effect of TNF-a over all time points
throughout a 25 h incubation period. Stimulated neutrophils are able to synthesise
and release various cytokines including TNF-a (Cassatella, 1995) and LPS is a
potent stimulus for TNF-a production (Dubravec et al., 1990; Bazzoni et ah, 1991).
This raised the possibility that the pro-apoptotic effect of LPS in equine neutrophils
might be a paracrine response, secondary to the release of endogenous TNF-a.
Therefore, the effect of human and erTNF-a on the rate of constitutive apoptosis in
equine neutrophils and the effect of an equine TNF-a neutralising antibody on the
pro-apoptotic LPS response were investigated.
Despite using the same batch of cytokine and taking care to maintain the standard
protocol of cell culture and harvest throughout this series of experiments, the effect
of hrTNF-a on equine cells was somewhat variable. The same batch of hrTNF-a
produced a consistent pro-apoptotic effect in human neutrophils at 12.5 ng/ml (Dr. J.
Murray, personal communication, data not shown). In preliminary experiments to
determine the time dependence of any effect, apoptosis was assessed in cells
incubated in the presence and absence of 25 ng/ml hrTNF-a for 2, 4, 6, 8, 10, 12 and





































Figure 4.10: The pro-apoptotic effect of LPS in equine neutrophils is unrelated to
adhesion
Equine (Eq - open bars) and human (Hu - hatched bars) neutrophils (5 x 106/ml) were
incubated in MF at 37°C for 20 h, either alone or in the presence of 1 pg/ml LPS, as
indicated. Cells were resuspended and percent apoptosis (bars: left-hand axis) assessed
morphologically on Diff Quik-stained cytocentrifuge preparations. Following aspiration of
entire well contents, adhesion (closed squares; right-hand axis) was assessed by methylene
blue staining of cells, followed by cell lysis and measurement of optical density. Values
represent the mean of triplicate determinations from a single experiment.
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findings contrast with the highly consistent priming effect of this recombinant human
cytokine in equine cells (Section 3.3.2.2).
In studies examining the effect of erTNF-a, the maximum final concentration of the
cytokine available for use was only 1 ng/ml; this concentration however, potently
primed equine cells (Section 3.2.3.2). Equine rTNF-a caused a small but significant
enhancement of apoptosis at 8 h (% apoptosis; control 11.2 ± 2.2, erTNF-a 16.6 ±
3.6, p<0.05, n = 11). There was also a trend toward enhancement of apoptosis at 20
h, but this was not significant (% apoptosis; control 43.0 ± 3.1, erTNF-a 51.3 ± 4.2,
p>0.05, n = 11). However, in 4 of these 11 experiments erTNF-a had either a
minimal effect (3 experiments) or inhibited apoptosis (1 experiment). If these data
were omitted from the analysis, a highly significant pro-apoptotic effect was
observed at both time points in the remaining 7 experiments (% apoptosis: 8 h;
control 10.6 ± 2.6, erTNF-a 20.3 ± 4.6, p<0.001; 20 h; control 40.6 ± 2.9, erTNF-a
57.4 ± 2.7, p<0.01, n = 7). This degree of donor variation in the response to erTNF-
a made it impossible to draw firm general conclusions regarding the effect of TNF-a
in neutrophils isolated from a random population of horses. However, variations in
both TNF-a synthesis (McGuire el al., 1994) and the sensitivity of neutrophils to the
pro-apoptotic effect of TNF-a (Sendo el al., 1996, Dr. J. Murray, personal
communication) are well recognized within groups of human subjects and such
heterogeneity in TNF-a responsiveness may be one explanation for the donor
variation observed in these equine data.
When the TNF-a neutralising Mab was used to address the potential role of TNF-a
in the pro-apoptotic effect of LPS in equine neutrophils, neither the neutralising Mab
itself nor an isotype-matched control Mab affected either basal or LPS-induced
apoptosis after 20 h (Figure 4.1 lb). The same antibody completely abrogated (91.0 ±
2.5%, n = 3) the priming effect of erTNF-a on fMLP-stimulated CL in equine
neutrophils (Figure 4.1 la), confirming its functional capability. An isotype-matched
control Mab had no significant effect (Figure 4.1 la).
This suggested that the novel pro-apoptotic effect of LPS in equine neutrophils was
independent of neutrophil TNF-a generation.
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Figure 4.11a, b: Effect of a TNF-a neutralising antibody on erTNF-a priming and LPS-
induced apoptosis in equine neutrophils
a: Cells were incubated with buffer (Control) or erTNF-a (1 ng/ml) in the presence and
absence of either an equine TNF-a neutralising Mab (HL801, 1 pg/ml), or an isotype control
Mab (Mab002, 1 pg/ml) for 30 min prior to stimulation with buffer (open bars) or fMLP (closed
bars, 1 pM). Values represent mean of triplicate determinations from a single experiment,
representative of 3 that gave similar results. Pre-incubation with antibodies alone gave
responses no different to control values.
b: Cells (5 x 106/ml) were incubated in MF at 37°C for 20 h, either alone or in the presence
of LPS, HL801 (1 pg/ml) or Mab002 (1 pg/ml) or co-incubated with LPS and each Mab.
Apoptosis was assessed morphologically. Values represent mean ± SEM of three separate
experiments, each performed in triplicate. NS: not significantly different
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4.2.2.4 Effect of phagocytosis on apoptosis in equine neutrophils
One of the primary roles of the neutrophil in the innate immune response is the
phagocytosis and subsequent intracellular killing of invading micro-organisms. This
process is greatly enhanced following opsonisation of micro-organisms by
immunoglobulins or complement (Edwards. 1994a).
Ingestion of opsonised Gram negative bacteria (.Escherichia coli) (Watson et al.,
1996a; Watson et al., 1996b), Oil-red-O particles (Coxon et al., 1996) and mouse
erythrocytes (Gamberale et al., 1998) stimulates apoptosis in human neutrophils.
These observations are consistent with a teleological view that would predict
direction of the phagocytosis-activated neutrophil toward non-phlogistic disposal.
One of the most striking observations in the current study was the extent to which
equine neutrophils were stimulated to undergo apoptosis rapidly following
incubation with opsonised sheep erythrocytes. The basal rate of apoptosis was
unaffected by incubation with non-opsonised cells (Figure 4.12). By 8 h, 74.7 ±
6.7% (morphological assessment, n = 6) of cells were apoptotic, compared to only
17.7 ± 2.6% of control cells and 17.4 ± 2.8% of cells incubated with non-opsonised
erythrocytes (Figure 4.12a). In initial experiments, this pro-apoptotic effect in the
presence of opsonised sheep erythrocytes was so dramatic that on some cytospin
preparations it was difficult to accurately distinguish all the individual apoptotic
cells. However, maintenance of the cells' ability to exclude trypan blue confirmed
their viability.
To confirm these data, apoptosis was subsequently assessed by Annexin V binding in
parallel with morphology (Figure 4.12). This indicated that morphological
assessment appeared to identify a larger proportion of apoptotic cells. After 8 h in
the presence of opsonised sheep erythrocytes, Annexin V binding identified only
57.5 ± 8.9% (n = 6) of cells as apoptotic. A similar enhancement of apoptosis in the
presence of opsonised sheep erythrocytes was recognized morphologically at 20 h (%
apoptosis; Control 44.6 ± 4.5%, OsRBC 93.3 ± 3.3, p<0.01, n = 6, Figure 4.12 c) and
again Annexin V binding identified a smaller population of apoptotic cells (%
apoptosis; Control 44.6 ± 3.9%, OsRBC 77.6 ± 4.2, p<0.01, n = 6, Figure 4.12d).
Whether this discrepancy reflected difficulty in distinguishing individual apoptotic
cells morphologically or some difference in the expression of Annexin V binding
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Figure 4.12a,b,c,d: Phagocytosis of OsRBCs stimulates apoptosis in equine
neutrophils
Equine neutrophils (5 x 106/ml) were incubated in MF at 37°C for 8 (a and b) or 20 h (c and
d) either in the absence (Control) or presence of non-opsonised (sRBC) or opsonised sheep
erythrocytes (OsRBC) prepared as described in Section 2.10.2 and added at a ratio of 3
RBCs per neutrophil. Cells were resuspended and apoptosis (%) assessed morphologically
(closed bars) on Diff-Quik stained cytocentrifuge preparations and by Annexin V binding
(hatched bars) analysed by flow cytometry,
a: Apoptosis assessed morphologically at 8 h.
b: Apoptosis assessed by Annexin V binding at 8 h.
c: Apoptosis assessed morphologically at 20 h.
d: Apoptosis assessed by Annexin V binding at 20 h.
Values represent mean ± SEM of six separate experiments, each performed in triplicate
(morphology) or duplicate (Annexin V binding).
(* ; p<0.01 ,** ; p<0.001 ,*** ;p<0.0001 compared with time-matched controls)
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sites in cells stimulated to undergo apoptosis by phagocytosis remains uncertain.
However, careful scrutiny of cytospins identified very few neutrophils with normal
morphology, suggesting that Annexin V binding underestimated the true proportion
of apoptotic cells.
A time course study of neutrophil apoptosis following phagocytosis of opsonised and
control sRBCs was performed and demonstrated an increased rate of morphological
apoptosis in OsRBC-stimulated cells at 3 h (Figure 4.13a). Neutrophils appeared
only to phagocytose non-opsonised cells after 5 h of co-culture, whereas ingestion of
opsonised erythrocytes was maximal by 1 h (Figure 4.13b). This is consistent with
other studies in equine neutrophils demonstrating that ingestion of opsonised bacteria
is maximal by 30 min (Raidal el al., 1998b).
Obviously, further experiments are required to confirm these observations, but these
preliminary findings suggest that phagocytosis-driven apoptosis (or possibly the
recognition mechanism involved in ingesting OsRBCs; see Figure 4.13b) could
represent a major anti-inflammatory control point in the neutrophil response to
microbial challenge. Indeed, study of other opsonins and different prey, such as
pathogenic bacteria, would be of great interest in the elucidation of the host response
to bacterial disease.
4.2.2.5 Dexamethasone inhibits equine neutrophil apoptosis
Glucocorticosteroids are widely used in the therapy of inflammatory diseases,
particularly of the respiratory tract, in both man (McFadden, 1998) and animals.
They are widely held as the pharmacological agents of choice in countering the
airway inflammation associated with COPD in the horse (Beech, 1991; Robinson,
1997a). Somewhat paradoxically, however, glucocorticosteroids have been shown to
inhibit the rate of constitutive human neutrophil apoptosis ( Cox, 1995; Liles el al.,
1995; Meagher et ah, 1996). In this context we evaluated the influence of
dexamethasone on apoptosis in equine neutrophils.
Dexamethasone (1 pM) proved to be a potent inhibitor of equine neutrophil
apoptosis (Figure 4.14 at both 8 h (% apoptosis; control 15.8 ± 3.0, DEX 3.5 ± 0.8,
p<0.001, n = 8) and 20 h (% apoptosis; control 52.0 ±4.1, DEX 22.8 ± 1.6,
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Figure 4.13a,b: Time course of phagocytosis-enhanced apoptosis in equine
neutrophils
Equine neutrophils (5 x 106/ml) were incubated in MF at 37°C either alone (Control) or in the
presence of either non-opsonised (sRBC) or opsonised sheep erythrocytes (OsRBC),
prepared as described in Section 2.10.2, at a ratio of 3 cells per neutrophil. Neutrophils were
resuspended at the time points indicated.
a: percent apoptosis assessed morphologically on Diff Quik-stained cytocentrifuge
preparations.
b: percent of phagocytic neutrophils assessed morphologically on Diff-Quik-stained
cytocentrifuge preparations.
Values represent mean of triplicate determinations from a single experiment.
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Figure 4.14a,b: Dexamethasone inhibits apoptosis in equine neutrophils
Equine neutrophils (5 x 106/ml) were incubated in MF at 37°C for 8 and 20 h. Cells were
resuspended and percent apoptosis assessed morphologically on Diff Quik-stained
cytocentrifuge preparations.
a: Cells incubated either alone (open bars) or in the presence of 1 pM Dexamethasone
(DEX; closed bars). Values represent mean ± SEM of eight separate experiments, each
performed in triplicate.
b: Cells incubated, either alone or in the presence of DEX (0.1-1000 nM) for 8 (squares) or
20 h (circles). Values represent mean ± SEM of three separate experiments, each
performed in triplicate.
(* ; p<0.01,** ; p<0.001,*** ;p<0.0001 compared with time-matched controls)
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provided further qualitative data to confirm the enhanced survival of neutrophils
incubated with dexamethasone (data not shown).
Moreover, this effect was concentration-dependent (Figure 4.14b), equine cells being
very sensitive to the inhibitory effect of dexamethasone (8h; IC50 0.6 ± 2.6 nM, 20h;
IC50 1.1 ±2.4 nM, n = 3). Although no human cells were examined in parallel, these
data suggest that equine neutrophils are significantly more sensitive to the
dexamethasone survival signal, since Liles et al. (1995) reported an IC50 for
dexamethasone of 50 nM in human cells when assessed after 24 h in culture.
4.3 DISCUSSION
The light microscopic features of equine neutrophils aged in culture were found to be
very similar to those observed in apoptotic human neutrophils (Savill et al., 1989b;
Lee et al., 1993). This is not unsurprising given the apparently universal occurrence
of the stereotypical features of cytoplasmic condensation, with or without
vacuolation, and the marked condensation of nuclear heterochromatin observed in
cells undergoing apoptosis or programmed cell death (Kerr et al., 1972; Wyllie et al.,
1980b; Kerr et al., 1995; Majno and Joris, 1995;). The time-dependent progression
of equine neutrophils manifesting these typical light microscopic and ultrastructural
features and the maintenance of plasma membrane integrity confirmed their
constitutive ability to undergo apoptosis.
Some of the earliest and most unmistakable morphological features of any cell
undergoing apoptosis are found in the nucleus, where condensed chromatin may fill
the whole of a nuclear remnant or be confined to distinct peripheral crescents ( Kerr
et al., 1995; Majno and Joris, 1995). Cytoplasmic vacuoles, although not a
consistent morphological feature of apoptosis (Kerr et al., 1995), are recognized in
neutrophils (Savill et al., 1989b) and have been associated with the large surface
craters observed with scanning electron microscopy in other cell types, suggesting
that cells with these features may have expelled part of their contents by exocytosis
(Kerr etal., 1995).
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Whilst such structural alterations remain the "gold standard" for identification of the
apoptotic phenotype, they must not be considered in isolation. In this study parallel
confirmatory biochemical evidence was obtained from electrophoresis of DNA. This
produced the classical "ladder' pattern of integer multiples of 180-200 base pair
nucleosomes (Wyllie, 1980a). This results from activation of an endogenous
endonuclease that cleaves DNA in the linker region between histones on the
chromosome (Bortner et al., 1995) to produce DNA fragments with 3'-OH and 5'-
phosphate ends (Eastman, 1995a). Indeed, 15 years ago Wyllie and co-workers
(1984) demonstrated that the condensed chromatin recognized morphologically in
apoptotic thymocytes was composed of endogenously fragmented chromatin. The
process of DNA cleavage may indeed proceed from large (50 - 300 kbp) fragments
followed by degradation into progressively smaller nucleosome multiples (Bortner et
al., 1995). This fragmentation tends to be more extensive in haematopoietic cell
lineages (Eastman, 1995a), such as neutrophils.
Apoptosis is also associated with a decrease in cell size (Majno and Joris, 1995);
hence its early description as "shrinkage necrosis", and although not assessed here,
both acridine orange staining (Liles et al., 1995) and flow cytometric analysis
(Hachiya et al., 1995) have demonstrated such a reduction in the size of apoptotic
human neutrophils. Flow cytometry has also permitted detailed cell-by-cell analysis
of changes in both the structure of the plasma membrane and its repertoire of surface
molecule expression in neutrophils undergoing apoptosis (Dransfield et al., 1994;
Dransfield et al., 1995; Homburg et al., 1995). These changes are highly specific for
the apoptotic phenotype. Down-regulation of both the expression and function of
certain surface adhesion receptors and ligands is recognized in human neutrophils
(Dransfield et al., 1995). For example, there is a tight correlation between reduced
expression of the low affinity IgG receptor FcyRIII (CD 16) and the appearance of
apoptotic morphology. This forms the basis of a sensitive assay for apoptosis in
human neutrophils (Dransfield et al., 1994; Homburg et al., 1995). Of particular
interest when studying cellular apoptosis in a species such as the horse, for which
there is a paucity of well-defined immunological reagents, are the apparently
universal changes in plasma membrane phospholipid structure that occur in apoptosis
(Martin et al., 1995). Normal blood cell membranes have an asymmetric distribution
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of their component phospholipids, with phosphatidylcholine and sphingomyelin
predominantly expressed on the outer leaflet and most of the
phosphatidylethanolamine and phosphatidylserine being confined to the inner leaflet
(Van Meer, 1993). As cells undergo apoptosis, these phospholipids become
redistributed (Mower et al., 1994), such that asymmetry is lost and
phosphatidylserine becomes exposed on the outer leaflet of the lipid bilayer (Martin
et al., 1995). Annexin V, a member of a family of high affinity aminophospholipid
binding proteins, preferentially binds phosphatidylserine. The use of FITC-labelled
Annexin V has demonstrated consistent early exposure of phosphatidylserine on a
wide variety of human and murine cell types undergoing either stimulated or
constitutive apoptosis, including neutrophils (Koopman et al., 1994; Homburg et al.,
1995; Martin et al., 1995). In most cell types, phospholipid redistribution and the
acquisition of Annexin V binding sites precedes chromatin condensation and DNA
fragmentation (Mower et al., 1994; Martin et al., 1995). In neutrophils however,
these changes appear to be more tightly associated (Homburg et al., 1995). Indeed,
as well as having demonstrated that apoptotic equine neutrophils also acquire
appropriate binding sites for Annexin V, this event appears to be tightly temporally
associated with nuclear condensation.
The importance of assessing apoptosis by a combination of assay methods is
highlighted when attempting to define the kinetics of cell death in vivo, as not all the
classical changes will be apparent prior to the rapid recognition and engulfment of
apoptotic cells by phagocytes (Nakamura et al., 1997). Measurement of Annexin V
binding may be particularly relevant in this context given the mechanistic
involvement of phosphatidylserine exposure in macrophage recognition of the
apoptotic phenotype in a number of cells lineages (Fadok et al., 1992; Savill, 1997b).
The TUNEL method of in situ staining of the exposed 3'-OH ends of fragmented
DNA (Ben-Sasson et al., 1995) clearly and specifically identified apoptotic cells in
short term (8 h) cultures of equine neutrophils. This was defined in vitro with a view
to utilising this technique to positively identify fragmented DNA in apparently
condensed nuclear material within both free cells and phagocytic macrophages in
BALF collected in vivo.
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When comparing apoptosis data obtained in different studies, it is important to
clearly define the cell culture conditions employed because the constitutive rate of
neutrophil apoptosis can be profoundly affected by pH (Leblebicioglu and Walters,
1999), cell density, the nature of the culture vessel and the presence or absence of
serum or protein in the culture medium (Hannah et al., 1998). Although no direct
parallel comparison was made, equine neutrophils appeared to become apoptotic at a
somewhat faster initial rate (< 8 h) but thereafter more slowly than human cells (e.g.
% apoptosis at 20 h; equine 42.1 ± 1.5, human 52.4 ± 4.8, n = 6). This results in a
more linear relationship between the proportion of apoptotic cells and time for
equine neutrophils compared with the more sigmoid kinetic relationship for human
cells (Savill et al., 1989b). Notwithstanding the part that donor variability might
play in determining the constitutive rate of apoptosis (Dransfield et al., 1994), this
trend is consistent with the reported circulating half-lives of 10.5 and 6.8 h for equine
(Carakostas et al., 1981) and human (Boggs, 1967) neutrophils, respectively.
Although more recent studies suggest that these ex vivo labelling and re-infusion
methods overestimate neutrophil disappearance rates (Bicknell et al., 1994), these
early investigations of granulocyte kinetics did provide preliminary evidence that the
lifespan of circulating neutrophils is prolonged during an inflammatory response.
Lee and colleagues (1993) demonstrated the ability of inflammatory mediators to
inhibit apoptosis and prolong the functional longevity of human neutrophils in vitro.
Many other studies have detailed the regulatory effects of cytokines and other
inflammatory mediators on neutrophil longevity (Cohen et al., 1992; Squier et al.,
1995; Liles et al., 1996). A unifying hypothesis began to emerge that agents known
to prime or activate neutrophil function (Lee et al., 1993; Murray et al., 1997) would
retard the constitutive rate of apoptosis. However, this concept was questioned by
the lack of such an effect with some priming/activating agents, for example, fMLP
and PAF and the demonstration of an early pro-apoptotic effect of TNF-a (Takeda et
al., 1993; Murray et al., 1997). Considerable disagreement also exists regarding the
effects of certain of these agents on neutrophil apoptosis; hence fMLP for example,
has been reported to inhibit (Lee et al., 1993; Watson et al., 1996b), promote (Hebert
et al., 1996) or to have no effect on human neutrophil apoptosis (Murray et al.,
1997).
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This preliminary study in equine neutrophils sought to address the regulation of
apoptosis by such inflammatory mediators. The lack of effect of fMLP (1 pM) on
equine neutrophil apoptosis is consistent with certain human studies e.g. (Watson et
al., 1996b; Murray et al., 1997). However, the former group did identify an
inhibitory effect at fMLP concentrations below 100 nM.
Although the direct functional responses of equine neutrophils to LTB4 are similar to
those reported in human cells (see Section 3.1), a promotion of neutrophil survival,
as reported in human neutrophils (Hebert el al., 1996), was not observed in equine
cells. However, parallel equine and human studies would be necessary to confirm
this discrepancy.
Functional responses to hrGM-CSF have been recognized in some equine cell types
(Dr D. Horohov, 1998, personal communication) and systemic administration of
canine rGM-CSF results in increased myeloid activity and a significant peripheral
neutrophilia in foals (Zinkl et al., 1994). However, the consistent concentration-
dependent enhancement of survival observed in human neutrophils (Figure 4.7, Cox
et al., 1992, Lee et al., 1993} was not observed in equine cells. Failure of equine
neutrophil GM-CSF receptors to recognize this particular recombinant cytokine may
explain this lack of effect.
The highly variable response of equine cells to TNF-a is difficult to explain, but
donor-specific effects may underlie a large part of this variability. Equally variable
donor responses are observed in human cells in response to hrTNF-a (Dr. J. Murray,
personal communication). Incubation of human neutrophils with LPS abolishes the
pro-apoptotic effect of TNF-a (Murray et al., 1997) and exposure of cells in these
experiments to even trace amounts of LPS during isolation might mask any TNF-a
effect. However, neutrophil priming studies performed in parallel demonstrated that
freshly isolated cells were not basally primed (based on their response to fMLP),
suggesting that significant LPS contamination did not occur. The highly consistent
priming of equine cells by both the human and equine recombinant cytokines (see
Sections 3.2.2 and 3.2.3.2) in the absence of a reliable effect on apoptosis, could
indicate differential engagement of equine TNF-a receptors by the two recombinant
molecules. In human neutrophils, TNF-a-induced priming and the late inhibitory
effect on apoptosis are mediated by the TNFR 55, whereas the early pro-apoptotic
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effect relies upon ligation of both the TNFR 55 and the TNFR 75 (Murray et al.,
1997). Obviously, further detailed experiments will be necessary before the true
nature of these responses is apparent. Indeed, identification and cloning of equine
TNF-a receptors may be required for further progress to be made on this question.
The potent anti-apoptotic effect of ZAS confirmed that inflammatory mediators
could indeed activate a respiratory burst and prolong equine neutrophil survival.
This agent may prove useful in future studies to dissect the modulation of equine
neutrophil apoptosis. However, in future, purification of C5a from ZAS and
identification of other pro-inflammatory components of this somewhat crude reagent
should be undertaken.
Undoubtedly, the most intriguing and novel data in this study is the marked pro-
apoptotic effect of LPS in equine neutrophils. Its concentration-dependence (EC50
32.3 ± 2.4 ng/ml at 20 h) is similar to that determined for priming the respiratory
burst (EC50 19.1 ± 4.7 ng/ml). The effect was confirmed on multiple occasions using
both morphological and biochemical criteria and subsequent experiments suggested
that the response was independent of TNF-a. This effect is diametrically opposed to
the profound concentration-dependent inhibitory effect of LPS in human neutrophils
(Figure 4.7, (Colotta et al., 1992; Lee et al., 1993; Yamamoto et al., 1993). This was
neither an anomaly of the culture system (as LPS enhanced the survival of human
cells incubated in parallel, see Figure 4.7) nor a LPS type-specific effect as identical
results were also obtained with a rough S. typhimurium LPS. Again in contrast to
human cells (Keel et al., 1997), this response was not mediated, even in part, by
TNF-a. LPS has been reported to play either a direct or facilitatory role in
stimulating apoptosis in a number of more long-lived cell types, including
lymphocytes (Norimatsu et al., 1995), vascular endothelial cells (Wong et al., 1996)
and alveolar macrophages by a ROS-dependent mechanism (Bingisser et al., 1996),
but this effect has not been previously recognized in granulocytes. Assessment of
apoptosis by multiple methods in response to a larger panel of LPS types and over a
more detailed time course will be required to confirm and dissect this novel pro-
apoptotic response in equine neutrophils.
In spite of the widespread use of glucocorticosteroids in the treatment of
inflammatory disease in the horse, information on the effects of such agents on
173
neutrophil function in vitro is lacking. Just two studies appear to have been
published both demonstrating the ability of DEX (1 - 500 pM) to inhibit ZAS-
stimulated adhesion of equine neutrophils (Slauson et al, 1987; Bochsler et al.,
1990). In contrast, the regulatory effects of glucocorticosteroids on human
neutrophil function and apoptosis in particular, are an area of intense study ( Cox,
1995; Liles et al., 1995; Meagher et al., 1996; Liu et al., 1999). Equine neutrophils
appeared to be even more sensitive than human cells to the dramatic inhibitory effect
of DEX on their rates of apoptosis (Liles et al., 1995). Furthermore, quite unlike
human neutrophils, which require at least 8 h exposure to DEX before inhibition is
seen (Meagher et al., 1996), in equine cells a significant inhibitory effect is already
apparent by this time point. In human cells this effect is mimicked by a number of
other glucocorticosteroids including Cortisol, hydrocortisone, budenoside and
methylprednisolone (Cox, 1995) by a receptor-mediated mechanism (Meagher et al.,
1996). However, unlike many other anti-apoptotic stimuli, such as GM-CSF, DEX
does not prime neutrophils for an enhanced respiratory burst (Cox, 1995). An inter¬
species difference in the response of equine neutrophils to DEX was also recognized
by Slauson et al. (1987), wherein DEX inhibited C5a-induced adhesion; in human
neutrophils it does not. The mechanism of DEX inhibition of neutrophil apoptosis is
currently unknown, but as human cells require at least 8 h of exposure to DEX before
an inhibitory effect is revealed, drug-induced synthesis of an anti-apoptotic protein
seems unlikely (Meagher et al., 1996). Whether a different or complimentary
mechanism underlies the response of equine neutrophils is a subject for future study.
The dramatic increase in peripheral neutrophil counts observed in both humans and
horses (Lassen and Swardson, 1995) following systemic administration of
glucocorticosteroids may be mediated, in part, by directly delaying neutrophil
apoptosis and clearance (Meagher et al., 1996). More importantly, this enhanced
longevity of DEX-exposed neutrophils may have major implications regarding the
clearance of these cells from an inflammatory site and could well be detrimental in
terms of the resolution of inflammation in vivo. However, this consideration is
balanced by the work of Liu and colleagues (1999), who observed a major
potentiation in the non-phlogistic phagocytosis of apoptotic neutrophils by
glucocorticoid-treated macrophages. This suggests that corticosteroid therapy may
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also positively promote the resolution of inflammation. If macrophage uptake of
apoptotic neutrophils is rate limiting, this effect may play an important part in the
reduction in BALF neutrophil count observed in horses with RAO following
administration of either aerosol beclomethasone dipropionate or parenteral
dexamethasone (Rush et al., 1998a).
Phagocytosis of opsonised particles is a key neutrophil effector function in host
defence and this produced a striking promotion of apoptosis in equine neutrophils. A
similar response has been observed in human neutrophils following ingestion of both
complement (Coxon et al., 1996; Watson et al., 1996a; Watson et al., 1996b) and
IgG opsonised targets (Gamberale et al., 1998). These effects were found to be
dependent upon ROS generation during a phagocytosis-induced respiratory burst.
Investigation of this response in equine cells identified no pro-apoptotic effect after
the delayed ingestion of non-opsonised sRBC, suggesting that the mechanism of
particle recognition and uptake is crucial in determining the cell's response. By
selectively blocking Fc receptors and phagocytosis with cytochalasin B, Gamberale
and colleagues (1998) demonstrated that particle ingestion was superfluous and that
apoptosis was also stimulated in association with a prolonged respiratory burst
following binding to Fcylla receptors. In a single experiment performed with equine
neutrophils, cytochalasin B at a concentration of 5 pg/ml (shown not to affect
apoptosis in the human study) enhanced apoptosis in equine cells, preventing
meaningful interpretation of the importance of ingestion per se in phagocytosis-
stimulated apoptosis (data not shown).
Whilst many of the foregoing studies reporting the modulation of constitutive
neutrophil apoptosis give clues to a number of key players, the intracellular
mechanisms underlying apoptosis and its regulation remain elusive. Undoubtedly,
constant protein synthesis is necessary to maintain the neutrophil's brief lifespan, as
evidenced by the rapid induction of apoptosis following exposure to the protein
synthesis inhibitor, cycloheximide (Tsuchida et al., 1995; Whyte et al., 1997).
Alterations in intracellular ion balance leading to cell acidification in association
with apoptosis (Cohen et al., 1992; Eastman, 1995b) have not been recognized in the
neutrophil. Indeed, transient elevations in cytosolic free calcium ions, induced by
low concentrations of the calcium ionophore A23187, retarded apoptosis and
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modulation of intracellular pH had no effect on neutrophil apoptosis (Whyte et al.,
1993a). However, a subsequent study suggested a causal relationship between the
appearance of apoptotic morphology in human neutrophils and an early and rapid fall
in pH (Gottlieb et al., 1995). Moreover, these authors suggested that G-CSF
inhibited apoptosis by upregulation of an H+-ATPase proton export pump thereby
preventing cell acidification.
Liles and co-workers (Liles et al., 1996) have proposed an autocrine mechanism
related to co-expression of the TNF/nerve growth factor family member Fas (CD 95)
and its ligand (FasL) on the neutrophil's surface to explain the cell's inexorable
progression toward death. Fas/FasL ligation is well recognized as a trigger for the
clonal deletion of autoreactive T cells, and both activation-induced T cell suicide and
cytotoxic T cell killing (Nagata and Golstein, 1995). Also Fas-mediated neutrophil
death is inhibited by well-described anti-apoptotic stimuli such as pro-inflammatory
cytokines, dexamethasone and tyrosine kinase inhibitors (Liles et al., 1996).
Human neutrophil apoptosis is abrogated by tyrosine phosphatase inhibitors,
indicating a central role for tyrosine phosphorylation in apoptosis signalling (Yousefi
et al., 1994). Recently, constitutive tyrosine phosphorylation and activation of the
serine/threonine kinase, p38-mitogen-activated protein kinase (p38-MAPK), a
protein kinase generally associated with cell survival signals (Eastman, 1995b), has
been identified in freshly isolated neutrophils and implicated in constitutive
apoptosis (Aoshiba et al., 1999). These workers also implicated constitutive
intracellular ROS generation, downstream to p38-MAPK, in the spontaneous death
programme. This supports other recent work demonstrating that changes in
intracellular redox status may be critical in the regulation of both constitutive and
stimulated neutrophil apoptosis ( Narayanan et al., 1997; Oishi and Machida, 1997;
Watson et al., 1997a).
As alluded to earlier, the onset of apoptosis is associated with down-regulation of
cellular functions. Equine neutrophils showed a dramatically reduced respiratory
burst in response to a receptor-mediated stimulus (ZAP); the magnitude of this
reduction (80%) being substantially greater than the proportion of morphologically
apoptotic cells (50%). This could suggest that the cells become functionally isolated
from their surroundings at an early stage in the apoptotic programme, prior to the
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development of typical morphologic features of apoptosis. These data concur with
findings in human neutrophils, where reductions in both basal (spreading on glass
and shape change) and stimulated responses (shape change, chemotaxis, respiratory
burst and degranulation) to receptor-mediated agonists (fMLP, C5a and opsonised
zymosan) closely mirrored levels of apoptosis in elutriation fractions of aged cells
(Whyte et al., 1993b). However, some of the data from the study by Whyte and
colleagues (1993) also indicated that the fall off in functional responses was greater
than the proportion of visibly apoptotic cells. These authors went on to demonstrate
by autoradiography that this was associated with a loss of functional fMLP receptors,
with fewer than 1% of apoptotic cells binding significant amounts of [3H] fMLP.
This may indicate some degree of receptor cross talk in the global down-regulation
of receptor-mediated function, given the association between reduced CD 16
expression and apoptosis (Dransfield et al., 1994) and the functional linkage of this
receptor with that for fMLP (Kew el al., 1992).
However, in contrast to the effect of a receptor-mediated stimulus, direct activation
of PKC and superoxide anion generation in response to PMA was maintained in aged
equine neutrophils. This suggests that the signal transduction mechanisms regulating
NADPH assembly are intact in apoptotic cells, but are inaccessible to receptor-
mediated stimuli. PMA-stimulated superoxide anion release is also maintained in
apoptotic human neutrophils (Whyte et al., 1993b; Narayanan et al., 1997).
However, recent, more detailed studies suggest that the regulation of intracellular
oxidative activity in apoptotic neutrophils is much more complex than these initial
experiments might indicate (Narayanan et al., 1997). Narayanan and co-workers
(1997) demonstrated a time-dependent reduction in PMA-stimulated H2O2
production in contrast to the maintenance of superoxide anion generation, suggesting
that the stability of the PMA response was pathway specific. Moreover, they
observed a fall in intracellular glutathione and superoxide dismutase content in cells
undergoing apoptosis, again implicating a disruption of redox status in both the
apoptotic programme and the associated down-regulation of oxidative capacity.
The changes in receptor number and function that accompany apoptosis, have many
implications for the limitation of neutrophil-mediated tissue injury in vivo. Notably,
apoptotic neutrophils show a reduction in both selectin- and integrin-mediated
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adhesion events associated with both decreased adhesion molecule/ligand expression
(selectins) and function (integrins) (Dransfield et al., 1995). As adhesion per se can
augment pro-inflammatory neutrophil functions (Schleiffenbaum and Fehr, 1990;
Anderson, 1995), the altered adhesive capacity of apoptotic cells may also serve to
limit release of their histotoxic contents.
Commitment to apoptosis as a means of limiting the pro-inflammatory potential of
neutrophils at an inflamed site presumes that resident phagocytes will clear these
cells. However, if this clearance route is inadequate or inoperable, impaired
functional responses to physiological stimuli may serve as a short-term brake on the
neutrophil's latent capacity to cause collateral cellular injury. Although prolongation
of neutrophil longevity by inflammatory mediators runs the risk of enhanced
neutrophil-mediated damage, this may also serve to maintain antimicrobial defences
and neutrophil integrity whilst awaiting recruitment of appropriate clearance routes
prior to commitment to apoptosis.
This study has served to initiate understanding of apoptosis and its regulation in
equine neutrophils and has established the potential of this programme of cell death
to play a central role in a resolution of inflammation favouring minimal host tissue
damage. Furthermore, the marked difference in the responses to LPS and the
difference in sensitivity and time dependence to DEX in equine cells in comparison
to those established for human neutrophils may be of value in dissecting the
underlying regulatory mechanisms of apoptosis in neutrophils.
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CHAPTER 5
CLINICAL, BRONCHOSCOPIC AND PERIPHERAL BLOOD RESPONSES
OF COPD - SUSCEPTIBLE HORSES TO HAY / STRAW CHALLENGE
5.1 INTRODUCTION
Although the precise aetiology of equine COPD remains elusive (Section 1.1.3) the
association between the development of lung dysfunction and the use of poorly saved
or frankly mouldy straw and hay is well recognized. Critical evaluation of horses
with evidence of chronic pulmonary disease has demonstrated the difficulty in
making a definitive diagnosis of COPD based on clinical signs alone (McPherson el
al., 1978; Mair, 1987a; Naylor et al., 1992; Dixon el al., 1995a). Attempts to
definitively diagnose COPD based on strict physiological criteria documenting
impaired pulmonary mechanics and gas exchange (Sasse, 1971; McPherson et al.,
1978) have been shown to be too insensitive to detect less severely affected animals
(Mair, 1987a; Dixon et al., 1995c).
Early pathological studies identified the pulmonary inflammation in COPD as a
chronic neutrophilic bronchiolitis (Section 1.1.4) and the introduction of routine
respiratory cytology to equine medicine has revolutionised the diagnosis of chronic
pulmonary diseases (Whitwell and Greet, 1984; Mair, 1987a; Mair et al., 1987b).
Cytological evaluation of tracheal secretions (Nuytten et al., 1983; Larson and
Busch, 1985; Mair, 1987a) and more importantly BALF confirmed that the
pulmonary inflammation in affected animals was invariably associated with
recruitment of neutrophils to the airspaces (Derksen et al., 1985b; Naylor et al.,
1992; McGorum et al., 1993d).
More detailed investigations utilising short term (5-7 h) experimental hay/straw
challenges showed deterioration in pulmonary mechanics within 90 min, arterial
hypoxaemia and recruitment of neutrophils (but not eosinophils or platelets) to the
179
lung within 3-5 h (Fairbairn et al., 1991; Fairbairn et al., 1993; McGorum et al.,
1993d).
Despite the consistent presence of neutrophilic pulmonary inflammation in equine
COPD (Robinson et al., 1996) and the potential for neutrophils to cause lung injury
(reviewed in Section 1.6), there is a relative paucity of information on the functional
status of these cells either within the airspaces or in the circulating granulocyte pool
of affected animals. Although some studies have begun to address the function of
blood and airspace neutrophils in COPD-affected horses (Nuytten et al., 1983;
Olszewski and Laber, 1993; Klucinski et al., 1994; Marr et al., 1997a; Olszewski et
al., 1999), the true pathogenetic role of the neutrophil in COPD remains unknown
(Derksen, 1993; Robinson et al., 1996).
Since its initial description as an in vitro phenomenon (Guthrie el al., 1984),
neutrophil priming has been shown to be a necessary step in the sequestration of
neutrophils in the lung (Worthen et al., 1987; Ussov et al., 1996) and to play a
critical role in endothelial cell injury (Smedly el al., 1986; Worthen et al., 1987).
However, systemic priming alone, although causing retention of neutrophils in the
pulmonary vascular or "marginated" pool, does not necessarily lead to migration into
the lung interstitium or lung damage (Ussov el al., 1996).
Having characterised priming and activation of equine neutrophils in vitro (see
Chapter 3), the same CL assay was used to assess the functional status of blood and
airspace neutrophils in the COPD lung inflammation model. Hence, because only
primed equine neutrophils undergo respiratory burst activity when challenged with
fMLP, it was hoped that the ex vivo fMLP-stimulated CL response of neutrophils
harvested during hay/straw challenge could be employed as an index of in vivo
"functional" priming. Indeed, this is the first study to specifically address the
question of in vivo neutrophil priming in the horse.
Experimental findings regarding the kinetics and functional status of neutrophils
harvested from the airspaces following hay/straw challenge and a discussion of this
data are presented in Chapter 6.
To date, it has not been possible to establish a direct causative association between
the lung injury observed in equine COPD (Kaup et al., 1990b; Votion et al., 1999;
Votion et al., 1999) and the presence of neutrophils in the lung using either nuclear
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medicine studies (Fairbairn et al., 1993) or experiments relying on recovery of
neutrophils from within the airspaces by BAL (McGorum et al., 1993d). Several
studies in human patients have suggested a causal relationship between the functional
status of circulating neutrophils and lung disease by establishing a significant
statistical correlation between the agonist-stimulated respiratory burst activity of
circulating neutrophils and both airway hyperresponsiveness in asthma (Meltzer et
al., 1989) and lung injury in ARDS (Zimmerman et al., 1983; Zimmerman et al.,
1984; Chollet-Martin et al., 1992). However, these conclusions seem less robust in
light of studies demonstrating firstly, that neutrophils can undoubtedly be primed and
migrate into the airways and not undergo a respiratory burst (Jones et al., 1997) or
cause lung injury (Martin et al., 1989; Garat et al., 1995) and secondly, that in
patients with extrapulmonary inflammatory diseases, priming is predictive for
sequestration in the pulmonary vasculature but does not necessarily lead to
transmigration and lung injury (Ussov et al., 1996). It is also possible that changes
in blood neutrophil function may be a consequence of lung inflammation in the same
way that extrapulmonary diseases such as massive trauma (Botha et al., 1995) and
inflammatory bowel disease and vasculitis (Ussov et al., 1996) cause systemic
neutrophil priming. Notwithstanding these controversies, investigation of peripheral
blood neutrophil kinetics and function in an in vivo experimental model was an initial
step toward evaluating the role of neutrophils in equine COPD and assessing whether
systemic neutrophil priming/activation occurred in this disease.
5.2 RESULTS
5.2.1 CHARACTERISATION OF COPD - SUSCEPTIBLE HORSES
All six horses recruited for the in vivo challenge studies had a prolonged history (> 6
months) of recurrent episodes of airway disease when exposed to poorly saved hay
and/or straw. The clinical signs of airway disease reported by the animals' owners
included coughing, bilateral mucopurulent nasal discharge, dyspnoea and exercise
intolerance. These signs resolved when the animals were kept at pasture or
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maintained in a "controlled environment". All animals were confirmed to be in
remission as assessed by combined clinical examination (clinical score not greater
than 1) and examination of BALF cytology (% neutrophils < 5%). To confirm their
susceptibility to COPD, all animals underwent a test hay/straw challenge as
described in Section 2.7.2. After challenge, all animals had an increased clinical
score and an elevated proportion of neutrophils in their BALF (Figure 5.1a,b), thus
confirming their disease status.
5.2.2 EFFECTS OF SHAM SERIAL BRONCHOALVEOLAR LAVAGE
The series of sham BAL procedures (see Section 2.7.3) performed whilst the animals
were maintained in a controlled environment, had no effect on clinical scores at
subsequent BAL collection times (p>0.05, n = 6, data not shown). Serial BAL alone,
also had no significant effect on either peripheral blood neutrophil numbers (p>0.05,
n = 3, data not shown) or PBS-, 1MLP-, ZAP- and PMA-stimulated Luci- and Lum-
DCL responses (p>0.05, n = 3, data not shown).
5.2.3 EFFECT OF CHALLENGE ON CLINICAL SCORES
Hay/straw challenge induced a significant increase in clinical scores compared to
baseline values at 5 h, 24 h and 4 days after challenge (p<0.05, n = 6, Figure 5.2).
Clinical scores immediately prior to challenge (0 h) were not significantly different
from baseline. Clinical scores were greatest at 24 h, but were not statistically
different from either the 5 h or the 4 day time points. Scrutiny of the individual
components of the clinical score indicated that abnormal respiratory sounds detected
over both the distal cervical trachea (6/6 horses at 5 and 24 h after challenge) and the
lung fields (6/6 horses at 5 and 24 h) and dyspnoea, characterized by an increased
abdominal expiratory effort (5/6 horses at 5 and 24 h), were the most consistent
clinical features of the induced respiratory disease.
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PRE POST
Figure 5.1a,b: Confirmation of COPD-susceptible status of experimental horses
Following an 8 week period at pasture or in a controlled environment horses were
challenged as described in Section 2.7.2 for 5 h (3 animals) or 8 h (3 animals) followed by
clinical examination and collection and cytological evaluation of BALF.
a: Clinical scores computed immediately before (PRE) and after (POST) a 5 or 8 h challenge
as described in Section 2.7.2 and Table 2.3. Plorizontal bars represent median values,
b: Proportion of neutrophils (%) in BALF collected 10 days before (PRE) and immediately
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Figure 5.2: Effect of hay/straw challenge on clinical score in COPD-susceptible horses
Clinical scores were computed as described in Section 2.7.2 and Table 2.3 at the time points
indicated. Data are presented as box and whisker plots indicating median values, 25th and
75th percentiles and maximum and minimum values. B/line; baseline examination 10 days
prior to challenge; h (hours) and days after the initiation of challenge. (*; p<0.05 compared
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Figure 5.3: Effect of hay/straw challenge on Pa02 in COPD-susceptible horses
Arterial blood was collected, transported and analysed as described in Section 2.7.2 at the
time points indicated. Data are presented as box and whisker plots indicating median values,
25th and 75th percentiles and maximum and minimum values. (* ; p<0.05 compared to
baseline values, n = 6)
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5.2.4 EFFECT OF CHALLENGE ON ARTERIAL BLOOD GASES AND pH
Arterial blood gas and pH analyses demonstrated significant hypoxaemia at 5 and 24
h after challenge compared to baseline values (baseline, 104 mmHg, 98 - 113 mmHg
(median and range); 5 h, 86.3 mmHg, 84 - 95 mmHg; 24 h, 97 mmHg, 67.1 - 100
mmHg, p<0.05, n = 6, Figure 5.3). PaOi values immediately prior to challenge (0 h)
were not significantly different from baseline. Arterial blood pH and PaC02 were
unaffected by challenge.
5.2.5 EFFECT OF CHALLENGE ON THE VOLUME OF TRACHEAL
SECRETIONS
The volume and nature of tracheal secretions were observed endoscopically and
scored subjectively at the prescribed time points as described in Section 2.7.4. At
baseline, four animals had grade 1 secretions (a few flecks) that were tenacious and
mucopurulent in nature, the remaining two had no visible secretions. After
challenge, all animals had copious tracheal secretions that were of a non-viscous,
mucopurulent nature. The volume of secretions was significantly increased in
comparison to baseline at 5 h and 24 h after challenge (p<0.05, n = 6, Figure 5.4) and
then gradually reduced over the 14 days after challenge.
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Figure 5.4: Effect of hay/straw challenge on the volume of tracheal secretions in
COPD-susceptible horses
The volume of tracheal secretions was graded semi-quantitatively (grade 0-5) as described
in section 2.7.4 at the time points indicated. Data are presented as box and whisker plots
indicating median values, 25th and 75th percentiles and maximum and minimum values.
(* ; p<0.05 compared to baseline values, n = 6)
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5.2.6 EFFECT OF HAY/STRAW CHAFFENGE ON PERIPHERAE BEOOD
LEUCOCYTE COUNTS
Total and differential leucocyte counts were performed on jugular venous blood
samples as described in Section 2.1. All haematological parameters measured
immediately prior to challenge (0 h) were not significantly different from baseline.
A significant increase in total leucocyte count was present 24 h after challenge
(p<0.05, n = 6, Figure 5.5a) that was due solely to a significant increase in absolute
neutrophil counts (p<0.05, n = 6, Figure 5.5b). This was mirrored by an increase in
differential neutrophil counts. Absolute and differential lymphocyte, monocyte,
eosinophil and basophil counts were unchanged following challenge (data not
shown).
5.2.7 EFFECT OF CHALLENGE ON THE RATE OF CONSTITUTIVE
APOPTOSIS IN PERIPHERAL BLOOD NEUTROPHILS
Neutrophils were isolated from peripheral blood and cultured as described in Section
2.6.1. Neutrophil apoptosis was quantified (Section 2.6.2) in cells cultured for 8 and
20 h. The constitutive rate of apoptosis was inhibited (in comparison to baseline
values) after 20 h in culture in cells collected 24 h after challenge (% apoptosis at 20
h: baseline, 58.8, 41.4 - 67.5 (median and range); 24 h post-challenge, 42.6, 31.3 —
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Figure 5.5a,b: Effect of hay/straw challenge on total leucocyte and absolute neutrophil
counts in the peripheral blood of COPD-susceptible horses
Total and differential leucocyte counts were performed on jugular venous blood samples as
described in Section 2.1 at the time points indicated. Data are presented as box and whisker
plots indicating median values, 25th and 75th percentiles and maximum and minimum
values. (* ; p<0.05 compared to baseline values, n = 6)
a: Total leucocyte counts
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Figure 5.6: Effect of hay/straw challenge on the rate of constitutive apoptosis in
peripheral blood neutrophils from COPD-susceptible horses
Neutrophils were isolated at the time points indicated and incubated in MF (5 x 106/ml) at
37°C for 20 h. Cells were resuspended and percent apoptosis assessed morphologically on
Diff-Quik stained cytocentrifuge preparations in triplicate. Data are presented as box and
whisker plots indicating median values, 25th and 75th percentiles and maximum and
minimum values. (* ; p<0.05 compared to baseline values, n = 6)
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5.2.8 EFFECT OF CHALLENGE ON PERIPHERAL BLOOD NEUTROPHIL
CHEMILUMINESCENCE
Chemiluminescence of neutrophils isolated 10 days before (baseline) and 5 h, 24 h
and 4, 7, and 14 days after the 5 h hay/straw challenge was measured in the presence
of lucigenin (Luci-DCL) and luminol (Lum-DCL) in response to PBS (Basal), fMLP
(lpM), ZAP (10% v/v) or PMA (100 ng/ml) as described in Section 2.8.4.
5.2.8.1 Basal chemiluminescence
Basal Luci- and Lum-DCL of neutrophils isolated 24 h after challenge was
significantly greater than baseline when CL was measured in parallel with fMLP
over a 5 min time course (p<0.05, n = 6, basal Luci-DCL; Figure 5.7a). However,
basal (unstimulated) data recorded in parallel with ZAP and PMA over a 90 min time
course showed that, although there was a trend toward an increased response at 24 h,
there was no significant difference in either basal Luci- or Lum-DCL of neutrophils
in comparison to baseline (p>0.05, n = 6) at any post-challenge time point. There
was however, considerable inter-animal variation in the basal Luci- (Figure 5.7a) and
Lum-DCL (data not shown) responses measured over the 5 min time course at all
time points (see box and whisker plots for all time points in Figure 5.7a). This
variability must cast doubt on the biological relevance of the statistical inference of a
significant increase in basal Luci-DCL at 24 h.
5.2.8.2 fMLP-stimulated chemiluminescence
At 24 h after challenge, fMLP-stimulated Luci-DCL was significantly greater than
the baseline fMLP-stimulated response (p<0.05, n = 6, Figure 5.7b) and significantly
greater than basal (unstimulated) Luci-DCL (p<0.05) at the same time point. This
indicated that circulating neutrophils were primed in vivo following hay/straw
challenge. There was a trend toward enhanced fMLP-stimulated Luci-DCL 4 days
after challenge but this was not significant. At 4 days after challenge however,
fMLP-stimulated Lum-DCL was significantly increased in comparison to both the
baseline response and unstimulated (PBS) Lum-DCL at that time point (p<0.05, n =




















Figure 5.7a,b: Effect of hay/straw challenge on basal and fMLP-stimulated Luci-DCL in
peripheral blood neutrophils from COPD-susceptible animals
Basal (unstimulated) and fMLP-stimulated (1 pM) Luci-DCL of peripheral blood neutrophils
isolated 10 days before and at the time points indicated after challenge were measured over
a 5 min time course. Data are presented as box and whisker plots indicating median values,
25th and 75th percentiles and maximum and minimum values. (* ; p<0.05 compared to
baseline values, n = 6)
a: Basal Luci-DCL (unstimulated); note scale (0-4 RLU).
b: fMLP-stimulated Luci-DCL; note scale (0-40 RLU).
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but as a group this response was not significantly greater than at baseline.
In conclusion, these data suggest that peripheral blood neutrophils are primed at 24 h
following hay/straw challenge, thus facilitating functional coupling of fMLP
receptors.
5.2.8.3 PMA- and ZAP-stimulated chemiluminescence
Both Luci- and Lum-DCL in response to PMA were significantly greater than
baseline values 24 h after challenge (p<0.05, n = 6, Figure 5.8a). Interestingly PMA-
stimulated Lum-DCL was significantly lower than baseline at 5 h after challenge
(p<0.05, n = 6, Figure 5.8b). ZAP-stimulated Luci- and Lum-DCL of peripheral
blood neutrophils was not different to that measured at baseline at any time point
after challenge (data not shown).
5.3 DISCUSSION
Experimental animals were defined as being affected with COPD based on a
prolonged clinical history of pulmonary disease and manifestation of clinical signs of
airway obstruction and the presence of more than 5% neutrophils in their BALF
following hay/straw challenge, as previously described by other workers in this
laboratory (McGorum et al., 1993b; Dixon et al., 1995a). Although the precise case
definition of COPD has varied between laboratories, the criteria employed herein are
very similar to those recently agreed by consensus at an international workshop, at
which all major groups involved in equine pulmonary research were represented.
This consensus defined equine COPD as a chronic (>3 months duration) pulmonary
disease, characterized by recurrent episodes of lower airway obstruction, that was in
part, immediately reversible on administration of bronchodilators and accompanied
by greater than 5% neutrophils in BALF (Dixon, 1998).
COPD is a disease of middle-aged to older horses with reported median ages of
affected animals ranging from 9-13 years (Naylor et al., 1992; Dixon et al., 1995b;
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Figure 5.8a,b: Effect of hay/straw challenge on PMA-stimulated Luci- and Lum-DCL in
peripheral blood neutrophils from COPD-susceptible animals
PMA-stimulated (100 ng/ml) Luci- and Lum-DCL of peripheral blood neutrophils isolated 10
days before and at the time points indicated after challenge were measured over a 90 min
time course. Data are presented as box and whisker plots indicating median values, 25th
and 75th percentiles and maximum and minimum values. (*; p<0.05 compared to baseline
values, n = 6)
a: PMA-stimulated Luci-DCL; note scale (0-700 RLU)
b: PMA-stimulated Lum-DCL; note scale (0-200 RLU)
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reflects the difficulty in recruiting animals with a readily managed disease for a long-
term study such as this, whilst they still have a useful working life.
The aim of the hay/straw challenge was to induce clinical signs of lung disease of
sufficient severity to significantly increase clinical scores (score > 3) and BALF
neutrophil numbers without compromising the horses' welfare. Indeed, although
clinical scores were significantly increased at 5 h, 24 h and 4 days after challenge, at
no time did any of the animals become overtly distressed.
The most common presenting clinical signs reported in animals suffering from
COPD that are examined in equine practice are chronic coughing, nasal discharge
and poor exercise tolerance (McPherson and Thomson, 1983; Dixon et al., 1995b;
Ainsworth, 1999). Cough and nasal discharge are often intermittent signs, and as
such were not regularly observed during the resting clinical examination at the post-
challenge time points in this study. By contrast, increased respiratory effort or
dyspnoea at rest was commonly observed after hay/straw challenge. The
inflammation and diffuse obstruction of airways that occurs in affected animals leads
to significant ventilation/perfusion mismatching resulting in a normocapnic
hypoxaemia (Derksen et al., 1988; West, 1992). This stimulates an increased
respiratory effort that can be measured as an increased maximal change in
intrapleural pressure (Robinson et al, 1996). Previous work in this laboratory
suggested that the dyspnoea detected clinically during the standard examination
protocol employed correlated well with independently measured, increased maximal
intrapleural pressure changes (Dixon et al, 1995c). After challenge, abnormal
respiratory sounds were frequently apparent on auscultation over both the lung fields
and the cervical trachea and their detection was enhanced during induced
hyperpnoea. In a recent prospective study of horses with naturally occurring COPD
presented to a Veterinary hospital (Naylor et al., 1992), abnormal lung sounds were
detected at rest in 69% of cases, but after inducing hyperpnoea with a rebreathing
bag this increased to 88%.
In the present study, clinical scores remained significantly elevated for at least 4 days
after a 5 h challenge, although by this time pulmonary gas exchange had improved
significantly, as evidenced by recovery from the arterial hypoxaemia detected at 5
and 24 h. Early studies of COPD-affected animals (Sasse, 1971; McPherson et al,
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1978) stressed the importance of a decreased PaC>2 (<85 mmHg) and an increased
maximal intrapleural change as prerequisites for the conclusive diagnosis of the
disease. However, more recent studies incorporating diagnostic respiratory cytology
have indicated that many clinical cases of COPD would not be identified by these
stringent diagnostic criteria (Mair, 1987a; Dixon et al., 1995c). Although PaC>2 fell
below 85 mmHg in only 2/6 animals after challenge, all horses developed arterial
hypoxaemia relative to baseline values suggesting that hay/straw challenge
significantly impaired pulmonary gas exchange in COPD-susceptible horses. The
response of COPD-susceptible horses to this challenge system is consistent with
previous work in this laboratory, where lung dysfunction (documented by
measurement of pulmonary mechanics) occurred within 90 min and arterial
hypoxaemia by 5 h. Furthermore, hay/straw challenge did not induce lung
dysfunction in normal horses (McGorum et al., 1993d).
The trachea of a normal horse should contain no visible secretions (Dixon, 1997) and
the presence of more than a few flecks (grade 1; Table 2.5) is a sensitive indicator of
pulmonary disease (Whitwell and Greet, 1984; Dixon et al., 1995c). However, even
normal horses will have small accumulations of secretions following periods of
housing under conventional (hay/straw) management conditions (Buechner-Maxwell
et al., 1996). Thus baseline endoscopic scoring of secretions (Section 5.2.5) was
consistent with the horses being in disease remission. In some horses, the volume of
tracheal secretions did remain elevated (>grade 1) beyond 24 h, when this increase
ceased to be significant for the whole group. This finding is consistent with our own
observations (A. Kemmish, T.J. Brazil and S.D. Carrington, unpublished
observations) and those of Jeffcoat et al. (1998), indicating that some horses with
COPD have significantly elevated levels of immunologically-detectable respiratory
mucins for long (2-3 weeks) periods after the resolution of clinical signs and BALF
neutrophilia. However, the period of 8 weeks between the test challenge and the
start of the experimental protocol was considered to be adequate for the resolution of
any significant pathology related to the previous challenge.
Information on the effect of hay/straw challenge on peripheral blood leucocyte
counts in COPD-susceptible horses is scant and highly variable (Derksen et al.,
1985b; Fairbairn et al., 1993; Watson et al., 1997; Marr et al., 1998a). In general,
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haematological indices have been considered to be of little value in the diagnosis of
clinical cases of COPD (McPherson et al., 1978; Beech, 1991). The current study is
the first to monitor horses sequentially during and after an acute episode of induced
COPD and to document a consistent increase in total leucocyte and neutrophil counts
after challenge. Derksen et al. (1985b) found no change in peripheral leucocyte
counts in either COPD-susceptible or control animals sampled following 3-7 days of
continuous hay/straw challenge. Watson et al. (1997) identified a peripheral
leucocytosis and neutrophilia in one of 5 affected horses after 12-14 days of
hay/straw challenge, whereas Olszewski and Laber (1993) reported a consistent
leucocytosis compared to control animals in horses with COPD of an undefined
duration. Fairbairn et al. (1993) observed a small yet significant increase in
peripheral blood neutrophil numbers at the end of a 7 h hay/straw challenge, but the
neutrophilia had returned to baseline levels by 24 h. However, subsequent studies
from the same laboratory have identified decreases in total leucocyte, neutrophil,
eosinophil and monocyte counts after 5-7 h of challenge (Marr et al., 1997a; Marr et
al., 1998a). In the current study, the leucocytosis present at 24 h was accounted for
entirely by an increase in the absolute number of neutrophils (Figure 5.5b), probably
due to mobilisation of neutrophils from the bone marrow storage pool into the
circulating granulocyte pool in response to inflammation (Boggs, 1967; Lassen and
Swardson, 1995). Release of marrow granulocytes occurs within hours of the onset
of an inflammatory response in both man (Boggs, 1967) and horses (Lassen and
Swardson, 1995) and relatively immature forms enter the circulation within 5 h of
the onset of lung inflammation in rabbits (Lawrence et al., 1996) or following
antigen inhalation challenge in allergic dogs (Wood et al., 1998).
In the face of an inflammatory response, total leucocyte and neutrophil counts in
peripheral blood are thought to reflect a balance between an increase in the size of
the marginated neutrophil pool and recruitment of cells to the inflammatory focus on
the one hand and the rate of outflow of neutrophils from the bone marrow on the
other (Boggs, 1967; Lassen and Swardson, 1995). This may account for the
maintenance of leucocyte numbers at baseline levels at 5 h after challenge (Figure
5.5b). At 24 h post-challenge, the reduction in BALF neutrophil cell counts from the
peak at 5 h (see Figure 6.1) suggests that recruitment of neutrophils to the lung has
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ceased, by which time bone marrow production of neutrophils may exceed tissue
demand and the rate of margination and allow a neutrophilia to develop (Carakostas
et al., 1981; Lassen and Swardson, 1995). A similar peak in peripheral blood
neutrophil counts associated with significant outflow of cells from the bone marrow
and an increase in the production of progenitor cells in the bone marrow has been
documented in dogs allergic to Ascaris suum, 24 h after antigen inhalation challenge
(Wood et al, 1998).
In the horse (Carakostas et al., 1981), as in man (Kronkite and Vincent, 1960), the
half-life of neutrophils in the circulating pool is increased during an inflammatory
response. This occurs in spite of the massive recruitment of neutrophils to the
inflammatory focus (Kronkite and Vincent, 1960). This may reflect release of
"younger" cells from the bone marrow, with a greater potential longevity as
suggested by the slower rate of constitutive apoptosis in neutrophils collected 24 h
after hay/straw challenge (Figure 5.6). Indeed, recent data from a model of
streptococcal pneumonia in rabbits demonstrated that although neutrophils recently
released from the bone marrow marginate and sequester normally in the pulmonary
vasculature, they migrate into infected tissue more slowly than "older" neutrophils
(Sato et al., 1998). Thus a hypothesis can be formulated that if recently released
cells are less susceptible to apoptosis and as neutrophils do not undergo apoptosis in
the circulation, as previously marginated "younger" cells re-enter the circulating
pool, the mean rate of apoptosis of neutrophils in a peripheral blood sample would
decrease.
However, neutrophil apoptosis may also be inhibited by inflammatory mediators
(Lee el al., 1993) such as cytokines, either circulating or generated locally during an
inflammatory response (Ussov et al., 1996; Keel et al., 1997). Identification of
delayed rates of apoptosis in peripheral blood neutrophils harvested from human
patients with severe sepsis (Keel et al., 1997), severe burns (Chitnis et al., 1996),
systemic inflammatory response syndrome and following major elective surgery
(Marshall and Watson, 1997) and from mice treated with thioglycollate (Coxon et
al., 1996), would suggest that exposure of neutrophils to circulating inflammatory
mediators is critically important in regulating rates of neutrophil apoptosis in
inflammatory diseases. Moreover, plasma from patients with severe burns and
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systemic inflammatory response syndrome can inhibit apoptosis in neutrophils from
healthy donors (Chitnis et al., 1996; Marshall and Watson, 1997). Also a
neutralising antibody to human GM-CSF abrogated the anti-apoptotic effect of the
burns patients' plasma, confirming a role for circulating cytokines such as GM-CSF
in the regulation of neutrophil lifespan in vivo. Very little is known about circulating
inflammatory mediators in horses with COPD since few studies have addressed this
question directly. Plasma thromboxane B2 (Gray et al, 1989), serotonin (Eyre,
1972) and 15-HETE (Gray et al., 1992a) and urine LTE4 (Doucet et al., 1991) are
elevated in affected horses following hay/straw challenge. The effects of serotonin
and thromboxane B2 on neutrophil apoptosis are unknown. 15-HETE has no effect
on human neutrophil apoptosis in vitro (Hebert et al., 1996) but despite LTB4
affording dose-dependent inhibition in human neutrophils, this eicosanoid had no
effect on equine neutrophil apoptosis (Section 4.2.2). Although platelets do not
appear to play any direct role in the pulmonary response to hay/straw challenge
(Fairbairn et al., 1993), peripheral blood platelet responsiveness is enhanced (Ablett
et al., 1997) and as demonstrated in human neutrophils in vitro (Cox and Radford,
1999), soluble factors released from platelets may be important in regulating
neutrophil lifespan in vivo.
Therefore, both of the above factors, namely an increased circulating number of
relatively immature neutrophils and the systemic release of inflammatory mediators,
may contribute to the observed inhibition of peripheral blood neutrophil apoptosis
following challenge.
BALF collection alone has been reported to induce increases in absolute peripheral
blood neutrophil numbers in humans (Von Essen et al., 1991), dogs (Cohen and
Batra, 1980) and monkeys (Cohen and Batra, 1980; Krombach et al., 1985; Haley et
al., 1989). Also peripheral blood neutrophil PMA-stimulated Luci-DCL was
significantly enhanced 24 h after a single BAL procedure in cynomolgus monkeys
(Krombach et al., 1985). The fever and flu-like symptoms experienced by 30% of
human patients after BAL has been associated with increased circulating levels of
TNF-a, IL-6 and IL-1 p (Krause et al., 1997). Although such cytokine assays were
not available in the current study, the repetitive sham BAL procedure had no effect
on peripheral blood neutrophil numbers or neutrophil CL activity (Section 5.2.2).
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This suggests that horses are more resilient to the insult of BAL than some other
species and that changes in blood neutrophil number and function observed in horses
after hay/straw challenge would not be confounded by an effect of the BAL
procedure itself.
It is well established that the presence of increased numbers of neutrophils in the
circulation and even within the airspaces does not in itself necessarily imply
causation of any ongoing lung injury and the functional status of these cells is a more
critical factor (Martin et al., 1989; Pittet et al., 1997). However, only a few studies
have addressed the functional status of peripheral blood neutrophils in horses
affected with COPD. The phagocytic capacity of neutrophils from COPD-affected
horses was reported to be unchanged compared to control animals (Nuytten et al.,
1983; Klucinski et al., 1994). The increased fMLP-stimulated CL response of
peripheral blood neutrophils after hay/straw challenge in the current study is the first
observation of in vivo neutrophil priming in the horse. This in vivo response is
consistent with the paradigm of priming in equine neutrophils as defined in the
preceding in vitro studies (see Figure 3.17). Hence the stimulus of hay/straw
challenge appears to prime circulating neutrophils, permitting functional coupling of
fMLP receptors, but does not itself stimulate a significant respiratory burst in these
cells. In a recent report (Olszewski et al., 1999) however, peripheral blood
neutrophils isolated from two COPD-affected horses after an undefined period of
hay/straw challenge showed significantly enhanced serum-treated zymosan-
stimulated superoxide anion generation in comparison to four control horses.
Although superoxide generation in neutrophils from the affected horses was only
40% greater than in those from controls, this data does suggest that neutrophils were
primed in vivo. This is in contrast to other reports of peripheral blood neutrophil
respiratory burst activity in COPD-affected horses (Olszewski and Laber, 1993; Marr
et al., 1997a). In an experimental study, Marr and co-workers (1997) found no
change in agonist (PAF, serum treated zymosan and PMA)- stimulated superoxide
anion generation 5 and 24 h after the start of a 7 h challenge. However, they did find
a small but significant increase in basal (unstimulated) superoxide anion generation
at 24 h. Olszewski and Laber (1993) found no difference in basal respiratory burst
activity, measured by the nitroblue tetrazolium method, between clinical COPD
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cases and control horses. The increase in basal superoxide anion production
following a controlled challenge (Marr et al., 1997a) is interesting in light of the
enhanced basal CL response over a 5 min time course detected in the current study,
24 h after challenge (see Figure 5.7a). These workers measured superoxide anion
generation over two time courses (15 and 30 min) but did not report the kinetics of
the enhanced response. However, given that the increment in basal respiratory burst
activity in both the current study and that reported by Marr et al. (1997) was very
small (Luci-DCL: 0.5 RLU, superoxide anion generation: 3.9 nmol/106 cells,
respectively) the biological significance of this observation remains unclear.
Increases in spontaneous (unstimulated), as well as agonist-stimulated, neutrophil
respiratory burst activity have been reported in human patients with severe
inflammatory disorders such as ARDS (Zimmerman el al, 1983; Chollet-Martin et
al., 1992) and after major trauma (Botha et al., 1995). However, such endogenous
intravascular activation is likely to be associated with significant tissue injury and
organ failure (Botha et al., 1995).
Although spontaneous neutrophil activation has been reported in the circulation of
asthmatics following antigen challenge (Durham et al., 1984; Carroll et al., 1985),
this was assessed by increased C3b receptor expression, and hence is more likely to
represent a priming related phenomenon (Condliffe et al., 1996). Basal respiratory
burst activity in human asthmatics is not increased following antigen challenge
(Sustiel et al., 1989). However, a number of studies in symptomatic asthma patients
have demonstrated significant neutrophil priming and the authors suggested that the
fMLP-stimulated response was a more sensitive index of in vivo priming than the
response to non-physiological agonists such as PMA (Meltzer et al., 1989; Sustiel et
al., 1989). Sustiel et al. (1989) also observed that not only were neutrophils primed
but they were also less sensitive to downregulatory signals such as adenosine and
prostaglandin E2. Although this was not confirmed in a similar study (Meltzer et al.,
1989), it is worthy of note given the reduced airway mucosal prostaglandin E2
production in horses with COPD (Gray et al., 1992b).
It is interesting to note that peripheral blood neutrophil priming in horses following a
single hay/straw challenge (Figures 5.7b) is shortlived, similar to that observed in
human patients with a high risk status for multi-organ failure following severe torso
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trauma. Botha and co-workers (1995) monitored fMLP-stimulated superoxide anion
generation over the first 72 h after trauma. Primed neutrophils were detected in the
circulation by 3-6 h but neutrophil function had returned to normal levels by 24-48 h.
Furthermore, in vivo neutrophil priming appeared to be maximal in these patients
(response was not further enhanced by subsequent PAF priming in vitro). This
suggests that although the functional status of circulating neutrophils is a risk factor
for neutrophil sequestration and tissue injury, in vivo priming per se does not reliably
predict either the severity or outcome of injury.
The response of blood neutrophils to PMA has been widely used to assess changes in
neutrophil function in humans (Zimmerman et al., 1983; Chollet-Martin el al., 1992)
and in animal models (Watts et al., 1990; Marr el al., 1997a) of lung inflammation.
Although priming of PMA-stimulated Luci-DCL in equine neutrophils did not occur
in vitro (see Section 3.2.3.6) and antigen challenge had no effect on PMA-stimulated
superoxide anion generation in a previous study (Marr et al., 1997a), PMA-
stimulated CL was significantly increased in vivo at 24 h with the current hay/straw
challenge system (Figure 5.8a,b). Similar increases in PMA-stimulated neutrophil
respiratory burst activity have been documented in many pulmonary inflammatory
conditions in humans including ARDS (Zimmerman et al., 1983; Chollet-Martin et
al., 1992), bacteraemia (Bass et al., 1986) and asthma (Meltzer et al., 1989). The
reduction in PMA-stimulated Lum-DCL in equine neutrophils 5 h after challenge
(Figure 5.8b) was initially somewhat perplexing, however a reduction in yeast-
stimulated peripheral blood neutrophil Lum-DCL has been reported in human
subjects 5 h after inhalation of LPS (Michel et al., 1997). The authors of this latter
study speculated that this might reflect sequestration of a primed subpopulation of
neutrophils in the pulmonary vasculature at this early time point. Indeed, this
contention may have some basis as flow cytometric studies of blood neutrophils
harvested from human patients with ARDS (Chollet-Martin et al., 1992) and
bacteraemia (Bass et al., 1986) suggested that the increased net PMA-stimulated
FLO2 production detected was mostly associated with a hyperresponsive sub-
population of cells. Furthermore, priming slows neutrophil transit time through
(Ussov et al., 1996), and increases sequestration within, the pulmonary vasculature
(Worthen et al., 1987) due to changes in cell size and stiffness (Worthen et al., 1989;
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Downey et al., 1990). In vivo priming of human neutrophils has been documented
by light microscopic assessment of cell shape change ex vivo (Ussov et al., 1996).
Although not formally assessed in this study, shape-changed neutrophils were rarely
recognized during many haemocytometer counts of isolated cells after challenge.
However, functional priming of equine neutrophils in vitro did not invariably result
in significant cell shape change (see Section 3.2.3.3).
Recently, Marr and colleagues (1997b) have extended their earlier work
demonstrating CD18-dependent and agonist-enhanced (PAF, hrIL-8 and hrC5a)
adherence of equine neutrophils to fibronectin-coated plastic (Foster et al., 1997;
Marr et al., 1999). They showed that unstimulated neutrophil adherence to
fibronectin-coated plastic was significantly increased in a CD18-dependent fashion at
24 h after challenge and remained elevated at 72 h but had returned to pre-challenge
levels by 1 week. The most interesting finding however was the lack of enhanced
adherence at 5 h post-challenge and the authors suggested that the early neutrophil
recruitment to the lung was independent of increased integrin function. These data
are consistent with neutrophil priming leading to enhanced integrin-mediated
adhesion (Bochsler et al1990; Worthen et al., 1992; Condliffe et al., 1998b).
However the absence of functionally upregulated neutrophils in the circulation at 5 h
may, as discussed earlier, reflect enhanced retention of primed cells within the
pulmonary vasculature at this early time point when recruitment to the lung is
maximal (Fairbairn et al., 1993).
Another factor that may play a role in the enhanced respiratory burst activity of
peripheral blood neutrophils after challenge is the enhanced potential for oxidant
generation in relatively immature neutrophils freshly released from the bone marrow.
Data from a rabbit model of bacteraemia indicate that during an inflammatory
response neutrophils are released from the bone marrow faster than they mature
(Sato et al., 1998). Although immature neutrophils have lower chemotactic and
phagocytic capacities than mature circulating cells (Altman and Stossel, 1974),
cytoplasmic granule size and number are increased. Primary or azurophil granules
form at an early stage in neutrophil development, reducing in size and number with
subsequent mitoses (Bainton, 1988). Hence, early release of neutrophils with more
granules, containing myeloperoxidase and other enzymes, may enhance the
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respiratory burst capacity and destructive capability of relatively immature cells
(Terashima et al., 1996). This may be of particular relevance in the generation of
luminol (myeloperoxidase)-dependent CL.
The stimulus or stimuli responsible for priming peripheral blood neutrophils in vivo
for enhanced respiratory burst activity following hay/straw challenge of COPD-
susceptible horses is unknown. Marr and colleagues (1997) speculated, quite
reasonably, that some "neutrophil activating factor(s)" or cytokine(s) was released
into the circulation in response to antigen challenge as has been detected in the serum
of human asthmatics in association with the early and late responses following
antigen challenge (Durham et al., 1984; Carroll et al., 1985). Also transit of
neutrophils through an inflamed site, in this case the lung, may be an important
priming mechanism as a consequence of neutrophil contact with "non-released"
cytokines and lipid mediators (such as PAF) expressed on the surface of activated
endothelial cells (Zimmerman et al., 1990).
This question has not as yet been addressed in equine COPD, but data from in vitro
studies have implicated IL-8 and MIP-2 secreted by equine alveolar macrophages as
possible mediators of the enhanced neutrophil chemotactic activity in BALF from
affected horses (Franchini et al., 1998). However, other likely candidates worthy of
investigation include TNF-a, GM-CSF and IL-6 (Michel et al., 1992; Clapp et al.,
1994; Pittet et al., 1997). The preliminary attempts made in the current study to
assess the potential roles of IL-8 and TNF-a are discussed in Section 6.2.4 and
further collaborative work is ongoing in this laboratory to improve the currently
available assays for equine IL-6, IL-8 and TNF-a.
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CHAPTER 6
KINETICS, FUNCTION AND FATE OF AIRSPACE NEUTROPHILS IN
COPD - SUSCEPTIBLE HORSES FOLLOWING HAY / STRAW
CHALLENGE
6.1 INTRODUCTION
It is now quite clear that the clinical signs of exercise intolerance, airway obstruction
and increased airway secretions recognized in horses suffering from COPD are
intimately associated with a neutrophilic inflammatory response in the small airways
(reviewed in Chapter 1). Although the numbers of neutrophils recovered from the
airways are not correlated with the severity of clinical signs (Grunig et al., 1989),
post-mortem studies demonstrated a close association between the neutrophil content
of BALF and the severity of histological changes in the lungs of affected horses
(Viel, 1983).
Thus if the neutrophil's armoury of proteolytic enzymes, reactive oxygen species and
highly cationic proteins were secreted to excess or inappropriately within the
pulmonary interstitium or airspaces, this cell type may well be central to the
pathogenesis of the structural and functional lung injury observed in equine COPD.
The classical double-edged sword (Smith, 1994) of the neutrophil's microbicidal
capability is well recognized in human medicine. The importance of neutrophils as
mediators of host tissue injury is now well accepted in the pathogenesis of many
inflammatory diseases that afflict humans (such as chronic bronchitis, emphysema,
asthma, rheumatoid arthritis and reperfusion injury after myocardial infarction) and
in clinically significant and potentially disabling disorders of the horse such as
intestinal ischaemia/reperfusion injury, septic arthritis and COPD (reviewed in
Sections 1.6 and 1.7). Decades of research in the field of human neutrophil biology
have helped to define both the regulation of neutrophil function and many of the
mediators implicated in this ''inappropriate" neutrophil-driven, tissue injury.
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Histopathological examination of pulmonary tissues from horses with longstanding
and severe COPD suggested that significant irreversible structural lung damage was
not a common feature of this disease (Kaup et al, 1990a; Kaup et al., 1990b).
However, the development of more sensitive techniques to evaluate airway structure
and function have documented increased small airway wall thickness (Broadstone et
al., 1997) and perhaps of more interest, alveolar epithelial damage inferred from
enhanced rates of alveolar clearance (Votion et al., 1998; Votion et al., 1999). It is
conceivable that such pathological changes may be caused by the release of pro¬
inflammatory and histotoxic neutrophil secretory products. Assessment of more
subtle measures of lung function in vivo, such as alveolar epithelial cell permeability,
may prove valuable in the investigation of the dynamic relationship between
neutrophil influx and lung injury in equine COPD.
Although some studies have begun to define certain aspects of equine neutrophil
function in vitro (discussed in Chapter 3), relatively few have investigated in or ex
vivo neutrophil function in COPD (Nuytten et al., 1983; Olszewski and Laber, 1993;
Klucinski et al., 1994; Marr et al., 1997a; Marr et al., 1997b; Olszewski et al., 1999).
Although the increased amounts of neutrophil-derived proteases found in the tracheal
secretions of affected animals (Maisi et al., 1994; Koivunen et al., 1997a; Koivunen
et al., 1997b; Raulo and Maisi, 1998) offer circumstantial evidence for neutrophil
degranulation in vivo, it is not possible from these data alone to conclude that this is
occurring in the small airways.
Although scintigraphic (Fairbairn et al., 1993) and bronchoalveolar fluid (McGorum
et al., 1993d) studies have reported the early kinetics of the pulmonary sequestration
of neutrophils and their appearance in the airways (within 5 h), knowledge of the
dynamics of airspace cell populations beyond the first 7 h are lacking.
The importance of cell priming in regulating both the functional responsiveness of
neutrophils to secretagogue stimuli in vitro, and the severity of neutrophil-mediated
injury in vivo, is now well established (Condliffe et al., 1998b). Preliminary reports
suggest that both peripheral blood neutrophil (Marr et al., 1997a; Olszewski et al.,
1999) and airway phagocyte respiratory burst activity (Olszewski and Laber, 1993)
are enhanced in equine COPD, but the kinetics of changes in the priming and
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activation status of both blood and airspace neutrophils following controlled
hay/straw challenge has not been previously studied.
The longstanding assumption that the fate of neutrophils recruited to an
inflammatory focus was one of in situ necrosis and disintegration seemed somewhat
at odds with clinical observations in some human diseases, such as lobar
streptococcal pneumonia, which although characterized by influx of massive
numbers of neutrophils, resolves completely and without residual lung injury
(Haslett, 1992). An alternative to in situ necrosis with the inevitable leakage of the
neutrophil's histotoxic constituents into the surrounding tissue was suggested by the
seminal work of the 19th Century cell biologist, Elie Metchnikoff (Metchnikoff,
1893). In 1891, in a series of lectures delivered at the Pasteur Institute in Paris,
Metchnikoff described vital microscopy studies in which he observed "englobemenf'
of "microphages" (later termed "neutrophils") by resident macrophages within an
inflamed focus. Almost a century later observation that ageing neutrophils
underwent constitutive apoptosis, thereby facilitating their recognition and
phagocytosis by local macrophages, formalised Metchnikoff s recognition of an
alternative clearance pathway for effete and functionally redundant neutrophils
(Newman el al. 1982; Savill et al. 1989).
Several features of the neutrophil apoptosis/macrophage clearance paradigm suggest
that this represents an indispensable pathway in the successful resolution of
inflammation without significant host tissue destruction and scarring. An individual
macrophage was capable of recognizing apoptotic cells by several discrete
mechanisms and could phagocytose and rapidly degrade several apoptotic
neutrophils without inciting a pro-inflammatory response by the macrophage
(reviewed in Section 1.5.4). Consequently it seemed likely that this process may also
be important in equine COPD.
With the neutrophil established as a central player in the pulmonary inflammatory
response that underlies equine COPD, the laboratory techniques and data that
provided initial characterization of equine neutrophil priming, activation and
apoptosis in vitro were harnessed to assess the functional status and role of these
cells in an experimental hay/straw challenge model in vivo.
206
It was hoped that a better understanding of the functional consequences of hay/straw
challenge on neutrophil function and kinetics in the airspaces of COPD-susceptible
horses would facilitate progress towards elucidating the cellular pathogenesis of this
disease and hence may assist in the development of novel therapeutic strategies.
6.2 RESULTS
6.2.1 EFFECT OF HAY/STRAW CHALLENGE ON THE KINETICS OF
AIRSPACE NEUTROPHIL RECRUITMENT AND CLEARANCE
6.2.1.1 Effect of sham BAL protocol on BALF cell numbers and function
To ensure that serial BAL alone did not cause significant alterations in BALF
absolute or differential cell counts or function, five sham exposure BAL collections
were performed at 0 h, 19 h, 4, 7 and 14 days in 6 asymptomatic COPD-susceptible
horses as described in Section 2.8.3 and Table 2.4.
At 0 h, median (range) recovery of BALF was 46.0% (38.0-63.3%) of the fluid
instilled (n = 6). Recovery of BALF at all subsequent time points was not
significantly different. Viability of cells in raw BALF (assessed by trypan blue
exclusion) at 0 h was 96.6% (93.6-100%). Cell viability at all subsequent time points
was not significantly different. The total nucleated and differential cell counts in
BALF collected at each time point are shown in Table 6.1. Total nucleated, absolute
and differential cell counts at the subsequent time points were not significantly
different to those determined at 0 h.
The effect of these lavages on the respiratory burst activity of BALF cells was
assessed in 3 horses. BALF cells were processed as described in Section 2.8.1 and
PBS- and fMLP (1 pM)-stimulated Luci- and Lum-DCL were measured over a 5 min
time course and PBS-, ZAP (10% v/v)- and PMA (100 ng/ml)-stimulated Luci- and
Lum-DCL were measured over a 90 min time course as described in Section 2.8.4.
Neither basal (PBS only) nor agonist-stimulated Luci- and Lum-DCL of BALF cells
harvested at the subsequent sham BAL collection time points (19 h and 4, 7 and 14
days) was significantly different to that measured at 0 h (data not shown).
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Table 6.1: Total and differential cell counts in BALF collected from 6 asymptomatic
COPD-susceptible horses during sham protocol
BALF was collected as described in Section 2.7.3 at the time points indicated. Total
nucleated and differential cell counts [mean (range)] were performed in duplicate on raw
BALF using a haemocytometer and on Leishman's-stained cytocentrifuge preparations,
respectively, as described in Section 2.8.2. Total and differential cell counts did not differ
throughout the sham protocol.
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6.2.1.2 BALF cell kinetics following challenge
BALF was collected at least 10 days prior (baseline) and 5 h, 24 h and 4, 7 and 14
days after the start of the 5 h hay/straw challenge (Section 2.7.3 and Table 2.4). The
volume of BALF recovered at baseline [44.5% (42.7-60.0%) of volume instilled]
was not different to that recovered during the first sham collection. Likewise, BALF
recovery was not significantly different from baseline at any of the post-challenge
time points. Cell viability in the baseline BALF sample [97.4% (94.9-98.7%)] was
not different to that in the first sham BALF sample and did not alter at any of the
post-challenge time points (data not shown).
Total nucleated cell counts in BALF were significantly elevated 5 and 24 h after
challenge, mirroring a massive influx (35-fold increase in median counts) of
neutrophils that peaked at the 5 h time point, remained elevated at 24 h, but returned
to baseline levels by 4 days (Table 6.2). Recruitment of neutrophils to the airspaces
was of sufficient magnitude to elevate total BALF cell numbers in spite of a
surprising but consistent net reduction in (i) the numbers of alveolar macrophages
recovered at 5 and 24 h and (ii) the number of lymphocytes recovered at 24 h (Table
6.2). This suggests that there is considerable trafficking of airspace macrophages
and lymphocytes as well as neutrophils after hay/straw challenge. Indeed, statistical
analysis of the serial differential cell counts demonstrated a small but significant
increase in the proportion of neutrophils in BALF at 4 days as well as 5 and 24 h (see
Table 6.3 and Figure 6.1). This probably reflects the significant decrease in absolute
macrophage numbers between 5 h and 7 days after challenge (at day 4 the reduction
in macrophage numbers just failed to reach statistical significance, p = 0.09, see
Figure 6.2). In fact in two horses with less striking BALF neutrophilia after
challenge, differential neutrophil counts showed a modest increase between 5 and 24
h (median values; 14.3 - 20.6% and 21.9 - 22.6%) in spite of the consistent decline in
absolute neutrophil numbers (2.3 - 1.9 x 105/ml and 2.2 - 1.4 x 105/ml). This effect
was likely to have been due to the reduced macrophage numbers at these time points.
A small but significant increase in the proportion of mast cells was observed 4 days
after challenge (Table 6.3).
Representative photomicrographs of BALF cells collected at baseline and 5 h after
the start of the hay/straw challenge are shown in Figure 6.3a,b on page 214.
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Table 6.2: Total and absolute cell counts in BALF collected from 6 COPD-susceptible
horses following hay/straw challenge
BALF was collected as described in Section 2.7.3 at the time points indicated. Total
nucleated and absolute cell counts [mean (range)] were performed in duplicate on raw BALF
using a haemocytometer and calculated from differential cell counts of Leishman's-stained
cytocentrifuge preparations, as described in Section 2.8.2. Values in bold text with an*are
significantly different from baseline values for the same cell type (p<0.05). B/line: Baseline.
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Table 6.3: Differential cell counts in BALF from 6 COPD-susceptible horses following
hay/straw challenge
BALF was collected as described in Section 2.8.3 at the time points indicated. Differential
cell counts [mean (range)] were performed in duplicate on Leishman's-stained cytocentrifuge
preparations of raw BALF as described in Section 2.9.2. Values in bold text with an *are










Baseline 5h 24 h 4 days 7 days 14 days
Figure 6.1: Kinetics of BALF neutrophil recruitment and clearance following hay/straw
challenge of 6 COPD-susceptible horses; differential cell counts
BALF was collected (as described in Section 2.7.3) 10 days before (baseline) and at the time
points indicated after challenge. Differential cell counts of raw BALF were performed in
duplicate on Leishman's-stained cytocentrifuge preparations. Data are presented as box
and whisker plots indicating median values, 25th and 75th percentiles and maximum and

















Baseline 5 h 24 h 4 days 7 days 14 days
Figure 6.2: Kinetics of BALF macrophage numbers following hay/straw challenge of 6
COPD-susceptible horses; absolute cell counts
BALF was collected (as described in Section 2.7.3) 10 days before (baseline) and at the time
points indicated after challenge. Absolute cell counts were performed in duplicate on raw
BALF using a haemocytometer and macrophage numbers (plotted on y-axis) calculated from
differential cell counts of Leishman's-stained cytocentrifuge preparations. Data are
presented as box and whisker plots indicating median values, 25th and 75th percentiles and
maximum and minimum values. ( *; p<0.05 compared to baseline values, n = 6)
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Figure 6.3a,b: Cytological features of BALF cell populations before and 5 h after
hay/straw challenge of COPD-susceptible horse
BALF was collected from COPD-susceptible horses 10 days before and immediately after a
5 h hay/straw challenge. Leishman's-stained cytocentrifuge preparations were examined
under oil immersion. Representative photomicrographs of BALF cells at baseline and 5 h
are shown.
a: baseline: Alveolar macrophages (AM) and lymphocytes (L) predominate. An atypical or
granular lymphocyte is also present (G). Magnification x 1320
b: 5 h: Neutrophils (N) are the predominant cell type. Magnification x 1280
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6.2.2 EFFECT OF CHAFFENGE ON BAFF CEFF CHEMIFUMINESCENCE
Chemiluminescence of BAFF cells harvested from 6 asymptomatic COPD-
susceptible horses at least 10 days prior (baseline) and 5 h, 24 h and 4, 7, and 14 days
after a 5 h hay/straw challenge was measured in the presence of lucigenin (Fuci-
DCF) and luminol (Fum-DCF) in response to PBS (Basal), fMFP (1 pM), ZAP
(10% v/v) or PMA (100 ng/ml) as described in Section 2.8.4.
6.2.2.1 Basal chemiluminescence
The basal (PBS, unstimulated) Fuci- and Fum-DCF of BAFF cells recovered
following hay/straw challenge (all time points) was not statistically different to the
CF activity of BAFF cells obtained prior to challenge (baseline) whether recorded
over a 5 min or a 90 min time course (p>0.05, n = 6, data not shown).
However, scrutiny of the individual horse data does highlight some noteworthy
findings.
(i) There was little change in basal BAFF cell Fuci-DCF after challenge
compared to baseline responses.
(ii) In three horses, basal luminol (myeloperoxidase and therefore neutrophil
specific, see Section 2.8.3.4)-DCF of BAFF cells was markedly enhanced
compared to baseline activity (approximately 100 fold) at 5 and 24 h after
challenge when neutrophil numbers in their BAFF were increased. However,
the variability between individual horses precluded this effect from reaching
significance for the group as a whole.
(iii) Two of the three horses whose basal BAFF cell Fum-DCF did not increase
greatly after challenge were the two animals with the smallest increases in
differential BAFF neutrophil count (baseline and 5 h neutrophil proportions:
4.8% and 21.9%; 3.1% and 14.3%).
These data demonstrate the considerable heterogeneity amongst different COPD-
susceptible horses in their response to hay/straw challenge.
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6.2.2.2 fMLP-stimulated chemiluminescence
fMLP-stimulated Luci-DCL (Figure 6.4a) and Lum-DCL (Figure 6.4b) of BALF
cells was greatly enhanced at 5 and 24 h after challenge. Although the increase in
the fMLP-stimulated Luci-DCL response at 5 h was not statistically significant,
scrutiny of the raw data indicated that this was due to an inexplicably low CL
response in only one horse, in which the CL response was less than at baseline.
However, ZAP-stimulated Luci-DCL of BALF cells from this animal was also
extremely low but fMLP- and ZAP-stimulated Lum-DCL responses were of a similar
magnitude to the rest of the group. Thus it is likely that this anomaly was due to
experimental error rather than an inherent defect in the respiratory burst mechanisms
of this animal's cells.
Scrutiny of the fMLP-stimulated Luci-DCL data indicate that other cell types in
BALF, most probably alveolar macrophages, contribute to fMLP-stimulated Luci-
DCL (Figure 6.4a, baseline data), consistent with studies of fMLP-stimulated
superoxide anion generation in adherent human alveolar macrophages (Holian and
Daniele, 1979). Although the Luci-DCL response of BALF cells at baseline was
small in comparison to that observed at 5 and 24 h when neutrophils were the
predominant cell type, it is not possible to assume that recruited neutrophils alone
were the source of the additional CL activity. Alveolar macrophage respiratory burst
activity is also likely to be enhanced after challenge as reported in human asthmatic
patients in comparison to normal control subjects (Calhoun and Bush, 1990) and in
ovalbumin sensitised guinea pigs following antigen challenge (Okada et al., 1993).
The fMLP-stimulated Lum-DCL response in BALF cells was markedly enhanced at
5 and 24 h in parallel with the number of neutrophils present (see Figures 6.4 and
6.1).
6.2.2.3 PMA - and ZAP -stimulated Chemiluminescence
PMA-stimulated Luci-DCL was significantly enhanced 24 h after challenge (Figure
6.5a). The median PMA-stimulated Luci-DCL of BALF cells was greatly enhanced
at 5h, but, like the fMLP-stimulated Luci-DCL data, due to considerable inter-animal
variation did not reach statistical significance (p = 0.09). The response of BALF
cells to PMA would also suggest that alveolar macrophage respiratory burst activity
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Figure 6.4a,b: Effect of hay/straw challenge on fMLP-stimulated Luci-DCL and Lum-
DCL of BALF cells collected from COPD-susceptible horses
fMLP-stimulated (1 pM) Luci- and Lum-DCL of BALF cells harvested 10 days before
(baseline) and at the time points indicated after challenge were measured over a 5 min time
course. Data are presented as box and whisker plots indicating median values, 25th and
75th percentiles and maximum and minimum values. (*; p<0.05 compared to baseline
values, n = 6)
a: fMLP-stimulated Luci-DCL; note scale (0-40 RLU)
















Baseline 5 h 24 h 4 days 7 days 14 days
Figure 6.5a,b: Effect of hay/straw challenge on PMA-stimulated Luci- and Lum-DCL of
BALF cells collected from COPD-susceptible horses
PMA-stimulated (100 ng/ml) Luci- and Lum-DCL of BALF cells harvested 10 days before
(baseline) and at the time points indicated after challenge were measured over a 90 min time
course. Data are presented as box and whisker plots indicating median values, 25th and
75th percentiles and maximum and minimum values. (* ; p<0.05 compared to baseline




was upregulated after challenge because the maximal CL response of BALF cells
was recorded at 24 h in 4/6 horses when BALF neutrophil numbers had fallen from
their peak at 5 h. Moreover, it is highly unlikely that the PMA responsiveness of the
residual neutrophils at 24 h was significantly greater than that of the neutrophils
present at 5 h. PMA-stimulated Lum-DCL was increased at both 5 and 24 h (Figure
6.5b), following a similar pattern to the fMLP- and ZAP-stimulated Lum-DCL
responses.
Simple comparison of the magnitudes of the Lum-DCL responses of BALF cells at 5
and 24 h after challenge with that of quiescent peripheral blood neutrophils (Figure
3.4b) would suggest that neutrophils recruited to the airspaces of COPD-susceptible
horses after hay/straw challenge are primed for an enhanced respiratory burst in
response to PMA.
Although individual variation was again apparent (see Section 6.2.2.2), there was
little difference in ZAP-stimulated Luci-DCL of BALF cells following hay/straw
challenge (median 54.3 RLU; range, 13.8-116.2 RLU omitting data from the horse
with extremely low response at 5 h) in comparison to baseline responses (86.0; 14.5-
115.2, p>0.05). As ZAP-stimulated Luci-DCL generation (qualitatively comparable
with superoxide anion generation) at baseline was of a similar magnitude to that
measured after challenge (when neutrophils make up a significant proportion of the
mixed BALF cell population studied) a number of conclusions could be drawn.
Firstly, cell types normally resident in the airspaces when horses are in clinical
remission, most probably alveolar macrophages, have a similar capacity to generate
superoxide anions in response to ZAP as neutrophils recruited to the airspaces
following challenge. Alternatively, the inhaled challenge stimulus may have
complex and differential effects on the superoxide anion generating capacity of
different cell types, which could only be dissected following the successful
separation of individual cell types into populations of high purity. Finally, a
desensitisation of the response of recruited neutrophils to C5a with concurrent
enhancement of alveolar macrophage activity seems unlikely in light of the major
ZAP-stimulated Lum-DCL response (again mirroring neutrophil numbers) of the
same mixed BALF cell populations (Figure 6.6). A lack of comparative literature on
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Figure 6.6: Effect of hay/straw challenge on ZAP-stimulated Lum-DCL of BALF cells
collected from COPD-susceptible horses
ZAP-stimulated (10% v/v) Lum-DCL of BALF cells harvested 10 days before and at the time
points indicated after challenge was measured over a 90 min time course. Data are
presented as box and whisker plots indicating median values, 25th and 75th percentiles and
maximum and minimum values. ( *; p<0.05 compared to baseline values, n = 6)
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6.2.2.4 Comparison of peripheral blood and BALF neutrophil respiratory burst
activity
The CL data presented in Chapter 5 confirm that peripheral blood neutrophils
harvested from COPD-susceptible horses are primed following hay/straw challenge.
Furthermore, the data presented above (Sections 6.2.2.1-6.2.2.3) indicate that the
respiratory burst activity of BALF cells is greatly enhanced after challenge; BALF
cytology (Section 6.2.1.2) and Lum-DCL responses would suggest that the latter
effect is largely due to the recruitment of large numbers of neutrophils into the
airways.
However, from these data alone it is not possible to compare directly the functional
status of peripheral blood and airspace neutrophils following challenge. This
represented a key question in this study and due to the difficulties in isolating pure
populations of neutrophils from BALF (Section 2.8.3) cannot be answered with
certainty. However, the highly neutrophil-specific CL signal generated in the
presence of luminol (Section 2.8.3.4) did offer an opportunity to begin to address this
question. Using differential cell count data (Table 6.3), fMLP-stimulated Lum-DCL
data was normalised to produce values of Lum-DCL equivalent to that generated by
1 x 106 BALF neutrophils. These normalised data were compared to the fMLP-
stimulated Lum-DCL response of 1 x 106 peripheral blood neutrophils at each time
point using the Mann Whitney U test for unpaired data. The results of these analyses
demonstrated that the fMLP-stimulated Lum-DCL response of neutrophils recruited
to the airspaces was significantly greater than that of peripheral blood neutrophils at
baseline, 5 h, 7 days and 14 days after challenge (Figure 6.7). Notably, analysis of
data at 24 h and 4 days after challenge showed no such difference in the responses of
the two populations of cells (Figure 6.7). These results suggest that for airspace
neutrophils, priming is an integral part of their recruitment to the lung and
transmigration into the airways. Comparison of data from the baseline, 7 and 14 day
time points (when BALF neutrophils numbers were low) with responses at 5 h (when
BALF neutrophilia was at its peak) supports this hypothesis. The difference in
magnitude of the Lum-DCL responses of 1 x 106 blood and airspace neutrophils at
these time points was similar, irrespective of the numbers of neutrophils recruited to
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Figure 6.7: Comparison of fMLP-stimulated Lum-DCL of peripheral blood and BALF
neutrophils from COPD-susceptible horses
fMLP-stimulated (1 pM) Lum-DCL of peripheral blood neutrophils (open boxes) and BALF
cells (hatched boxes) harvested 10 days before (baseline) and at the time points indicated
after challenge was measured over a 5 min time course. The Lum-DCL values for BALF
neutrophils are the normalised data for the equivalent CL generation by 1 x 106 neutrophils.
Data are presented as box and whisker plots indicating median values, 25th and 75th
percentiles and maximum and minimum values. (**; p<0.01, *; p<0.05 compared to
values for peripheral blood neutrophils, n = 6)
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The similarity in the Lum-DCL response of peripheral blood and BALF neutrophils
at 24 h and 4 days is intriguing. Firstly the fMLP-stimulated Lum-DCL response of
peripheral blood neutrophils was significantly increased in the whole group at 4 days
and in 4/6 horses at 24 h (although this was not significant; Section 5.2.8.2).
However of greater interest is the apparent reduction in the Lum-DCL activity of
BALF (1 x 106) neutrophils at these time points. Neutrophil numbers in the lung had
declined substantially by 24 h suggesting that the rate of recruitment had already
decreased significantly. Consequently the reduced fMLP-stimulated Lum-DCL
response of BALF neutrophils at 24 h and 4 days most likely reflects a
downregulation in the functional status of the population of neutrophils that have yet
to be cleared from the airspaces.
It must be recognized however, that the integrity of the derived data on which these
conclusions are based is heavily reliant on the strength of the relationship between
the proportion of neutrophils in BALF and the luminol-dependent CL signal (Section
2.8.3.4 and Figure 2.8a,b). Although this relationship was very robust in the in vitro
experiments (r = 0.81, p<0.0001, Figure 2.8a), the correlation was weaker when the
in vivo challenge data were analysed (r = 0.76, p<0.0001, Figure 2.8b). The kinetics
of the BALF neutrophilia induced by hay/straw challenge over the 14 day study
period meant that the data were highly skewed, with only 8/36 BALF samples
containing more than 25% neutrophils. This relationship should be re-examined
using a larger number of BALF samples with a more balanced range of neutrophil
proportions before this technique of assessing BALF neutrophil respiratory burst
activity can be adopted with confidence. However, bearing in mind the constraints
of the failure to isolate pure populations of neutrophils from BALF, this method does
allow an initial appreciation of the comparative function of peripheral blood and
BALF neutrophils harvested from COPD-susceptible horses before and after
hay/straw challenge.
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6.2.3 EFFECT OF CHALLENGE ON NEUTROPHIL ELASTASE
CONCENTRATION AND ACTIVITY IN BALF
The concentration of ENE 2A in the supernatant of BALF collected 10 days before
and at the routine time points after hay/straw challenge was measured using a
specific ELISA (Section 2.8.5). The concentration of ENE 2A in BALF supernatant
was significantly greater than baseline at 5 h, 24 h and 4 days after challenge (Figure
6.8), indicating that neutrophil degranulation occurred following recruitment to the
airspaces. Of particular note was the continued presence of significant amounts of
ENE 2A in BALF at 4 days (Figure 6.8) when neutrophil numbers had returned to
baseline levels (Table 6.2). Peak concentrations of ENE 2A (55.3 ng/ml, 4.9-360.3;
median and range) and peak neutrophil numbers in BALF were detected concurrently
at 5 h after challenge. There was a strong correlation between the concentration of
ENE 2A in BALF supernatant and the absolute numbers of neutrophils in whole
BALF (r = 0.74, p <0.0001). Also there was a significant correlation between the
concentration of ENE 2A in the BALF supernatant and the basal (unstimulated)
Lum-DCL of BALF cells (r = 0.65, p <0.0001) suggesting that an increase in the
spontaneous release of oxidants and extracellular proteinase secretion are closely
associated. This evidence of degranulation of neutrophils recruited to the airspaces
following challenge is further supported by a recent collaborative study undertaken
in this laboratory investigating the role of matrix metalloproteinases in equine
COPD (P. Maisi [University of Helsinki] and T.J. Brazil, unpublished observations).
These studies have demonstrated significantly increased concentrations of MMP-9
(of which neutrophils are a major source [Clegg et al., 1997a]), in BALF supernatant
following hay/straw challenge and MMP-9 levels followed almost identical kinetics
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Figure 6.8: Effect of hay/straw challenge on equine neutrophil elastase 2A content of
BALF from COPD-susceptible horses
The ENE 2A content in BALF supernatant harvested 10 days before (baseline) and at the
time points indicated after challenge was measured by specific ELISA using purified ENE 2A
as a standard. Data are presented as box and whisker plots indicating median values, 25th
and 75th percentiles and maximum and minimum values. ( *; p<0.05 compared to baseline
values, n = 6)
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The presence of increased concentrations of immunologically detectable ENE 2A in
BALF does not however, necessarily infer any pathogenetic role for elastase in
COPD. Therefore, functional elastase activity was assayed in BALF supernatant
using the specific substrate N-methoxysuccinyl-ALA-ALA-PRO-VAL p-nitroanilide
(Section 2.8.6). Elastase activity was not detectable in any of the BALF supernatant
samples collected either before or after challenge, even when incubated in the
presence of an excess of the chromogenic substrate for up to 18 h in an attempt to
detect very low levels of elastase activity. The change in absorbance and hence
activity of the lowest concentration (3.2 ng/ml) of purified ENE 2A remained linear
over this period (data not shown). These data would suggest that although neutrophil
proteinases are released into the airspaces following challenge their appropriate
antiproteinase inhibitors rapidly inactivate them.
6.2.4 EFFECT OF CHALLENGE ON CYTOKINE LEVELS IN BALF
The concentration of equine IL-8 in BALF supernatant harvested before and 5 h, 24
h and 4 days after challenge was measured by a dot blot assay, using erIL-8 as a
reference standard, as described in Section 2.8.10. Although there was much inter-
animal variation at all the time points studied, levels of IL-8 in BALF were
significantly increased at 5 h after challenge (Figure 6.9). However, despite the only
statistical difference in IL-8 concentrations being the increase between baseline and 5
h, a distinct pattern was noticed for all 6 horses. IL-8 levels increased at 5 h then fell
markedly at 24 h before increasing again at 4 days (Figure 6.8) suggesting biphasic
IL-8 production within the airways following hay/straw challenge. Analysis of
cytokine levels in the same BALF samples using the specific human TNF-a and IL-8
and ovine IL-8 ELISA systems failed to demonstrate any cross-reactivity indicating
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Figure 6.9: Effect of hay/straw challenge on levels of IL-8 in BALF from COPD-
susceptible horses
The concentration of IL-8 in BALF supernatant harvested 10 days before (baseline) and at
the time points indicated after challenge was measured by specific dot blot assay using
purified erlL-8 as a standard (Section 2.8.10). Data are presented as box and whisker plots
indicating median values, 25th and 75th percentiles and maximum and minimum values.
(* ; p<0.05 compared to baseline values, n = 6)
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6.2.5 FATE OF NEUTROPHILS IN THE RESOLUTION OF AIRWAY
INFLAMMATION FOLLOWING CHALLENGE
Cytological examination of BALF collected from COPD-susceptible horses
confirmed that there was a rapid influx of neutrophils into the airspaces in response
to hay/straw challenge (Figure 6.1). However, the kinetics of clearance of the
recruited neutrophils and in particular their fate were central questions in the
investigation of the resolution of airway inflammatory response. Figure 6.1 and
Table 6.2 show that neutrophils are cleared rapidly from the airspaces after
termination of the challenge stimulus. By 24 h, absolute neutrophil numbers had
already fallen to a median of only 27.8% (12.8-67.7%) of their peak at 5 h (end of
hay/straw challenge period) and had returned to baseline levels by 4 days.
Cytological and immunohistochemical examinations of BALF, harvested before and
after challenge, were performed to investigate the potential role of apoptosis of
airspace neutrophils and whether phagocytosis by alveolar macrophages was
involved in the clearance of the pulmonary neutrophil burden following hay/straw
challenge.
6.2.5.1 Kinetics of airspace neutrophil apoptosis following challenge
The number of neutrophils with typical features of apoptosis was counted on Diff
Quik-stained cytocentrifuge preparations; this staining technique gave the best
definition of this morphological phenotype under oil immersion light microscopy
(Figure 6.10a). Attempts to enumerate free apoptotic neutrophils on cytocentrifuge
preparations stained by the TUNEL method proved unrewarding. The rigours of cell
fixation and the labelling procedure appeared to cause significant disruption of
neutrophil morphology and a high level of non-specific labelling making accurate
enumeration of cells impossible. On Diff Quik-stained preparations, small numbers
of apoptotic neutrophils were identified at all time points, even prior to challenge, but
this number was significantly greater than baseline values at 24 h and 4 days after
challenge (Figure 6.1 la). The proportion (%) of the neutrophils present in BALF
that had typical light microscopic features of apoptosis was significantly increased 4
days after challenge (Figure 6.1 lb).
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Figure 6.10a,b: Airspace neutrophils undergo apoptosis and are phagocytosed by
alveolar macrophages in vivo; light microscopic evidence
BALF was collected 24 h after hay/straw challenge and the light microscopic morphology of
neutrophils and alveolar macrophages examined on Diff Quik-stained cytocentrifuge
preparations under oil immersion. Representative photomicrographs are shown,
a: Free apoptotic neutrophil in BALF (arrow); note densely staining pyknotic chromatin
fragments. Magnification x 1240
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Figure 6.11 a,b: Kinetics of airspace neutrophil apoptosis in vivo
BALF was collected 10 days before (baseline) and at the time points indicated after
challenge. Neutrophils with typical light microscopic features of apoptosis were counted on
duplicate Diff Quik-stained cytocentrifuge preparations. Data are presented as box and
whisker plots indicating median values, 25th and 75th percentiles and maximum and
minimum values. (* ; p<0.05 compared to baseline values, n = 6)
a: Absolute number of apoptotic neutrophils in BALF
b: Percentage of neutrophils in BALF with morphological features of apoptosis
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6.2.5.2 Qualitative morphological evidence for macrophage clearance of
apoptotic neutrophils in vivo
Light microscopic examination of Diff Quik-stained cytocentrifuge preparations of
BALF clearly identified a small sub-population of alveolar macrophages that
contained densely staining intracytoplasmic chromatin remnants consistent with
these macrophages having phagocytosed apoptotic neutrophils in vivo; (Figure
6.10b). The appearance of these remnants varied from being clearly identified as an
intact apoptotic neutrophil to a cluster of densely staining bodies to a tight group of
tiny specks. The range in morphology of these remnants suggested that there was a
continuum in macrophage processing of these effete cells in vivo, from recent
ingestion of an intact (apoptotic) cell to complete degradation. Alveolar
macrophages identified as having phagocytosed apoptotic chromatin contained either
a single apoptotic cell or group of apoptotic bodies or up to 5 discrete apoptotic cells
or clusters of pyknotic chromatin. To ensure that what appeared to be pyknotic
chromatin on Diff Quik-stained preparations did indeed constitute apoptotic DNA,
representative cytocentrifuge preparations of BALF collected 24 h after challenge
were fixed and stained by TUNEL as described in Sections 2.6.6 and 2.8.8.
TUNEL staining clearly identified clusters of apoptotic DNA within the cytoplasm of
alveolar macrophages (Figure 6.12a). Typically this was recognized as tightly
grouped clusters of apoptotic bodies. Although non-specific labelling was prominent
in some preparations, in general, alveolar macrophages appeared to be more resilient
to the processing required for TUNEL than neutrophils.
To confirm that this apoptotic DNA was of neutrophil origin, cytocentrifuge
preparations were fixed and stained immunohistochemically specifically for equine
neutrophil elastase 2A as described in Section 2.8.7. Counterstaining with Mayer's
Haematoxylin clearly demonstrated that the intensely stained neutrophil elastase co-
localised with the densely staining condensed nuclear chromatin within the
cytoplasm of alveolar macrophages (Figure 6.12b). The pattern of ENE 2A staining
of this ingested material complimented that recognized on Diff Quik-stained slides.
Hence, some alveolar macrophages appeared to contain intact apoptotic neutrophils,
others contained a small cluster of apoptotic bodies surrounded by intense ENE 2A




Figure 6.12a,b: Alveolar macrophages ingest apoptotic neutrophils in vivo;
immunohistochemical evidence
BALF was collected 24 h after challenge and fixed and stained by the TUNEL method
(Sections 2.6.6 and 2.8.8, Panel a) and immunohistochemically for ENE 2A (Section 2.9.7,
Panel b) and examined under oil immersion. Representative photomicrographs are shown,
a: Alveolar macrophage containing several clusters of TUNEL +ve apoptotic bodies. TUNEL
labeling detected with DAB, slides counterstained with Methyl green, Magnification x 1850
b: Alveolar macrophage containing densely staining pyknotic bodies co-localised with ENE
2A (red). ENE 2A detected with AEC, slides counterstained with Mayer's Haematoxylin,
Magnification x 1330
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well-circumscribed cluster of granular ENE 2A staining remained. These patterns of
ENE 2A staining are very similar to those of neutrophil myeloperoxidase identified
in BALF macrophages from babies with neonatal respiratory distress syndrome
(Grigg et al., 1991). In the current study, individual ENE 2A positive alveolar
macrophages demonstrated snapshots of a process that appeared to progress from
engulfment of an intact apoptotic neutrophil to complete degradation of its
component parts. These morphological features suggested that elastase remained
immunologically detectable for some time after the processing and complete
destruction of visible nuclear chromatin. However, from this limited number of
observations undertaken in the clearance phase of the induced pulmonary
neutrophilia, it is still not possible to determine whether all alveolar macrophages
containing neutrophil remnants had initially engulfed an intact apoptotic cell.
Alveolar macrophages may also have scavenged remnants of neutrophils that had
undergone apoptosis and broken up into several smaller apoptotic bodies in vivo.
Furthermore, neutrophil elastase either secreted by functionally competent
neutrophils or liberated following secondary necrosis of apoptotic neutrophils in vivo
may similarly have been scavenged by alveolar macrophages.
Further confirmatory evidence of alveolar macrophage clearance of effete
neutrophils was sought from ultrastructural examination of BALF cells collected
from COPD-susceptible horses 24 h after the start of the 5 h hay/straw challenge.
BALF was collected and prepared for TEM as described in Sections 2.3.2.1 and
2.8.9. With careful examination of TEM grids, small numbers of both free apoptotic
neutrophils and alveolar macrophages that had ingested intact apoptotic neutrophils
could be identified (Figure 6.13a,b).
These investigations indicate that alveolar macrophage engulfment of apoptotic
neutrophils play at least some part in the clearance of the neutrophil burden from the
airspaces during the recovery phase of the acute pulmonary neutrophilia induced in
COPD-susceptible horses by hay/straw challenge.
6.2.5.3 Kinetics of macrophage clearance of apoptotic neutrophils in vivo
Having confirmed that macrophage phagocytosis of effete neutrophils contributed to
the resolution of the pulmonary neutrophil burden, the kinetics of this process were
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Figure 6.13a,b: Alveolar macrophages ingest apoptotic neutrophils in vivo;
ultrastructurai evidence
BALF was collected 24 h after hay/straw challenge and washed, fixed, prepared, examined
and imaged as described in Section 2.3.2.1. Representative electron photomicrographs are
shown.
a: Alveolar macrophage (AM) and two apoptotic neutrophils (N) "free" in BALF are shown.
Note condensed nuclear chromatin and retention of intracellular granules in neutrophils.
Magnification x 3730
b: Alveolar macrophage (AM) that has engulfed an intact apoptotic neutrophil (arrow).
Magnification x 4800
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examined by counting the number of alveolar macrophage that contained ENE 2A
positive cell remnants at each time point. Even prior to challenge a small proportion
of macrophages (0.5%, 0.3-0.9%, Figure 6.14) contained ENE 2A positive cell
remnants indicating that macrophage clearance may represent a normal,
physiological disposal pathway for neutrophils reaching the end of their functional
life in the airways. The number of ENE 2A positive macrophages rose to a peak at
24 h (Figure 6.14), coinciding with the period of most rapid decline in BALF
neutrophil numbers (Figure 6.1), and remained significantly elevated at 4 days when
BALF neutrophil numbers had fallen to pre-challenge levels (Figure 6.14).
The temporal relationships between the percentages of neutrophils, apoptotic
neutrophils and ENE 2A positive macrophages counted on appropriately stained
cytocentrifuge preparations of BALF cells are shown in Figure 6.15a,b. Although
not strictly valid for data that is not normally distributed, the data in Figure 6.15a,b
are presented as means ± SEM in order to demonstrate the relationships between the
kinetics of these three parameters with greater clarity. These figures show a wave of
ENE 2A positive alveolar macrophages that appear in BALF 24 h after challenge as
neutrophil numbers in the airspaces are declining rapidly. The true significance of
the contribution of macrophage phagocytosis to neutrophil clearance cannot be
estimated from these data alone because, as demonstrated in Figure 6.2, absolute
macrophage numbers were markedly reduced from 5 h until at least 7 days after
challenge. However this apparent net egress of macrophages takes no account of
possible trafficking of these cells into as well as out of the airspaces. Consequently,
if the population of macrophages that had engulfed one or more apoptotic neutrophils
rapidly migrated from the airspaces with their newly ingested prey and at least a
proportion of them were replaced by an influx of rapidly differentiating
monocytes/macrophages, the load of apoptotic neutrophils cleared by this route
would be greatly underestimated. In this context, it is interesting to note that there
was a significant increase in the proportion of apoptotic neutrophils in BALF at 4
days after challenge (Figure 6.15b), i.e. after the peak in ENE 2A positive
macrophages numbers was recorded. As a large wave of apoptotic neutrophils was
not observed in parallel with peak numbers of phagocytic macrophages (24 h, Figure
6.15b), this route of neutrophil disposal would appear to be highly efficient.
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Figure 6.14: Kinetics of macrophage clearance of apoptotic neutrophils in vivo
BALF was collected 10 days before (baseline) and at the time points indicated after
challenge. Cytocentrifuge preparations were stained immunohistochemically for the
presence of ENE 2A. At each time point 500 alveolar macrophages were examined on
duplicate slides and the proportion containing ENE 2A positive cell remnants was recorded.
Data are presented as box and whisker plots indicating median values, 25th and 75th







































































Baseline 5 h 24 h 4 days 7 days 14 days
Figure 6.15a,b: Temporal relationships between kinetics of neutrophils, apoptotic
neutrophils and ENE 2A positive macrophages in BALF in vivo
BALF was collected at the time points indicated. The proportions of neutrophils, apoptotic
neutrophils (Apop PMNs) and ENE 2A +ve macrophages were counted on Leishman's, Diff
Quik, and immunohistochemically stained cytocentrifuge preparations, respectively. For
improved clarity data are presented as mean ± SEM values (n = 6).
a: relationship between differential neutrophil count and proportion of ENE +ve macrophages
b: relationship between proportion of apoptotic neutrophils and ENE +ve macrophages
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However, after 4 days, when fewer ENE 2A positive macrophages were present,
greater proportions of apoptotic neutrophils were observed (Figure 6.15b) even
though their absolute numbers had fallen (Figure 6.1 la). This finding could indicate
a lower net phagocytic capacity of the population of alveolar macrophages resident
in the airspaces at this stage in the resolution of the inflammatory response. Further
studies of equine alveolar macrophage phenotype and function will be required to
address this hypothesis.
Although the number of macrophages that had ingested neutrophils or their remnants
was quantified by the use of a neutrophil specific marker (ENE 2A), cytopathologic
features consistent with this process were also observed on Diff Quik-stained slides
(Figure 6.10b). To determine how specific these findings in Diff Quik-stained cells
were for the presence of ingested neutrophils, a correlation between the two sets of
data was examined. The proportion of alveolar macrophages determined to have
ingested neutrophil remnants on Diff Quik-stained preparations was significantly
correlated with the proportion identified by the specific immunohistochemical
method (r = 0.7, p<0.0001). There was however, a tendency to slightly overestimate
the number of phagocytic macrophages on Diff Quik-stained slides suggesting that
the densely staining intracytoplasmic chromatin fragments observed may, in some
cases, originate from cells other than neutrophils.
6.2.5.4 Effect of BALF supernatant on the rate of constitutive apoptosis in
peripheral blood neutrophils in vitro
Studies using synovial fluid from human rheumatoid arthritis patients (Bell et al.,
1995) and BALF from rabbits with experimental bacterial pneumonia (Lawson et al.,
1998b) have demonstrated that during the resolution phase of inflammation a
humoral factor is expressed with the capacity to induce apoptosis in peripheral blood
neutrophils in vitro. The implication that apoptosis of the neutrophil burden is
facilitated by a switch in the local cytokine/mediator profile to promote clearance
was examined in the current equine COPD model. Peripheral blood neutrophils
isolated from healthy normal horses were cultured with BALF supernatants
harvested from COPD-susceptible horses at the previously described study time
points and with NaCl as a control. Apoptosis was assessed in neutrophils after 8 and
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20 h in culture. After 8 h in culture the rate of apoptosis was unaffected by any of
the BALF supernatants. After 20 h however, Kruskal-Wallis testing identified a
significant difference amongst the groups (p<0.01). Comparison of apoptosis in cells
cultured with BALF from each time point with control cells (NaCl) demonstrated a
significant inhibition of apoptosis at 5 and 24 h after challenge (p<0.05, n = 6, Figure
6.16). At no time point after challenge did BALF induce apoptosis in peripheral
blood neutrophils. The presence of inflammatory mediators, such as IL-8 (Figure
6.9), that might inhibit apoptosis would be expected at 5 h post-challenge when
neutrophil numbers were maximal. Flowever the continuing inhibition at 24 h would
suggest that clearance of the airspace neutrophil burden and cessation of further
neutrophil recruitment occur in spite of the continuing influence of other such pro¬
inflammatory mediators.
6.3 DISCUSSION
Migration of leucocytes from the pulmonary circulation into normal lung tissue is a
dynamic process supplying monocytes/macrophages for clearance of non-self
particles and lymphocytes for immune surveillance, but the movement of neutrophils
from the vascular space into the pulmonary tissue only occurs in response to an
inflammatory stimulus (Flogg and Doerschuk, 1995). Indeed, normal horses have
only a small proportion of neutrophils (< 5%) in their BALF (Sweeney el al., 1992a;
McGorum and Dixon, 1994; Sweeney et al., 1994; Dixon et al., 1995c; Hobo et al.,
1997). Moreover, healthy horses kept permanently at pasture where dust levels are
very low may have few if any neutrophils recoverable in BALF (P.M Dixon, B.C.
McGorum, R.S. Pirie and T.J. Brazil, unpublished observations). Neutrophils that
are observed in the respiratory secretions of horses without any history or clinical
signs of lung disease may reflect a particular sensitivity of the horse to non-specific
irritants.
Bronchoalveolar lavage is now used routinely in equine clinical practice to sample
cell populations in the lower respiratory tract of the horse (McGorum and Dixon,
1994; Moore and Cox, 1996). In developing a protocol for repetitive BAL, the
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Figure 6.16: Effect of BALF supernatant on apoptosis in peripheral blood neutrophils
Equine peripheral blood neutrophils from healthy horses (5 x 106/ml) were incubated in MF at
37°C for 20 h in the presence of NaCI (Control) or BALF supernatant collected 10 days
before (Baseline) and at the time points indicated after hay/straw challenge of COPD-
susceptible horses. Cells were resuspended and percent apoptosis assessed
morphologically on Diff-Quik-stained cytocentrifuge preparations. Data are presented as box
and whisker plots indicating median values, 25th and 75th percentiles and maximum and
minimum values. (* ; p<0.05 compared to control values, n = 6)
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effects of the previous lavage on the make-up and function of the cell populations
harvested at subsequent time points was critically evaluated. In humans (Von Essen
et al., 1991) and experimental animal species (Cohen and Batra, 1980; Krombach et
al., 1985; Haley et al., 1989; Murray, 1998) a single BAL can induce significant
changes in both local pulmonary and systemic neutrophil numbers and function
associated with the release of chemotactic factors by resident airway cells (Cohen
and Batra, 1980; Teran et al., 1996; Krause et al., 1997). Although studies in
humans (Von Essen et al., 1991), dogs and monkeys (Cohen and Batra, 1980) have
indicated that a single lavage can induce inflammation diffusely within the lung, in
general, the pulmonary neutrophil response is localised to the lung segment lavaged
(Krombach et al., 1994) with minor changes occasionally observed in immediately
adjacent segments (Weiss et al., 1983). The induced pulmonary neutrophilia
resolves over the ensuing 48 h (Pinsker et al., 1980; Weiss et al., 1983; Haley et al.,
1989) to 72 h (Von Essen el al., 1991), with the increases in peripheral blood
neutrophil numbers and function returning to normal levels within 24 h (Krombach
et al., 1985; Von Essen et al., 1991). The localised inflammatory response to BAL is
not solely related to saline lavage as bronchoscopy alone has been shown to induce a
similar response in both sheep (Weiss et al., 1983) and humans (Krause et al., 1997).
Sweeney et al. (1994) reported a similarly localised neutrophilic response to BAL in
horses, which lasted for at least 48 h but did not affect adjacent airways. However,
BALF cell function was not addressed in their study. Several serial BAL protocols
were evaluated in the current study. Performing 3 lavages with 0.9% NaCl within 48
h (0 h; right lower segment, 19 h; left lower segment 43 h; right upper segment) did
result in more diffuse pulmonary inflammation with increased numbers of
neutrophils in the 43 h BAL in 2/3 horses. This is in contrast to a study by Derksen
et al. (1987), who found no changes in BALF or blood cell counts when performing
3 lavages in different lung segments of normal ponies over a 48 h period. These
workers used phosphate buffered saline, which may be less irritant than the more
acidic (pH 5.7) 0.9% saline (Sweeney et al., 1994) used in this pilot study. However,
the final protocol employed (Section 6.2.1.1) had no significant effect on BALF cell
numbers or their CL activity indicating that, with care, serial segmental BAL can be
performed in the horse without affecting other lung segments. In calves, a single
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lavage can induce changes in alveolar macrophage function (superoxide anion
generation, antibody dependent cellular cytotoxicity) in the lavaged segment for
between 2 and 6 days (Ohmann and Babiuk, 1986). In the current study, not
returning to previous BAL sites for at least 10 days obviated any potential longer
term effects on alveolar macrophage function. This was borne out by the sham BAL
Luci-DCL studies (Section 6.2.1.1) and the return of absolute alveolar macrophage
numbers to baseline levels by 14 days after hay/straw challenge (Figure 6.2).
Previous work in this laboratory has shown that in equine COPD the pulmonary
inflammatory response is homogenous throughout different lung segments such that
a single BAL sample is representative of the entire lung at a particular time point
(McGorum et al., 1993e).
To maximise the cell yield during BAL, 0.9% NaCl (without divalent cations) was
used to aid cell detachment (particularly of alveolar macrophages) from the airway
mucosa and alveolar walls (Brain and Frank, 1973; Naylor et al., 1992). Using
lavage fluid at 37°C may help reduce coughing and bronchospasm (Klech and Pohl,
1989; Rennard et al., 1998). Recovery of BALF was approximately 50% of the
volume instilled and the volume recovered did not differ significantly after challenge
of COPD-susceptible horses as reported previously (Derksen el al., 1985b; Sweeney
et al., 1992a; McGorum et al., 1993d; Rush et al., 1998a). BALF cell counts were
performed by haemocytometer after removal of mucus and debris by filtration
through nylon gauze (which did not affect BALF cell counts, Section 2.8.1). Counts
were performed prior to centrifugation to improve accuracy and minimise cell losses
(Klech and Pohl, 1989).
An increase in the proportion of neutrophils (> 5%) in BALF concurrent with
exposure to hay and straw has become recognized as the cytological hallmark of
COPD in susceptible horses in both experimental studies (Derksen et al., 1985b;
McGorum et al., 1993d; Rush et al., 1998a) and clinical surveys (Viel, 1983; Winder
et al., 1991; Winder et al., 1991; Naylor et al., 1992; McGorum and Dixon, 1994).
After hay/straw challenge total BALF cell counts increased due to an influx of
neutrophils (Table 6.2). This is consistent with a similar experimental hay/straw
challenge study (McGorum et al., 1993d) and one retrospective equine hospital
practice study (Vrins et al., 1991). Other experimental studies using much longer
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challenge periods (3-7 days) have not observed increased total BALF cell counts in
spite of elevated neutrophil counts (Derksen et al., 1985b; Rush et al., 1998a),
suggesting that the relative trafficking, and hence proportions of the constituent cell
types in BALF may vary depending upon the duration of challenge. Indeed, an
initial indication of this is gained from the net decline in the numbers of the other
predominant cell types in BALF, macrophages and lymphocytes, at various time
points after challenge (Table 6.2).
Apart from the obvious fall in the relative proportions of the other major component
BALF cell types (namely lymphocytes and macrophages) following neutrophil
influx, absolute numbers of these cells were also reduced significantly after
challenge (Table 6.2). Similar reductions in absolute macrophage counts have been
reported in previous experimental challenge studies of COPD-susceptible (Derksen
et al., 1988; McGorum et al., 1993d; Hare et al., 1999) or artificially sensitised
horses (Derksen et al., 1987) and in other lung diseases characterised by pulmonary
neutrophilia, such as bacterial pneumonia and pleuropneumonia in the horse (Rossier
et al., 1991), bacterial pneumonia in mice (Kooguchi et al., 1998) and ozone
exposure in dogs (Fabbri et al., 1984).
This decline in absolute macrophage numbers in BALF is particularly intriguing and
interplay among several mechanisms may be involved. Firstly, an increase in the
numbers of macrophages that are tightly adherent to the airway walls (Lavnikova et
al., 1993) or any obstruction of bronchioles (Robinson et al., 1996) may reduce the
numbers of alveolar macrophages that can be aspirated from the distal small airways
and alveoli. Secondly, numbers may be depleted by macrophages undergoing
apoptosis following challenge and subsequently being phagocytosed by adjacent
alveolar macrophages (Khelef et al., 1993; Bingisser et al., 1996; Hussain et al.,
1998). Finally, emigration of alveolar macrophages from the airways after the initial
inflammatory response to challenge, perhaps to draining lymph nodes (Lan et al.,
1993; Bellingan et al., 1996; Hughes et al., 1997) could lead to a decline in
macrophage numbers. The study by Bellingan and co-workers (1996) using semi-
allogeneic adoptive transfer of inflammatory macrophages, elegantly demonstrated
rapid and directed emigration of these cells (within 96 h) to the draining lymph nodes
in the resolution phase of experimentally induced peritonitis in mice. Furthermore, a
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study of anti-glomerular basement membrane glomerulonephritis (Lan et al., 1993)
gives further evidence that significant trafficking of macrophages from an
inflammatory focus to local draining lymph nodes may be a general feature of
macrophage population dynamics during inflammation. Indeed, although the
clearance of radiolabeled neutrophils via lymphatics in the resolution of experimental
glomerular capillary injury in rats is minimal, a small neutrophil signal was detected
in draining lymph nodes that was exclusively co-localised with macrophages
(Hughes et al., 1997). Thus, although the purpose of macrophage emigration is
unclear, it may facilitate processing of engulfed material including neutrophils and
presentation of antigens to lymphocytes within the lymph nodes (Lan et al., 1993;
Bellingan et al., 1996).
The reduction in absolute lymphocyte numbers at 24 h is likely to be a reflection of
the considerable traffic of these cells through the airspaces that is known to occur in
COPD-susceptible horses during and after antigen challenge (McGorum et al.,
1993b; Watson et al., 1997; Rush et al., 1998a). Although increases in lung
eosinophil numbers (measured in BALF) (Derksen et al., 1985b) and eosinophil
recruitment (monitored by external scintigraphy) (Fairbairn et al., 1993) have been
reported in small sub-groups (2/6 and 2/13 horses in these two studies respectively)
of COPD-susceptible horses following hay/straw challenge, eosinophil numbers were
unaffected by challenge in the current study consistent with previous work in this
laboratory (McGorum et al., 1993d).
This is the first study to specifically address the kinetics of air space neutrophil
recruitment and clearance following hay/straw challenge of COPD-susceptible
horses. By hourly external monitoring of In1 "-labelled peripheral blood neutrophils,
Fairbairn and co-workers (1993b) demonstrated recruitment of neutrophils to the
lungs of COPD-susceptible horses within 4 h of the onset of hay/straw challenge.
Recruitment reached a plateau by 6 h but monitoring was not pursued beyond 7 h.
Increased numbers of neutrophils are evident in BALF by 5 h (McGorum et al.,
1993d) and their numbers remain elevated after 3-7 days of continuous hay/straw
challenge (Derksen et al., 1987). Although the very early kinetics of neutrophil
recruitment to the airspaces following challenge has not been documented in equine
COPD, evidence from other models of neutrophilic airway inflammation
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demonstrate the rapidity of the neutrophilic response to pulmonary insult. For
example, in mice, after inhalation of grain dust, BALF neutrophil numbers increased
almost 100 fold to a peak 1 h later and by 4 h had already fallen by 50% (Deetz et
al., 1997). Similarly, BALF neutrophil numbers were increased 30 min after
intrapulmonary instillation of C5 fragments in rabbits and reached a peak at 4 h
(Doherty el al., 1988). However, following direct intratracheal instillation of LPS in
mice, BALF neutrophil numbers peaked somewhat later at 6-24 h (Xing et al., 1993;
Cox et al., 1995). Perhaps more pertinent to the study of equine COPD which is
believed to be associated with a delayed hypersensitivity response (Robinson et al.,
1996), the intense pulmonary neutrophilia observed in the ovalbumin sensitised rat
model of allergic asthma does not reach its peak until 24 h after aerosol ovalbumin
challenge (Schneider et al., 1997). Although direct comparison of varying models of
neutrophilic inflammation in different species is unwise, a clear pattern begins to
emerge with an initial rapid (within hours) neutrophil recruitment phase after
pulmonary insult being followed by a precipitous loss of further chemoattractant
activity. Indeed, studies of acute arthritides induced by intra-articular C5 fragments
in rabbits (Haslett et al., 1989a) or carageenin (Auer et al., 1990) and LPS (Hawkins
et al., 1993; Gottschalk el al., 1998) in horses, demonstrate a rapid cessation of
further neutrophil influx within 2-8 h of the initiating insult. In the rabbit model
(Haslett et al., 1989a), the rapid fall-off in neutrophil recruitment was due to a time-
dependent loss of in vivo chemoattractant activity from the synovial cavity.
Although in an early study (Derksen et al., 1987), 2/6 COPD-susceptible horses
continued to have elevated BALF neutrophil counts 7 days after termination of
challenge, no other workers have performed sequential BAL at time points beyond 5
h to monitor the resolution of the pulmonary neutrophilia. The kinetics of the
resolving BALF neutrophilia, with a reduction in neutrophil numbers at 24 h and a
return to baseline levels by 4 days (Table 6.2) followed a very similar time course to
models of neutrophilic pulmonary inflammation induced by grain dust in humans
(Deetz et al., 1997) and mice (Wohlford-Lenane et al., 1999), LPS in rodents (Xing
et al., 1993; Cox, 1996; Wohlford-Lenane et al., 1999), C5 fragments in rabbits
(Doherty et al., 1988), oleic acid in rats (Hussain et al., 1998), ovalbumin in
sensitised rats (Schneider et al., 1997) and guinea pigs (Underwood et al., 1995) and
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bacillus Calmette-Guerin hypersensitivity in mice (Shellito et al., 1987). These
comparative data suggest that the time course of clearance of a population of
neutrophils recruited to the airspaces by a single self-limiting insult has a consistent
pattern irrespective of the model studied. Indeed, it is likely that the kinetics of such
a response is governed, at least in part, by the relatively short lifespan of the
neutrophil (see Chapter 4). Once further neutrophil recruitment has ceased, the
resident population of neutrophils is cleared from the airspaces.
The pathogenetic impact of airway neutrophil accumulation cannot be extrapolated
from their presence in BALF alone and investigation of the functional status of the
recruited cells is paramount (Sibille and Reynolds, 1990; Pittet et al., 1997; Jones et
al., 1997). As discussed in Section 2.1 and Chapter 3, neutrophils are exquisitely
sensitive to functional modulation by inappropriate handling or preparative
procedures. To ensure that BALF collection and processing per se did not artificially
modulate neutrophil function, BALF was collected and processed consistently and
rapidly (usually < 60 min) throughout all the challenge experiments. Work from
human studies suggests that BALF cell function is stable for up to 4 h (Klech and
Pohl, 1989; Rennard et al., 1998). PMA- and fMLP-stimulated superoxide anion
generation in human and sheep blood neutrophils has been shown to be unaffected by
incubation at room temperature for up to 3 h in the presence of either saline or BALF
supernatant from normal human subjects (Nguyen et al., 1989). Furthermore,
superoxide anion generation by human peripheral blood neutrophils was unchanged
after a 60 min co-incubation with alveolar macrophages from patients with ARDS
(Martin et al., 1991). Also, the in vitro sham lavage experiments (reported in
Sections 2.8.4 and 2.8.5) using peripheral blood neutrophils isolated in a manner to
minimise cell priming demonstrated that the trauma of BALF collection itself did not
prime neutrophils nor induce degranulation. Thus the ex vivo respiratory burst
activity of cells recovered from the lower airways as assessed by CL was considered
to be a valid indicator of the functional status of the resident cell population in vivo.
In the absence of a reliable technique for isolating neutrophils from the mixed cell
population in equine BALF, luminigenic probe-dependent CL offered a compromise
solution for assessing neutrophil-specific respiratory burst activity (Williams and
Cole, 1981; Ward et al., 1990). Despite some detailed studies demonstrating the
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myeloperoxidase-dependence of luminol-enhanced CL in neutrophils (Dahlgren and
Stendahl, 1983; Allen, 1986) and the identification of neutrophils as the exclusive
source of Lum-DCL within mixed populations of human BALF cells (Ward et al.,
1990; Williams and Cole, 1981)), a number of early reports also documented
significant Lum-DCL activity in adhesion purified populations of alveolar
macrophage from both humans (Cluzel et al., 1987; Calhoun and Bush, 1990) and
horses (Dyer and Leid, 1983). However, even with greater understanding of the
biochemical mechanisms underlying the generation of Lum-DCL, these latter data
remain unexplained and continue to stimulate controversy within the literature (Ward
et al., 1990; Stevens et al., 1995b). Certainly, stimulus-dependent Lum-DCL
measured following addition of purified peripheral blood neutrophils to mixed BALF
cells demonstrated a tight correlation between neutrophil numbers and luminol-
dependent CL (Humans [Ward et al., 1990]; r2 = 0.99, horses [Section 2.8.3.4, Figure
2.8a,b]; r = 0.81). Moreover, studies on a group of human patients with various
inflammatory lung diseases demonstrated a similarly tight association (r = 0.91)
between ex vivo Lum-DCL activity and the proportion of neutrophils in mixed BALF
cell populations (Williams and Cole, 1981). However, despite their in vitro data
suggesting that the Lum-DCL response of mixed BALF cell populations reflected
only neutrophil activity, Ward and colleagues (1990) found a weaker but still
significant correlation between the proportion of neutrophils in BALF from human
asthmatics and ex vivo Lum-DCL responses than that computed following addition of
allogenic peripheral blood neutrophils to normal human BALF. This disparity
concurs with the current findings with equine BALF and the levels of correlation
between neutrophil numbers and BALF cell Lum-DCL responses in Ascaris suum-
challenged allergic dogs (Stevens et al., 1995b) and human patients with acute
pneumonia (Dalhoff et al., 1994).
The reduced strength of the correlation between BALF neutrophil numbers and Lum-
DCL in vivo may reflect heterogeneity in the functional status of neutrophils resident
in the air spaces at a particular time point (Ward et al., 1990) or could suggest that an
alternative source of myeloperoxidase was present in BALF. Eosinophil peroxidase
can also generate Lum-DCL (Shult et al., 1986), but the consistently low proportion
of eosinophils present in BALF in the current study tends to rule out a confounding
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effect from eosinophils. Although no information could be found in the literature
regarding the peroxidase content of normal equine alveolar macrophages, none is
detectable in human alveolar macrophages (Nichols et al., 1971) including cells
harvested from stable asthmatics (Ward et al., 1990). However, during neutrophilic
pulmonary inflammation, alveolar macrophages can acquire peroxidase activity in
vivo by the uptake of soluble myeloperoxidase (Shellito et al., 1987), apoptotic
neutrophils (Grigg et al., 1991; Cox et al., 1995) or their remnants (Shellito et al.,
1987). Despite being unable to release their acquired myeloperoxidase load (Shellito
et al., 1987), alveolar macrophages may utilise this internalised enzyme to enhance
killing of micro-organisms that are subsequently phagocytosed (Ramsey et al.,
1982). Acquired myeloperoxidase activity may permit alveolar macrophages to
contribute to the Lum-DCL generated by a mixed population of BALF cells, thereby
reducing the specificity of the assay for neutrophil metabolic activity. Functional
studies of purified equine alveolar macrophages before and after challenge are
necessary to address this hypothesis.
Notwithstanding the proposed difficulties in the interpretation of equine BALF cell
CL activity, several critical points regarding the respiratory burst activity of BALF
cells following hay/straw challenge can be made with confidence. Firstly, hay/straw
challenge leads to a large increase in the respiratory burst capacity of BALF
phagocytes. Secondly, the time course of this enhanced responsiveness is intimately
associated with the presence of neutrophils in the airspaces and agonist-stimulated
Lum-DCL data suggest that neutrophils are the origin of many of the ROS released.
Thirdly, in light of the requirement for priming to induce functional fMLP receptor
coupling in equine neutrophils (Section 3.2.3.2), the magnitude of the fMLP-
stimulated Lum-DCL responses at 5 and 24 h after challenge would indicate that
recruited neutrophils are "heavily" primed in vivo. This is further supported by the
marked PMA-stimulated Lum-DCL responses at 5 and 24 h (Figure 6.5b) and the
enhanced fMLP-stimulated Lum-DCL response of pulmonary neutrophils in
comparison to peripheral blood neutrophils (Figure 6.7).
Although several studies have demonstrated changes in the phagocytic activity of
BALF phagocytes in horses with chronic pulmonary disease (Nuytten et al., 1983;
Klucinski et al., 1994), only a single study investigating their respiratory burst
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activity was found in the literature (Olszewski and Laber, 1993). This latter study,
using pooled tracheal and BALF cells collected from a heterogeneous population of
clinical cases of COPD, found an increase in the spontaneous production of ROS in
BALF cells compared to mixed blood leucocytes using the nitroblue tetrazolium
method. Flowever, the animals were not studied whilst in remission nor was the
BALF phagocyte respiratory burst activity compared to that of cells collected from
healthy control animals, making these findings difficult to interpret.
Increases in airspace cell respiratory burst activity are a common feature of
pulmonary inflammatory diseases including acute pneumonia (Dalhoff et al., 1994;
Jones et al., 1997), ARDS (Ching-Chi and Ching-Yuang, 1992), sarcoidosis (Kelly et
al., 1988a) and asthma (Cluzel et al., 1987; Kelly et al., 1988b; Calhoun and Bush,
1990; Ward et al., 1990; Taylor et al., 1996) in humans, allergic airway disease in
sensitised dogs (Stevens et al., 1995a; Stevens et al., 1995b) and experimental
Streptococcus pneumoniae- and bleomycin-induced lung inflammation in rabbits
(Jones et al., 1994). However, this is by no means a consistent feature in all
inflammatory lung diseases, as BALF neutrophil function may also be significantly
compromised in human patients with ARDS (Martin et al., 1991).
Until recently, investigation of the metabolic activity of individual BALF cell types
has required physical ex vivo isolation of cell populations, for example by adherence
purification of alveolar macrophages (Cluzel et al., 1987; Calhoun and Bush, 1990)
or use of differential density gradients (Ching-Chi and Ching-Yuang, 1992; Delclaux
et al., 1997). In spite of the difficulties described earlier, luminol-dependent CL, as
employed in this study has permitted analysis of neutrophil function when physical
isolation of neutrophils has been unreliable. Luminol-DCL has proved valuable in
the assessment of BALF neutrophil function in Ascaris suum sensitised dogs after
antigen challenge (Stevens et al., 1995a; Stevens et al., 1995b) and in a number of
human lung diseases (Williams and Cole, 1981) including asthma (Kelly et al.,
1988b; Ward et al., 1990) as well as in the current equine COPD model. However,
all these methods rely heavily on the assumption that the ex vivo activity of
neutrophils is a true reflection on their behaviour in situ. The recognition that within
a mixed population of BALF cells, alveolar macrophages may both inhibit neutrophil
respiratory burst activity (Sibille and Reynolds, 1990) and scavenge ROS released by
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neutrophils (Martin et al., 1991) may further explain the reduced specificity of this
technique in some situations.
The functional status of neutrophils within the airspaces is highly dependent on the
initiating cause of the lung inflammation, which determines the presence, nature and
concentration of neutrophil-activating stimuli within the inflammatory milieu (Ward
and Mulligan, 1995; Pittet et al., 1997). The development of the non-metabolisable
glucose analogue 2-[l8F]-fluoro-2-deoxy-D-glucose as positron emission tomography
imaging agent (Taylor et al., 1996) has permitted not only the measurement of
neutrophil specific metabolic activity in situ (Jones et al., 1994) but has also
highlighted the dissociation between emigration of neutrophils into the airways and
their subsequent post-migratory respiratory burst activity (Jones et al., 1997).
Indeed, this method has demonstrated a link between the persistence of neutrophil
metabolic activity in the airways of humans and the development of chronic
pulmonary inflammation, scarring and lung fibrosis (Jones et al., 1994; Jones el al.,
1998). If such technology could be harnessed for use in the horse, great progress
could be made in the investigation of the cellular pathogenesis of both
experimentally-induced COPD and the heterogeneous population of animals with
longstanding lung inflammation encountered in equine clinical practice, some of
which have evidence of irreversible lung injury.
The apparent reduction in the fMLP-stimulated Lum-DCL activity of 1 x 10() BALF
neutrophils in comparison to 1 x 106 blood neutrophils at 24 h and 4 days after
challenge (Figure 6.7) raises several interesting questions as to the functional
capabilities of airspace neutrophils during this phase of rapid neutrophil clearance.
Firstly, the residual neutrophils present in the airways at these time points may have
already undergone a sustained period respiratory burst activity and henceforth simply
be either desensitised to, or incapable of further stimulation (Pittet et al., 1997).
Perhaps of more interest, is the possibility that, at these time points, a significant
proportion of the neutrophils present in the airspaces may be undergoing apoptosis.
Previous work with human neutrophils (Whyte et al., 1993b) and the data presented
in Section 4.2.1.6 and Figure 4.6 have demonstrated that initiation of the apoptotic
programme in neutrophils is associated with a reduction in receptor-mediated
respiratory burst activity. Indeed, the significant increase in the absolute numbers of
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free apoptotic neutrophils and the proportion of ENE 2A positive alveolar
macrophages at 24 h and 4 days would support this hypothesis. However, further
studies of isolated BALF neutrophils collected at these time points after challenge
would be necessary to address this hypothesis in detail.
Although elevated levels of proteolytic activity have been previously demonstrated
in the tracheal secretions of horses with COPD (Koivunen et al., 1996; Koivunen et
al, 1997a; Koivunen et al, 1997b; Raulo and Maisi, 1998), the increased
concentration of ENE 2A measured in BALF at 5 h, 24 h and 4 days after challenge
in the current study (Figure 6.8) is the first recognition of significant neutrophil
degranulation and elastase release in the distal airways of horses with COPD. This
strengthens the case for neutrophils, and neutrophil elastase in particular, playing a
central role in the observed lung injury. Despite these data, previous studies of
equine tracheal secretions have suggested that serine proteinases, such as elastase,
are unlikely to have significant importance in the pathogenesis of equine COPD
(Koivunen et al, 1996). Indeed, the absence of functional elastase activity in BALF
(Section 6.2.3), suggesting that the released elastase had been rapidly inactivated in
situ by serine proteinase inhibitors, such as a-1-proteinase inhibitor (Potempa et al,
1991; Milne et al, 1994), would support this contention. However, the absence of
functional elastolytic activity in BALF does not in itself refute a role for neutrophil
elastase in lung injury. Although the presence of functional elastase has been
reported in the BALF of human patients with acute lung injury (Lee et al, 1981),
others have failed to identify such activity (Dent et al, 1995), even in severe
pulmonary diseases associated with significant structural damage such as ARDS
(Lee et al, 1981; Pittet et al, 1997). In view of the high concentrations of serine
proteinase inhibitors in the plasma and the PELF during pulmonary inflammation
(Milne et al, 1994; Owen and Campbell, 1999), and the rapid association of these
inhibitors with their target proteinases (Owen and Campbell, 1999), it is not at all
surprising that I was unable to measure elastase activity in the current study.
In 1989, Weiss suggested that the interaction between antiproteases, ROS and
proteases, compartmentalised within the immediate pericellular environment
adjacent to a neutrophil and its target, would dictate the destructive capability of
neutrophil elastase (reviewed in Section 1.6). In humans, ROS may oxidise and
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inactivate a-1-proteinase inhibitor by oxidation of a critical active site methionine
residue thereby permitting progression of unbridled, yet highly localised elastase
activity (Weiss, 1989; Dallegri and Ottonello, 1997). Although the horse possesses
several oxidation-resistant forms of a-1-proteinase inhibitor, other proteases such as
MMP-9 (high levels of which were detected in BALF in the current study; P. Maisi
and T.J. Brazil, unpublished observations) may also inactivate inhibitors (Owen and
Campbell, 1999). Work in human neutrophils has identified several other
mechanisms to enable localised pericellular neutrophil elastase activity to persist
even in the presence of high affinity proteinase inhibitors (Owen and Campbell,
1999). High local concentrations of proteases may be compartmentalised by tight
adhesion between neutrophil or elastase molecules and a target cell or substrate with
physical exclusion of the much larger inhibitor molecules (Owen and Campbell,
1999). Such steric hindrance may also underlie the continuing functional integrity of
elastase molecules that remain tightly bound to the neutrophil plasma membrane
(Owen et al., 1995). Finally, very high levels of proteinases may overwhelm the
antiproteinase screen either within a dense focus of neutrophils (Dent et al., 1995;
Owen and Campbell, 1999) or in the immediate vicinity of release of an individual
elastase-bearing azurophil granule, so-called "quantum proteolysis" (Liou and
Campbell, 1996).
Therefore, the presence of significant amounts of elastase in BALF may be of critical
pathogenetic relevance. Although significant proteolytic lung damage is rare in
equine COPD, the ability of neutrophil elastase to stimulate goblet cell degranulation
and mucus hypersecretion in other species (Agusti el al., 1998) might indicate just
one potential role for neutrophil elastase in the genesis of airway obstruction in
equine COPD (Robinson et al., 1996). Of particular note is the recent demonstration
that neutrophil elastase stimulates a time-dependent increase in mRNA expression of
the major human respiratory mucin gene, MUC5AC in human bronchial epithelial
cells (Voynow et al., 1999). Indeed, it was a cross-reacting antibody to human
MUC5AC protein, which was used by Jeffcoat et al. (1998) and in our own work
(A.J. Kemmish, T.J. Brazil and S.D. Carrington, unpublished observations) to
demonstrate increased mucin levels in the airways of horses with experimentally-
induced COPD.
252
The current study is also the first to document increased concentrations of the potent
neutrophil chemoattractant cytokine, IL-8 (Baggiolini and Clark-Lewis, 1992;
Baggiolini et al., 1994) in the BALF of COPD-susceptible horses following
hay/straw challenge (Section 6.2.4 and Figure 6.9). The increase in IL-8 at 5 h is
consistent with IL-8 production as a contributing signal for local neutrophil
accumulation (Baggiolini et al., 1994). Moreover, this finding supports the
hypothesis based on in vitro data, that proposed a switch in alveolar macrophage
function from a primarily phagocytic role to an enhanced secretory role, producing
increased levels of the neutrophil chemotactic cytokines IL-8 and MIP-2 in the
pathogenesis of the pulmonary neutrophilia observed in equine COPD (Franchini et
al., 1998). Although the initial kinetics of IL-8 production closely matched those of
the pulmonary neutrophilia, with a peak at 5 h and a decline thereafter (Figure 6.9),
further work is necessary to answer several fundamental questions regarding these
data. Firstly, the differential between baseline concentrations of IL-8 (when BALF
neutrophil numbers were minimal) and those measured at 5 h (peak BALF neutrophil
response), although significant, was surprisingly small. Secondly, the concentrations
of IL-8 detected in BALF at baseline in the current study (145.2 ng/ml, 61.9-615.4
ng/ml; median and range), despite seeming quite high, are similar to those detected in
BALF from both normal and other COPD-susceptible horses whilst in remission (Dr
M. Francini, personal communication). However, the concentrations of IL-8 protein
in BALF were substantially (50-fold) higher than those measured by specific ELISA
in the BALF of high-risk human patients who progressed to develop ARDS
(Donnelly et al., 1993). The apparently biphasic release of IL-8 detected in equine
BALF is not without precedent with messenger RNA expression in isolated bovine
alveolar macrophages showing a biphasic pattern following LPS stimulation, with
peaks at 1-2 and 16-24 h (Lafleur et al., 1998). Furthermore, in other species,
neutrophils themselves are a significant source of IL-8 that may serve to amplify the
inflammatory response by recruiting more neutrophils (Baggiolini et al., 1994).
Further detailed investigation of IL-8 production, kinetics and biological activity in
the horse is required to address these apparent discrepancies.
Physical mechanisms such as mucociliary clearance and coughing undoubtedly
provide an important route for expulsion of at least part of the neutrophil load within
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the inflamed lungs (Boggs, 1967; Nicod, 1999). External monitoring of radiolabeled
neutrophils during the investigation of lung inflammation has often shown evidence
of neutrophil movement up the conducting airways, which are subsequently
swallowed and observed within the stomach (Haslett et al., 1989c; Jones et al.,
1997). Furthermore, in the current study, tracheal secretions collected immediately
after challenge (5 h) were greatly increased in volume and contained massive
numbers of neutrophils (T.J. Brazil, unpublished observations).
However, over the last 10 years an ever increasing body of literature has
accumulated to provide compelling evidence that apoptosis of neutrophils with
subsequent clearance by both macrophages and other "semi-professional"
phagocytes also plays a crucial and perhaps primary role in the resolution of
neutrophilic inflammation in vivo (Haslett, 1997; Savill, 1997a; Savill, 1997b). It
would now appear that this pathway from apoptosis of neutrophils, through
recognition and engulfment of intact cells by macrophages to complete degradation
of the neutrophil's component parts, may represent the normal and physiological
("intended") fate of neutrophils reaching the end of their functional lifespan at sites
of inflammation. Light and electron microscopic evidence of this process has been
reported in inflammatory diseases of the kidney (Savill et al., 1992), joints (Spiggs et
al, 1978; Savill et al., 1989b), gut (Whyte et al., 1997), peritoneal cavity (Sanui et
al., 1982) and lungs (Grigg et al., 1991; Cox et al., 1995; Matute-Bello et al., 1997;
Lawson et al., 1998a; Pryjma et al., 1999) in man and experimental animals. Also,
the onset of neutrophil apoptosis in oleic acid-induced lung injury in rats correlates
with general histological evidence of its resolution (Hussain et al., 1998). This
author has recognized both free apoptotic neutrophils, and resident macrophages that
appeared to have phagocytosed apoptotic neutrophils, in cytological specimens from
a variety of naturally occurring, septic and non-septic, inflammatory disorders of the
joints, peritoneal cavity, uterus and lungs of the horse (T.J. Brazil, unpublished
observations).
In the current study, detection of small numbers of apoptotic neutrophils and ENE
2A positive alveolar macrophages (mean 0.2%) in BALF collected whilst the horses
were in clinical remission, suggests that this may be an ongoing physiological
process to scavenge effete neutrophils, even during periods of relative pulmonary
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health. Small numbers of alveolar macrophages (mean 0.27%) containing apoptotic
neutrophils were also found by Cox et al. (1995) in normal Sprague-Dawley rats and
in BALF (0.6%) from normal rabbits (Lawson et al, 1998a).
The morphological evidence presented in Section 6.2.5 clearly demonstrated that
apoptosis and macrophage phagocytosis of neutrophils is a prominent feature in the
resolution of the inflammatory process observed in equine COPD. The light and
electron microscopic features were very similar to those observed in human neonatal
respiratory distress syndrome (Grigg et al., 1991) and ARDS (Matute-Bello et al.,
1997) and in lung injury induced experimentally with intratracheal LPS (Cox et al.,
1995) or intravenous oleic acid (Hussain et al., 1998) in rats. Also the morphology
of non-ingested apoptotic equine neutrophils observed in vivo appeared identical to
that of neutrophils aged in vitro (Section 4.2.1.1).
As discussed earlier, the kinetics of BALF neutrophil recruitment and clearance
reported herein were similar to those reported for LPS- (Cox et al., 1995) and oleic
acid-induced (Hussain et al., 1998) lung injury in rats and bacterial pneumonia in
rabbits (Lawson et al., 1998a); models in which the contribution of neutrophil
apoptosis and macrophage phagocytosis to the resolution of pulmonary neutrophilia
have been investigated in some detail. However, some differences are noteworthy in
the context of the current kinetic data. In the equine COPD model, BALF neutrophil
numbers were greatest at 5 h (the end the challenge period), whereas in the rabbit
pneumonia model (Lawson et al., 1998a) and following intratracheal administration
of LPS or intravenous administration of oleic acid in the rat, neutrophil numbers
were maximal at 12, 18 and 24 h, respectively. In all four models however, a wave
of apoptotic neutrophils began to appear 4-12 h after the onset of the inflammatory
response and peaked at 24 h. In the oleic acid model, apoptotic neutrophils detected
by TUNEL constituted nearly 40% of total BALF cells and almost 60% of the
neutrophil burden at 24 h (Underwood et al., 1995). In the LPS model, where
apoptotic neutrophils were identified by typical morphologic features on Diff Quik-
stained slides, these cells accounted for only 1.8% of total neutrophil numbers at 24 h
(Cox et al., 1995), a similar proportion to that found in equine BALF at 24 h (Figure
6.1 lb). Numbers of apoptotic neutrophils in the pneumonia model were intermediate
(7.3%). The large numbers of apoptotic neutrophils detected by TUNEL probably
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reflects the possibly higher sensitivity and much lower specificity of this technique in
comparison to simple light microscopic assessment (Labat-Moleur et al., 1998).
These data suggest that neutrophils that undergo apoptosis in vivo are most likely
recognized very rapidly after the onset of apoptosis, and perhaps more critically, that
to prevent leakage of their noxious contents in the post-apoptotic phase, a large
neutrophil burden can be recognized and cleared extremely efficiently by local
macrophages. This hypothesis assumes that few neutrophils proceed from apoptosis
to secondary necrosis whereupon they are no longer identifiable. However, the lack
of cytologically detectable cell debris after hay/straw challenge and the very high
BALF cell viability as assessed by trypan blue exclusion, would suggest that necrosis
of neutrophils in situ is a very rare event in equine COPD.
The apparently abrupt switch from recruitment and activation of neutrophils to
apoptosis and clearance raised the question as to whether this simply reflected
neutrophils reaching the end of their useful life in the airways or was an event
orchestrated by some fundamental change in the local mediator profile. The latter
explanation has been hinted at by studies with the anti-inflammatory cytokine IL-10.
Interleukin-10 attenuates the anti-apoptotic (survival) effect of LPS in human
neutrophils in vitro (Cox, 1996; Keel et al., 1997) and pre-treatment of mice with IL-
10 significantly reduced the neutrophilic response to intratracheal LPS at time points
beyond 18 h, suggesting that it facilitated neutrophil clearance (Cox, 1996). In light
of the important inhibitory role of some cytokines produced by alveolar macrophages
in the regulation of neutrophil apoptosis (Herlihy et al., 1996; Matute-Bello et al.,
1997), a recent report of a potent inhibitory effect of hrIL-10 on the production of
pro-inflammatory cytokines by LPS-stimulated equine peritoneal macrophages
(Hawkins et al., 1998) offers an exciting new avenue of investigation in equine
neutrophil biology.
Further evidence for directed neutrophil apoptosis in vivo has come from reports of
pro-apoptotic activity in human synovial fluid (Bell et al., 1995) and pneumonic
rabbit BALF (Lawson et al., 1998b) collected during the resolution phase of an acute
inflammatory response. Although, the arz/7-apoptotic effect of BALF fluid collected
from horses during the rapid phase of neutrophil clearance would tend to rule out the
presence of dominant anti-inflammatory factors, their expression may be short lived.
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Collection of BALF at time points between 5 and 24 h after hay/straw challenge of
horses would help to address this question.
The use of a highly specific immunological marker for equine neutrophils (ENE 2A)
permitted accurate and sensitive quantitation of macrophages containing neutrophil
remnants at each timepoint. ENE 2A immunostaining also complemented
observations from Diff Quik-stained preparations suggesting that degradation ensued
rapidly following phagocytosis of intact cells. Cox et al. (1995) reported that
histochemical staining of alveolar macrophages for peroxidase activity was almost
seven times more sensitive for the detection of intracytoplasmic neutrophil remnants
than examination of Diff Quik-stained specimens. However, in that study many
peroxidase positive cells had only very diffuse staining, precluding any assertion that
this originated from degradation of cells ingested intact. In the current study,
alveolar macrophages were only scored as positive if ENE 2A staining was
associated with condensed nuclear material or formed tight clusters consistent with
engulfment of an entire cell.
Data from interactions between monocyte-derived macrophages and aged neutrophils
suggest that recognition and phagocytosis of the apoptotic cells is a rapid event,
occurring within minutes of their co-incubation (Newman et al., 1982), with ingested
neutrophils being no longer recognizable as such by 1 h (Haslett, 1992). Studies of
apoptosis in other cell types confirm the rapidity with which they are eliminated; for
example, rat hepatocytes become histologically undetectable within 3 h (range 139-
226 min) of induction of apoptosis in vivo (Bursch et al., 1990). Although formulae
are available for the calculation of rates of cell loss by apoptosis in solid organs such
as the liver (Bursch et al., 1990), they should be applied with caution to the dynamic
environment of the airways. Without taking macrophage trafficking into account,
with such rapid degradation of cells even a very low point prevalence of pulmonary
neutrophil apoptosis (either free or newly ingested by macrophages) may equate to a
very large capacity for neutrophil elimination.
The kinetics of ENE 2A positive macrophages and their close temporal association
with neutrophil disappearance from the airspaces was almost identical to the models
described earlier (Cox et al., 1995; Underwood et al., 1995; Lawson et al., 1998a)
and to an early study of "neutrophil-phagocytosing macrophages" in a guinea pig
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model of self limiting peritonitis (Sanui et al., 1982). This early study by Sanui and
colleagues (1982) also suggested that macrophage clearance might have an ongoing
role in more chronic inflammation. A second pulse of neutrophils induced by re-
injection of peritoneal irritant was followed by a second wave of phagocytosing
macrophages that cleared the neutrophil influx over a similar time course.
These data offer a persuasive case for macrophage clearance of redundant
neutrophils (without exacerbating the inflammatory response (Meagher et al., 1992),
as an almost obligatory step in the successful resolution of an acute inflammatory
response irrespective of stimulus or anatomical site (Savill, 1997a). Moreover, a
similar paradigm is recognized in the resolution of eosinophilic airway inflammation
in experimentally sensitised mice (Kodama et al., 1998) and human asthma (Woolley
et al., 1996).
Although the current study has focussed on the regulation of the potentially
deleterious effects of the neutrophil, much evidence suggests that in fact, the
macrophage may be the critical control point in the successful resolution of the
inflammatory process. It is well recognized that increased numbers of alveolar
macrophages is associated with increased survival in humans with acute lung injury
(Pittet et al., 1997). Blocking macrophage phagocytosis in vivo in the guinea pig
peritonitis model greatly prolonged local neutrophilia (Sanui et al., 1982). Even
more persuasively, in experimental murine pneumonia, depletion of alveolar
macrophages in vivo, despite slowing neutrophil recruitment, also causes a more
prolonged neutrophil response, with reduced bacterial clearance, exaggerated lung
injury and increased mortality (Kooguchi et al., 1998). A recent study of children
prone to recurrent respiratory infections reported less efficient phagocytosis of
a^optotic neutrophils by their alveolar macrophages in vitro, both in the presence and
absence of active infection in comparison to both normal and asthmatic children
(Pryjma et al., 1999).
The seminal studies by Newman et al. (1982) demonstrating that the "age" of a
neutrophil was critical for it to be recognized by macrophages, gave an initial
indication that macrophage phenotype was also critical in this mechanism. They
showed that monocyte-derived macrophages and inflammatory lung macrophages
readily phagocytosed senescent neutrophils but resident alveolar macrophages did so
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only very poorly. More recent in vitro studies have demonstrated that maturation of
monocytes into macrophages with the capacity for neutrophil clearance, represents a
distinct macrophage differentiation pathway (Henson and Riches, 1994). Also the
very signals that promote neutrophil recruitment and activation and retard their
progression to apoptosis such as GM-CSF and IL-1(3 also potentiate macrophage
phagocytosis of apoptotic neutrophils (Ren and Savill, 1995). A further indication
that resolution of the inflammatory response encompasses a complex network of
interactive negative feedback loops, comes from data showing that in contrast to
other particles, the engulfment of apoptotic neutrophils not only fails to elicit release
of pro-inflammatory enzymes, cytokines and thromboxanes (Meagher et al., 1992;
Savill, 1997a; Liu el al., 1999) but also actively downregulates further production of
pro-inflammatory cytokines such as TNF-a and IL-8 by macrophages (Fadok et al.,
1998).
In conclusion, these data provide the first in vivo evidence of a pivotal role for
neutrophil priming, recruitment and activation with subsequent apoptosis and
macrophage clearance in the genesis and resolution of the lung inflammation and




It is clear from studies in human neutrophils that to accurately model neutrophil
function in vitro requires careful preparation and handling of cells throughout the
experimental protocol. It was indeed serendipitous that a neutrophil isolation method
capable of producing populations of human neutrophils with high purity and minimal
cell priming proved to be similarly valuable for the isolation of equine neutrophils.
Great care was taken to collect and prepare equine neutrophils in such a way to avoid
cell trauma or contamination with even trace amounts of LPS that might cause
neutrophil priming. Freshly isolated equine neutrophils prepared in this way showed
minimal cell shape change. Although subsequent experiments suggested that, at least
in vitro, functional priming was not invariably associated with shape change (e.g.
LPS), the lack of shape change in freshly isolated equine neutrophils lent support to
the choice of isolation method. Assessment of basal (unstimulated) CL activity in
freshly isolated neutrophils further suggested that cell function was minimally
perturbed during purification. The discovery that in equine neutrophils, priming
appeared to be a prerequisite for functional coupling of fMLP receptors, permitted
the fMLP-stimulated Luci-DCL response of freshly isolated cells to be used as a gold
standard to confirm the absence of priming during cell preparation.
The fMLP-stimulated Luci-DCL response of equine neutrophils was also invaluable
in the characterization of their priming by inflammatory mediators (such as LPS,
PAF and TNF-a). Recognition that exposure of equine neutrophils to a variety of
pro-inflammatory mediators greatly enhances their subsequent secretagogue-induced
respiratory burst activity and is likely to have profound effects on their sequestration
in the microvasculature in vivo, has great implications for the future investigation of
equine inflammatory disease pathogenesis.
Circulating lipopolysaccharide or endotoxin is perceived to be central to the
pathogenesis of many life-threatening equine diseases, particularly gastro-intestinal
obstruction and/or mucosal inflammation, pulmonary infection and acute
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endometritis; all diseases with high mortality even in the face of aggressive
antibacterial, anti-inflammatory and supportive therapy. It is important to note that
in comparison to other mammals, the horse appears to be exquisitely sensitive to the
biological effects of LPS in vivo. The lethal intraperitoneal dose of LPS in the horse
(on a mg/kg basis) is some 20-fold lower than in laboratory animals such as rats,
mice, guinea pigs and rabbits (Berczi et al., 1966; Burrows, 1981). The
complimentary role of plasma lipolysaccharide binding proteins and CD 14 in the
recognition of LPS by cells leading to transmembrane signaling is now thought to be
central to the pathogenesis of endotoxaemia and septic shock. The enhanced
sensitivity of equine neutrophils to LPS priming in the presence of serum (either
equine or human) demonstrated in the current study suggests that a similar
LBP/CD14 paradigm may be equally important in the horse. Further investigation of
the cellular pathophysiology of LPS exposure should be an urgent imperative in
equine cell biology research.
The current study provides the first detailed evidence that equine neutrophils undergo
constitutive apoptosis when aged in culture. Ageing equine neutrophils developed
the archetypal features of nuclear condensation, chromatin fragmentation and plasma
membrane phospholipid redistribution recognized in many apoptotic cell types
including human neutrophils. Furthermore, the constitutive rate of apoptosis in
equine neutrophils can be profoundly altered by exposure to some of the pro¬
inflammatory mediators that are likely to be active during inflammation in vivo and
which I had previously characterized as priming or activating agents of equine
neutrophil function in vitro. The marked inhibition of constitutive apoptosis
mediated by glucocorticosteroids in both human (Meagher et al., 1996) and equine
neutrophils indicated the capacity that pharmacological intervention may have for
modulation of neutrophil longevity and hence function in vivo. Indeed, the
contrasting, />ro-apoptotic effect of glucocorticosteroids on human eosinophils in
vitro has been reported to be, at least in part, responsible for the resolution of airway
inflammation in human asthmatics treated with corticosteroids (Woolley et al.,
1996). The apparent discrepancy, in terms of both the time- and concentration-
dependence of the anti-apoptotic effect of dexamethasone, between the two species'
neutrophils remains unexplained but is worthy of further study.
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Two other findings from these in vitro studies of apoptosis in equine neutrophils are
worthy of particular note. Firstly, the pro-apoptotic effect of LPS was entirely
unexpected. This effect was shown to be concentration-dependent and independent
of autocrine TNF-a activity. Although preliminary characterization suggested that
this was a novel species variation, further work will be necessary to confirm these
data. One can speculate upon the evolutionary advantage of such a pro-apoptotic
effect in a species so profoundly sensitive to the biological effects of endotoxin.
Perhaps the induction of apoptosis in equine neutrophils following interaction with
LPS prevents additional neutrophil-mediated host tissue damage. The often severe
neutropaenia associated with acute equine endotoxaemia in vivo (Moore and Barton,
1999) may in part be mediated by early removal of neutrophils in much the same
way as has been suggested for the induction of eosinopaenia following corticosteroid
therapy in vivo (Meagher et al., 1996). Such a response undoubtedly has
consequences for efficient antimicrobial defence as evidenced by the propensity for
persistently clinically endotoxaemic horses to develop secondary sepsis associated
with jugular thrombophlebitis and surgical incisions. As stated above, these
contentions remain speculative and await further study of both the complex
pathophysiology of equine endotoxaemia and the effects of LPS on equine
neutrophils.
The second interesting finding was the marked pro-apoptotic stimulus provided by
phagocytosis of immunoglobulin-coated ovine erythrocytes. The obvious question
arising from this data is "what would be the effect of phagocytosis of pathogenic
bacteria?" Certainly phagocytosis of opsonised E. coli provides a similar pro-
apoptotic signal for human neutrophils (Watson et al., 1996b). The effect that
phagocytosis of the causative agents of important equine bacterial infections (such as
Streptococcus equi) may have on equine neutrophil apoptosis might provide useful
information in the investigation of bacterial pathogenicity.
The in vitro studies discussed above serve to initiate understanding of the potential
for fine tuning of neutrophil function by cell priming, activation and apoptosis in
maintenance of the delicate balance between appropriate and efficient microbicidal
activity and host tissue injury. The experimental techniques developed during the
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first phase of the project helped to provide answers to several of the fundamental
questions regarding neutrophil function in vivo in equine COPD as initially proposed
in Section 1.8.
Serial study of the fMLP-stimulated Luci-DCL response of peripheral blood
neutrophils suggested that these cells become primed in the circulation, in response
to hay/straw challenge of COPD-susceptible horses. Simultaneous reduction in the
rate of constitutive apoptosis of peripheral blood neutrophils supports in vitro studies
linking neutrophil priming and longevity (Lee et al., 1993). Whether these effects
are due to release of neutrophil priming agents into the circulation or a consequence
of cells trafficking through inflamed/activated pulmonary microvasculature or a
combination of these potential sources of pro-inflammatory mediators, remains
unknown. It was not possible to assess either the priming capability or effects on
neutrophil apoptosis of serum collected during the genesis and resolution of the
induced disease, but such experiments would yield valuable data.
The current hay/straw challenge studies confirm that neutrophil recruitment to the
airways is the key cytological feature of the pulmonary inflammation in equine
COPD. Concurrent serial assessment of BALF cell CL demonstrated for the first
time that the respiratory burst activity of cells resident in the airspaces was markedly
enhanced following hay/straw challenge and agonist-stimulated Lum-DCL responses
suggested that recruited neutrophils were responsible for much of this enhanced
oxidative activity. Notwithstanding the difficulties inherent to the interpretation of
agonist-stimulated Lum-DCL data in mixed BALF cell populations in vivo that were
discussed in Chapter 6, these data suggest that neutrophils recruited to the airspaces
are functionally upregulated.
The BALF cell CL data clearly demonstrates the difficulty in drawing a clear line
between priming and activation of neutrophils in vivo. The markedly increased basal
Lum-DCL of BALF cells harvested from 3/6 horses at 5 h suggests that neutrophils
were activated in the airspaces in vivo. The detection of large amounts of neutrophil
elastase in BALF supernatant after challenge would support this. However, since
BALF cells were capable of generating significant agonist-stimulated CL ex vivo, it
would be reasonable to conclude that at least some of the neutrophils or indeed some
of their oxidant generating pathways remained in a primed state with the capacity to
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produce an enhanced response upon subsequent secretagogue activation. These
arguments are difficult to conclude but may be rationalised by hypothesising that the
airspace neutrophil burden is composed of sub-populations of cells with a spectrum
of priming/activation states. This hypothesis could be tested by cell-by-cell analysis
of basal and agonist-stimulated respiratory burst activity of purified BALF
neutrophils in a flow cytometry assay (Chollet-Martin et al., 1992). This, of course,
presumes that methods can be developed to purify equine BALF neutrophils without
altering their functional status. However, it is clear that at least some neutrophils
undergo a respiratory burst and degranulate within the airspaces and this evidence
only strengthens the case for neutrophils and their products being central to the
pathogenesis of the lung injury observed in equine COPD.
As ever in equine research, the significance of these functional data could be
strengthened considerably by the inclusion of more animals in the study population.
Moreover, heterogeneity amongst the responses of different COPD-susceptible
horses to hay/straw challenge could be more clearly recognized. A particular
disappointment in this study was that, due to financial constraints, it was impossible
to include a group of healthy control animals. Previous studies from this laboratory
have reported that a similar 5 h hay/straw challenge protocol did not induce lung
dysfunction or BALF neutrophilia in healthy control animals (McGorum et al.,
1993d). However, comparison of the effects of hay/straw challenge on both BALF
cell and in particular, peripheral blood neutrophil CL activity with a control
population would have greatly increased the strength of the current data, wherein
conclusions were reliant upon comparison with cell function whilst COPD-
susceptible animals were in remission.
A significant feature of the BALF cell kinetics after hay/straw challenge was the
rapidity with which the pulmonary neutrophil burden was cleared after the 5 h
challenge period. Although the relative importance of potential neutrophil clearance
routes cannot be derived from the current data, this study does substantiate a
significant role for neutrophil apoptosis and macrophage clearance in the resolution
of equine pulmonary inflammation in vivo. Light microscopic,
immunohistochemical and ultrastructural examination of BALF cells confirmed that
alveolar macrophages ingested apoptotic neutrophils in vivo. The appearance of
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increased numbers of ENE 2A positive alveolar macrophages as BALF neutrophil
numbers declined was striking, in spite of the net reduction in BALF alveolar
macrophage numbers for at least 7 days after challenge. The eventual fate of the
ingested and degraded neutrophil components is unclear. Although the precise
nature of macrophage trafficking through the airways is as yet unknown, it is
tempting to speculate that having ingested effete neutrophils, alveolar macrophages
migrate from the airways, possibly to draining lymph nodes as suggested by
experimental models of peritonitis and glomerulonephritis in rodents (Lan et al.,
1993; Bellingan et al., 1996).
Corticosteroid therapy significantly attenuates both airway dysfunction and
inflammation (as evidenced by a reduction in BALF neutrophil counts) in
symptomatic COPD horses (Rush el al., 1998a; Rush et al., 1998b). In light of the
promotion of phagocytosis of apoptotic neutrophils afforded by exposure of
macrophages to glucocorticoids in vitro (Liu et al., 1999), it would be fascinating to
monitor BALF neutrophil apoptosis and macrophage clearance following
corticosteroid therapy of COPD-affected horses.
During this study it has become clear that alveolar macrophages may in fact be
pivotal to the initiation, amplification and not least the resolution of the pulmonary
inflammatory response in equine COPD. Already some progress has been made in
defining the cytokine profile of activated equine alveolar macrophages (Franchini et
al., 1998) and as recently developed primers for quantitation of equine cytokine
mRNA (Giguere and Prescott. 1999) become more widely available, the undoubtedly
complex array of cytokines involved in equine inflammation will begin to be
unravelled. In the mean time, investigation of equine alveolar macrophage
recognition of apoptotic neutrophils in vitro would be a valuable endeavour.
Although the results of this study have served to increase understanding of neutrophil
function in equine COPD, assessment of the precise role of the neutrophil in the
pathogenesis of airway dysfunction in equine COPD is beyond the scope of the
current study. However, these data do suggest that the residence of neutrophils in the
airways (approximately 4 days) may be temporally associated with the duration of
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airway hyperresponsiveness (at least 3 days; Fairbairn et al. 1993a, but less than 7
days; Derksen et al. 1985a) induced by a single short-term hay/straw challenge.
The associations between inflammatory cell function and airway dysfunction are
complex. If their effects were solely related to release of typically short-lived
histotoxic agents, correlations between airway dysfunction and the presence of
neutrophils or their secretory products might be more easily appreciated. Not only
can granulocytes also generate lipid mediators and chemokines, with the ability to
both recruit other inflammatory cells and activate resident airway cells, but the action
of histotoxic neutrophil products on host tissues may produce further pro¬
inflammatory molecules. This interplay leads to amplification of the inflammatory
changes beyond those caused by the any single cell type or mediator alone (reviewed
in Sections 1.3.3, 1.6 and 1.7). Thus proof of a direct causative relationship between
inflammation and airway dysfunction continues to elude clinical researchers even in
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Abstract: The synthetic formylpeptide fMLP is
widely used as a model chemoattractaiit ami secre¬
tagogue for mammalian neutrophils. Despite pos¬
sessing fMLP receptors, equine neutrophils do not
produce superoxide anions in response to IMLP
and there is no inflammatory reaction in the horse
when fMLP is injected intradermally. The func¬
tional capability of these receptors was investigated
after pretreatment with recognized priming agents.
Purified neutrophils were pretreated with lipopoly-
saccharide (LPS), platelet-activating factor (PAF),
or tumor necrosis factor a (TNF-a) and superoxide
anion generation and shape change quantified by
lucigenin-dependent chemiluminescence (LDCL)
and flow cytometry, respectively. LPS, TNF-a, and
PAF pretreatment induced significant LDCL in
response to fMLP; similarly LPS pretreatment was
a prerequisite for fMLP-stimulated neutrophil polar¬
ization in response to fMLP. However, LPS failed to
induce fMLP-mediated ehemotaxis of equine neu¬
trophils. These data indicate that equine neutrophil
fMLP receptors are not vestigial as previously
thought hut can trigger both respiratory burst
activity and cell polarization responses after prim¬
ing. J. Leukoc. Biol. 63: 380—388; 1998.
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INTRODUCTION
Neutrophils play a pivotal role in the acute cellular response to
infection and injury and have evolved a series of unique
functions that facilitate both their recruitment to sites of
inflammation and their ability to destroy invading micro¬
organisms [1-4]. During the inflammatory process, however,
inappropriate or excessive secretion of histotoxic or pro¬
inflammatory substances by the neutrophil can contribute to
host tissue damage [1-4], and this sequence of events is also
recognized in the horse [5, 6], In many species the responsive¬
ness of granulocytes to secretagogue stimuli is governed by
prior exposure to priming agents such as bacterial products
[e.g., lipopolysaccharide (LPS) and A-formylated peptides],
cytokines [e.g., tumor necrosis factor a (TNF-a) and granulocyte-
macrophage colony-stimulating factor (GM-CSF)], and lipid-
derived mediators [e.g., platelet-activating factor (PAF) and
leukotriene B4]. Such agents sensitize the neutrophil to en¬
hance certain functional responses, e.g., superoxide anion
generation, adhesion, and proteolytic enzyme release when
subsequently exposed to secretagogue agonists [7—12], In
addition, neutrophil priming is thought to be crucial to the
initial recruitment of these cells to an inflamed site [13] and
appears to be a prerequisite for neutrophil-mediated host tissue
damage [14. 15],
The synthetic tripeptide, A-formyl-methionyl-leucyl-phenyl-
alanine (fMLP), which mimics the effects of a number of
bacterial cell wall-derived peptides, is recognized by specific
high-affinity receptors on the neutrophil [16] and has been
widely used as a model agonist for studying the response of
mammalian neutrophils to bacterial infection, sepsis, and
tissue injury [16]. The large and consistent nature of the
secretory and chemotactic response induced by fMLP in human
cells has also made it the agent of choice in studies exploring
the mechanisms underlying priming and activation. However,
despite possessing a small number of seemingly identical
high-affinity fMLP receptors [17], equine neutrophils appear to
display a very different pattern of responses to this agent, to the
extent that most recent reports have regarded the equine fMLP
receptor as being of little, if any, functional significance
[18-20]. This conclusion is supported by the lack of any
inflammatory response when fMLP is injected intradermally in
the horse even at concentrations as high as 10 mM per 100 pL
180 Journal of Leukocyte Biology Volume 63. March 1998
injection volume [21]. Despite this, a small and selective
number of early in vitro studies reported fMLP effects in equine
neutrophils, including induction of chemotaxis, albeit only at
very high fMLP concentrations [22], and lysosomal enzyme
release [17]. Although Snyderman and Goetzl [23] stated that
fMLP could induce superoxide anion generation in equine
neutrophils, no experimental data were provided to support
this. Hence, although inter-species differences have been
demonstrated in studies of inflammation in the horse [20, 24],
the precise function and role of the fMLP receptor in equine
neutrophils remains uncertain. In view of both the importance
of bacterial endotoxemia to the pathogenesis of many equine
diseases [4, 5, 25], and the relative lack of information
regarding the effects of LPS on equine neutrophils, we have
chosen to examine the functional effects of this and other
human granulocyte priming agents on the equine neutrophil.
These studies (1) provide clear evidence ol fMLP-receptor-
mediated superoxide anion generation and cell polarization in
equine neutrophils after LPS incubation and (2) suggest that the
underlying mechanism for LPS priming in these cells is similar
to that documented in other mammalian cells because the
sensitivity to LPS is enhanced in the presence of serum and
hence likely to be mediated by the LPS-binding protein
(LBP)/CD14 pathway. This study permits a greater understand¬
ing of the interaction of LPS with equine neutrophils and
indicates the potential for fMLP-like peptides to induce equine
granulocyte activation via functional fMLP receptors. This
model should also permit assessment of the importance of
neutrophil priming to the recruitment and function of these
cells at inflamed sites.
MATERIALS AND METHODS
Reagents
Bovine serum albumin (BSA), Dextran T500, fMLP, glutaraldehyde, LPS from
Escherichia coli serotype 0111:B4, Hanks' balanced salt solution (HBSS),
lucigenin (bis-/V-methylacridinium nitrate), /V-2-hydroxyethylpiperazine-/V'-2-
ethanesulfonic acid (HEPES) buffer, and phosphate-buffered saline with (PBS)
or without (PBS w/o) 0.9 mM CaCl2 and 0.5 mM MgCl2, PAF, and zymosan were
purchased from Sigma (Poole, Dorset, UK). Sodium citrate (3.8%) was
purchased from Phoenix Pharmaceuticals Ltd. (Gloucester, UK) and the
silicone oil F-50 was obtained from Croylek Ltd. (Surrey, UK). TNF-a was
purchased from Genzyme, (Cambridge, MA). Percoll was obtained from
Pharmacia (Uppsala, Sweden). [,5H]fMLP [specific activity 1.48-3.219 TBq
(40—87 Ci)/mmol] was purchased from New England Nuclear Life Science
Products (Stevenage, Herts, UK). Diff-Quik was purchased from B. M. Brown
Ltd. (Reading, Berks, UK). All other chemicals were of molecular or reagent
grade and were obtained from BDH (Leicestershire, UK). Autologous heat-
inactivated serum was prepared by the addition of 220 pL of 10 mM CaCl2 to 10
mL of platelet-rich plasma, incubating for 90 min at 37°C in a humidified 5%
CO2 atmosphere, then heating at 56°C for 30 min. Zymosan-activated plasma
(ZAP) was used as a source of the complement fragment C5a and was produced
by adding 5 mg/mL zymosan to platelet poor plasma (PPP), followed by
sonication and incubation at 37°C for 60 min. The suspension was centrifuged
at 1,400 g for 15 min. The supernatant was removed and stored in 100 pL
aliquots at —20°C until required. ZAP was used in all experiments at a final
concentration of 10% (v/v).
Preparation of equine neutrophils
Blood was drawn from healthy adult horses by jugular venipuncture and
anticoagulated with 1 mL of 3.8% sodium citrate per 10 mL of blood in 50-mL
sterile polyethylene tubes. Thereafter three different methods [8, 26, 27] for
isolating equine neutrophils were compared. The methods of Jain et al. [26] and
Pycock et al. [27] both employed a single-step isolation technique with
discontinuous isotonic Percoll gradients (59 + 75 and 70 + 85% Percoll in
HBSS, respectively) and were used as originally detailed. The third technique
was a modification of a method originally described for isolating human
neutrophils which uses discontinuous hypotonic plasma/Percoll gradients [8].
In this method, whole blood was allowed to sediment under gravity for 30 min at
room temperature and the upper leukocyte-rich plasma layer aspirated and
centrifuged at 367 g for 6 min. The platelet-rich plasma supernatant was
decanted and centrifuged at 2400 g for 20 min to prepare PPP. The initial
leukocyte-rich pellet, obtained typically from 80 mL of whole blood, was
resuspended in 2 mL PPP in a 15-mL polystyrene tube and underlayered with
42 and 51% PPP/Percoll solutions before centrifugation at 255 g for 10 min.
Cytospins prepared after gradient centrifugation indicated that the majority of
the neutrophils accumulated in a tight band at the 42/51% Percoll interface
with the mononuclear cells held up at the upper, PPP/Percoll, interface. The
very small number of eosinophils present (2.5 ± 0.26% of total leukocyte yield)
settled in either the 51% Percoll layer or with the erythrocyte pellet.
Neutrophils were harvested from the 42/51% interface and washed sequentially
in PPP, PBS without Ca2+ Mg2+/0.1% BSA, and PBS before resuspension in
PBS. Subsequent experiments indicated that a more extensive wash protocol
(three extra washes in PBS without Ca2+ Mg24/0.1% BSA) was necessary to
reveal the true serum dependence of the mechanism of neutrophil priming by
LPS in equine neutrophils. All the procedures outlined were performed at room
temperature. Cell purity was assessed using cytocentrifuge preparations stained
with Diff-Quik; cell viability was assessed by trypan blue exclusion. In a
limited number of studies, human neutrophils were also employed and these
were prepared in an identical manner to that detailed above, with the exception
that citrated venous blood was allowed to sediment with 6% dextran T500 to
obtain the initial leukocyte-rich layer [8J.
Superoxide anion generation
Neutrophils were resuspended at 12.5 X 106 cells/mL in PBS and incubated in
a shaking waterbath at 37°C for 5 min before stimulation at predetermined
optimal times, with LPS (0.1-1000 ng/mL ± 1% serum for 30, 60, or 90 min),
PAF (100 nM, 10 min), or TNF-a (200 U/mL, 30 min). Basal and agonist-
stimulated superoxide anion generation was measured by lucigenin-dependent
chemiluminescence (LDCL) using a ML 3000 microtiter plate luminometer
(Dynatech Laboratories Ltd., Billingshurst, West Sussex, UK). Lucigenin (0.25
mM in PBS containing 1 mg/mL BSA) was added (100 pL) to each well and
allowed to equilibrate at 37°C for 15 min before the addition of 80 pL (1 X 106)
of freshly isolated cells. After a 5-min equilibration period, basal LDCL was
recorded over 12 min to ensure that the cells were not basally activated (stable
basal peak LDCL <0.005 RLU). After preincubation, 20 pL of buffer or fMLP
was added to triplicate wells and chemiluminescence recorded at 8-s intervals
for 5 min. This time course was extended to 60 min in experiments using ZAP.
Data were recorded and analyzed on-line (Cellular Chemiluminescence,
Dynatech Laboratories Ltd.) to produce mean peak and integral chemilumines¬
cence values from triplicate wells. All chemiluminescence data are presented
as integral (area under the curve) values unless otherwise stated.
Neutrophil shape change
Neutrophils (2 X 106 in 900 pL PBS) were incubated at 37°C in the presence or
absence of LPS (1 pg/mL) for 90 min in a shaking waterbath. Duplicate samples
were then incubated for 10 min with 100 pL buffer or 100 nM fMLP.
Incubations were terminated by the addition of an equal volume of 2.5%
glutaraldehyde. Shape change was quantified by flow cytometry (EPICS Profile
II, Coulter Electronics, Luton, Bedfordshire, UK) using a minor modification of
the method described by Cole et al. [28] as previously detailed [29]. Values
obtained for shape change using this analysis method correlate closely with
those obtained by direct light microscopic assessment of shape change, with the
exception that the flow cytometric method of assessment slightly overestimates
the extent of basal shape change [28].
Neutrophil chemotaxis
Neutrophils resuspended in PBS (3 X 106 cells/mL) were incubated with 1%
serum for 90 min in the presence or absence of LPS (final concentration 1
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TABLE 1. Comparison of Three Different Methods for Isolating
Equine Neutrophils from Peripheral Blood
Cell purity Cell viability Cell recovery
Isolation method (% ± SEM) (% ± SEM) (% ± SEM)
Jain et al., 1990 [25] 96.3 ± 2.4 98.0 ± 0.5 26.5 ± 2.6
Pycock et al., 1987 [26] 98.7 ± 0.6 97.7 ± 0.9 35.0 ± 4.7
Haslett et al., 1985 [8] 98.2 ± 0.3 99.3 ± 0.1 43.8 ± 2.6
Three previously published techniques for preparing equine [26, 27] and
human [8] neutrophils were compared. Cell purity was assessed morphologi¬
cally on fixed and stained cytospin preparations, cell viability by trypan blue
exclusion, and cell recovery by comparison of final yields measured using a
hemocytometer to automated Coulter counting of whole blood samples. Data
represent mean ± SEM of n = 4—15 separate experiments.
pg/mL) and chemotaxis assayed in a Neuroprobe 96-well chemotaxis chamber
(Porvair Filtronics Ltd.) incorporating a 5-pm pore size polycarbonate filter.
PBS (control), fMLP (0.01—1000 nM), or ZAP (10% v/v) were placed into the
lower wells (35 pL) and 225 pL of buffer or LPS-pretreated neutrophils added to
the upper wells. The chamber was incubated in a humidified 5% CO2
atmosphere at 37°C for 90 min. The filter was then removed, the upper surface
scraped with a cell scraper, washed with 0.9% saline, air dried, fixed, and
stained with Diff-Quik. Cell migration into, and retention within, the filter was
quantified by measuring the optical density of each well footprint at 500 nm in a
MR 5000 plate reader (Dynatech Laboratories Ltd., Billingshurst, UK).
[3H]fMLP binding to equine neutrophils
The [3H]fMLP binding assay was based on the method described by O'Flaherty
et al. [30]. In brief, neutrophils (12.5 X 106/mL) were pre-incubated for 90 min
in PBS plus 1% serum in the presence or absence of 1 pg/mL LPS then diluted
with an equal volume of ice-cold PBS containing 10 mM HEPES (pH 7.4),
centrifuged at 235 g for 6 min and resuspended at 5.26 X 106 cells/mL.
[3H]fMLP binding was performed by incubating 5 X 106 cells in the above
buffer at 4°C for 60 min with 0.0632, 0.2, 0.632, or 2 nM [3H]fMLP alone or 2
nM [3H]fMLP with sufficient fMLP to make up final ligand concentrations of
0.0632-6320 nM in half log dilution steps. Incubations were terminated by
centrifugation (10,000 g, 2 min, 4°C) through a 400-pL silicone oil cushion.
Aliquots (200 pL) of the supernatant and the isolated cell pellets were
transferred to scintillation vials; the pellets were incubated with 500 pL
methanol for 15 min and 4 mL of scintillation fluid was added to each sample
before scintillation counting. Data underwent Scatchard analysis using LI¬
GAND software [31], where the number of fMLP molecules bound per
neutrophil was calculated using Avogadro's constant and the picomoles of fMLP
bound per 5 X 106 cells.
Statistics
Results were expressed as means ± SEM values for (n) sets of separate
experiments. Data were analyzed using analysis of variance followed by the
Student-Newman-Keuls post test or by the Student's paired t test. Results were
considered to be significant with P values < 0.05. EC50 values were obtained
by analysis using Kaleidagraph (Macintosh) software.
RESULTS
Comparison of different methods for purifying
equine neutrophils
Table 1 shows the cell purity, viability, and recovery rates for
equine neutrophils isolated using the three different Pereoll
gradient methods outlined. The method of Haslett and co¬
workers [8] generated cells of consistent and high purity
(98.2 ± 0.3%) and superior cell viability and recovery
compared to the methods of Jain et al. [25] and Pycock et al.
[26]. This method was therefore chosen as the technique of
choice for the subsequent experiments. The method of Haslett
et al. [8] has also been shown to induce minimal priming and
shape change of human neutrophils and, in 12 sequential
neutrophil isolations from different horses, basal shape change
assessed by light microscopy was confirmed to be extremely low
at 2.9 ± 1.3%.
Induction of fMLP-induced superoxide anion
generation by neutrophil priming agents
Preliminary experiments were designed to characterize C5a-
stimulated LDCL in freshly isolated equine neutrophils to
facilitate subsequent assessment of fMLP-stimulated effects.
ZAP, a biological source of C5a, stimulated a large LDCL signal
(24.3 ± 5.8 RLU, n = 8), with the peak of superoxide anion
generation occurring between 20 and 25 min post-stimulation
(Fig. 1). The effect of ZAP was significantly enhanced by
pretreatment with 100 ng/mL LPS (147 ± 10%, n = 8, P <
0.01, Fig. 1). In contrast, incubation of neutrophils with 1 pM
fMLP did not stimulate superoxide anion release compared with
buffer-treated control cells (control, 0.2 ± 0.04 RLU; fMLP,
0.3 ± 0.1 RLU; n = 17, P > 0.05). After LPS priming,
however, a significant and rapid fMLP-induced respiratory
burst response was apparent (LPS + buffer, 0.4 ± 0.1 RLU;
LPS + fMLP, 2.4 ± 0.1 RLU, n = 8, P < 0.05, Fig. 1),
although this was less marked than that obtained with ZAP. Due
to the fast kinetics of this response, a more detailed time course
was examined (Fig. 2). This demonstrated a peak of superoxide
anion generation at 2 min after fMLP stimulation of LPS-primed
cells and again a lack of effect of fMLP in cells preincubated
with buffer alone. The optimum conditions for LPS priming
were then investigated.
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Fig. 1. Effect of LPS on ZAP- and fMLP-induced superoxide anion genera¬
tion. Equine neutrophils were incubated with PBS or 100 ng/mL LPS + 1%
serum for 90 min before addition of lucigenin and stimulation with PBS, 10%
v/v ZAP, or 100 nM fMLP. Lucigenin-dependent chemiluminescence (LDCL)
was monitored over a 60-min time period using a ML3000 microtiter plate
luminometer and expressed in relative light units (RLU). The LDCL signal
generated by PBS or LPS pretreated cells stimulated with PBS, and PBS
pretreated cells stimulated with fMLP was not significantly different to baseline
and hence these values have been omitted for clarity. Values represent means of






































Fig. 2. Time course of fMLP-stimulated superoxide anion generation. Time-
course of fMLP-stimulated LDCL after a 90-min pretreatment with PBS or 1
pg/mL LPS both performed in the presence and absence of 1% serum. Values
represent means ± SEM of triplicate measurements from three separate
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Fig. 3. Characterization of LPS enhancement of fMLP-stimulated superoxide
anion generation. LPS concentration-response curves for fMLP (1 pM) -stimu¬
lated LDCL after incubation with buffer or LPS (0.1—1000 ng/mL) in the
presence (circles) or absence (triangles) of 1% equine serum for (A) 30, (B) 60,




Fig. 4. Human serum also enhances LPS priming of equine neutrophils. LPS
concentration-response curves for 1 pM fMLP-stimulated LDCL in equine
neutrophils after a 30-min incubation with LPS (0.1—1000 ng/mL) in the
presence and absence of equine or human serum. Values represent means ±
SEM of three separate experiments.
be both time- and concentration-dependent (Fig. 3, A—C).
Addition of 1% serum significantly potentiated both the
temporal initiation of the primed fMLP response and the cells'
sensitivity to LPS (Fig. 3, A-C). In the presence of serum the
LPS-primed response was maximal by 60 min with a mean EC50
of 19.1 ± 4.7 ng/mL. However, in the absence of serum, a
90-min LPS incubation was required to achieve an equivalent
maximal response, albeit with the cells remaining less sensitive
to LPS (Fig. 3, A—C). It is interesting to note that the true serum
dependence of this effect in equine neutrophils was only
revealed after an extensive initial wash protocol, suggesting
that LBP or its equine equivalent is tightly adherent to equine
neutrophils.
LPS priming for enhanced superoxide anion generation in
human neutrophils is well recognized to be largely serum
dependent due to a requirement for LBP [32, 33] and these data
would suggest the involvement of a similar LBP/CD14 mecha¬
nism for LPS priming in equine neutrophils. Indeed we show
that human serum can substitute for equine serum in potentiat¬
ing the LPS priming of equine neutrophils (Fig. 4) and vice
versa (data not shown). The fMLP effect on superoxide anion
generation in LPS-primed neutrophils was also shown to be concen¬
tration dependent with an EC50 of 10.2 ± 3.9 nM (Fig. 5).
To examine whether LPS was unique in its ability to induce
functional coupling ol the 1MLP receptor in equine cells, the
effects of PAF and TNF-a were also investigated. Although,
compared to its effects in human cells [29], PAF appeared to
have a very weak priming effect, TNF-a induced a major
up-regulation of fMLP-induced LDCL (Fig. 6). However,
TNF-a treatment alone also stimulated a significant LDCL
response, indicating that this cytokine was acting as a secreta-
gogue in addition to its priming action (Fig. 6).
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Fig. 5. Concentration-response curve for fMLP-stimulated superoxide genera¬
tion in LPS-primed equine neutrophils. Equine neutrophils were pre-incubated
with PBS (open triangles) or 1 pg/mL LPS + 1% serum (filled circles) for 90
min before addition of lucigenin and stimulation with 0.01—1000 nM fMLP.
LDCL was determined over a 5-min period. Data represent mean ± SEM of
triplicate determinations from a single experiment representative of three
(mean maximal LDCL 9.9 ± 0.6 RLU).
Induction of fMLP-induced neutrophil shape
change by LPS
In contrast to the effects of ZAP (10%, v/v), which caused a
dramatic shape change response (96.3 ± 0.7% cells shape
changed, 10 min), freshly isolated equine neutrophils did not
polarize when exposed to 1 pM fMLP for the same period of
time (% shape change: control, 9.0 ± 1.5%; fMLP, 9.9 ± 1.9;
n = 4, P > 0.05). Likewise, incubation of cells with buffer
alone for 90 min did not influence this lack of response to fMLP
(% shape change: control, 12.9 ± 1.5%; fMLP, 16.8 ± 2.1; n =
Control LPS PAF TNF
Fig. 6. Priming of fMLP-stimulated superoxide anion generation by LPS, PAF,
and TNF-a in equine neutrophils. Equine neutrophils were pre-incubated with
LPS + 1% serum (1 pg/mL, 90 min), PAF (100 nM, 10 min), TNF-a (200 U/mL,
30 min), or PBS (90 min) before addition of lucigenin and stimulation with PBS
(open bars, left of pair) or 100 nM fMLP (filled bars, right of pair). LDCL was
recorded at 8-s intervals for 5 min. Peak values presented as means ± SEM of
three separate experiments, each performed in triplicate.
4, P > 0.05, Fig. 7). However, after treatment of cells with 1
pg/mL LPS for 90 min, fMLP induced a significant increase in
equine neutrophil shape change (% shape change: LPS 14.5 ±
3.8%; LPS + 1 pM fMLP, 29.4 ± 5.0%; n = 4, P < 0.05, Fig.
7) with an EC50 for fMLP of 1.9 ± 0.9 nM (data not shown). The
inability of fMLP to induce cell polarization in unprimed cells
is in marked contrast to its effects in human neutrophils, which
undergo a rapid and concentration-dependent shape change
response to this agent alone [29] (Fig. 7).
LPS fails to induce fMLP-mediated chemotaxis
in equine neutrophils
Analysis of chemotaxis data failed to demonstrate any chemo-
tactic response of unprimed equine neutrophils to 0.01-1000
nM fMLP (Fig. 8). In contrast to the above superoxide anion
generation and cell polarization data, pretreatment of equine
neutrophils with 1 pg/mL LPS for 90 min did not permit
fMLP-directed chemotaxis (Fig. 8). Positive control chemotaxis
data were obtained both in equine cells using ZAP (Fig. 8) and
human cells using fMLP (data not shown).
[3H]fMLP radioligand binding studies
To determine that the effect of fMLP was likely to be
receptor-mediated, radioligand binding studies were under¬
taken to quantify fMLP receptor number and affinity in equine
neutrophils and to examine the effects of LPS priming on
receptor expression.
Scatchard analysis of [3H]fMLP binding to equine neutro¬
phils demonstrated a single set ol high-affinity fMLP receptors
(A'd 9.3 X 10""11 M), with a mean of 660 ± 159 (n = 3) receptors
per cell (Fig. 9). This compares to data obtained in parallel
experiments in human neutrophils where Scatchard analysis
demonstrated a two-receptor site model with a mean of 36,000
low-affinity receptors (K,\ 3.2 X 10~8 M) and 2,100 high-affinity
receptors (A',| 9.2 X 10"10 M) per cell (n = 3), consistent with
previous reports [30]. After LPS priming (1 pg/mL, 90 min) of
equine cells, a similar single receptor site model fit was again
obtained (Ad 1.4 X 10_1° M), with a significant (P < 0.05)
2.5-fold increase in total receptor numbers to 1,400 ± 398 per
cell (n = 3; Fig. 9).
DISCUSSION
Although several methods for the isolation of neutrophils from
equine peripheral blood have been described [26, 27], no
comparison of these methods has been reported. The impor¬
tance of employing a neutrophil isolation technique that
produces a highly purified population of minimally primed cells
has been established as a crucial factor in studying neutrophil
natural biology in humans [8] but this factor has not been
previously addressed in equine leukocytes. The very high
erythrocyte sedimentation rate in the horse obviates the need
for the initial cell centrifugation and dextran sedimentation
steps required for the preparation of human cells. With this
modification, the method of Haslett et al. [8] allowed isolation of
a population of highly purified cells with minimal basal shape
change and LDCL generation, and a superior cell yield
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Fig. 7. Effect of LPS on fMLP-induced shape change. Equine or
human neutrophils were pre-incubated for 90 min with PBS or 1
pg/mL LPS before stimulation with buffer or 100 nM fMLP for 10
min. Representative flow cytometry histograms of glutaraldehyde-
fixed equine (left panels) and human (right panels) neutrophils are
shown (pre-incubation/stimulation conditions are indicated within
the panels). Data represent mean forward light scatter (*-axis)
plotted against cell number (y-axis). Similar data were obtained
from three additional experiments, each performed in duplicate.
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compared to the two isotonic HBSS/Percoll gradient methods
used. The high cell purity obtained is aided by the relatively
low numbers of eosinophils present in equine blood. Although
the extent of basal activation and/or priming was not directly
compared between the three isolation methods used, the high
viability values recorded for all three techniques and the
extremely low basal shape change and I.DCL values obtained
for the plasma/Percoll isolated cells suggest that basal activa¬
tion was minimal for all three preparative methods.
Lucigenin-enhanced chemiluminescence (LDCL) has been
Fig. 8. Inability of LPS to induce fMLP-stimulated chemotaxis.
Equine neutrophils were incubated for 90 min in PBS + 1% serum
in the presence (filled circles) or absence (open circles) of 1 pg/mL
LPS. Chemotaxis toward fMLP (0.01-1000 nM) or ZAP (10% v/v)
was assayed using a Neuroprobe 96-well chemotaxis chamber
incoiporating a 5-pm pore filter that was stained with Diff-Quick
before measurement of optical density. Data represent mean ± SEM
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Fig. 9. Scatchard analysis of [3H]fMLP binding to equine neutrophils. Equine
neutrophils were pre-incubated in bulk for 90 inin in PBS plus 1% autologous
serum in the presence (filled circles) or absence (open circles) of 1 pg/mL LPS
before assessment of [!H]fMLP binding as detailed in Materials and Methods.
Scatchard transformed data is shown where each point represents the mean of
three experiments each performed in triplicate.
used widely to study oxidative metabolism during phagocyte
respiratory burst activity [34, 35]. It is independent of myeloper¬
oxidase [34] and has been demonstrated to provide a sensitive
and selective measurement of extracellular superoxide anion
release [36]. Previous studies examining superoxide anion
generation in equine neutrophils using superoxide dismutase-
inhibitable reduction of cytochrome c suggested that freshly
isolated equine cells were unresponsive to fMLP. In light of the
absent, extremely weak, or inconsistent in vitro [17-19, 22, 35]
and in vivo [21] responses elicited by fMLP in the horse, the
lack of effect of fMLP on superoxide anion release in this
species was initially attributed to a lack of any fMLP receptor
coupling. Indeed we were unable to detect any chemotactic or
polarization response to fMLP in unprimed equine neutrophils
despite the very clear mobility effects of this agent in human
neutrophils, which are observed even in fully unprimed cells
[29, 37, 38]. However, previous data demonstrating a concentra¬
tion-dependent induction of lysosomal enzyme release by fMLP
[17] suggested that functional coupling of fMLP receptors might
be possible in the horse and that superoxide anions might be
produced under appropriate conditions because these two
effects usually occur concurrently [8j.
Our model was specifically developed for its high sensitivity
for detecting superoxide anion release from cells [34] and
demonstrated that fMLP-stimulated LDCL could indeed be
observed, but this only occurred to any significant extent after
LPS pretreatment, i.e. consistent with this being a primed
response [7, 8]. A similar effect was also observed with PAF and
TNF-a, both well-recognized neutrophil priming agents in
other species [29], Furthermore, the priming effect of LPS was
not restricted to fMLP, since, in agreement with a previous
report [11], ZAP-stimulated LDCL was also enhanced by LPS
pretreatment. The kinetics of fMLP-induced LDCL in LPS-
primed equine neutrophils demonstrated an extremely brisk
superoxide anion response with significant LDCL observable
30 s post-fMLP addition with peak LDCL occurring between 60
and 120 s. Thereafter, respiratory burst activity abated rapidly
with virtually complete desensitization of the response by 4
min. This pattern of superoxide generation is very similar to
that reported for human cells [34, 36].
The induction of fMLP-induced shape change following
priming was also of interest, not least because a very brisk
polarization response is observed in human neutrophils and this
is not dependent on priming status [29]. In human cells,
however, LPS exposure has been shown to enhance the rate and
maximal extent, and reduce the lag time, of F-aetin polymeriza¬
tion induced by fMLP [39]. In equine cells, the pre-incubation
conditions necessary for LPS-indueed priming for enhanced
1MLP LDCL responses did not produce significant cell shape-
change with LPS alone and hence in this species, unlike in
humans [8], measurement of cell shape change alone rather
than more complex cytoskeletal changes may not be the most
appropriate or indeed accurate method of detecting cell priming
or of modeling the control of cytoskeletal elements in vitro. This
necessity for LPS priming to facilitate equine neutrophil shape
change by functional fMLP receptor-ligand coupling could
provide an important and novel model to dissect signal
transduction pathways linking priming responses to cell polar¬
ization.
Detailed characterization of the priming effect of LPS in
equine cells demonstrated that enhancement of the fMLP-
stimulated LDCL response, although requiring slightly higher
LPS concentrations (^10 ng/mL) than human cells [7, 10, 31]
evolved over a very similar time course. The ability of serum to
enhance the responsiveness of leukocytes from other species to
LPS [32, 33, 41], reflects the formation of a complex between
LPS and a serum LBP that is recognized by the glycosyl-
phosphatidylinositol-anehored membrane protein, CD 14 [42].
These data provide strong evidence for a similar paradigm
underlying the mechanism of LPS interaction with equine
neutrophils. The presence of LBP has not previously been
studied in the horse and consequently appropriate reagents for
its quantitative analysis are not available. However, the ability
of human and equine serum to substitute for one another in
these experiments suggests that a functional homologue of LBP
is indeed present in equine serum. The currently available
anti-human CD14 monoclonal antibodies do not bind to equine
neutrophils [T. J. Brazil, unpublished data] and hence the
presence or absence of CD14 on these cells and a more detailed
dissection of this mechanism, remains to be explored in this
species.
The chemotaxis data presented are in agreement with most
previous reports in equine neutrophils [17, 18]. However. Zinkl
et al. [22] and Sedgwick et al. [19] observed a chemotactic
effect of fMLP but only at high, non-physiological, concentra¬
tions, i.e. 100 pM; all other groups have failed to observe any
chemotactic response to this agonist [17, 181. Taken together,
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these data suggest that fMLP is at best a very poor chemotactic
agent for equine neutrophils and that LPS exposure is unable to
modulate this lack of response. Of note, LPS exposure actually
reduces the chemotactic responsiveness of human neutrophils
to fMLP [8], however, the response of equine neutrophils to
ZAP in our system was unaffected by LPS (data not shown).
Scatchard analysis of [!H]fMLP binding to equine neutro¬
phils was able to confirm the presence of specific fMLP binding
sites in equine neutrophils and also identified a 2.5-fold
increase in fMLP receptor number after LPS priming without
altering the single receptor site model fit or changing receptor
affinity. A similar single site model for equine neutrophils was
described by Snyderman and Pike [17] in which they identified
630 ± 184 receptors per cell equivalent to the number we
found in unprimed cells. A single 1MLP receptor site has also
been identified in rabbit neutrophils where receptor expression
was increased eightfold after intravenous endotoxin administra¬
tion [43]. However, this was not accompanied by any compa¬
rable effect on neutrophil function, suggesting that the two
effects were not directly related [44]. This point is reinforced by
studies in human neutrophils that have demonstrated that the
increase in 1MLP receptor expression observed in response to
priming [30, 45] or bacterial infection [46] either lags behind
[30] or does not correlate with [45, 46], the enhanced functional
response but results from translocation of preformed fMLP
receptors to the plasma membrane, which occurs as a conse¬
quence of fusion of specific granules with the cell surface [47],
The possibility that the small change in fMLP receptor number
identified in equine cells post-LPS treatment is a consequence,
rather than a cause, of priming, is supported by the observation
that receptor numbers for other human neutrophil agonists (e.g.,
C5a), whose responses are equally enhanced, are not affected
by LPS [45]. It is unlikely therefore, that changes in receptor
number alone represent a major control point determining the
magnitude of the fMLP receptor-mediated response. Hence, the
dramatic augmentation of the fMLP response observed most
likely occurs at a level downstream from ligand-receptor
binding in the signal transduction cascade. Although further
studies are required to dissect both the precise mechanism of
LPS interaction with equine neutrophils and the subsequent
intracellular signaling steps that stimulate functional coupling
of the fMLP receptors in these cells, the very dramatic and
selective priming response observed in the horse neutrophil
may make this cell an ideal, and hitherto unrecognized, model
for the investigation of functional coupling of leukocyte G-
protein-linked chemoattractant receptors.
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ABSTRACT: Role of neutrophil apoptosis in the resolution
ofpulmonary inflammation. K. Mecklenburgh, J. Murray, T.
Brazil, C. Ward, A.G. Rossi, E.R. Chilvers.
Ncutrophil-mcdiatcd lung injury may result from one
ui more of the following possible causes: 1) loss of the nor
mal mechanisms that regulate and switch off neutrophil
influx, 2) inappropriate or uncontrolled neutrophil activa¬
tion within the lung, 3) inhibition of neutrophil apoptosis,
and 4) impairment or saturation of the normal macrophage-
dependent process for the removal of apoptotic neutrophils.
Current in vitro data indicate that many factors operating
at the inflamed site (e.g. cytokines, growth factors, chemo-
tactic peptides, hypoxia, acidosis, etc.) serve a dual func¬
tion in both priming and activating these cells, and delay
apoptosis. The observation that the rate of eosinophil apop
tosis can be accelerated by corticosteroid therapy in vivo
suggests a novel mode of action for this drug and indicates
that targeting this process in other granulocyte-dependent
inflammatory conditions may offer a novel therapeutic
approach in inflammatory lung disease.
Monaldi Arch Chest Dis 1999; 54: 4, 345-349.
Keywords: Acute respiratory distress syndrome, apoptosis, lung inflammation, neutrophils.
*Respiratory Medicine Unit, Dept of Medicine (RIE), University of Edinburgh Medical School, Edinburgh UK and **Respiratory
Medicine Unit, Dept of Medicine, University of Cambridge School of Clinical Medicine, Addcnbrooke 's Hospital, Cambridge, UK.
Correspondence: E.R. Chilvers, Dept of Medicine, University of Cambridge School of Clinical Medicine, Box 157, Level 5,
Addenbrooke's Hospital Hills Road, Cambridge CB2 2QQ, UK.
The authors' work is funded by the Wellcome Trust, the Medical Research Council and Papworth Hospital, National Health Service
Trust.
Neutrophils are major effector cells of the immune
system and play a central role in the pathogenesis of
many inflammatory lung disorders. Hence, the accu¬
mulation and activation of these cells at an inflamed
site, while important for host defence against invad¬
ing micro-organisms, is also responsible for releas¬
ing into the lung highly toxic proteases and reactive
oxygen radicals. This "unwanted" consequence of
neutrophil activation has been implicated in causing
the lung parenchymal abnormalities associated with
acute respiratory distress syndrome (ARDS), the air¬
way wall damage observed in acute severe asthma
and the inflammatory damage seen in many chronic
interstitial lung diseases [1-3]. It has long been rec¬
ognized, however, that, in the setting of acute bacte¬
rial pneumonia, neutrophil influx can occur on such
a scale as to completely fill and obliterate the normal
alveolar airspace and yet this process can resolve
rapidly with minimal or no residual tissue damage.
This simple paradox implies that the presence of
neutrophils per se at an inflamed site does not auto¬
matically equate with tissue injury, even within an
organ as delicate as the lung, and that other factors
dictate whether damage ensues or is avoided. To
date, most research has focused on trying to explain
such differences in terms of the duration of neutro¬
phil influx into the lung, virulence issues relating to
the infecting micro-organisms and the presence or
absence of other costimulatory cells. However, the
recognition that neutrophils, when aged in vitro,
undergo rapid and spontaneous apoptosis or "pro¬
grammed cell death" has suggested a novel and quite
alternative explanation for such differences i.e. that
the timely death and active removal of extravasated
neutrophils may be a key issue determining whether
granulocytic inflammation resolves ("beneficial inflam¬
mation") or persists ("detrimental inflammation").
Neutrophil apoptosis and the
resolution of inflammation
The process of apoptosis (fig. 1) is important for
two main reasons: first, it switches off the secretory
capacity of the neutrophil [4] and, secondly, it results
in the recognition and prompt removal of these cells
by inflammatory macrophages [5]. Since the plasma
membrane of the neutrophil remains intact follow¬
ing apoptosis and the phagocytic engulfment of such
cells fails to incite macrophage activation, this event
appears to represent an "inbuilt", efficient and safe
mechanism for the removal of potentially hazardous
cells and may explain how it is that neutrophil inflam¬
mation can so frequently resolve without causing tis¬
sue damage. Likewise, if the process of apoptosis is
delayed or perverted, the potential for these cells to
degranulate and/or release other more damaging his¬
totoxic agents increases dramatically. The whole
concept that cell death may be beneficial has revolutio¬
nized our understanding of the events that control
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Fig. 1. - Morphological change associated with neutrophil apoptosis.
Human neutrophils were purified from nuclear venous blood of healthy
donors and cultured for 20 h in the presence of 10% autologous scrum.
Cytocentrifuge preparations were then performed revealing the clear
morphological features of the apoptotic (denser nuclear staining) and
non apoptotic (normal) neutrophils. Identical preparations using fresh
ly isolated neutrophils demonstrate no evidence of apoptosis.
neutrophil behaviour at the inflamed site and offers
many exciting and novel opportunities for develop¬
ing anti-inflammatory drugs which may target this
process. Although there are a number of recent re¬
views detailing the biology of neutrophil apoptosis
[6], the principal aim of this article is to address
how this event relates to inflammation in the lung.
Detection of neutrophil apoptosis in
inflammatory lung disease
Recent data suggest that bacterial infection in the
lung triggers a rapid but surprisingly transient efflux
of neutrophils from the blood into the alveolar wall
and airspace [2, 7] and that, unlike in the systemic
circulation, these cells exit at the the pulmonary cap¬
illary level rather than from postcapillary venules
[8]. For example, in experimental pneumonia caused
by Streptococcus pneumoniae, neutrophil efflux only
occurs during the first 6 h following instillation of
the organism, and 11'indium-labelled autologous neu¬
trophils fail to accumulate in the lung in patients
with bacterial pneumonia, even when studied with¬
in hours of presentation (see [2]). Although granulo¬
cyte influx undoubtedly occurs on a more sustained
basis in conditions such as chronic bronchial sepsis
[7], the above data predict that in the setting of acute
inflammation, neutrophil influx is switched off early
and that events influencing neutrophil survival with¬
in tissues are likely to dominate the subsequent clini¬
cal course.
Neutrophil apoptosis has now been observed in a
number of human diseases and experimental models
including neonatal lung injury [9], ARDS [10], and
experimental pneumonia and lung injury in animals
[11], and supports previous predictions made on the
basis of in vitro work [2]. The animal studies have
also demonstrated a close correlation between the onset
of neutrophil apoptosis in the lung, the subsequent
ingestion of apoptotic cells by alveolar and inflam¬
matory macrophages, and the resolution of the alve¬
olitis [11]. A similar correlation has been made for
the eosinophil; apoptosis and the subsequent clear¬
ance of these cells from the airways has been demon¬
strated in patients with acute severe asthma treated
with systemic corticosteroids [12]. In this latter study,
clinical improvement was mirrored by the appear¬
ance of apoptotic eosinophils in the sputum. Hence,
there is little doubt that granulocyte apoptosis occurs
in vivo and is particularly prominent in situations in
which spontaneous or drug-induced resolution of in¬
flammation occurs. Likewise, mice that lack the major
po integrin cell surface adhesion molecule CD lib/
CD 18 (which is required for phagocytosis-induced
apoptosis) arc unable to effectively clear neutrophils
lioin the inflamed peritoneal cavity [13J.
Functional consequences of
neutrophil apoptosis
Time-lapse video microscopy studies indicate that
neutrophil apoptosis is an energetic and rapidly exe¬
cuted event. The major morphological changes that
occur include cell shrinkage, nuclear condensation
and cytoplasmic vacuolation. These events are asso¬
ciated with the shedding of a number of cell surface
receptors, including CD 16 (FcyRIII) and the tumour
necrosis factor receptor (TNFR)-1, and the extemaliza-
tion of phosphatidylserine, which is normally locat¬
ed only on the inner leaflet of the plasma membrane.
This dramatic change in the morphology of the neu¬
trophil is associated with a "functional isolation" of
the cell, and an abrupt reduction in the cell's capac¬
ity to respond to stimuli that normally induce chemo-
taxis, degranulation or superoxide anion generation
[4].
The second major consequence of neutrophil apop¬
tosis is the acquisition of a phenotype that allows
these cells to be recognized and engulfed by macropha¬
ges [5]. Although alveolar macrophages and fibro¬
blasts all display some ability to phagocytose apoptotic
granulocytes [14], this capacity appears dwarfed by
the ability of "professional" inflammatory macrophages
to engulf and degrade these cells, and this "eating"
capacity can be further enhanced by a range of inflam¬
matory mediators including granulocyte-macrophage
colony-stimulating factor (GM-CSF), interferon-y in-
terleukin-(IL)-l [3 and transforming growth factor-pi
[15], Although the "ligand" on the apoptotic neutro¬
phil cell surface that allows the senescent neutrophil
to be recognized by macrophages is not known, the
macrophage side of this interaction involves both
the cq.p, vitronectin receptor integrin and CD36, which
bind thrombospondin, which engages the apoptotic
neutrophil cell surface [5].
Macrophage uptake of apoptotic neutrophils has
been observed at a number of inflammatory sites, in¬
cluding nonsuppurative arthritis, acute lung injury in
neonates, ARDS, streptococcal lobar pneumonia, expe¬
rimental peritonitis and resolving glomerulonephri¬
tis, and is thought to be the major disposal route of
these cells in vivo. The crucial benefit of such a mec¬
hanism is that the phagocytic process removes cells
that are potentially highly histotoxic in a "silent" and
nonphlogistic manner [16]. Under in vitro conditions,
blocking macrophage uptake using agents such as col¬
chicine allows apoptotic cells to undergo secondary
necrosis, causing the release of their granule contents,
again underlining the need for neutrophil apoptosis
to be co-ordinately linked to macrophage uptake [5].
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Regulation of neutrophil apoptosis
The speed at which neutrophils undergo apopto¬
sis when aged in vitro suggests the existence of a
very strong and inbuilt apoptotic programme in these
cells, which if triggered in vivo, could (and in strep¬
tococcal lobar pneumonia probably does) result in a
very rapid and effective process for switching off
and removing these cells from an inflamed site. Rat¬
her surprisingly therefore, it was revealed that the
vast majority of input signals to the neutrophil (e.g.
GM-CSF, lipopolysaccharide, complement factor 5a
and (C5a), IL-6 and IL-8; fig. 2) cause a profound
inhibition of apoptosis [17-19] and, moreover, that
many of the pharmacological manipulations shown
to induce apoptosis in other cell types (including the
thymocyte and the lymphocyte) have the opposite
effect on the apoptotic programme in the neutrophil.
The most striking example of this difference is the
effect of raising intracellular calcium or cyclic ade-
nasine monophosphate, since both stimulate thymo¬
cyte apoptosis but delay this process in neutrophils
[20, 21]. This early indication that neutrophils dif¬
fer from most other inflammatory cells in their apop¬
totic programming was further supported by the
observation that corticosteroids markedly delay apop¬
tosis in the neutrophil yet clearly stimulate this process
in the eosinophil [22]. This latter observation may
explain, at least in part, the relative inability of cor¬
ticosteroids to influence the clinical outcome of many
neutrophil-dominated inflammatory diseases such as
ARDS.
It has also been demonstrated that the rate of neu¬
trophil apoptosis can be severely inhibited by hypo¬
xia [23]. This influence is again contrary to the effect
of hypoxia on apoptosis in other cells types, e.g.
neurons and gut-derived epithelial tumour cells, and
suggests that hypoxia may be a further factor oper¬
ating to delay the resolution of neutrophil-mediated
tissue inflammation.
In view of these data, recent studies have focused
on how neutrophil apoptosis may be stimulated or,
at the very least, how the above largely cytokine-
mediated survival effects may be blocked. This has
proved a somewhat frustrating challenge since although
agents such as TNF-a and Fas ligand (Fas-L) are
both capable of inducing neutrophil apoptosis through
binding to the cell membrane p55 and p75 TNF-a
receptors and Fas respectively [24—27], the magni¬
tude of the killing effect, at least in vitro, is small.
Furthermore, neutrophils previously primed by agents
such as platelet-activating factor, IL-8 or lipopolysac¬
charide, or cells isolated from an inflammatory focus,
appear unresponsive to the same signals [26, 28, 29].
This implies that the early and often intense increase
in TNF-a levels observed in many acute inflamma¬
tory lung states may be unable to promote effective
neutrophil removal if the cells within the lung have
been costimulated by other priming or activating
agents. Early reports suggested that neutrophils active¬
ly produce and release Fas-L and thereby regulate
their own survival via autocrine or paracrine Fas-L/
Fas interactions [27, 30], However, Fas-L/Fas-mediat-
ed apoptosis may not be as important in regulating
neutrophil survival in vivo since inflammatory neutro¬
phils harvested from Fas-L (glcl) and Fas (7/;r)-defi-
cient mice undergo apoptosis at an identical rate to
cells from normal mice [31).
Other physiological stimuli known to enhance the
rate of neutrophil apoptosis include human immuno¬
deficiency vims infection [32], ingestion of Escherichia
coli [33] and other particulate material [13], and, in¬
terestingly, migration of cells through an endothelial
monolayer [34]. This latter observation may explain
why apoptotic neutrophils are rarely if ever observed
in circulating blood, and may relate to the previous¬
ly noted ability of P2 integrins to facilitate constitu¬
tive and TNF-a-stimulated neutrophil apoptosis [ 13,
34], There is also an early and fascinating sugges¬
tion that bronchoalveolar lavage fluid recovered from
animals with experimental streptococcal (resolving)
pneumonia contains a factor that drives neutrophil
apoptosis in vitro and that this factor(s) is absent in
E. coli (non-resolving) pneumonia [35].
LPS, IL-1 [3, TNF-a, IL-6, IFN-y, G-CSF,
GM-CSF, C5a, IL-8, NGF, calcium, cAMP,
corticosteroids, ATP, Ap3A, Ap4A
Inhibition
Normal \ w / a











TNF-a/FasL, phorbol esters, CD11b/CD18
cross-linking, protein synthesis inhibitors,
sodium arsenite, ROS, nitric oxide, IL-10





Fig. 2. - Regulation of neutrophil apoptosis. Summary of the physiological (left) and pharmacological (right) manipulations demonstrated to either
inhibit or accelerate the rate of neutrophil apoptosis in vitro. E. coli: Escherichia coli; UV: ultraviolet; HIV: human immunodeficiency virus; LPS:
lipopolysaccharide; IL: interleukin; TNF-a: tumour necrosis factor-a; IFN-y: interferon-y; G-CSF: granulocyte colony-stimulating factor; GM-CSF:
granulocyte-macrophage colony-stimulating factor; C5a: complement factor 5a; NGF: nerve growth factor; cAMP: cyclic adenosine monophos¬
phate; ATP: adenosine triphosphate; Ap,A, Ap_,A: diadenosine polyphosphates; FasL: Fas ligand; ROS: reactive oxygen species.
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Although the intracellular pathways mediating
the above effects are uncertain, the proapoptotic effect
of TNF-a, unlike its priming/activation functions,
are uniquely dependent on ligation of TNFR75 in
addition to TNFR55, and both TNF-a and Fas-L-
induced killing are blocked by compounds that inhi¬
bit the caspase family of cysteinyl proteases, which
orchestrate cell death in other mammalian cells. The
major nuclear and cytosolic targets of caspases in the
neutrophil are, again, uncertain but appear to include
gelsolin, which acts to sever actin filaments and
induce cells to round up, detach and undergo nuclear
fragmentation [36], and a Ca2+/Mg2+-independent
acid endonuclease [37]. The ability of protein synthe¬
sis inhibitors to induce neutrophil apoptosis also
implies that these normally short-lived cells are "pre¬
programmed" to die and that an actively produced
antiapoptotic protein factor or factors exist to prevent
premature cell death. Intriguingly, mature neutrophils
do not possess Bcl2, a major antiapoptotic factor pre¬
sent in most other cells [29, 38], and it has been
proposed that the loss of this protein, which occurs
during the final stages of granulocyte maturation, re¬
moves an important brake on the apoptotic capaci¬
ty of the neutrophil prior to entry into the circulation.
Current contenders for such survival proteins include
other members of the BcL family, namely Mcl-1 and
Bax [39].
Potential for therapeutic manipulation
From the above line of argument, it follows that
devising a therapeutic strategy based on driving pro¬
grammed cell death or blocking the antiapoptotic
effects of certain agents should, if executed at the
appropriate stage of the inflammatory response, offer
a novel and effective form of anti-inflammatory ther¬
apy. "Proof principle" for this is the well-recognized
and major proapoptotic effect of glucocorticosteroids
in eosinophils and the ability of Fas-L administration
to induce resolution of eosinophilic inflammation in
the airways [40]. Such selective targeting is not yet
available for the neutrophil, but there are experimen¬
tal data to support both of the above approaches.
First, although the "solo" killing effect of TNF-a in
neutrophils appear to be modest and are easily over¬
come by other costimuli, it is now possible to increase
dramatically the efficacy of this response by coincubat-
ing neutrophils with the nuclear factor-KB inhibitor
gliotoxin [41], which also unmasks a capacity for
TNF-a to drive eosinophil apoptosis. Likewise, the
protein synthesis inhibitor cycloheximide, used at a
concentration that alone does not influence the rate
of constitutive apoptosis, can also enhance TNF-a-
mediated neutrophil apoptosis [41], Secondly, the anti¬
inflammatory cytokine IL-10 has been shown to be
able to block the survival (anti-apoptotic) effect of
lipopolysaccharide in vitro [42], and a similar effect
has been demonstrated with certain synthetic cell-
permeable inhibitors that block certain intracellular
second messenger phosphorylation pathways [43].
The very unusual and atypical apoptotic programme
that exists in the neutrophil, and the ability to deliver
drugs in a selective manner to the lungs, fuels current
optimism that such an approach may be feasible.
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(mean ± SEM, n = 11 individual horses) per neutrophil, respectively. This represents twice as
much elastase as previously found in the equine neutrophil and a comparable amount to that
reported in human neutrophils. Immunolocalisation demonstrated that ENE 2A has a granular
distribution within the cytosol of neutrophils, whereas API exhibits a uniform non-granular
cytoplasmic appearance. In addition the kinetics of simultaneous generation and release of
superoxide anions (SOA) and release of ENE 2A from equine neutrophils, stimulated in vitro by
zymosan-activated serum (ZAS) in the presence and absence of the cation chelator ethylene glycol-
lV,A,./V',lV-tetraacetic acid (EGTA), showed a close relationship between total SOA generation and
total ENE 2A release during the initial 90 min post-ZAS stimulation and the dependence of both
events on extracellular cations. In conclusion these studies have shown that horse and human
neutrophil elastase content and mediator release functions are more closely matched than was
previously thought. This suggests that the species differences in pathology resulting from
neutrophil-mediated respiratory disease are determined by other factors such as differences in the
abundance and function of intra- and extra-cellular protease inhibitors. © 1999 Elsevier Science
B.V. All rights reserved.
Keywords: Horse; Equine; Neutrophil; Elastase; Alpha-l-proteinase inhibitor
1. Introduction
Neutrophil elastase (NE) is a major component of the neutrophil's proteolytic armoury
being essential for migration to extravascular compartments (Henson and Johnston,
1987), oxygen independent bactericidal activity (Ganz et al., 1987) and the remodelling
of damaged tissues. However, inappropriate or excessive release of NE can be detrimental
to host tissues as NE is a powerful serine proteinase (Bieth, 1986) capable of degrading
many structural proteins including virtually any component of the pulmonary
extracellular matrix (Dale et al., 1972; Ganz et al., 1988; Haslett et al., 1989; Bokoch,
1995; Downey et al., 1995). Consequently, delicate alveolar structures of the lung are
extremely sensitive to unregulated NE activity. Neutrophil elastase is synthesised in bone
marrow precursor cells, especially promyelocytes (Fouret et al., 1989), and found in the
primary cytoplasmic granules of the mature circulating cell (Cramer et al., 1989). Under
normal conditions the activities of NE are precisely controlled by serine proteinase
inhibitors (serpins) such as alpha-l-proteinase inhibitor (API) (Gadek et al., 1981a;
duBois et al., 1991; Mason et al., 1991), secretory leukocyte proteinase inhibitor (SLPI)
(Sallenave et al., 1997) and alpha-2-macroglobulin (Travis and Salvesen, 1983). Plasma
derived API is the main regulator of NE activity in the lower respiratory tract (Gadek et
al., 1981b). Its critical importance is highlighted by a human hereditary disorder
associated with API deficiency and a greatly reduced plasma concentration of API which
leads to the development of panacinar pulmonary emphysema in the third to fourth
decade of life (Laurell and Eriksson, 1963; Hayes et al., 1975; Janoff et al., 1977;
Perlmutter, 1996).
The recognition of pulmonary emphysema in some API sufficient humans, as well as
those with API deficiency, suggests that NE host tissue damage results from two basic
mechanisms; either a fault in the antiproteinase screen (e.g. reduced amount or
inactivation), or failure due to an excessive burden of proteolytic enzymes which
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overwhelm the capacity of the inhibitors present. These are two extremes and it is
probable that a combination of the two occur in many cases of pulmonary emphysema in
API sufficient individuals giving rise to 'the proteinase : antiproteinase theory of lung
disease' (Shapiro, 1995). Human API is susceptible to inactivation by a host of different
oxidants produced by activated neutrophils (Ossanna et al., 1986; Ottonello et al., 1992;
Ras et al., 1992), macrophages (Hubbard et al., 1987; Mast et al., 1991) and cigarette
smoke (Travis et al., 1980). This susceptibility to oxidative inactivation is due to the
presence of a methionine residue in the P! position on the exposed reactive site loop
(Johnson and Travis, 1979; Padrines et al., 1989) which, when oxidised to methionine
sulphoxide, results in a thousand fold reduction of the association rate constant (kass) of
API with NE (Matheson et al., 1982). This phenomenon has also been reported for equine
API (Patterson and Bell, 1989). Inactivation of API by SOA generation may allow
neutrophils to induce a micro-environment around the cell in which NE activity can
proceed unimpaired (Ossanna et al., 1986; Ras et al., 1992). For this theory to be valid a
rapid respiratory burst resulting in extra-cellular SOA must be temporally co-ordinated
with the release of NE.
Equine chronic obstructive pulmonary disease (COPD) is considered to be an immune
complex-mediated hypersensitivity response to inhaled antigens characterised by airway
obstruction and neutrophil recruitment into the airways (Robinson et al., 1996).
Histopathology shows accumulation of neutrophilic exudate down to the bronchiolar
level of airways, however, peribronchiolar emphysema is minimal and the deeper alveoli
are rarely affected (Kaup et al., 1990). Panacinar and centrilobular emphysema,
prominent features of some neutrophil associated pulmonary diseases in humans (Creagh
and Krausz, 1992), are not documented in equine COPD (Kaup et al., 1990) suggesting a
major species difference, either in the susceptibility of the alveoli to NE or the amount, or
activity, of the NE present. Previous reports suggest that equine neutrophils contain a
lower concentration of elastase (0.4 pg/cell measured by elastinolytic activity of cell
extracts, Dubin and Koj, 1986) compared to human neutrophils (1.1 pg/cell measured by
competitive ELISA of cell extracts, Tetley et al., 1989). If these figures are correct the
explanation for the different patterns of emphysema present in the two species may
simply be due to the lower concentration of elastase available in the horse which is
therefore more easily controlled by inhibitors present in the locality. However, as NE
inhibitors have been described in the cytosol and NE containing granules of both human
(duBois et al., 1991; Mason et al., 1991; Sallenave et al., 1997) and horse neutrophils
(Dubin, 1977; Potempa et al., 1988; Korzus et al., 1991; Dubin et al., 1992; Kordula et al.,
1993), the measurement of elastinolytic activity may underestimate the amount of
elastase present in equine neutrophils as an unknown proportion may be inhibited during
the extraction process. However, it must be remembered that tissue damage in vivo is
caused by active elastase and that while extraction methods may result in apparent loss of
elastase activity immunological techniques are also imperfect in that they do not indicate
what proportion of the protease is functionally available. The aim of the study was to
determine whether the content and intracellular compartmentalisation of NE and API and
the kinetics of release of NE and SOA generation from equine neutrophils, after exposure
to secretagogue, were comparable with the previously published data for human
neutrophils. To enable a more accurate determination of ENE in neutrophils using
260 M.P. Dagleish et al./Veterinary Immunology and Immunopathology 72 (1999) 257-275
immunological techniques which would allow direct comparison with the human
literature antibodies specific for ENE 2A (the most abundant NE found in equine
neutrophils, Von Fellenberg et al., 1985; Dubin and Koj, 1986) were produced.
Using immunological techniques, (i) the presence and distribution patterns of both
ENE 2A (free or complexed) and equine API in venous blood neutrophils was
demonstrated, (ii) the amount of ENE 2A per cell was shown to be greater than
previously reported and (iii) the release kinetics of ENE 2A and generation of SOA were
compared suggesting the potential for synergistic interaction of these mediators during
the period of the oxidative burst.
2. Materials and methods
2.1. Reagents and chemicals
Sodium citrate 3.8% was purchased from Phoenix Pharmaceuticals, (Gloucester, UK),
Percoll and CNBr-activated Sepharose from Pharmacia (Uppsala, Sweden), Diff Quik™
from B. M. Brown (Reading, Berks, UK) and dried skimmed milk from J. S. Sainsbury
(London, UK). FluoroLink-Ab™ Cy3™ Labelling Kit was purchased from Amersham
Life Science (Arlington Heights, IL, USA). Vectashield, 3,3'-diaminobenzidine (DAB)
and 3-amino-9-ethylcarbazole (AEC) from Vector Laboratories (Peterborough, UK) and
microtitre plates and 3,3',5,5'-tetramethylbenzidine (TMB) peroxidase substrate from
Dynex Technologies (Billingshurst, West Sussex, UK). Crystal/mount™ was purchased
from Biomeda (Foster City, CA, USA). All other reagents were of tissue culture or
reagent grade and supplied by Sigma Chemicals (Poole, Dorset, UK).
Zymosan-activated serum (ZAS) was used as a biological source of the complement
fragment C5a in order to obtain a species homologous, receptor mediated, physiological
stimulus for equine neutrophils. Serum was prepared by the recalcification of platelet rich
plasma followed by incubation for 90 min at 37°C in an humidified 5% C02 atmosphere.
Zymosan (5 mg/ml) was added to the serum followed by sonication, incubation at 37°C
for 60 min and centrifugation at 1400 x g for 15 min. Heat inactivated zymosan-activated
serum (HIZAS) was produced by an identical procedure except that the serum was heat
inactivated at 56°C for 30 min before addition of zymosan. Both supernatants were stored
in aliquots at —20°C.
2.2. Neutrophil isolation
Venous blood neutrophils were isolated by modification of a previously published
method (Haslett et al., 1985). All blood was taken by jugular venipuncture and
anticoagulated with 1 ml of 3.8% sodium citrate per 10 ml of blood. Free sedimentation
under gravity for 30 min at room temperature revealed an upper leukocyte rich plasma
layer which was aspirated and centrifuged at 380 x g for 6 min. Platelet-rich plasma
supernatant was decanted and centrifuged at 2400 x g for 20 min to prepare platelet poor
plasma (PPP). The initial leukocyte rich pellet, obtained typically from 80 ml of whole
blood, was resuspended in 2 ml PPP in a 15 ml polystyrene tube and underlayered with
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40% and 52% PPP/Percoll solutions prior to centrifugation at 255 x g for 12 min. Two
tight bands appeared, cytospins preparations from these revealed the mononuclear cells
were held up in the PPP/40% Percoll interface and neutrophils in the 52%/40% interface.
Neutrophils harvested from this layer were washed sequentially in PPP, three times in
Dulbecco's PBS without calcium and magnesium (w/o)/0.1% BSA and once in
Dulbecco's PBS with calcium and magnesium/0.1% BSA prior to resuspension in the
latter. All procedures were performed at room temperature. Purity was assessed by
differential count of Diff-Quik™ stained cytospin preparations and viability by trypan
blue exclusion.
2.3. Measurement of equine API by ELISA
Purification of equine API, production and characterisation of anti-equine API
antibodies used in this study and the sandwich ELISA for API have previously been
reported by this group (Scudamore et al., 1994; Dagleish et al., 1998). Briefly ELISA
plates were coated with purified sheep anti-equine API (1 mg/ml). Standards (in
triplicate) and samples (in duplicate) were then added to the wells and bound API was
detected by addition of the same antibody conjugated to HRPO and the peroxidase
substrate TMB. The optical density of the colour reaction in the wells was measured at
450 nm on a MR7000 ELISA plate reader (Dynex Technologies, Billingshurst, West
Sussex).
2.4. Purification ofequine neutrophil elastase 2A and production ofa sheep anti-ENE 2A
antibody
ENE 2A was purified from 6 1 of whole blood collected immediately post-mortem.
Neutrophil granules were separated by cell homogenisation followed by centrifugation
and solubilised by stirring overnight in I M NaCl, 0.05% Triton-X 100 at 4°C. ENE 2A
was purified from the resultant supernatant using ion exchange chromatography and
stored at —70°C following buffer exchange in to PBS (Scudamore et al., 1993).
Antisera to ENE 2A was raised by injecting a sheep with a complex of API : ENE 2A
prepared by pre-incubation of 50 pg of ENE 2A and 100 pg of API at room temperature
for 30 min. Three similar injections were given over a 6 month period in either Freund's
complete (initial challenge) or incomplete adjuvants (subsequent challenges). Antibodies
were purified from sera by affinity chromatography using a column of purified ENE 2A
linked to CNBr-activated Sepharose 4B. Purified antibody was stored in PBS in aliquots
at —20°C.
2.5. SDS-PAGE and Western blotting techniques to characterise the proteolytic activity
and demonstrate immunodetection offree and complexed ENE 2A and API
Crude neutrophil extracts were prepared by five cycles of freeze/thaw extraction of
pellets of 126 x 106 purified equine neutrophils in 600 pi reducing on non-reducing
sample buffer containing 1 M NaCl. The extract in reducing buffer was heated to 95°C
and then both extracts were centrifuged (20 000 x g, 30 min at 4°C) and the supernatants
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retained and stored at —70°C. Four identical immunoblots were prepared by separation of
purified ENE 2A, neutrophil extract, API and API : ENE 2A complex (0.5 pg, 20 pi of
the above extracts, 1.0 and 1.5 pg per lane, respectively) by 10% SDS-PAGE under
reducing and non-reducing conditions, the proteins being transferred to Immobilon-P by
semi-dry Western blotting. Non-specific binding to the blots was blocked by 3% dried
skimmed milk in PBS (3% MPBS) prior to addition of sheep anti-ENE 2A Ab at 5 pg/ml
(in 3% MPBS), or 0.5% Tween 80 in PBS (PBST) prior to addition of monoclonal anti-
equine API (mAb IB, Dagleish et al., 1998), at 40 pg/ml in PBST. Donkey anti-sheep
IgG: HRPO conjugate at 1/4000 dilution in 3% MPBS, or goat anti-mouse IgG (FAB-
specific): HRPO diluted 1/5000 in PBST plus a DAB peroxidase substrate kit were used
to visualise binding of the respective primary antibodies.
Proteolytic activity of purified ENE 2A, neutrophil extract, API and API : ENE 2A
complex was assessed by incorporating 20 mg azocasein per 10 ml of resolving gel
solution in 10% SDS-PAGE under non-reducing conditions (Horie et al., 1984). Sample
loading was as above. Following electrophoresis the gel was washed three times in 2.5%
Triton-X 100 for 30 min before overnight incubation in PBS. The resultant gel was
stained with Coomassie brilliant blue and destained in the usual manner; proteolysis
being seen as a clear band on the gel.
2.6. Immunofluoresent detection of ENE 2A and API in equine leukocytes
Citrated whole equine blood (10 ml) was allowed to stand for 30 min to allow
sedimentation of erythrocytes. Leukocyte rich plasma was removed and centrifuged
(330 x g, 6 min) at 21°C, the resultant cells were washed and centrifuged (235 x g,
6 min, 21°C) four times in Dulbecco's PBS without calcium and magnesium (w/o). Cells
were resuspended at 0.5 x 106/ml in Dulbecco's PBS with calcium and magnesium,
100 pi samples were used to make cytospin preparations (300 rpm, 3 min, Cytospin 3,
Shandon, Pittsburgh, USA) onto TESPA (3-aminopropyltriethoxysilane) coated slides
which were fixed in 4% paraformaldehyde in PBS (45 min at 45°C) and stored in 70%
ethanol at 4°C.
Sheep anti-ENE 2A and sheep anti-API (Dagleish et al., 1998) antibodies were
conjugated, using kits, with Cy3™ and FITC, respectively. Endogenous fluorescence was
quenched with DAB (0.4 mg/ml PBS), 5% normal sheep serum (5% NSS) blocked non-
specific binding followed by application of anti-ENE 2A : Cy3 at 20 pg/ml and anti-
API : FITC at 14 pg/ml, both in 5% NSS (40 pi of each/slide). Negative controls were
treated identically except that the primary antibodies were substituted by normal sheep
IgG conjugated to Cy3 and FITC. After washing, cytospin preparations were mounted in
Vectashield.
2.7. ELISA for equine neutrophil elastase 2A
ELISA plate wells were coated with 50 pi of affinity purified sheep anti-ENE 2A
(1.5 pg/ml) in 0.1 M carbonate/bicarbonate buffer (pH 9.6). After incubation at 4°C
overnight, plates were washed six times with 0.9% NaCl containing 0.05% Tween 20
(0.9% NaCl-T20). Samples (in duplicate) and standards (in triplicate) were diluted in 5%
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MPBS containing 0.05% Tween 20 (5% MPBST20), and 50 pi added per well. Purified
ENE 2A was used as a standard over the range 0.5—4.0 ng/ml. Wells containing either
50 pi 5% MPBST20 or samples from a single stored batch of ENE 2A constituted
negative and positive controls, respectively. Plates were incubated at room temperature
for 1 h followed by washing six times in 0.9% NaCl-T20. 50 pi of affinity purified sheep
anti-ENE 2A conjugated with HRPO (1 pg/ml in 5% MPBST20) was added per well and
plates incubated a for a further 1 h at room temperature followed by a final six washes in
0.9% NaCl-T20. To initiate colour development 50 pi of TMB was added per well and
the reaction terminated by addition of 25 pi of 0.18 M H2S04. The optical density was
measured at 450 nm on a MR7000 ELISA plate reader (Dynex Technologies,
Billingshurst, West Sussex). The ELISA was used to compare the detection of ENE
2A in the free and complexed state by addition of samples of purified ENE 2A pre-
incubated in the presence or absence of excess purified API (samples containing ENE 2A
in the range 0.5—4 ng/ml were examined). The amount of ENE 2A present in equine
neutrophils was measured in samples taken from the venous blood of 11 horses (six
mares, four geldings and one stallion, median age 10 years, range 5-19 years). Following
purification as previously described neutrophils were resuspended at 5 x 106 cells/ml in
Iscove's modified Dulbecco's PBS freeze/thawed five times, centrifuged (13 800 x g,
10 min at 4°C) and the resultant supernatant assayed for both ENE 2A and API content.
2.8. Zymosan-activated serum stimulation ofsuperoxide generation and elastase release
from equine neutrophils
A sample of the purified neutrophils (n = 6 individual horses, 2 geldings, 4 mares,
mean age 15.8 years, range 8-29 years) was resuspended at 12.5 x 106 cells/ml in
Dulbecco's PBS/0.1 % BSA at 37°C. Basal (PBS), ZAS, HIZAS and ZAS with EGTA
(final concentration of EGTA 4 mM) stimulated superoxide generation was measured by
lucigenin-dependent chemiluminescence (LDCL) (Allen, 1986; Benbarek et al., 1996)
using a ML 3000 microtitre plate luminometer (Dynex Technologies, Billingshurst, West
Sussex, UK). Lucigenin (0.25 mM in Dulbecco's PBS/0.1% BSA at 37°C) 100 pi and
1 x 106 freshly isolated cells (80 pi) were added to each well. Dose response curves were
derived for SOA generation and ENE 2A release in response to ZAS stimulation to
determine the optimal amount of secretagogue (data not shown). After a 5 min
equilibration phase, basal LDCL was recorded over 12 min to ensure that cells were not
basally activated (stable basal peak < 0.005 RLU), followed by addition of 20 pi of buffer
(PBS), ZAS, HIZAS or ZAS with EGTA to wells (final cell concentration 5 x 106/ml).
Chemiluminescence was recorded to determine mean peak and integral (area under the
curve) chemiluminescence values from triplicate wells over a 90 min period (area under
the curve, determined by GraphPad Prism™ version 2.0, GraphPad Software, San Diego,
CA, USA).
Concurrently the rest of the purified neutrophils were resuspended at 5.56 x 106 cells/
ml in Dulbecco's PBS/0.1% BSA and 4.5 ml aliquots placed into universal containers.
One-half millilitre of either PBS, ZAS, HIZAS or ZAS with EGTA was added (final cell
concentration 5 x 106/ml), following gentle mixing 0.5 ml samples were then withdrawn
at 0 (immediately after addition of secretagogues), 15, 30, 45, 60, 90, 120 and 150 min.
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Fig. I. Characterisation of sheep anti-ENE 2A antibody. (A) 10% SDS-PAGE of determining antigens under
reducing conditions. Molecular weight markers (MW in kDa), purified equine neutrophil elastase 2A (ENE 2A)
(0.5 pg/lane), neutrophil extract (20pl/lane), API : ENE 2A complex (1 mg: 0.5 pg/lane) and purified API
(1 pg/lane) in lanes 1-5, respectively. Note the presence of uncomplexed ENE 2A and API as well as complex in
lane 4. (B) Analysis of antibody specificities. Western blot of gel under reducing conditions, similar loading to
gel in Fig. 1A. Lane 1: Coomassie brilliant blue stained molecular weight markers, lanes 2-5 probed with anti-
ENE 2A antibody, lanes 6-9 with anti-API antibody (mAb IB). Lane contents 2, 3, 4 and 5 repeated in lanes 6,
7, 8 and 9, respectively. Note: (i) 31 kDa band common to lanes 2, 3 and 4 corresponding to ENE 2A, (ii) 55 kDa
band in lane 3 (thick arrow) suggestive of ENE 2A : HLEI complex, (iii) API : ENE 2A complex in lanes 4
(arrow head) & 8 (thin arrow) (MW 79-108 kDa) showing both antibodies recognise ENE 2A : API complex,
(iv) multiple isoforms of uncomplexed API in lane 8 below API : ENE 2A complex, (v) uncomplexed ENE 2A is
not recognised by mAb 1B in lane 8 (vi) equine API multiple isoforms (MW 57-69 kDa) present in lane 9.
Differences in molecular weight between API in lanes 8 and 9 are probably due to proteolytic cleavage of
uncomplexed API in lane 8 by uncomplexed ENE 2A. (C) Proteolytic activity of purified antigens and
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Each sample was centrifuged at 13800 x g for 10 min at 4°C, the supernatant decanted
and stored at —70°C until analysis by ELISA.
2.9. Statistical analysis
Intra and inter-ELISA plate variations for ENE 2A evaluations were calculated from
the values obtained for the positive control samples giving coefficients of variation of 1.3
and 16.1%, respectively. All analyses of superoxide anion generation and elastase release
between neutrophil stimulants were by Kruskal-Wallis and Mann-Whitney Tests using a
95% confidence interval. Results were considered to be significant with p < 0.05.
3. Results
3.1. Affinity purified antibodies specifically recognise their complexed and uncomplexed
respective proteins
Separation of purified ENE 2A by 10% SDS-PAGE under reducing conditions
produced a single band of MW 31 kDa (Fig. 1A) in agreement with our previous study
(Scudamore et al., 1993). Purified API isoforms and API: ENE 2A complex had MW
from 57-69 kDa and 79-108 kDa, respectively (Fig. 1A), the ranges reflecting the
differing MW of API isoforms (Patterson et al., 1991). Western blots probed with anti-
Fig. 1. (Continued) -s
neutrophil contents. 10% SDS PAGE under non reducing conditions incorporating 20 mg azocascia'10 ml of
resolving gel. Loading is identical in concentration to gel 1A. Clear bands denote proteolysis. The clear band
common to lanes 2, 3 and 4 represents ENE 2A. Note lack of any proteolysis above this common line in lane 3
yet two smaller bands below it, Also note slight proteolysis in tho API: ENE 2A complex region of lane <1
depicting the lack of complete inhibition in this 'pseudo-irreversible' reaction.
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Fig. 2. Localisation ofENE 2A and An in venous blood leukocytes. Studies performed on eytospin preparations of
mixed populations of equine venous blood leukocytes (100 pi of 0.5 x 106 cells/ml per cytospin). Original
magnification of all figures x 1000. (A) Immunolocalisation of ENE 2A. Immunofluorescence using sheep
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ENE 2A or anti-equine API antibodies showed no cross reactivity to API or ENE 2A,
respectively, in reduced (Fig. IB) or non-reduced states (data not shown), yet both clearly
recognised API : ENE 2A complex. Further scrutiny of the specificity of the sheep anti-
ENE 2A antibody showed that it identified both its target protein in the presence of
soluble neutrophil contents and a band of 55 kDa MW (Fig. IB). On the azocasein gel
proteolysis was absent in the equivalent area of this higher MW band yet all uncomplexed
ENE 2A displayed proteolytic activity (Fig. 1C). Two smaller bands of proteolysis of
lower MW than uncomplexed ENE 2A were also detected demonstrating the presence of
other proteases in the neutrophil extract. Purified API demonstrated no proteolytic
activity but the API : ENE 2A complex exhibited a trace amount (Fig. 1C).
3.2. Equine neutrophils contain cytosolic API and neutrophil elastase with different
patterns of distribution
Immunofluorescent labelling of a mixed population of venous blood leukocytes with
sheep anti-ENE 2A antibody clearly demonstrated the presence of ENE 2A in multiple
cytosolic granules in neutrophils (Fig. 2A). Other cell types were negative for ENE 2A as
were all cell nuclei.
In contrast a more uniform, less intense and non-granular pattern of immunostaining
was seen in the cytosol of neutrophils when probed with an anti-API antibody (Fig. 2B).
Cytoplasmic staining was also present in some mononuclear leukocytes.
Double immunofluorescence emphasised the contrasting distribution patterns of API
and ENE 2A in the cytosol of neutrophils but also indicated that the two proteins were
partially colocalized (Fig. 2C). Negative control preparations were devoid of
immunofluorescence.
3.3. Elastase and API content per neutrophil
The presence of intracellular ENE 2A inhibitors (Kordula et al., 1993, current study)
capable of forming complexes with NE during the extraction process meant that it was
important that the ELISA technique used recognised ENE 2A in both the free and
complexed form. Using the ELISA reported in this study no significant difference in OD
values was found between samples containing equivalent concentrations of ENE 2A in
the presence or absence of an excess of API (p = 0.07). The ELISA techniques were then
used to measure ENE 2A and API in supernatants of cell extracts of purified neutrophils
<
anti-equine neutrophil elastase 2A (ENE 2A) antibody labelled with Cy3™ (red) for visualisation. Note granular
pattern of fluorescence confined to cytoplasm of neutrophils. (B) Immunolocalisation of Equine Alpha-1-
Proteinase Inhibitor. Immunofluorescence of the same field of cells in 2A but using sheep anti-equine API
labelled with FITC for visualisation (green). Positive fluorescence representing API is variable in intensity but
remains non-granular in nature. A monocyte (M) also shows positive fluorescence for API. (C) Co-localisation
of ENE 2A and API. Dual immunofluorescence of same field of cells as seen in A and B. This clearly illustrates
the granular nature of ENE 2A and the non-granular nature of API. Note that API distribution covers the whole
of the cells cytoplasm (green) but ENE 2A distribution is restricted to certain parts (yellow).
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(94.2% neutrophils ± 0.9, cell viability of 99.8 ± 0.8%, mean ± SEM). Mean elastase
content per neutrophil was 0.813 pg ± 0.179 SEM. Mean API content was
0.021 pg ± 0.003 SEM per neutrophil.
3.4. Zymosan-activated serum induces both superoxide anion generation and elastase
release with complimentary kinetics
In view of the fact that in this study the ENE 2A content of neutrophils was found to be
comparable to that reported in humans the possibility of a difference in the kinetics of
ENE 2A release and SOA generation between the species was investigated.
The ZAS induced respiratory burst produced a peak SOA generation at 25 min post-
stimulation, with complete desensitisation of the response by 90 min, despite the
continued presence of the agonist (Fig. 3). Comparison of the total amount of SOA
produced over 90 min, as represented by the areas under the curves, show that a
statistically significant greater quantity of SOA was generated by neutrophils stimulated
with ZAS when compared (Kruskal-Wallis test) to the amounts generated in response to
the other three stimuli (ZAS versus HIZAS p = 0.01, ZAS vs. PBS p = 0.005 and ZAS
versus ZAS + EGTA p = 0.005). Stimulation with HIZAS resulted in similar kinetics for
SOA generation but with a significant reduction in magnitude (ZAS versus HIZAS
p = 0.01). Cells stimulated with PBS or ZAS + EGTA released negligible amounts of
SOA. Zymosan-activated serum stimulation in the presence of EGTA abolished the SOA
generation such that the LDCL response was not significantly different to control cells
treated with PBS (p = 0.9).
In contrast, the kinetics of ENE 2A release (in response to ZAS stimulation) were
prolonged with continuing accumulation in supernatants for up to 150 min (the final
sampling point. Fig. 4). ZAS stimulated neutrophils consistently released significantly
greater amounts of ENE 2A over the whole 150 min (when analysed by Kruskal-Wallis
test) compared with values for PBS (p = 0.005). However, the ENE 2A released after
Fig. 3. Superoxide anion (SOA) generation from ZAS, heat inactivated ZAS (HIZAS), ZAS + ethylene glycol-
AWAfA'Aetraacetic acid (EGTA) and phosphate buffered saline (PBS) stimulated equine neutrophils detected
by LDCL (relative light units [RLUJ, mean ± SEM of six individual horses) over 90 min. Note peak of SOA
generation in both ZAS and HIZAS stimulated cells is at 25 min post-stimulation and total abrogation of
response occurs by 90 min.
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Fig. A. Cumulative release of oquino neutrophil olaotase 2A (ENE 2A) from Pcrcoll purified equine venous
blood neutrophils stimulated with (ZAS), heat inactivated ZAS (HIZAS), ZAS + ethylene glycol-AWW./V'-
tetraacetic acid (EGTA) and phosphate buffered saline (PBS), mean ± SEM of 6 individual horses. Note
different characteristics of release pattern compared to superoxide anion (SOA) generation (Fig. 3) and the
consistently higher concentration of ENE 2A in tho ZAS + EGTA treatod neutrophils compared to those treated
with PBS.
stimulation with ZAS is significantly greater than that generated in the presence of
HIZAS only over the first 90 min (p = 0.03-0.005). EGTA did not completely abrogate
ENE 2A release in response to ZAS; there was no statistical difference between ZAS
treated cells with or without EGTA in the amount of ENE 2A present in the supernatant at
time zero (p = 0.1). The amount of ENE 2A released from neutrophils stimulated with
ZAS + EGTA varies very little from the initial value at time zero suggesting that there is
little or no further release of ENE 2A after this. Over the initial 90 min there is a
significant difference between the amount of ENE 2A released from neutrophils treated
with ZAS + EGTA and those treated with PBS (p = 0.03-0.005). By 120 min the
'leakage' of ENE 2A from cells treated with PBS had risen to a concentration whereby
the difference between the two stimuli was no longer significant (p = 0.07).
Cell viability, as denoted by trypan blue exclusion, was 100% (n = 6 for each of the
four stimuli) at time zero in all four stimuli. At 150 min post-stimulus mean cell viability
in all cases was still > 99%.
4. Discussion
Equine neutrophils have been reported to contain about one third the NE found in
human neutrophils (Dubin and Koj, 1986; Campbell et ah. 1989) and this has been
proposed as an explanation for emphysema being a relatively rare pathological change in
the horse (Edelman et ah, 1992). In this study, using an ELISA, we have shown the
amount of ENE 2A per neutrophil to be over 0.8 pg/cell which is 100% greater than
previous estimates derived by evaluation of enzyme activity (Dubin and Koj, 1986). In
addition equine neutrophils contain an immunologically distinct elastase, elastase 2B
(ENE 2B), (MW 20.5 kDa) at approximately a third the concentration and five times the
elastinolytic activity of ENE 2A (Dubin et ah, 1976), suggesting that the total amount of
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ENE per equine neutrophil is even closer to the figure accepted for human neutrophils
(1.1 pg/cell) (Campbell et al., 1989). The presence of cytosolic inhibitors of elastase in
human and equine neutrophils means that elastase activity may be reduced during the
extraction process when granular and cytosolic compartments are disrupted and their
contents mixed. This implies that measurements of elastinolytic activity may under¬
estimate the amount of elastase present. The present study supports this suggestion as a
55 kDa band was identified in horse neutrophil extracts (Fig. IB) by the anti-ENE 2A
antibody which had no demonstrable proteolytic activity (Fig. 1C) suggesting an elastase:
inhibitor complex. The most likely candidate inhibitor in the horse neutrophil cytosol
available to form this complex is horse leukocyte elastase inhibitor (HLEI) which has a
MW of 35.2 kDa and is reported to be present at 0.5 pg/cell (Dubin, 1977; Dubin and Koj,
1986; Potempa et al.. 1988). This study has also confirmed the presence of API in equine
neutrophils at a low concentration (0.02 pg/cell) indicating that it may have a minor role
to play compared to HLEI. This is probably analogous to human neutrophils which
contain an abundant and probably major cytosolic inhibitor, SLPI, as well as lower levels
of API (duBois et al., 1991; Sallenave et al., 1997).
While the release of elastase from human neutrophils has been investigated there is no
similar data for the horse system. Previous studies have shown SOA generation and
human NE release from human neutrophils to be variably dependent on extracellular
divalent cations, the secrctagoguc type and concentration used (Khalfi et al., 1996). SOA
generation from human neutrophils is dependent on extracellular calcium when the
stimulus used is /V-formyl-methionyl-leucyl-phenylalanine (FMLP) but not when
stimulated by phorbol-myristate-acetate (PMA) or opsonised zymosan (Khalfi et al.,
1996). Elastase release from stimulated human neutrophils is more complicated. PMA
stimulation is independent of calcium when the extracellular concentration ranges from 0
to 1.0 mM, but dose dependent from 1.54.0 mM; greater concentrations of calcium
resulting in greater release of human NE (Khalfi et al., 1996). Conversely, FMLP induced
human NE release is dependent upon extracellular calcium from 0 to 1.5 mM yet less
affected at concentrations greater than 1.5 mM (Khalfi et al., 1996). In the current study
the addition of EGTA abolished ZAS stimulated superoxide anion generation suggesting
that this response is dependent on extracellular calcium and/or magnesium, typical of a
receptor mediated, secondary messenger signalling mechanism (Korchak et al., 1984;
Buhl et al., 1994) and similar to FMLP stimulated human neutrophils (Khalfi et al.,
1996). However, ZAS-stimulated ENE 2A release from equine neutrophils appears to be
only partially dependent upon extracellular calcium and/or magnesium. Immediately after
the addition of ZAS the ENE 2A concentration in the supernatant was the same whether
or not EGTA was present. This suggests a small degree of cation independence, utilisation
of stored intracellular cations, or a significant difference in the kinetics of ZAS
stimulation compared to chelation of cations by EGTA. This phenomenon requires
further study as human neutrophils have been shown not to require a cytosolic calcium
transient for dcgranulation or oxidative burst when stimulated by come receptor mediated
stimuli (IgG, Seetoo et al., 1997). Another aspect requiring further investigation is the
nature of the heat lesislaul components of ZAS as heat inactivation of ZAS did not
completely remove its ability to stimulate neutrophil degranulation or SOA generation
suggesting that there must be some stimulus present other than heat labile C5a.
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The relationship between total SOA generation and total ENE 2A release during the
initial 90 min post-ZAS stimulation (the duration of the oxidative burst) suggests that the
extra-cellular release of the two products are closely linked, however, the kinetics of
release are markedly different. Superoxide anions are generated and released in a
respiratory burst lasting about 90 min, whereas elastase release although initiated at the
start of the oxidative burst continues leading to a nearly linear increase in the extracellular
concentration for at least 150 min post-ZAS stimulation. These findings indicate that
while there may be a common signalling pathway initiating superoxide anion and elastase
release (Roos, 1991), the post-initiation mechanisms of release are clearly different.
Previous studies in other species have shown that superoxide anion generation by
NADPH oxidase can become refractory despite continued presence of the stimulus
(Rossi, 1986; Roos, 1991). However in these experiments elastase release does not appear
to become refractory and this is something which requires further investigation as in vivo
inflammatory stimuli may be present continuously for prolonged periods of time. In this
study, on average, less than 10% of the total elastase content of equine neutrophils was
released in the first 90 min post-stimulation. This suggests that either not all the ENE 2A
present can be released under these conditions or, that there is sustained release that
continues for some time after the respiratory burst.
In the healthy subject plasma derived API provides the main defence against elastase
mediated tissue damage. Human API and the equine API isoform Spil are oxidation
sensitive due to the presence of methionine residues at critical positions in the API
molecules (Johnson and Travis, 1979; Matheson et al., 1982; Padrines et al., 1989;
Patterson and Bell, 1989). One possibility that arises from the results of this study is that
the simultaneous release of elastase and generation of SOA may allow for synergistic
interaction. For example the early peak of superoxide anion release may act to down-
regulate serpin inhibition of elastase activity in the extracellular micro-environment of the
neutrophil by oxidising the sensitive API methionine residue. This would reduce the Kass
and Kt of the API/elastase interaction thereby reducing the effectiveness of inhibition
(Cohen, 1979; Nakajima et al., 1979; Beatty et al., 1980; Travis et al., 1980; Hubbard et
al., 1987; Potempa et al., 1991; Snider, 1992; Buhl et al., 1996). Potentially this
mechanism would allow relatively uncontrolled proteolysis by elastase in the neutrophil's
immediate environment resulting in tissue damage. This mechanism would be effective
because as more neutrophils were recruited and activated at an on-going site of
inflammation their oxidative bursts would act locally to overcome API inhibition. Recent
data (Dagleish, unpublished observations), has shown that stimulating neutrophils in
enriched media such as Iscove's modified Dulbecco's medium can increase the amount
and duration of SOA generation. This implies that a nutrient rich environment, for
example the extracellular tissue fluid present in vivo, may further enhance the respiratory
burst resulting in greater potential for API inactivation than has been shown in the current
in vitro studies.
The absence of panacinar emphysema in horses with COPD (Kaup et al., 1990),
despite a pulmonary neutrophilia (Freeman et al., 1993; Dixon et al., 1995), a comparable
NE content to human neutrophils and concurrent release of SOA and ENE 2A still needs
to be addressed. Alpha-!-proteinase inhibitor is believed to be the most important
protection against elastase activity at the alveolar level (Ohlsson, 1980; Hubbard et al.,
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1989). As well as the oxidation sensitive isoform (Spil) discussed above equine API also
occurs as several abundant oxidation resistant isoforms (Spi2, 3 and occasionally 4)
which are not found in humans (Patterson and Bell, 1989; Potempa et al., 1991). These
isoforms may be resistant to SOA inactivation and therefore in the horse fully active API
may always be present even in the presence of SOA generation whereas in human tissue
all API present is oxidation sensitive. Alternatively equine neutrophils, despite pulmonary
sequestration, may not be stimulated to degranulate fully in vivo, as is suggested by the
low levels of release seen in the current study, resulting in a reduced proteolytic burden in
equine pulmonary tissues.
5. Conclusion
This work shows that horse and human neutrophils have a similar elastase content to
that reported in humans and thus species differences in the elastase content of neutrophils
is not, as previously considered, responsible for observed differences in pulmonary
emphysema patterns in humans and horses in neutrophil associated pulmonary disease. In
addition ZAS stimulated equine neutrophils are wholly dependent on extracellular
calcium and/or magnesium for SOA generation and highly dependent on extracellular
cations for ENE 2A release. Further work is required to evaluate the release of ENE in
response to other stimuli in vitro and to more clearly characterise the mechanisms
involved. In addition the development of specific antibodies recognising equine API and
elastase will make it possible to examine their relative content in pulmonary epithelial
fluid lining and potential role in the pathogenesis of COPD.
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